data_2mao_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mao _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -55.11 -17.55 4.25 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.157 0.583 . . . . 0.0 112.21 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -66.0 -51.98 53.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.99 -0.444 . . . . 0.0 110.251 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.89 -25.58 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 122.396 0.278 . . . . 0.0 110.611 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.84 -28.74 64.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.154 -0.341 . . . . 0.0 110.703 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.1 t -82.17 -28.45 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 118.534 0.606 . . . . 0.0 109.876 176.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 39.8 mt-10 -70.9 -37.02 72.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.69 -0.631 . . . . 0.0 110.345 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -71.7 -36.42 70.54 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.44 -24.6 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.032 0 CA-C-N 118.338 0.517 . . . . 0.0 110.956 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -78.77 -18.26 54.45 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -83.16 -5.18 59.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.446 0.699 . . . . 0.0 111.898 174.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.52 0.14 34.75 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.614 -0.548 . . . . 0.0 113.351 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -88.77 84.29 6.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.232 1.016 . . . . 0.0 109.547 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -63.7 -20.61 65.86 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.711 0.405 . . . . 0.0 110.831 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -62.85 -23.23 67.19 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.095 0.558 . . . . 0.0 111.294 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.52 -18.7 44.14 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.378 -0.202 . . . . 0.0 110.674 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -77.1 -36.51 55.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -62.52 -41.11 98.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -75.19 -18.95 60.05 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.288 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.5 tp -83.54 -47.34 11.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 122.405 0.282 . . . . 0.0 111.238 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 m -67.61 -24.69 31.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.399 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.68 -26.97 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 119.133 0.878 . . . . 0.0 110.891 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -67.93 -32.17 72.45 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -101.49 -8.63 21.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -62.73 -27.6 69.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.342 0.519 . . . . 0.0 110.503 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -86.59 -30.56 21.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.339 -0.226 . . . . 0.0 110.512 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -76.83 -41.87 42.5 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -82.18 -25.5 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.074 0 CA-C-N 118.0 0.364 . . . . 0.0 110.997 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.18 -23.64 63.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.179 0.445 . . . . 0.0 110.193 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 t -76.19 -44.22 38.89 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -80.04 -24.94 40.39 Favored 'General case' 0 C--O 1.227 -0.093 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 p -86.76 -17.64 8.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 CA-C-N 118.104 0.411 . . . . 0.0 111.145 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.9 t -67.75 -9.18 41.68 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 122.046 -0.409 . . . . 0.0 110.197 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -88.42 -5.84 58.03 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.033 0.533 . . . . 0.0 111.713 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -122.18 -12.42 8.29 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.56 154.02 59.28 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.813 0.845 . . . . 0.0 109.1 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.18 163.69 35.13 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.363 2.708 . . . . 0.0 110.611 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.0 p -65.61 -10.63 37.42 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.82 -19.54 53.53 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.05 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -116.31 -3.41 11.95 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 117.718 0.759 . . . . 0.0 111.618 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.425 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 5.9 p -67.02 -32.85 5.19 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 117.615 -1.183 . . . . 0.0 113.381 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 95.6 Cg_endo -77.75 -25.17 8.04 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 122.093 1.783 . . . . 0.0 111.492 -177.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -79.73 -29.67 40.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.586 0.232 . . . . 0.0 110.449 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -80.57 -25.89 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -70.79 -36.23 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -72.02 -40.98 68.06 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.895 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -66.24 -29.73 70.03 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.98 -27.8 63.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 122.243 -0.286 . . . . 0.0 110.728 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -85.32 -31.4 23.04 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.278 0.49 . . . . 0.0 111.597 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.3 mt -71.29 -37.13 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -75.58 -32.61 60.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.948 0.499 . . . . 0.0 110.471 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.59 -45.17 69.23 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 119.456 -0.306 . . . . 0.0 110.336 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -60.51 -37.78 82.24 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.594 0.634 . . . . 0.0 111.609 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -72.31 -25.83 61.72 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.826 0.45 . . . . 0.0 111.148 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.22 -12.91 29.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.06 0.544 . . . . 0.0 111.576 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 tp -76.78 -25.84 53.81 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.143 0.577 . . . . 0.0 110.792 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.32 -14.92 63.34 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.307 0.243 . . . . 0.0 110.408 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.0 p -112.94 8.14 18.46 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.241 0.616 . . . . 0.0 111.789 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 t80 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-N 118.025 0.375 . . . . 0.0 110.639 177.364 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.3 t80 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -69.09 -36.41 77.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.658 0.663 . . . . 0.0 111.786 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -70.76 -33.76 71.12 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.59 0.632 . . . . 0.0 109.756 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 58.6 t90 -75.32 -27.98 59.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 122.752 0.421 . . . . 0.0 110.902 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.5 tp -85.81 -37.0 19.71 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.74 0.416 . . . . 0.0 111.312 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -61.63 -32.31 72.44 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.788 0.267 . . . . 0.0 110.344 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -75.56 -22.42 57.04 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.993 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.08 -36.79 75.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.775 0.716 . . . . 0.0 109.5 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.87 -38.74 57.6 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.0 p -78.24 -29.78 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 118.271 0.487 . . . . 0.0 110.801 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -75.28 -23.83 57.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.994 0.361 . . . . 0.0 110.159 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.8 m -79.17 -31.42 43.91 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.76 -29.83 62.44 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 117.56 0.164 . . . . 0.0 110.647 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -80.4 -28.6 37.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 119.444 -0.313 . . . . 0.0 110.999 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.171 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.58 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 CA--C 1.526 0.055 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -55.29 -17.33 4.48 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.454 0.701 . . . . 0.0 112.046 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -67.04 -51.58 52.97 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 122.016 -0.428 . . . . 0.0 110.3 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.59 -26.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 122.993 0.517 . . . . 0.0 110.73 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -69.05 -29.02 67.06 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.02 -0.425 . . . . 0.0 110.532 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.5 t -82.31 -28.78 9.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 118.565 0.621 . . . . 0.0 110.105 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.32 -35.48 68.62 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.571 -0.706 . . . . 0.0 110.433 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -69.97 -37.29 75.75 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.311 0.244 . . . . 0.0 111.347 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 m -73.44 -23.76 19.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 121.771 -0.581 . . . . 0.0 111.078 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -78.38 -16.25 57.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.273 0.229 . . . . 0.0 110.576 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -91.91 3.91 54.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.67 0.788 . . . . 0.0 111.764 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.15 1.64 51.32 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.977 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.88 83.98 4.09 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.851 0.826 . . . . 0.0 109.442 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -67.11 -18.09 65.16 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.982 0.513 . . . . 0.0 110.675 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -60.75 -25.38 66.45 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.582 0.353 . . . . 0.0 110.69 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.12 -18.81 45.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.54 0.155 . . . . 0.0 111.056 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -76.7 -36.77 57.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.57 -40.59 97.34 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.83 -19.04 59.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.272 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.9 tp -83.51 -47.11 11.69 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.428 0.291 . . . . 0.0 111.242 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.04 -24.9 30.87 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.541 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.8 p -70.71 -26.98 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.32 0.964 . . . . 0.0 110.879 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -67.95 -31.62 71.5 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.84 -8.7 21.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -62.03 -29.2 70.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.334 0.515 . . . . 0.0 110.665 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -86.47 -30.53 21.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.044 -0.071 . . . . 0.0 110.955 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.29 -42.27 55.19 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 m -80.94 -25.32 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-N 118.306 0.503 . . . . 0.0 110.98 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.79 -22.09 62.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.083 0.402 . . . . 0.0 110.195 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -77.2 -41.63 40.68 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.87 -24.9 30.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -88.71 -19.38 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 118.343 0.519 . . . . 0.0 111.717 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.2 t -68.34 -9.37 47.43 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -90.32 -4.35 57.17 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.7 0.8 . . . . 0.0 111.66 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -122.4 -13.0 8.13 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.686 0.394 . . . . 0.0 111.864 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 m -144.0 154.53 58.4 Favored Pre-proline 0 N--CA 1.462 0.152 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.71 164.46 31.24 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.269 2.646 . . . . 0.0 111.08 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.8 p -66.34 -10.17 40.44 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.29 -17.95 56.36 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.175 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -116.37 -6.4 11.77 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 117.423 0.611 . . . . 0.0 111.691 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.413 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 9.9 p -66.34 -33.52 6.82 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 117.587 -1.197 . . . . 0.0 113.428 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 95.5 Cg_endo -76.13 -25.25 10.34 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 CA-C-N 122.212 1.826 . . . . 0.0 111.4 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -81.96 -29.42 32.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.631 0.253 . . . . 0.0 110.381 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.5 t -78.4 -26.94 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.1 t -71.74 -34.95 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 118.419 0.554 . . . . 0.0 109.531 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -72.96 -43.07 62.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -67.73 -26.49 66.17 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.234 0.47 . . . . 0.0 110.156 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.78 -29.32 63.19 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.58 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -85.14 -28.72 25.35 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.575 0.625 . . . . 0.0 111.113 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.6 mt -73.03 -37.92 54.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -75.41 -32.28 60.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.789 0.436 . . . . 0.0 110.613 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.85 -44.51 76.97 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.104 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -60.87 -37.15 81.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.587 0.63 . . . . 0.0 111.621 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -72.87 -25.26 61.03 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.758 0.423 . . . . 0.0 111.047 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.18 -11.03 28.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.144 0.577 . . . . 0.0 111.278 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.96 -23.64 55.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.228 0.611 . . . . 0.0 110.201 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.25 -11.07 56.51 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.261 0.224 . . . . 0.0 110.552 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -110.91 3.18 18.64 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.639 0.776 . . . . 0.0 111.672 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.1 t80 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.506 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 73.7 t80 . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -69.41 -38.04 77.74 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.544 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.7 m -69.62 -37.96 77.05 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.8 t90 -69.05 -31.2 69.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.741 -0.208 . . . . 0.0 110.993 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.6 tp -83.22 -35.15 25.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.576 0.35 . . . . 0.0 111.313 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -63.01 -26.8 69.02 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.005 0.366 . . . . 0.0 110.209 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.64 -27.03 61.04 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 122.8 0.44 . . . . 0.0 111.318 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.2 mm -72.05 -36.25 56.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.94 -36.34 56.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -78.83 -28.87 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.475 0.579 . . . . 0.0 111.274 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.91 -25.28 52.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.152 0.433 . . . . 0.0 110.407 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.2 m -80.63 -28.14 37.03 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 122.448 -0.158 . . . . 0.0 110.597 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.16 -32.84 56.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.087 0.403 . . . . 0.0 111.205 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.45 -26.19 51.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t30 . . . . . 0 CA--C 1.533 0.291 0 C-N-CA 122.454 0.302 . . . . 0.0 110.327 174.601 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.1 m . . . . . 0 CA--C 1.528 0.114 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -55.28 -17.34 4.44 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.164 0.585 . . . . 0.0 112.385 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -66.23 -53.18 40.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.111 -0.368 . . . . 0.0 110.418 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -84.48 -26.13 7.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.779 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -69.69 -28.99 66.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.642 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.1 t -82.26 -28.22 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 118.839 0.745 . . . . 0.0 109.894 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.85 -37.63 70.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.641 -0.662 . . . . 0.0 110.368 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -69.57 -36.16 76.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 122.057 -0.402 . . . . 0.0 111.76 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -73.62 -23.78 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.038 0 CA-C-N 118.299 0.5 . . . . 0.0 111.205 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -79.69 -14.64 58.62 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.408 0.283 . . . . 0.0 110.335 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -93.18 3.2 56.08 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.632 0.773 . . . . 0.0 112.028 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.54 1.24 43.5 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 119.75 -0.472 . . . . 0.0 113.345 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -92.69 84.24 4.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.025 0.912 . . . . 0.0 109.558 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -65.09 -20.11 66.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.655 0.382 . . . . 0.0 110.659 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -61.72 -24.54 66.86 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.142 0.577 . . . . 0.0 111.007 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.36 -18.79 40.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 119.62 -0.228 . . . . 0.0 110.873 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -77.38 -36.83 53.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.51 -41.95 98.07 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.9 mt -76.53 -18.41 58.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.628 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 tp -81.97 -42.87 18.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.713 0.233 . . . . 0.0 110.659 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 m -69.83 -27.03 31.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.538 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -66.23 -26.86 39.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 CA-C-N 119.859 1.209 . . . . 0.0 111.129 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -69.44 -33.27 72.7 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.016 0.436 . . . . 0.0 109.919 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -100.27 -8.71 23.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.349 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -61.55 -30.08 70.42 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.234 0.613 . . . . 0.0 110.824 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -86.75 -29.5 22.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 121.994 0.118 . . . . 0.0 111.084 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -76.35 -41.22 49.0 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 m -82.79 -24.86 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 118.062 0.392 . . . . 0.0 111.064 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.15 -25.23 63.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -76.81 -46.27 25.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.834 0.35 . . . . 0.0 110.817 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.06 -24.62 59.53 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.595 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.8 -19.95 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 118.139 0.427 . . . . 0.0 112.146 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.3 m -66.6 -9.93 40.41 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.36 0.527 . . . . 0.0 112.245 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -95.11 -3.75 47.46 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.229 0.468 . . . . 0.0 111.671 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -111.03 -20.63 12.34 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.854 0.462 . . . . 0.0 110.997 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -141.83 152.63 62.93 Favored Pre-proline 0 C--N 1.34 0.176 0 C-N-CA 124.057 0.943 . . . . 0.0 109.541 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.54 167.43 24.17 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.716 2.944 . . . . 0.0 111.249 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.7 m -65.58 -11.77 47.09 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.054 0.542 . . . . 0.0 112.418 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.81 -18.86 53.6 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.609 -0.55 . . . . 0.0 112.795 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.47 -6.98 11.71 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 117.808 0.804 . . . . 0.0 112.035 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.415 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 7.6 p -66.25 -36.04 11.95 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 83.2 Cg_endo -73.68 -24.37 15.88 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 CA-C-N 121.697 1.642 . . . . 0.0 111.246 -172.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.5 -30.49 29.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.07 -30.2 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 122.556 0.342 . . . . 0.0 110.133 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -72.16 -33.53 47.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -72.5 -42.9 64.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -65.59 -30.71 71.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.418 0.554 . . . . 0.0 109.595 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.57 -29.3 66.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 117.746 0.248 . . . . 0.0 110.952 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -85.18 -28.92 25.14 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.299 0.5 . . . . 0.0 111.385 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 99.2 mt -72.93 -36.87 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -77.76 -31.07 51.82 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.445 0.698 . . . . 0.0 111.015 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.67 -42.47 74.13 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.121 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -62.05 -38.33 88.34 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.536 0.607 . . . . 0.0 111.485 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.23 -25.78 62.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.622 0.369 . . . . 0.0 111.166 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.34 -10.53 29.86 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.967 0.507 . . . . 0.0 111.395 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.5 tp -75.24 -24.53 57.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.972 0.509 . . . . 0.0 110.249 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.09 -10.25 52.47 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.454 0.302 . . . . 0.0 110.473 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.0 m -110.83 0.75 17.36 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.647 0.779 . . . . 0.0 111.662 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.5 t80 . . . . . 0 N--CA 1.454 -0.269 0 C-N-CA 123.103 0.561 . . . . 0.0 109.68 176.962 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 N--CA 1.455 -0.222 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -68.88 -37.15 78.86 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.737 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.0 m -69.41 -39.61 77.82 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -67.37 -32.96 74.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.95 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.3 tp -81.12 -34.11 32.77 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.726 0.41 . . . . 0.0 111.515 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.4 m-30 -64.0 -27.37 69.07 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.074 -0.391 . . . . 0.0 110.431 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -75.68 -25.04 56.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.165 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.5 mm -70.29 -39.25 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-N 118.296 0.498 . . . . 0.0 109.726 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.56 -37.06 57.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.06 -30.66 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-N 118.469 0.577 . . . . 0.0 111.43 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -76.07 -24.55 55.1 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.969 -0.457 . . . . 0.0 110.167 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.7 m -77.34 -29.37 53.4 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.08 62.5 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.877 0.308 . . . . 0.0 110.973 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.44 -29.7 57.08 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.6 t30 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-N 116.828 -0.169 . . . . 0.0 110.615 176.524 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -55.52 -17.67 5.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.154 0.582 . . . . 0.0 112.222 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.69 -52.81 40.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -85.94 -25.9 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 122.85 0.46 . . . . 0.0 110.882 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mp -69.44 -28.18 65.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.909 -0.494 . . . . 0.0 110.515 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.3 t -81.14 -28.54 10.9 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 CA-C-N 118.398 0.545 . . . . 0.0 109.839 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.458 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 38.8 mt-10 -72.45 -34.7 67.94 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.824 -0.547 . . . . 0.0 110.271 174.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -68.98 -39.79 79.2 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.688 0.395 . . . . 0.0 111.257 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 m -72.94 -24.16 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 117.698 0.226 . . . . 0.0 111.054 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -78.67 -20.5 50.07 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.887 0.312 . . . . 0.0 110.301 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -81.42 -5.22 57.68 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.328 0.651 . . . . 0.0 111.799 174.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.88 0.38 34.05 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.487 -0.618 . . . . 0.0 112.79 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -87.68 83.96 7.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.008 0.904 . . . . 0.0 109.471 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -66.39 -20.6 66.11 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.683 0.393 . . . . 0.0 110.6 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -60.77 -24.92 66.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.998 0.519 . . . . 0.0 110.834 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.26 -18.77 41.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 119.583 -0.246 . . . . 0.0 111.07 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -76.51 -36.85 57.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -62.49 -40.76 97.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.74 -18.76 59.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.521 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.0 tp -83.7 -47.81 10.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.39 0.276 . . . . 0.0 110.885 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.89 -25.08 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.383 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.3 p -70.37 -26.63 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 119.329 0.968 . . . . 0.0 110.681 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -68.65 -33.13 73.47 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -99.66 -8.91 23.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.352 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -62.62 -27.2 69.04 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.4 0.545 . . . . 0.0 110.609 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -86.12 -30.82 22.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -76.9 -42.23 40.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.3 m -81.59 -25.36 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 118.158 0.435 . . . . 0.0 110.911 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.86 -22.89 62.25 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.177 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.0 t -76.53 -43.38 39.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.3 -25.22 36.66 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 p -87.35 -18.45 8.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.089 0 CA-C-N 118.094 0.406 . . . . 0.0 111.226 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.2 t -68.21 -9.51 47.62 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 174.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -90.86 -3.87 57.03 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.659 0.784 . . . . 0.0 111.484 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.35 -14.45 8.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.75 0.42 . . . . 0.0 111.807 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.41 153.46 59.08 Favored Pre-proline 0 N--CA 1.462 0.148 0 C-N-CA 123.953 0.901 . . . . 0.0 109.466 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.72 164.5 31.07 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.559 2.839 . . . . 0.0 110.756 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.3 p -66.61 -10.11 42.41 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.06 -18.33 56.07 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 118.262 0.483 . . . . 0.0 112.093 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.36 -5.09 11.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.427 0.613 . . . . 0.0 111.451 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.425 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 5.2 p -67.3 -33.08 5.21 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 117.707 -1.139 . . . . 0.0 113.368 -177.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 97.0 Cg_endo -76.84 -25.25 9.28 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 CA-C-N 122.12 1.793 . . . . 0.0 111.687 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.4 -29.79 30.59 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -78.06 -25.84 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.97 -37.07 59.71 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -71.31 -42.85 68.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -67.83 -26.45 66.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.233 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.41 -27.9 61.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.668 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -85.26 -29.67 24.43 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.531 0.605 . . . . 0.0 111.069 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.99 -37.46 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 175.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -75.58 -32.93 60.54 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.197 0.599 . . . . 0.0 110.538 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.72 -42.75 77.21 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 119.141 -0.456 . . . . 0.0 110.733 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -62.49 -37.62 86.68 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.906 0.776 . . . . 0.0 111.255 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -71.53 -25.12 62.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.679 0.392 . . . . 0.0 111.014 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.98 -11.77 27.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.132 0.573 . . . . 0.0 111.508 176.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -74.72 -24.53 58.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 110.264 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.56 -10.79 58.0 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.276 0.23 . . . . 0.0 110.506 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -109.43 1.92 20.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.649 0.78 . . . . 0.0 111.722 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.5 t80 . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 123.092 0.557 . . . . 0.0 109.732 177.534 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.6 t80 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -69.03 -37.64 78.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.67 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -69.65 -37.25 76.67 Favored 'General case' 0 C--O 1.227 -0.095 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -70.22 -32.18 69.93 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 122.246 0.218 . . . . 0.0 110.953 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.9 tp -81.89 -34.78 29.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.644 0.378 . . . . 0.0 111.319 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -63.63 -28.0 69.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -72.82 -26.04 61.35 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 122.817 0.447 . . . . 0.0 111.527 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mm -72.84 -38.38 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.159 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.85 -35.44 59.94 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 p -77.41 -31.87 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 118.344 0.52 . . . . 0.0 111.245 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -77.87 -23.96 48.67 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.038 0.381 . . . . 0.0 110.649 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.6 m -77.3 -30.45 54.17 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.44 -32.41 62.62 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.726 0.239 . . . . 0.0 111.415 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.53 -30.89 61.94 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.9 t30 . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 176.917 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -54.94 -18.87 5.55 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.103 0.561 . . . . 0.0 112.284 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -65.79 -52.28 52.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 p -85.68 -25.6 6.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 122.795 0.438 . . . . 0.0 110.923 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 mp -71.67 -28.34 63.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.783 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.4 t -81.86 -28.97 9.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 118.442 0.565 . . . . 0.0 110.055 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.92 -37.15 72.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.719 -0.613 . . . . 0.0 110.206 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -69.82 -37.88 76.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.494 0.318 . . . . 0.0 111.532 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.21 -23.98 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 O-C-N 121.901 -0.499 . . . . 0.0 110.907 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -80.44 -14.62 58.14 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.21 -0.306 . . . . 0.0 110.398 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -93.13 3.65 55.34 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.623 0.769 . . . . 0.0 111.709 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.47 2.79 47.34 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.168 172.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -95.92 84.02 3.79 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.04 0.92 . . . . 0.0 110.086 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -65.58 -20.34 66.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.276 0.63 . . . . 0.0 110.966 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -61.02 -23.81 65.7 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 122.883 0.473 . . . . 0.0 110.871 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.87 -19.03 41.78 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.583 -0.246 . . . . 0.0 110.835 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -76.57 -37.23 56.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.5 -41.86 97.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -76.62 -18.49 58.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.451 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.2 tp -81.0 -43.04 20.22 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.253 -0.279 . . . . 0.0 110.805 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.07 -27.1 31.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.459 -175.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -65.72 -27.3 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 119.97 1.259 . . . . 0.0 111.216 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -70.56 -32.29 69.64 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.121 0.419 . . . . 0.0 109.954 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -100.02 -8.65 23.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.381 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -62.69 -27.97 69.61 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.421 0.689 . . . . 0.0 110.446 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -86.31 -29.67 22.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.475 -0.141 . . . . 0.0 110.859 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -76.67 -43.04 39.51 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -80.92 -25.89 10.84 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 O-C-N 121.928 -0.483 . . . . 0.0 111.145 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.55 -22.16 61.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.049 0.386 . . . . 0.0 110.104 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 t -76.51 -41.62 46.27 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.123 0.169 . . . . 0.0 110.58 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.96 -25.29 30.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 p -88.25 -18.95 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.036 0 CA-C-N 118.165 0.439 . . . . 0.0 111.55 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.5 t -68.61 -8.88 45.98 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 173.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -90.91 -3.87 56.99 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.033 0.933 . . . . 0.0 111.289 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -121.37 -17.5 7.59 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.831 0.452 . . . . 0.0 111.458 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.4 m -141.09 153.19 66.69 Favored Pre-proline 0 N--CA 1.463 0.176 0 C-N-CA 123.406 0.682 . . . . 0.0 109.441 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.82 165.62 29.12 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.718 2.946 . . . . 0.0 111.17 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.7 m -64.87 -11.02 32.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.09 -18.09 56.47 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.272 0.487 . . . . 0.0 112.07 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -116.64 -6.11 11.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.223 0.511 . . . . 0.0 111.642 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.423 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 6.0 p -67.66 -33.18 5.03 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.592 -1.195 . . . . 0.0 113.462 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 98.2 Cg_endo -76.51 -25.5 9.53 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 CA-C-N 122.23 1.832 . . . . 0.0 111.511 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.43 -30.39 30.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.415 -0.178 . . . . 0.0 110.593 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -77.15 -27.02 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.3 t -72.27 -35.44 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -72.05 -42.61 66.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.03 -28.04 67.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.24 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.99 -28.4 63.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.458 -0.305 . . . . 0.0 110.793 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -85.08 -29.97 24.44 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.576 0.625 . . . . 0.0 111.216 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 99.0 mt -72.05 -37.23 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -76.64 -32.37 57.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.118 0.567 . . . . 0.0 110.98 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.71 75.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.32 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -61.58 -38.7 88.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.383 0.538 . . . . 0.0 111.419 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -71.53 -26.12 62.52 Favored 'General case' 0 C--O 1.228 -0.05 0 C-N-CA 122.779 0.431 . . . . 0.0 111.175 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.8 -11.29 31.6 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.063 0.545 . . . . 0.0 111.462 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.1 tp -75.74 -25.81 56.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.689 0.396 . . . . 0.0 110.45 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.86 -10.7 59.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.511 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.6 m -113.37 0.08 14.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.796 0.838 . . . . 0.0 111.213 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.4 t80 . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.367 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 59.2 t80 . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -68.59 -35.74 77.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.97 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.8 m -70.86 -37.84 73.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -70.47 -32.21 69.66 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.249 0.22 . . . . 0.0 111.016 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.8 tp -81.33 -34.77 31.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.602 0.361 . . . . 0.0 111.516 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.2 m-30 -63.52 -28.4 69.92 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 122.086 -0.383 . . . . 0.0 110.109 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -74.01 -25.08 59.69 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.552 0.341 . . . . 0.0 111.363 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.67 -38.24 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.02 -36.26 59.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -174.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.2 p -78.21 -31.23 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-N 118.329 0.513 . . . . 0.0 111.471 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.86 -24.02 52.65 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.137 0.426 . . . . 0.0 110.091 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.5 m -78.73 -29.64 45.43 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.77 -32.97 66.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.876 0.307 . . . . 0.0 110.906 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.24 -30.13 57.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.347 -0.22 . . . . 0.0 110.477 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.5 t30 . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.674 0.274 . . . . 0.0 110.513 177.251 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.4 m . . . . . 0 C--O 1.232 0.165 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -55.6 -17.1 4.87 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 123.384 0.673 . . . . 0.0 112.182 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.0 tp60 -66.36 -52.76 43.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 121.825 -0.547 . . . . 0.0 110.159 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 p -85.02 -25.79 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 C-N-CA 122.626 0.37 . . . . 0.0 110.9 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.96 -28.54 64.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.079 -0.388 . . . . 0.0 110.841 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.2 t -82.44 -29.18 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 CA-C-N 118.683 0.674 . . . . 0.0 109.771 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.6 -40.92 76.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.514 -0.741 . . . . 0.0 109.971 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -68.39 -36.9 79.83 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.051 0.54 . . . . 0.0 112.204 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -70.47 -22.56 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.051 0 O-C-N 121.489 -0.757 . . . . 0.0 110.43 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -81.03 -14.56 57.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 119.592 -0.242 . . . . 0.0 110.67 174.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -80.41 -6.4 58.0 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.156 0.435 . . . . 0.0 110.759 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.61 4.02 52.57 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.6 0.619 . . . . 0.0 112.187 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -89.6 84.06 6.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.802 0.801 . . . . 0.0 109.487 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -65.68 -19.27 65.84 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.73 0.412 . . . . 0.0 110.774 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -60.32 -24.99 65.44 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 122.753 0.421 . . . . 0.0 110.977 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.57 -18.59 40.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.595 -0.24 . . . . 0.0 110.9 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -77.66 -37.38 50.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -61.32 -41.22 96.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.8 mt -76.94 -18.32 58.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.6 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.1 tp -82.13 -41.9 19.83 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.995 -0.441 . . . . 0.0 110.637 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.8 -26.76 28.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.587 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.4 m -66.58 -27.21 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.933 1.242 . . . . 0.0 111.253 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -70.84 -31.85 68.69 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -100.27 -8.73 23.13 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.376 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -62.95 -28.15 69.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.195 0.598 . . . . 0.0 110.514 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -86.61 -29.42 22.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.448 0.165 . . . . 0.0 110.749 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -77.39 -42.39 36.51 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -80.82 -26.69 11.04 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 118.127 0.421 . . . . 0.0 110.988 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.59 -22.53 62.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 t -77.78 -41.99 35.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.413 0.149 . . . . 0.0 110.668 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.6 -24.97 36.11 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.4 -18.8 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.18 0.446 . . . . 0.0 111.407 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -67.28 -11.09 56.62 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.986 -0.446 . . . . 0.0 110.043 173.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -86.7 -6.46 58.84 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.594 0.758 . . . . 0.0 111.535 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -122.66 -13.09 8.01 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -143.32 153.07 58.93 Favored Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 123.642 0.777 . . . . 0.0 109.211 173.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.08 164.0 33.72 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.66 2.907 . . . . 0.0 110.997 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.0 m -64.84 -10.64 29.78 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.06 -19.17 54.24 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 118.147 0.43 . . . . 0.0 112.166 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.18 -4.92 11.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.501 0.651 . . . . 0.0 111.619 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.423 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 5.3 p -67.43 -32.76 4.79 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.4 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 96.7 Cg_endo -76.78 -24.87 9.73 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 CA-C-N 122.095 1.784 . . . . 0.0 111.79 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.76 -30.8 32.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.289 -0.257 . . . . 0.0 110.528 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.1 t -77.98 -25.49 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.8 t -73.25 -35.42 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.38 -42.22 68.69 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -66.03 -30.84 71.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.78 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.1 -28.39 65.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.477 -0.296 . . . . 0.0 110.932 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -85.38 -28.73 24.97 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.519 0.6 . . . . 0.0 111.386 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.3 mt -72.7 -37.69 56.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -76.91 -32.81 57.66 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.105 0.562 . . . . 0.0 110.92 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.49 -42.16 79.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.279 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -61.82 -39.29 91.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.601 0.637 . . . . 0.0 111.542 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -70.82 -25.12 62.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.73 0.412 . . . . 0.0 111.289 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.22 -11.93 27.18 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.23 0.612 . . . . 0.0 111.419 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.0 tp -74.94 -24.82 58.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.005 0.522 . . . . 0.0 110.444 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.85 -10.75 51.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.271 0.228 . . . . 0.0 110.676 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.3 m -110.93 2.27 18.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.535 0.734 . . . . 0.0 111.7 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 t80 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.655 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.6 t80 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -69.56 -36.67 76.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.479 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.2 m -70.4 -34.23 72.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 62.0 t90 -76.21 -26.83 56.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 122.908 0.483 . . . . 0.0 111.325 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.8 tp -86.25 -35.19 20.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.22 -0.3 . . . . 0.0 111.289 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -63.91 -30.63 71.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -74.49 -22.17 59.21 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 117.999 0.363 . . . . 0.0 111.817 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.4 mm -70.26 -37.61 71.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.716 0.689 . . . . 0.0 109.504 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.97 -37.38 55.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 p -78.91 -29.35 14.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 CA-C-N 118.45 0.568 . . . . 0.0 111.336 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -76.13 -24.82 54.92 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.884 -0.51 . . . . 0.0 109.975 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.8 m -80.1 -30.74 39.21 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 122.206 -0.309 . . . . 0.0 110.246 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.56 -34.63 65.24 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.13 0.423 . . . . 0.0 111.016 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.44 -27.77 52.27 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.5 t30 . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 176.648 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.23 0.075 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -55.18 -17.38 4.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.498 0.719 . . . . 0.0 112.11 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.44 -53.25 37.62 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.101 -0.375 . . . . 0.0 110.144 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 p -85.08 -26.14 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.965 0.506 . . . . 0.0 110.781 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.78 -28.66 64.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.758 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.7 t -82.22 -28.78 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 118.791 0.723 . . . . 0.0 110.013 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.93 -37.65 72.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.584 -0.697 . . . . 0.0 110.401 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -71.64 -35.4 70.38 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.133 -0.354 . . . . 0.0 111.952 -175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -73.24 -23.88 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.174 0.443 . . . . 0.0 111.036 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -80.13 -14.96 58.07 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -92.39 3.32 55.68 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.47 0.708 . . . . 0.0 111.922 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.06 0.11 41.42 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.583 -0.565 . . . . 0.0 113.471 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -93.95 84.15 4.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.164 0.982 . . . . 0.0 109.294 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.2 tm0? -65.66 -19.91 66.09 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.82 0.448 . . . . 0.0 110.438 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -62.57 -22.44 66.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.102 0.561 . . . . 0.0 111.119 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.66 -18.78 43.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.842 0.292 . . . . 0.0 110.494 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -76.88 -36.11 56.97 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -61.98 -40.39 95.43 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.96 -19.07 59.04 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.292 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 tp -83.67 -48.08 10.55 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 119.634 -0.222 . . . . 0.0 111.126 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -66.72 -25.04 33.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.616 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.28 -26.74 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 119.399 1.0 . . . . 0.0 111.083 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -68.72 -31.68 70.93 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -101.52 -9.01 21.4 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -62.08 -28.38 69.57 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.389 0.54 . . . . 0.0 110.332 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -86.69 -31.39 21.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.716 -0.105 . . . . 0.0 110.716 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -75.74 -42.17 51.26 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -80.84 -25.22 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 O-C-N 121.739 -0.601 . . . . 0.0 110.873 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.39 -23.43 63.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.115 0.416 . . . . 0.0 110.149 176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -76.27 -44.47 37.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 pp -79.05 -25.21 43.2 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 p -88.51 -17.95 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 118.108 0.413 . . . . 0.0 111.626 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.7 t -67.17 -9.36 39.17 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.941 -0.474 . . . . 0.0 110.009 173.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -86.71 -7.65 58.11 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.346 0.659 . . . . 0.0 111.501 176.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -120.9 -13.8 8.58 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 m -144.42 154.23 56.54 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 124.152 0.981 . . . . 0.0 109.182 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.62 164.45 33.0 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.368 2.712 . . . . 0.0 110.881 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -66.51 -9.96 39.96 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.11 -19.14 54.21 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.05 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -116.35 -5.2 11.79 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.554 0.677 . . . . 0.0 111.621 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.427 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 5.0 p -66.39 -32.69 5.63 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.67 -1.157 . . . . 0.0 113.703 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 91.4 Cg_endo -76.75 -25.46 9.2 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 CA-C-N 121.989 1.746 . . . . 0.0 111.458 -176.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.06 -30.39 31.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.132 -0.355 . . . . 0.0 110.57 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.2 t -75.53 -27.21 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.92 -35.74 55.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -71.85 -43.17 65.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -67.28 -27.91 67.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.089 0.404 . . . . 0.0 110.18 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.62 -27.17 61.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.7 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -84.58 -31.32 24.39 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.538 0.608 . . . . 0.0 110.918 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.9 mt -70.08 -36.94 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -78.03 -33.75 50.9 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.443 0.297 . . . . 0.0 110.921 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.29 -39.85 89.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.585 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -64.94 -36.77 85.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.521 0.601 . . . . 0.0 111.07 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -71.58 -17.74 62.27 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.943 0.497 . . . . 0.0 110.78 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.28 -10.8 17.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.137 0.575 . . . . 0.0 111.439 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.1 tp -76.06 -23.95 55.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.279 0.631 . . . . 0.0 110.155 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.62 -9.12 47.82 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.663 0.385 . . . . 0.0 110.463 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.1 m -113.17 4.8 16.72 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.114 0.966 . . . . 0.0 111.528 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.3 t80 . . . . . 0 C--O 1.233 0.186 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.232 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.0 t80 . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -69.76 -36.51 75.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.705 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.3 m -70.78 -34.31 71.66 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -74.23 -28.84 61.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.061 0.544 . . . . 0.0 110.947 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.7 tp -86.24 -35.36 20.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.558 0.343 . . . . 0.0 111.387 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -62.74 -33.62 75.51 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -74.86 -21.86 59.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.678 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.8 mm -68.71 -39.91 80.89 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 118.836 0.744 . . . . 0.0 109.231 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.04 -34.47 64.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.65 -30.92 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.082 0 CA-C-N 118.713 0.688 . . . . 0.0 111.05 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -78.51 -19.02 53.89 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.979 -0.451 . . . . 0.0 110.522 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 81.4 m -78.64 -31.45 46.89 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.66 -35.55 62.81 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.743 0.247 . . . . 0.0 111.188 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -77.67 -24.03 49.45 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.9 t30 . . . . . 0 CA--C 1.532 0.272 0 O-C-N 122.361 -0.212 . . . . 0.0 111.111 175.473 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.461 0.124 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -55.29 -17.13 4.13 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.988 0.515 . . . . 0.0 112.165 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -66.96 -51.2 58.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.111 -0.368 . . . . 0.0 110.226 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.57 -26.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 122.772 0.429 . . . . 0.0 110.818 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.64 -29.16 67.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.252 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.66 -28.66 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 118.611 0.641 . . . . 0.0 110.154 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.94 -35.07 69.5 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.598 -0.689 . . . . 0.0 110.269 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -70.6 -37.37 73.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.451 0.3 . . . . 0.0 111.647 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -73.09 -23.69 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 118.139 0.427 . . . . 0.0 111.291 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -79.64 -16.42 55.81 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.362 0.265 . . . . 0.0 110.608 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -91.72 3.36 55.27 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.939 0.896 . . . . 0.0 111.88 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.25 3.11 48.03 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.782 -0.454 . . . . 0.0 113.28 173.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -97.99 83.64 3.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 117.923 0.862 . . . . 0.0 109.526 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 tm0? -67.01 -17.73 65.05 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.158 0.583 . . . . 0.0 110.62 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -60.67 -24.6 65.72 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.85 0.46 . . . . 0.0 110.927 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.0 -18.92 41.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 119.639 -0.22 . . . . 0.0 110.892 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -76.76 -37.22 56.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.26 -39.85 94.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.823 0.344 . . . . 0.0 110.282 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.4 -18.95 58.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.808 0.443 . . . . 0.0 111.335 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -83.48 -47.09 11.74 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.775 0.43 . . . . 0.0 111.008 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -69.5 -24.44 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.881 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.47 -26.27 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 119.231 0.923 . . . . 0.0 110.62 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -67.78 -33.93 75.8 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -97.7 -8.93 27.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.41 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -63.58 -29.49 70.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.357 -0.839 . . . . 0.0 110.479 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -86.81 -32.04 20.53 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -83.87 -32.16 25.35 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.32 -38.41 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.24 -25.78 68.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.919 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.3 t -72.9 -48.04 40.63 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.007 0.367 . . . . 0.0 110.942 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 pp -79.34 -27.17 42.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.553 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 p -84.93 -15.35 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 117.715 0.234 . . . . 0.0 111.463 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.4 t -68.34 -11.86 60.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.977 -0.452 . . . . 0.0 109.973 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -84.8 -6.76 59.36 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.963 0.505 . . . . 0.0 111.686 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -122.31 -12.52 8.23 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 m -146.31 153.96 48.95 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 123.509 0.723 . . . . 0.0 109.118 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.19 162.76 36.99 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.469 2.779 . . . . 0.0 111.07 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.3 p -65.08 -10.14 27.95 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.18 -19.04 54.46 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.194 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -116.15 -5.03 11.9 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.591 0.696 . . . . 0.0 111.224 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.419 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 6.3 p -66.85 -32.3 4.83 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -176.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 85.0 Cg_endo -78.17 -22.81 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 CA-C-N 121.789 1.674 . . . . 0.0 111.162 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -81.56 -28.82 33.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.526 0.203 . . . . 0.0 110.499 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.97 -27.79 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.58 -37.06 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -70.18 -42.91 71.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.3 -27.25 65.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.23 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -35.45 70.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -74.98 -33.7 61.9 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 118.256 0.48 . . . . 0.0 111.788 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.3 mt -70.23 -38.73 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -74.38 -31.95 62.55 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.144 0.578 . . . . 0.0 110.462 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.32 -44.85 70.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.249 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -61.36 -37.14 82.29 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.913 0.779 . . . . 0.0 111.329 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -71.65 -25.88 62.32 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 122.663 0.385 . . . . 0.0 110.989 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.23 -11.18 28.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.145 0.578 . . . . 0.0 111.393 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.9 tp -75.36 -24.45 57.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.243 0.617 . . . . 0.0 110.277 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.99 -10.77 53.12 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 173.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.7 m -108.22 3.76 24.0 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.668 0.787 . . . . 0.0 111.856 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.2 t80 . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 123.11 0.564 . . . . 0.0 109.994 178.754 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 64.7 t80 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -69.72 -34.89 74.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.037 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 88.5 m -76.03 -32.66 59.45 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 57.3 t90 -72.92 -28.0 62.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.56 0.344 . . . . 0.0 110.66 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.5 tp -85.87 -37.45 19.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.394 0.277 . . . . 0.0 111.167 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -69.33 -20.6 63.87 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.942 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -77.94 -21.89 50.38 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.445 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.9 mm -71.63 -37.42 63.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.82 -39.64 66.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.56 -29.01 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 118.181 0.446 . . . . 0.0 111.07 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -76.46 -23.62 53.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.172 -0.33 . . . . 0.0 110.479 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.5 m -80.16 -29.12 38.73 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.27 -33.14 61.22 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.322 -0.236 . . . . 0.0 111.22 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -75.98 -28.58 57.92 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.3 t30 . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 174.6 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -55.27 -17.21 4.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.087 0.555 . . . . 0.0 112.261 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -65.21 -53.52 43.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.725 0.298 . . . . 0.0 110.203 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 p -85.5 -26.23 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 123.038 0.535 . . . . 0.0 111.006 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.02 -28.83 64.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 122.065 -0.397 . . . . 0.0 110.957 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.7 t -82.58 -28.19 8.63 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 CA-C-N 118.562 0.619 . . . . 0.0 110.153 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.428 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 42.9 mt-10 -71.37 -35.74 71.2 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.561 -0.712 . . . . 0.0 110.36 175.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -71.22 -38.78 71.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.654 0.382 . . . . 0.0 111.637 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.05 -24.22 22.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 O-C-N 121.92 -0.488 . . . . 0.0 110.81 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -78.39 -18.78 54.56 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -79.12 -5.84 55.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.336 0.654 . . . . 0.0 111.21 172.135 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.95 2.54 48.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 123.235 0.445 . . . . 0.0 112.61 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.88 83.99 7.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 117.915 0.858 . . . . 0.0 109.505 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -64.98 -19.87 66.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.911 0.484 . . . . 0.0 110.714 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -60.27 -25.05 65.41 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.865 0.466 . . . . 0.0 111.096 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.89 -18.93 38.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.285 -0.259 . . . . 0.0 111.078 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -77.17 -36.93 54.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.74 -42.14 96.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.4 mt -76.2 -18.32 59.12 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.9 tp -82.27 -41.6 19.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.906 0.321 . . . . 0.0 111.009 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.2 m -72.26 -24.7 22.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.739 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.26 -26.87 37.23 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-N 119.915 1.234 . . . . 0.0 110.884 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -69.91 -31.7 69.61 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -99.49 -8.76 24.21 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.328 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -62.98 -29.7 71.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.186 -0.946 . . . . 0.0 110.853 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -86.87 -32.09 20.42 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.379 0.14 . . . . 0.0 111.379 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -81.06 -33.69 33.26 Favored 'General case' 0 CA--C 1.527 0.082 0 O-C-N 122.037 -0.414 . . . . 0.0 111.995 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -74.88 -37.18 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.513 0.725 . . . . 0.0 109.415 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.47 -27.22 69.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.531 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -73.67 -49.41 26.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.945 0.339 . . . . 0.0 111.191 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.23 -25.02 57.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.151 -0.343 . . . . 0.0 111.211 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.415 ' CG1' HG23 ' A' ' 46' ' ' VAL . 1.4 p -86.76 -16.86 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.2 m -66.41 -12.4 56.82 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.807 -0.558 . . . . 0.0 111.669 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -92.87 -3.68 54.2 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.673 0.67 . . . . 0.0 111.941 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -113.11 -19.52 11.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.714 0.406 . . . . 0.0 111.419 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 m -142.65 152.87 60.8 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 123.472 0.709 . . . . 0.0 109.485 173.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.15 168.82 20.95 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.614 2.876 . . . . 0.0 111.446 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.9 m -65.14 -11.65 42.49 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.106 0.562 . . . . 0.0 112.404 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.8 -19.31 51.99 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.832 -0.427 . . . . 0.0 112.986 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -116.22 -5.64 11.85 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.601 0.701 . . . . 0.0 112.122 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.425 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 4.0 p -64.7 -34.73 11.34 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 87.5 Cg_endo -73.9 -25.52 14.2 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 CA-C-N 121.738 1.656 . . . . 0.0 111.33 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.03 -27.68 28.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 122.449 -0.157 . . . . 0.0 110.735 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.4 t -80.45 -29.98 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.0 t -69.25 -35.96 70.33 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.84 -44.03 70.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -67.44 -30.3 69.99 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.834 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.34 -34.84 76.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -75.96 -34.41 59.83 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.105 0.412 . . . . 0.0 111.764 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.5 mt -71.01 -36.35 63.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -77.1 -33.29 56.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.248 0.619 . . . . 0.0 110.333 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.54 82.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 119.323 -0.37 . . . . 0.0 110.16 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -63.34 -37.71 88.33 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.66 0.664 . . . . 0.0 111.262 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -70.57 -20.07 62.82 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 122.862 0.465 . . . . 0.0 111.358 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 -10.43 18.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.01 0.524 . . . . 0.0 111.106 177.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.07 -24.06 58.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.282 0.633 . . . . 0.0 110.159 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.06 -9.8 43.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.4 m -111.8 1.43 16.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.76 0.824 . . . . 0.0 111.454 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 86.3 t80 . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.511 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.4 t80 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 119.577 -0.249 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -69.96 -37.61 75.85 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.379 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.1 m -70.39 -37.84 74.58 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -68.77 -33.43 73.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.87 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.8 tp -79.09 -35.91 41.59 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.178 0.191 . . . . 0.0 111.198 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -69.43 -20.28 63.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.215 -0.303 . . . . 0.0 111.593 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -74.0 -26.44 60.44 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.4 mm -73.76 -36.1 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.08 -36.91 64.32 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 p -81.35 -28.74 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 118.119 0.418 . . . . 0.0 110.93 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -76.7 -25.41 53.57 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 117.817 0.28 . . . . 0.0 110.359 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.3 m -79.21 -29.73 42.98 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.92 -33.5 63.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.259 -0.276 . . . . 0.0 111.369 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -76.39 -31.07 57.76 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.1 t30 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 175.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 CA--C 1.524 -0.025 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -55.29 -18.04 5.64 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.257 0.623 . . . . 0.0 112.437 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -65.85 -52.45 50.22 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.82 -0.55 . . . . 0.0 110.041 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -85.22 -26.03 6.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 C-N-CA 122.704 0.402 . . . . 0.0 111.022 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.73 -27.99 64.38 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.887 -0.508 . . . . 0.0 110.803 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.0 t -81.84 -28.63 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.04 0 CA-C-N 118.833 0.742 . . . . 0.0 110.077 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.72 -36.66 70.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.707 -0.62 . . . . 0.0 110.461 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -71.15 -35.89 71.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -72.71 -25.05 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 118.098 0.408 . . . . 0.0 110.945 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -79.49 -14.81 58.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.172 0.189 . . . . 0.0 110.521 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -92.74 3.23 56.01 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.908 0.883 . . . . 0.0 112.143 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.81 -0.49 39.07 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.558 172.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -93.47 84.06 4.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.107 0.953 . . . . 0.0 109.633 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -66.33 -19.98 65.96 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.52 0.328 . . . . 0.0 110.467 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -62.26 -23.08 66.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.218 0.607 . . . . 0.0 111.137 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.83 -18.92 42.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 117.786 0.266 . . . . 0.0 110.533 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -77.46 -36.63 52.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -61.45 -41.18 96.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -76.92 -18.54 58.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.593 0.357 . . . . 0.0 111.507 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.8 tp -81.41 -42.71 20.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 122.328 -0.232 . . . . 0.0 110.593 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.4 m -71.77 -24.39 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.863 -176.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.6 -26.45 35.45 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 119.944 1.247 . . . . 0.0 111.012 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -69.9 -31.73 69.68 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -99.03 -8.85 24.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.343 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -63.07 -30.06 71.3 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.254 -0.904 . . . . 0.0 110.786 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -86.92 -31.73 20.54 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -81.27 -35.43 31.14 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.138 -0.351 . . . . 0.0 111.808 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.1 t -72.39 -38.57 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.493 0.717 . . . . 0.0 109.175 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.49 -24.48 67.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.195 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.2 t -73.97 -45.7 48.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.297 -0.252 . . . . 0.0 111.088 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 pp -81.61 -28.29 33.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.726 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -83.78 -15.88 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 117.954 0.343 . . . . 0.0 111.552 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -68.89 -11.61 60.75 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.922 -0.486 . . . . 0.0 109.802 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -86.01 -4.72 59.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.245 0.618 . . . . 0.0 111.409 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.84 -16.12 7.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.008 0.523 . . . . 0.0 112.295 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.76 154.51 62.65 Favored Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 123.671 0.789 . . . . 0.0 109.517 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.72 164.01 32.98 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.671 2.914 . . . . 0.0 111.013 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.0 p -66.05 -10.33 39.04 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.56 -19.13 55.46 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.629 -0.54 . . . . 0.0 111.987 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.45 -5.08 11.74 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.68 0.74 . . . . 0.0 111.53 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.43 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 5.5 p -67.08 -32.8 5.1 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 75.3 Cg_endo -78.18 -22.8 9.52 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.699 1.643 . . . . 0.0 111.384 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.48 -28.65 31.06 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.308 -0.245 . . . . 0.0 110.492 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.9 t -77.94 -28.68 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.02 -36.85 75.87 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -71.27 -43.4 67.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.47 -27.59 66.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.142 0.428 . . . . 0.0 110.266 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.4 69.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -72.22 -35.37 68.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.491 0.587 . . . . 0.0 111.493 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.0 -40.99 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -76.7 -28.85 56.03 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.552 0.341 . . . . 0.0 111.143 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.95 -40.66 75.3 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 119.25 -0.405 . . . . 0.0 110.006 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.58 -38.22 89.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.846 0.748 . . . . 0.0 111.295 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.03 -24.65 62.4 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.977 0.511 . . . . 0.0 111.027 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.82 -11.26 27.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.025 0.53 . . . . 0.0 111.393 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.6 tp -75.29 -24.29 57.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.217 0.607 . . . . 0.0 110.138 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.15 -11.1 56.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.79 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.0 m -110.36 4.56 20.81 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.559 0.744 . . . . 0.0 111.615 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.1 t80 . . . . . 0 C--O 1.235 0.323 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.237 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.2 t80 . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -70.41 -36.86 74.28 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.421 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.0 m -71.84 -33.23 68.28 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -75.46 -27.25 58.82 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.381 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 tp -86.02 -35.94 20.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.377 0.271 . . . . 0.0 111.293 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -70.21 -20.64 63.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.083 -0.386 . . . . 0.0 111.745 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -76.63 -24.19 53.37 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.494 0.588 . . . . 0.0 110.56 172.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.8 mm -70.69 -41.2 77.63 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.7 74.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.67 -29.91 16.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 118.193 0.452 . . . . 0.0 110.791 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.65 -19.14 53.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.844 -0.535 . . . . 0.0 110.409 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -83.1 -26.73 30.75 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.069 0.395 . . . . 0.0 110.034 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.12 -36.13 64.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.94 -0.475 . . . . 0.0 110.333 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -74.03 -28.59 61.5 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 123.961 0.904 . . . . 0.0 111.065 177.236 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 CA--C 1.528 0.123 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -56.08 -17.73 7.82 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.663 0.385 . . . . 0.0 111.942 -178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -62.82 -53.44 54.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 p -86.0 -26.38 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.146 0.578 . . . . 0.0 110.896 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.0 -28.7 64.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 119.086 -0.483 . . . . 0.0 110.964 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.1 t -82.64 -30.74 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 CA-C-N 118.862 0.756 . . . . 0.0 109.97 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.1 -41.62 81.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.812 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -69.66 -35.44 75.17 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.2 m -71.31 -22.19 22.22 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-N 118.554 0.616 . . . . 0.0 110.441 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -80.46 -14.79 57.98 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.858 0.299 . . . . 0.0 110.385 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -80.45 -8.04 59.39 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 122.006 -0.434 . . . . 0.0 110.908 172.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.86 2.47 45.97 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.464 0.554 . . . . 0.0 112.826 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.48 84.17 7.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.042 0.921 . . . . 0.0 109.505 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.97 -21.41 66.48 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.825 0.45 . . . . 0.0 110.417 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -61.72 -24.62 66.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.918 0.487 . . . . 0.0 111.239 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.19 -18.79 41.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.363 -0.211 . . . . 0.0 110.682 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -77.79 -35.57 51.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -62.56 -41.03 98.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.29 -19.0 59.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.201 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -83.68 -46.82 11.88 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.137 -0.352 . . . . 0.0 111.528 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.3 m -67.63 -25.49 33.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 118.654 -0.689 . . . . 0.0 111.34 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.7 -26.41 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 119.337 0.971 . . . . 0.0 110.893 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -68.62 -32.31 72.09 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -100.83 -8.66 22.42 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -63.07 -28.01 69.79 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 118.421 0.555 . . . . 0.0 110.758 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -85.83 -30.14 23.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -76.38 -43.25 41.49 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 m -81.35 -26.01 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.18 0.445 . . . . 0.0 111.24 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.53 -22.5 62.61 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 t -76.8 -43.14 37.88 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.594 0.235 . . . . 0.0 110.754 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.46 -25.1 39.06 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 p -87.58 -18.54 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-N 118.007 0.367 . . . . 0.0 111.169 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -63.23 -13.55 39.1 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 171.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -89.32 -3.94 58.3 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.799 0.84 . . . . 0.0 111.78 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -122.51 -17.73 6.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.779 0.432 . . . . 0.0 111.815 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.27 153.68 66.62 Favored Pre-proline 0 N--CA 1.462 0.146 0 C-N-CA 123.353 0.661 . . . . 0.0 110.055 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.21 164.01 35.62 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.584 2.856 . . . . 0.0 110.755 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -66.29 -10.29 41.04 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.14 -18.61 57.33 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -116.52 -6.69 11.68 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.216 0.607 . . . . 0.0 111.258 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.425 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 4.5 p -66.78 -33.11 5.72 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 117.811 -1.09 . . . . 0.0 113.772 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 86.8 Cg_endo -77.11 -25.01 9.12 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 122.004 1.752 . . . . 0.0 111.518 -175.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -81.97 -29.55 32.1 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.235 -0.29 . . . . 0.0 110.341 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.4 t -77.85 -27.52 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.3 -33.91 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -72.97 -42.52 63.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -66.13 -29.05 69.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.785 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.67 -29.53 64.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.755 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -85.04 -28.97 25.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.278 0.49 . . . . 0.0 111.362 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.4 mt -72.13 -38.42 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -75.01 -32.51 61.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.215 0.606 . . . . 0.0 110.652 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.94 -46.86 67.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.208 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -59.69 -37.19 78.14 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.613 0.642 . . . . 0.0 111.508 -175.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -72.66 -25.7 61.37 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.907 0.483 . . . . 0.0 111.253 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.18 -13.52 28.3 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.077 0.551 . . . . 0.0 111.548 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.8 tp -76.71 -25.81 53.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.293 0.637 . . . . 0.0 110.819 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.4 -12.74 61.91 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -112.48 -0.4 15.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.664 0.786 . . . . 0.0 111.909 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.9 t80 . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.35 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.0 t80 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -70.52 -43.62 69.27 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 118.505 0.593 . . . . 0.0 111.651 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -68.69 -33.2 73.55 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -72.82 -28.46 62.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.925 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.0 tp -85.89 -37.85 18.68 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.846 0.458 . . . . 0.0 111.034 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -60.09 -32.0 70.55 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.616 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -77.07 -21.3 54.62 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.107 -0.473 . . . . 0.0 111.951 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.72 -38.3 75.85 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.942 0.792 . . . . 0.0 109.492 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.62 -38.96 58.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.5 p -76.4 -31.84 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.064 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -75.88 -20.88 57.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.035 -0.416 . . . . 0.0 110.552 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 m -78.68 -30.46 46.16 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.99 -29.78 63.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 122.263 -0.273 . . . . 0.0 110.319 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -79.51 -28.94 41.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.332 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-N 118.771 0.714 . . . . 0.0 110.644 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -59.86 -17.01 33.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.058 0.543 . . . . 0.0 110.763 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -69.94 -52.27 25.84 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.539 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.2 -26.65 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 122.673 0.389 . . . . 0.0 110.934 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 mp -70.04 -30.08 67.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.841 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.9 t -80.59 -28.01 11.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-N 118.623 0.647 . . . . 0.0 110.0 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.32 -36.44 68.88 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.627 -0.671 . . . . 0.0 110.188 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -69.95 -37.13 75.75 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.506 0.322 . . . . 0.0 111.497 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.5 m -73.46 -23.62 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.06 0 CA-C-N 118.117 0.417 . . . . 0.0 111.224 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -79.95 -15.76 56.61 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.534 0.334 . . . . 0.0 110.72 174.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -92.23 4.34 53.47 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.728 0.811 . . . . 0.0 111.99 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.28 2.38 51.03 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 119.8 -0.445 . . . . 0.0 113.128 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -97.26 83.88 3.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.001 0.901 . . . . 0.0 109.771 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -66.95 -18.35 65.34 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -60.79 -23.96 65.43 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.73 0.412 . . . . 0.0 110.824 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.77 -18.61 43.55 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.378 -0.201 . . . . 0.0 110.849 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -77.48 -36.98 52.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -61.85 -40.11 94.21 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.46 -19.07 58.42 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.442 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.6 tp -83.62 -46.46 12.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.691 0.396 . . . . 0.0 111.008 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.87 -24.55 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.546 -175.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.48 -27.13 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.157 0.89 . . . . 0.0 110.674 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -67.39 -32.77 73.91 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -98.67 -9.08 25.17 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -62.86 -28.82 70.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.474 -0.766 . . . . 0.0 110.48 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -86.91 -32.51 20.13 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -82.0 -33.03 30.3 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 122.054 -0.404 . . . . 0.0 111.998 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.8 t -74.23 -38.33 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.85 -23.95 67.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.934 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.7 t -74.64 -46.07 40.65 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.944 0.338 . . . . 0.0 111.019 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.88 -29.47 39.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.181 -0.325 . . . . 0.0 111.473 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.4 -15.71 11.41 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.056 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.4 t -67.7 -11.72 58.94 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.858 -0.526 . . . . 0.0 109.887 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -84.7 -6.54 59.36 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.042 0.537 . . . . 0.0 111.644 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -122.5 -13.44 8.0 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.27 154.8 57.79 Favored Pre-proline 0 C--O 1.231 0.123 0 C-N-CA 123.923 0.889 . . . . 0.0 109.567 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.27 162.94 38.26 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.455 2.77 . . . . 0.0 110.758 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.4 p -65.88 -10.61 40.0 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.13 -18.89 54.9 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.81 -0.439 . . . . 0.0 112.05 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -116.35 -4.78 11.81 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.384 0.592 . . . . 0.0 111.677 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.424 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 5.7 p -66.51 -32.12 4.95 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 117.79 -1.1 . . . . 0.0 113.719 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 74.5 Cg_endo -78.18 -23.28 9.11 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 CA-C-N 121.904 1.716 . . . . 0.0 111.266 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -81.74 -27.74 33.69 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.96 -27.42 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.5 -34.59 62.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.67 -42.92 66.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -67.5 -28.58 67.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.383 0.538 . . . . 0.0 109.99 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.42 -36.42 74.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.2 -33.18 61.37 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.371 0.532 . . . . 0.0 111.967 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.57 -38.89 75.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -75.22 -31.72 60.94 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.081 0.552 . . . . 0.0 110.555 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.73 -43.93 71.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.236 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -61.28 -37.91 84.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.863 0.756 . . . . 0.0 111.36 -176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -71.68 -25.39 62.09 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.552 0.341 . . . . 0.0 111.062 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.93 -10.76 27.91 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.28 0.632 . . . . 0.0 111.441 176.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.4 tp -74.93 -23.84 58.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.104 0.562 . . . . 0.0 110.119 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.35 -11.48 51.36 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.509 0.324 . . . . 0.0 110.544 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -110.39 2.68 19.16 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.722 0.809 . . . . 0.0 111.851 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 t80 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.553 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.5 t80 . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -70.39 -36.57 74.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.62 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -72.02 -36.28 69.65 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 64.5 t90 -70.28 -32.88 70.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.678 -0.201 . . . . 0.0 110.747 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.0 tp -80.23 -37.15 33.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.597 0.359 . . . . 0.0 111.292 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -68.67 -20.27 64.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.133 -0.354 . . . . 0.0 111.63 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -74.69 -26.75 60.04 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.186 0.448 . . . . 0.0 110.323 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.76 -36.88 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.98 -40.08 63.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.63 -32.04 15.9 Favored 'Isoleucine or valine' 0 C--N 1.337 0.043 0 O-C-N 121.993 -0.442 . . . . 0.0 111.268 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -74.61 -24.33 58.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.014 -0.429 . . . . 0.0 110.3 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.1 m -78.08 -30.45 49.63 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 117.741 0.246 . . . . 0.0 110.44 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.29 -29.46 62.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.316 -0.24 . . . . 0.0 110.496 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.05 -31.05 55.9 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.339 0.137 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.837 176.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.8 m . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -55.26 -18.19 5.81 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.005 0.522 . . . . 0.0 111.937 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -65.17 -51.37 61.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.238 -0.289 . . . . 0.0 110.453 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 p -84.06 -25.8 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 122.594 0.357 . . . . 0.0 110.631 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.89 -30.14 67.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.095 -0.378 . . . . 0.0 110.634 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.9 t -81.74 -28.48 9.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 CA-C-N 118.634 0.652 . . . . 0.0 110.029 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.05 -40.8 71.45 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.066 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -69.06 -34.35 75.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -70.49 -23.01 24.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 118.702 0.683 . . . . 0.0 110.398 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -81.15 -14.98 57.11 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 119.503 -0.284 . . . . 0.0 110.92 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.62 -7.0 59.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.287 0.494 . . . . 0.0 110.752 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.48 3.12 47.28 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.479 0.562 . . . . 0.0 112.779 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.81 83.98 5.33 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 117.954 0.877 . . . . 0.0 108.991 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -64.48 -17.73 64.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.091 0.557 . . . . 0.0 110.643 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -60.82 -25.62 66.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.991 0.516 . . . . 0.0 110.794 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.34 -18.99 43.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.781 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -76.54 -36.97 57.36 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -61.82 -39.8 93.04 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.8 mt -76.79 -18.98 58.09 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.352 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.6 tp -83.3 -47.36 11.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.554 0.342 . . . . 0.0 111.308 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.8 m -68.13 -25.69 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.222 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.56 -26.92 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.326 0.966 . . . . 0.0 110.915 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -67.82 -33.05 74.03 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -100.85 -8.73 22.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.308 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -62.16 -28.78 69.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.357 0.526 . . . . 0.0 110.42 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -86.1 -28.94 23.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 121.977 0.111 . . . . 0.0 110.763 174.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -78.4 -40.64 35.41 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 m -83.85 -23.53 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 O-C-N 121.966 -0.459 . . . . 0.0 110.835 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.63 -22.09 61.0 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.5 t -79.37 -40.23 30.67 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -81.38 -24.56 36.93 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 119.242 -0.409 . . . . 0.0 112.081 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.16 -21.08 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.674 0.67 . . . . 0.0 112.212 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -69.27 -10.53 58.24 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.845 -0.534 . . . . 0.0 111.611 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -92.28 -4.01 54.61 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 121.805 -0.56 . . . . 0.0 111.642 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -110.16 -23.57 11.19 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.644 0.378 . . . . 0.0 111.304 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.13 155.73 74.21 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 123.433 0.693 . . . . 0.0 109.461 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.42 170.59 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.515 2.81 . . . . 0.0 111.339 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.0 m -63.41 -11.91 26.76 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.118 0.567 . . . . 0.0 112.132 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.68 -16.28 58.61 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.593 -0.559 . . . . 0.0 112.598 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -116.3 -10.86 11.33 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 117.938 0.869 . . . . 0.0 111.801 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.415 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 8.0 p -62.89 -34.34 13.75 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 117.78 -1.105 . . . . 0.0 112.929 -177.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 94.7 Cg_endo -77.5 -25.42 8.16 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 CA-C-N 121.927 1.724 . . . . 0.0 112.135 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.38 -33.11 23.87 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.191 0.45 . . . . 0.0 111.098 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.5 t -78.17 -25.39 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.16 -34.68 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -71.44 -42.05 68.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -66.36 -29.64 69.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.29 0.496 . . . . 0.0 110.0 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.01 -28.38 64.38 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 119.478 -0.296 . . . . 0.0 110.837 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -85.2 -29.33 24.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.523 0.601 . . . . 0.0 111.232 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -72.42 -37.86 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -76.54 -32.29 58.13 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.224 0.61 . . . . 0.0 110.804 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.92 77.65 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.463 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -62.06 -38.35 88.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.755 0.707 . . . . 0.0 111.329 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -71.36 -24.94 62.18 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.599 0.36 . . . . 0.0 111.336 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.7 -11.74 28.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.972 0.509 . . . . 0.0 111.454 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.0 tp -75.68 -24.24 56.29 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.951 0.5 . . . . 0.0 110.538 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.95 -10.37 57.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.468 0.307 . . . . 0.0 110.741 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.4 m -109.63 3.03 20.64 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.682 0.793 . . . . 0.0 111.442 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 t80 . . . . . 0 CA--C 1.531 0.224 0 C-N-CA 123.144 0.578 . . . . 0.0 109.817 178.023 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.0 t80 . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -69.72 -37.41 76.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.838 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.6 m -70.58 -33.78 71.47 Favored 'General case' 0 CA--C 1.527 0.068 0 O-C-N 121.895 -0.503 . . . . 0.0 109.757 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -73.96 -28.64 61.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.968 0.507 . . . . 0.0 110.881 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.7 tp -86.01 -36.0 20.03 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.804 0.442 . . . . 0.0 111.297 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -61.87 -32.57 72.94 Favored 'General case' 0 C--O 1.23 0.077 0 O-C-N 122.201 -0.312 . . . . 0.0 110.599 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -76.54 -21.24 55.95 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.075 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.3 mm -68.01 -38.83 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 118.979 0.809 . . . . 0.0 109.216 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.01 -38.38 53.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.26 -28.01 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 CA-C-N 118.919 0.781 . . . . 0.0 111.171 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -75.42 -24.76 57.15 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.105 0.411 . . . . 0.0 110.101 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.2 m -79.05 -29.97 43.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 176.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.83 -33.77 66.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.049 0.386 . . . . 0.0 111.025 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -77.96 -29.0 49.6 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.6 t30 . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.955 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 47.0 m . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -55.69 -16.93 4.81 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.18 0.592 . . . . 0.0 112.479 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -67.25 -51.43 53.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 117.917 0.326 . . . . 0.0 110.127 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.66 -25.67 6.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 122.449 0.3 . . . . 0.0 110.981 -176.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -68.56 -30.13 68.84 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.276 -0.265 . . . . 0.0 110.439 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.8 t -81.58 -28.43 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 118.316 0.507 . . . . 0.0 110.215 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.63 -35.11 70.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.574 -0.704 . . . . 0.0 111.357 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -83.6 -25.41 30.88 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.454 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.07 -23.06 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 119.16 0.891 . . . . 0.0 109.358 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -78.86 -25.54 43.96 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.282 0.233 . . . . 0.0 110.68 174.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -89.33 -7.26 55.68 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.84 -3.52 8.0 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 118.835 -0.98 . . . . 0.0 114.889 170.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -86.61 83.72 7.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.331 1.566 . . . . 0.0 109.961 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -66.38 -21.79 66.24 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.39 -24.58 66.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.536 0.734 . . . . 0.0 110.897 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.69 -19.2 35.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 119.579 -0.248 . . . . 0.0 110.742 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -76.97 -35.89 56.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -63.22 -40.81 98.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.41 -18.81 59.83 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.154 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.9 tp -83.41 -47.09 11.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.521 0.328 . . . . 0.0 111.044 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.4 m -69.32 -24.53 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.717 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.5 p -69.24 -27.32 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 119.146 0.884 . . . . 0.0 110.771 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -67.11 -33.1 74.74 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -98.4 -8.92 26.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.102 0.561 . . . . 0.0 112.326 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -63.32 -30.44 71.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.503 -0.748 . . . . 0.0 110.633 -174.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -87.03 -32.05 20.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -81.43 -34.74 31.32 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -71.28 -38.86 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.56 -24.21 67.71 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.095 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.2 t -73.85 -48.16 33.13 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.851 0.296 . . . . 0.0 110.734 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 pp -79.98 -27.82 39.6 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.479 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 p -83.5 -15.74 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.334 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 t -68.92 -9.65 53.01 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.825 -0.547 . . . . 0.0 110.28 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -88.8 -3.91 58.64 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.408 0.683 . . . . 0.0 111.427 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.31 -16.2 7.45 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.2 m -143.17 153.78 60.34 Favored Pre-proline 0 C--N 1.338 0.069 0 C-N-CA 124.168 0.987 . . . . 0.0 109.613 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.28 164.25 33.15 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.483 2.788 . . . . 0.0 111.062 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.2 p -65.92 -10.25 37.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.43 -18.03 55.96 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -116.44 -5.64 11.74 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.527 0.664 . . . . 0.0 111.481 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.426 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 5.8 p -67.28 -32.03 4.27 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 117.755 -1.117 . . . . 0.0 114.001 -176.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 81.2 Cg_endo -78.12 -23.53 8.98 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 CA-C-N 121.758 1.664 . . . . 0.0 111.308 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.84 -29.24 32.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.5 t -77.09 -28.54 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.4 t -69.72 -35.71 66.79 Favored 'Isoleucine or valine' 0 C--N 1.337 0.063 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -70.95 -42.83 69.27 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -67.31 -28.77 68.28 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.731 -0.606 . . . . 0.0 109.873 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.23 -36.13 74.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -75.39 -32.65 60.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.353 0.524 . . . . 0.0 112.204 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -71.33 -38.16 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -76.22 -31.37 58.35 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.015 0.526 . . . . 0.0 110.458 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.27 -44.0 72.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.187 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -61.19 -38.1 85.32 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.812 0.733 . . . . 0.0 111.366 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -71.45 -25.32 62.25 Favored 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 122.596 0.358 . . . . 0.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.08 -10.74 27.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.184 0.594 . . . . 0.0 111.266 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.42 -23.97 57.04 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.999 0.52 . . . . 0.0 110.3 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.02 -11.47 48.35 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.335 0.254 . . . . 0.0 110.508 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.4 m -110.8 -2.24 16.25 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.622 0.769 . . . . 0.0 112.034 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.6 t80 . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.404 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.0 t80 . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -69.51 -36.97 76.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.863 -0.523 . . . . 0.0 110.708 -176.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.2 m -72.7 -36.43 67.85 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -69.39 -33.27 72.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -78.94 -36.62 41.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.557 0.343 . . . . 0.0 111.578 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -69.17 -20.09 64.0 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.078 -0.388 . . . . 0.0 111.574 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -74.6 -25.9 59.56 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 117.965 0.348 . . . . 0.0 110.283 173.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.4 mm -73.23 -35.74 47.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.11 -39.52 60.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.3 p -79.05 -30.63 14.39 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 O-C-N 122.26 -0.275 . . . . 0.0 110.979 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -76.3 -23.04 54.32 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.053 0.388 . . . . 0.0 110.623 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.5 m -80.21 -28.49 38.59 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.7 -33.26 66.36 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.209 0.459 . . . . 0.0 110.284 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.39 -25.82 54.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.9 t30 . . . . . 0 CA--C 1.531 0.249 0 C-N-CA 122.464 0.306 . . . . 0.0 110.711 177.132 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -56.02 -17.31 6.52 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -66.67 -53.5 33.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 122.148 -0.345 . . . . 0.0 110.391 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 p -83.63 -25.41 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 122.676 0.39 . . . . 0.0 110.782 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.88 -27.92 64.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.847 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -82.6 -28.45 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.058 0 CA-C-N 118.899 0.772 . . . . 0.0 109.909 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 44.3 mt-10 -72.51 -35.95 68.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.498 -0.751 . . . . 0.0 110.322 176.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -71.28 -37.12 71.89 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.53 -23.87 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 118.155 0.434 . . . . 0.0 110.749 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -78.27 -17.39 56.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.759 0.254 . . . . 0.0 110.438 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -82.54 -5.86 59.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.219 0.608 . . . . 0.0 111.695 172.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.36 0.63 37.81 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.322 -0.71 . . . . 0.0 113.098 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -85.52 84.16 7.7 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.304 1.052 . . . . 0.0 109.071 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -64.38 -20.91 66.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.548 0.339 . . . . 0.0 110.87 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -62.48 -23.95 67.19 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.575 0.75 . . . . 0.0 111.168 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.34 -19.2 39.79 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.614 0.188 . . . . 0.0 110.784 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -77.77 -36.64 50.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -60.75 -42.79 98.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.57 -18.47 59.74 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.571 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.0 tp -81.47 -43.1 19.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.214 -0.304 . . . . 0.0 110.931 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.7 m -70.92 -24.58 24.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.874 -175.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.86 -26.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 119.685 1.13 . . . . 0.0 110.706 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -70.15 -31.2 68.59 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -99.76 -9.01 23.51 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.481 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -62.69 -30.27 71.27 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.189 -0.944 . . . . 0.0 110.499 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -86.56 -32.84 20.46 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.475 0.31 . . . . 0.0 111.601 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -80.67 -36.37 32.5 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.0 t -71.21 -38.86 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.47 -23.38 67.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.934 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 t -74.47 -45.93 42.9 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.019 -0.426 . . . . 0.0 111.112 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.409 HD23 ' CD1' ' A' ' 75' ' ' TYR . 3.8 pp -82.61 -26.43 32.27 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.432 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 p -85.45 -16.91 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 118.131 0.423 . . . . 0.0 111.761 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.8 t -69.67 -9.07 52.82 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -89.29 -4.42 58.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.47 0.708 . . . . 0.0 111.221 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -122.76 -15.21 7.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.891 0.476 . . . . 0.0 112.245 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -143.1 153.84 60.65 Favored Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 123.721 0.808 . . . . 0.0 109.541 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -68.59 164.85 31.42 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.551 2.834 . . . . 0.0 111.062 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -65.76 -10.3 35.89 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.49 -18.02 55.87 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 118.094 0.407 . . . . 0.0 112.333 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -116.58 -5.78 11.66 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 117.561 0.681 . . . . 0.0 111.605 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.42 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 6.0 p -67.37 -32.63 4.73 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 77.9 Cg_endo -77.86 -23.85 9.05 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 CA-C-N 121.844 1.694 . . . . 0.0 111.437 -176.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.4 -28.74 34.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -79.03 -27.91 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.64 -36.01 68.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.14 -43.09 68.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -67.84 -28.99 68.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.427 0.558 . . . . 0.0 109.765 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.22 73.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -75.61 -33.73 60.56 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 118.272 0.487 . . . . 0.0 112.203 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -71.41 -37.26 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -77.18 -32.86 56.42 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.909 0.483 . . . . 0.0 110.586 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.47 -44.92 81.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -61.55 -36.71 81.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.508 0.595 . . . . 0.0 111.215 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -72.05 -20.72 61.63 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 122.694 0.397 . . . . 0.0 111.281 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.85 -11.83 18.74 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.94 0.496 . . . . 0.0 111.109 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.2 tp -76.26 -25.71 55.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.583 0.753 . . . . 0.0 110.617 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.94 -13.18 62.28 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.376 0.27 . . . . 0.0 110.651 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.9 m -113.45 0.9 14.87 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.592 0.757 . . . . 0.0 111.785 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.9 t80 . . . . . 0 N--CA 1.453 -0.286 0 O-C-N 121.963 -0.46 . . . . 0.0 110.454 179.95 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.5 t80 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -67.73 -37.83 82.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.303 0.501 . . . . 0.0 111.984 -174.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.7 m -70.72 -37.7 73.53 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -69.27 -34.02 74.12 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.7 -0.191 . . . . 0.0 110.798 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.8 tp -77.09 -36.53 55.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.716 0.406 . . . . 0.0 111.199 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.409 ' CD1' HD23 ' A' ' 36' ' ' LEU . 20.9 m-85 -69.56 -20.03 63.67 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.804 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -76.1 -23.98 54.98 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.087 0.403 . . . . 0.0 110.456 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.2 mm -73.55 -35.94 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.44 -39.69 62.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.71 -29.66 13.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 O-C-N 122.086 -0.384 . . . . 0.0 111.402 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -75.74 -23.21 56.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.821 -0.55 . . . . 0.0 110.618 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.2 m -82.94 -28.93 29.5 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 119.556 -0.259 . . . . 0.0 110.339 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.09 -32.78 61.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.093 0.406 . . . . 0.0 110.932 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.37 -29.68 53.43 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t30 . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 175.889 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.4 m . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -55.34 -17.29 4.55 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.982 0.513 . . . . 0.0 111.87 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -65.88 -51.51 58.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 p -85.81 -26.48 6.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 122.734 0.413 . . . . 0.0 110.952 -176.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.72 -29.92 68.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 122.136 -0.352 . . . . 0.0 110.34 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.8 t -84.23 -27.35 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.186 0.448 . . . . 0.0 110.296 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.37 -35.68 65.98 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.51 -0.744 . . . . 0.0 109.998 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -70.81 -34.9 72.22 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.0 m -74.75 -24.09 18.08 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 CA-C-N 118.108 0.413 . . . . 0.0 111.228 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -77.13 -16.14 59.28 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 174.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.36 2.26 56.75 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.723 0.809 . . . . 0.0 112.161 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.23 44.18 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.55 -0.583 . . . . 0.0 113.554 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -91.81 83.97 5.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.413 1.107 . . . . 0.0 109.31 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.69 -20.2 66.18 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.727 0.411 . . . . 0.0 110.435 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -62.08 -24.52 67.16 Favored 'General case' 0 N--CA 1.458 -0.041 0 C-N-CA 122.863 0.465 . . . . 0.0 111.441 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.44 -18.75 44.25 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.792 0.269 . . . . 0.0 110.574 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -77.8 -37.14 49.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -61.73 -40.22 94.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.43 -19.22 58.3 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.401 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.4 tp -83.47 -46.9 11.96 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.426 0.29 . . . . 0.0 111.245 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.65 -25.09 29.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 CA-C-O 118.578 -0.725 . . . . 0.0 111.479 -175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.4 p -69.7 -26.64 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 119.32 0.964 . . . . 0.0 110.693 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.9 mtp85 -68.54 -34.54 76.02 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -97.35 -8.73 28.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.282 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -63.33 -28.35 69.94 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 118.453 0.57 . . . . 0.0 110.8 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -85.07 -30.17 24.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -77.05 -43.47 34.38 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 m -79.78 -25.32 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 O-C-N 121.971 -0.456 . . . . 0.0 110.885 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.03 -22.75 63.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.149 0.432 . . . . 0.0 110.436 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -76.31 -42.3 45.7 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.43 -24.85 31.7 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -87.94 -19.44 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 118.326 0.512 . . . . 0.0 111.467 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.4 t -67.26 -9.26 38.88 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.878 -0.514 . . . . 0.0 109.854 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -90.45 -3.92 57.33 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.7 0.8 . . . . 0.0 111.438 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -122.18 -15.38 7.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.985 0.514 . . . . 0.0 111.884 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 m -142.42 153.32 62.32 Favored Pre-proline 0 N--CA 1.463 0.176 0 C-N-CA 123.829 0.852 . . . . 0.0 109.229 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.38 165.33 29.27 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.385 2.723 . . . . 0.0 110.959 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -65.38 -12.54 53.13 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.782 0.433 . . . . 0.0 112.132 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.02 -19.58 59.03 Favored Glycine 0 CA--C 1.527 0.83 0 O-C-N 121.928 -0.483 . . . . 0.0 112.192 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -116.55 -5.67 11.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.633 0.716 . . . . 0.0 111.681 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.418 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 5.9 p -66.58 -33.32 6.25 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.782 -1.104 . . . . 0.0 113.7 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 93.7 Cg_endo -76.68 -25.88 8.88 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 122.084 1.78 . . . . 0.0 111.774 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -82.7 -28.84 30.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.227 -0.296 . . . . 0.0 110.408 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.2 t -77.76 -27.63 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -71.72 -35.59 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -72.27 -43.2 64.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -67.45 -27.35 66.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.784 -0.572 . . . . 0.0 110.208 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.48 -28.51 62.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.683 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.31 -29.81 24.25 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.411 0.551 . . . . 0.0 110.89 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.66 -37.11 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -78.74 -31.64 46.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.865 0.466 . . . . 0.0 111.016 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.94 -42.46 85.25 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.165 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -62.76 -36.5 83.27 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 118.63 0.65 . . . . 0.0 111.211 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -71.64 -17.68 62.25 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 122.501 0.32 . . . . 0.0 111.122 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.49 -11.51 16.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.863 0.465 . . . . 0.0 111.066 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.2 tp -73.77 -23.22 59.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.472 0.709 . . . . 0.0 110.099 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.48 -13.13 37.46 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.445 0.298 . . . . 0.0 110.673 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.2 t -113.48 4.44 16.24 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.6 t80 . . . . . 0 C--N 1.339 0.11 0 O-C-N 121.509 -0.744 . . . . 0.0 109.503 177.286 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.8 t80 . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 119.701 -0.19 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -69.69 -40.4 76.36 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.042 0.383 . . . . 0.0 111.297 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -70.78 -35.11 72.44 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -69.53 -31.02 68.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.5 tp -82.92 -36.15 25.49 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.586 0.354 . . . . 0.0 111.629 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -62.44 -29.13 70.29 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.129 -0.357 . . . . 0.0 110.387 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -73.33 -25.29 60.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.489 0.315 . . . . 0.0 111.48 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mm -71.53 -39.76 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.035 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.56 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.41 -36.11 68.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -174.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -75.64 -29.25 20.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.378 0.536 . . . . 0.0 110.775 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -79.07 -20.54 48.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.266 -0.271 . . . . 0.0 110.609 177.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 79.1 m -79.85 -33.37 40.2 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 122.014 -0.429 . . . . 0.0 109.963 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.96 69.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.281 -0.262 . . . . 0.0 110.928 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -75.17 -28.64 60.14 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 t30 . . . . . 0 N--CA 1.455 -0.195 0 C-N-CA 122.128 0.171 . . . . 0.0 110.99 177.154 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -55.17 -16.81 3.44 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.319 0.648 . . . . 0.0 111.822 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -65.76 -54.12 31.37 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 122.107 -0.37 . . . . 0.0 110.032 176.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.52 -25.44 6.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.756 0.423 . . . . 0.0 111.031 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 mp -70.1 -31.72 69.42 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 119.299 -0.381 . . . . 0.0 110.338 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.0 t -80.17 -27.91 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 118.62 0.645 . . . . 0.0 110.15 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.02 -39.37 75.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.815 -0.553 . . . . 0.0 111.373 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -82.19 -25.1 34.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.74 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.41 -24.25 23.61 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 CA-C-N 118.755 0.707 . . . . 0.0 109.695 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -78.78 -21.66 47.49 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.674 0.389 . . . . 0.0 110.293 174.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -89.43 -7.3 55.42 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.368 0.667 . . . . 0.0 111.818 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.69 0.58 17.81 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.932 -0.927 . . . . 0.0 114.16 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -87.32 83.71 7.31 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.213 1.507 . . . . 0.0 109.761 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -65.88 -23.77 66.72 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -59.69 -24.35 63.86 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.425 0.69 . . . . 0.0 111.048 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.37 -20.12 32.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 119.777 -0.154 . . . . 0.0 111.26 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -76.45 -35.12 58.66 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.06 -40.63 98.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.0 mt -75.01 -19.02 60.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.672 0.389 . . . . 0.0 111.396 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 tp -83.55 -46.75 12.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.899 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 m -68.77 -24.34 28.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.646 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.9 p -69.88 -26.76 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 119.239 0.927 . . . . 0.0 110.756 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -68.1 -30.67 69.9 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -101.09 -8.89 21.87 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.75 -30.22 71.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.134 -0.979 . . . . 0.0 110.551 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -86.87 -32.47 20.21 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -79.29 -36.39 39.76 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -71.7 -39.01 68.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 123.449 0.7 . . . . 0.0 109.316 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.46 -23.09 67.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.235 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 t -75.02 -45.62 40.55 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.145 -0.347 . . . . 0.0 111.126 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 pp -82.02 -28.12 32.71 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.56 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 p -83.55 -16.92 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 118.219 0.463 . . . . 0.0 111.515 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -67.96 -11.99 59.88 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.103 0.478 . . . . 0.0 109.786 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -86.01 -4.26 59.13 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.341 0.656 . . . . 0.0 111.346 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -122.78 -16.44 7.15 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.938 0.495 . . . . 0.0 112.289 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -142.74 154.48 62.69 Favored Pre-proline 0 N--CA 1.462 0.166 0 C-N-CA 123.587 0.755 . . . . 0.0 109.353 175.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.96 164.21 30.77 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.423 2.748 . . . . 0.0 111.009 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.5 p -66.43 -9.5 34.54 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.05 54.35 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.818 -0.435 . . . . 0.0 112.05 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -116.18 -6.01 11.88 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 117.518 0.659 . . . . 0.0 111.453 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.424 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 8.1 p -66.45 -32.76 5.65 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 117.774 -1.108 . . . . 0.0 113.853 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 78.9 Cg_endo -77.96 -23.07 9.6 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 CA-C-N 121.834 1.691 . . . . 0.0 111.056 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.86 -29.39 32.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.95 -28.91 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.78 -35.8 66.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -71.11 -42.77 68.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -67.98 -29.89 69.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.22 0.464 . . . . 0.0 109.855 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.09 -36.56 77.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 119.55 -0.262 . . . . 0.0 110.297 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -74.69 -33.57 62.47 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.245 0.475 . . . . 0.0 112.024 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.54 -39.17 75.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -75.37 -30.84 60.31 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.812 0.445 . . . . 0.0 110.638 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.53 -44.67 67.06 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.344 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -59.6 -39.23 83.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.61 0.641 . . . . 0.0 111.38 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -72.19 -28.46 63.21 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.512 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 -12.01 40.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.803 0.441 . . . . 0.0 111.351 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.7 tp -75.55 -28.06 58.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.349 0.659 . . . . 0.0 110.721 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -71.38 -6.26 38.79 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.1 m -113.4 4.15 16.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.83 0.852 . . . . 0.0 111.198 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.6 t80 . . . . . 0 CA--C 1.531 0.248 0 C-N-CA 122.973 0.509 . . . . 0.0 110.14 179.549 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.3 t80 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -70.07 -37.41 75.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.817 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -71.28 -33.79 70.08 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 56.9 t90 -73.75 -28.23 61.57 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.483 0.313 . . . . 0.0 110.846 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -85.63 -36.66 20.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.929 0.331 . . . . 0.0 111.029 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -69.36 -21.03 63.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.989 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -78.27 -21.87 49.13 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.908 0.776 . . . . 0.0 110.61 173.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mm -70.44 -34.33 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.95 -41.24 52.18 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.35 -29.03 13.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 O-C-N 121.997 -0.44 . . . . 0.0 111.356 -178.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -75.69 -24.22 56.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.152 -0.343 . . . . 0.0 110.287 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -81.73 -26.98 34.12 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.201 -0.312 . . . . 0.0 110.363 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.91 -32.64 63.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.423 0.556 . . . . 0.0 110.72 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.33 -25.74 46.57 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.4 t30 . . . . . 0 CA--C 1.531 0.245 0 CA-C-O 120.447 0.165 . . . . 0.0 110.701 175.154 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -55.16 -17.14 3.79 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -66.41 -53.05 40.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.056 -0.402 . . . . 0.0 110.257 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -85.34 -25.75 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 122.906 0.482 . . . . 0.0 110.559 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.8 mp -70.85 -28.65 64.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.154 -0.451 . . . . 0.0 110.974 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.8 t -82.54 -28.12 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 118.858 0.754 . . . . 0.0 110.024 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.439 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 44.1 mt-10 -72.11 -36.61 69.49 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.762 -0.586 . . . . 0.0 110.504 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -70.58 -36.67 73.72 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 m -73.13 -23.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 118.298 0.499 . . . . 0.0 110.827 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -78.0 -18.16 56.26 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -80.99 -5.93 58.16 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.297 0.639 . . . . 0.0 111.863 172.494 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.72 2.13 46.36 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 119.559 -0.578 . . . . 0.0 112.876 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -85.86 84.19 7.62 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.19 0.995 . . . . 0.0 109.349 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -64.36 -19.65 65.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.419 0.288 . . . . 0.0 110.624 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -61.48 -25.5 67.29 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.94 0.496 . . . . 0.0 111.121 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.88 -18.8 38.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.74 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -77.91 -36.16 49.78 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -61.84 -41.07 97.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -76.83 -18.41 58.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 tp -82.08 -41.66 20.25 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 122.139 -0.351 . . . . 0.0 110.74 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.6 m -72.16 -24.28 22.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.885 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -67.74 -26.33 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 119.866 1.212 . . . . 0.0 110.887 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -69.74 -32.13 70.49 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -99.34 -9.08 23.97 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.411 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -62.77 -30.4 71.42 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.206 -0.934 . . . . 0.0 110.751 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -86.99 -32.36 20.09 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 176.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -80.24 -36.37 34.74 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.96 -38.44 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.96 -23.27 67.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 t -74.68 -45.19 46.16 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.047 0.385 . . . . 0.0 111.012 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -82.92 -27.03 30.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.498 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 p -84.97 -16.71 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 118.117 0.417 . . . . 0.0 111.478 -178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -68.35 -11.77 60.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.21 0.529 . . . . 0.0 109.845 172.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -85.83 -5.98 59.16 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.425 0.69 . . . . 0.0 111.312 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -122.6 -16.51 7.22 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.799 0.44 . . . . 0.0 112.164 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 m -141.34 153.76 66.46 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 123.462 0.705 . . . . 0.0 109.443 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.9 164.97 29.61 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.656 2.904 . . . . 0.0 110.984 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -65.87 -10.75 41.1 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -175.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.41 -17.98 56.09 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.082 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -116.49 -5.85 11.71 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 117.726 0.763 . . . . 0.0 111.538 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.423 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 6.8 p -67.35 -32.02 4.21 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 117.785 -1.102 . . . . 0.0 113.722 -176.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 82.4 Cg_endo -78.41 -23.11 8.93 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 121.804 1.68 . . . . 0.0 111.076 -177.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -82.4 -28.21 31.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.343 -0.223 . . . . 0.0 110.62 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.4 t -79.36 -28.61 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -69.15 -35.85 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -70.36 -43.24 70.55 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -68.17 -29.16 67.97 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.736 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.63 -35.47 75.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.987 0.358 . . . . 0.0 110.2 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.46 -33.62 60.86 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.076 0.398 . . . . 0.0 111.72 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.04 -38.46 71.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -75.39 -32.35 60.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.04 0.536 . . . . 0.0 110.579 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.27 77.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.098 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -61.14 -37.8 84.13 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.769 0.713 . . . . 0.0 111.287 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -71.81 -24.72 61.77 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.709 0.404 . . . . 0.0 111.059 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.11 -11.85 25.67 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.167 0.587 . . . . 0.0 111.442 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.2 tp -75.63 -24.06 56.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.26 0.624 . . . . 0.0 110.376 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.56 -11.33 57.83 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.422 0.289 . . . . 0.0 110.604 174.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.2 m -109.46 0.23 19.21 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.754 0.822 . . . . 0.0 111.65 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.6 t80 . . . . . 0 N--CA 1.455 -0.179 0 C-N-CA 123.125 0.57 . . . . 0.0 110.196 178.026 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -69.84 -38.81 76.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.839 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.2 m -70.45 -35.66 73.47 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -69.28 -33.59 73.44 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 122.379 -0.201 . . . . 0.0 110.74 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.2 tp -79.8 -35.91 37.77 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.261 0.225 . . . . 0.0 111.18 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -69.18 -20.25 64.0 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.787 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.5 mtm105 -75.51 -23.76 56.75 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.412 0.551 . . . . 0.0 110.517 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.54 -33.72 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.23 -39.13 55.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -173.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -80.52 -29.65 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 O-C-N 122.126 -0.359 . . . . 0.0 111.409 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -75.88 -23.92 55.65 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 122.208 -0.307 . . . . 0.0 110.309 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.3 m -81.67 -29.59 33.02 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.177 -0.327 . . . . 0.0 110.399 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.84 -35.28 67.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.207 0.458 . . . . 0.0 110.877 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -76.87 -28.27 55.34 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 t30 . . . . . 0 N--CA 1.455 -0.198 0 C-N-CA 122.261 0.224 . . . . 0.0 110.595 176.79 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.277 0.084 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -141.04 160.98 38.93 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.051 0.54 . . . . 0.0 110.387 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -84.49 161.13 20.37 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.778 0.431 . . . . 0.0 110.663 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -89.1 -3.75 58.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.641 0.376 . . . . 0.0 111.719 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -119.93 148.17 43.85 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 m -139.43 172.54 12.67 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.497 0.719 . . . . 0.0 109.352 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -55.11 -17.55 4.25 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.157 0.583 . . . . 0.0 112.21 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -66.0 -51.98 53.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.99 -0.444 . . . . 0.0 110.251 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.89 -25.58 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 122.396 0.278 . . . . 0.0 110.611 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.84 -28.74 64.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.154 -0.341 . . . . 0.0 110.703 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.1 t -82.17 -28.45 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 118.534 0.606 . . . . 0.0 109.876 176.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 39.8 mt-10 -70.9 -37.02 72.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.69 -0.631 . . . . 0.0 110.345 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -71.7 -36.42 70.54 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.44 -24.6 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.032 0 CA-C-N 118.338 0.517 . . . . 0.0 110.956 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -78.77 -18.26 54.45 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -83.16 -5.18 59.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.446 0.699 . . . . 0.0 111.898 174.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.52 0.14 34.75 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.614 -0.548 . . . . 0.0 113.351 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -88.77 84.29 6.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.232 1.016 . . . . 0.0 109.547 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -63.7 -20.61 65.86 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.711 0.405 . . . . 0.0 110.831 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -62.85 -23.23 67.19 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.095 0.558 . . . . 0.0 111.294 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.52 -18.7 44.14 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.378 -0.202 . . . . 0.0 110.674 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -77.1 -36.51 55.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -62.52 -41.11 98.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -75.19 -18.95 60.05 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.288 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.5 tp -83.54 -47.34 11.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 122.405 0.282 . . . . 0.0 111.238 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 m -67.61 -24.69 31.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.399 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.68 -26.97 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 119.133 0.878 . . . . 0.0 110.891 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -67.93 -32.17 72.45 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -101.49 -8.63 21.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -62.73 -27.6 69.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.342 0.519 . . . . 0.0 110.503 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -86.59 -30.56 21.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.339 -0.226 . . . . 0.0 110.512 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -76.83 -41.87 42.5 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -82.18 -25.5 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.074 0 CA-C-N 118.0 0.364 . . . . 0.0 110.997 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.18 -23.64 63.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.179 0.445 . . . . 0.0 110.193 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 t -76.19 -44.22 38.89 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -80.04 -24.94 40.39 Favored 'General case' 0 C--O 1.227 -0.093 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 p -86.76 -17.64 8.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 CA-C-N 118.104 0.411 . . . . 0.0 111.145 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.9 t -67.75 -9.18 41.68 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 122.046 -0.409 . . . . 0.0 110.197 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -88.42 -5.84 58.03 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.033 0.533 . . . . 0.0 111.713 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -122.18 -12.42 8.29 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.56 154.02 59.28 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.813 0.845 . . . . 0.0 109.1 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.18 163.69 35.13 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.363 2.708 . . . . 0.0 110.611 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.0 p -65.61 -10.63 37.42 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.82 -19.54 53.53 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.05 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -116.31 -3.41 11.95 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 117.718 0.759 . . . . 0.0 111.618 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.425 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 5.9 p -67.02 -32.85 5.19 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 117.615 -1.183 . . . . 0.0 113.381 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 95.6 Cg_endo -77.75 -25.17 8.04 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 122.093 1.783 . . . . 0.0 111.492 -177.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -79.73 -29.67 40.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.586 0.232 . . . . 0.0 110.449 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -80.57 -25.89 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -70.79 -36.23 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -72.02 -40.98 68.06 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.895 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -66.24 -29.73 70.03 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.98 -27.8 63.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 122.243 -0.286 . . . . 0.0 110.728 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -85.32 -31.4 23.04 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.278 0.49 . . . . 0.0 111.597 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.3 mt -71.29 -37.13 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -75.58 -32.61 60.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.948 0.499 . . . . 0.0 110.471 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.59 -45.17 69.23 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 119.456 -0.306 . . . . 0.0 110.336 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -60.51 -37.78 82.24 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.594 0.634 . . . . 0.0 111.609 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -72.31 -25.83 61.72 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.826 0.45 . . . . 0.0 111.148 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.22 -12.91 29.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.06 0.544 . . . . 0.0 111.576 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 tp -76.78 -25.84 53.81 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.143 0.577 . . . . 0.0 110.792 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.32 -14.92 63.34 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.307 0.243 . . . . 0.0 110.408 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.0 p -112.94 8.14 18.46 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.241 0.616 . . . . 0.0 111.789 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -87.23 113.05 22.62 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.025 0.375 . . . . 0.0 110.639 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -139.21 29.71 2.22 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.388 1.075 . . . . 0.0 109.07 176.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.2 -5.62 42.58 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.135 0.874 . . . . 0.0 113.816 -173.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.9 t70 52.0 31.04 8.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.27 1.035 . . . . 0.0 111.431 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 t -129.1 177.01 7.45 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.965 0.906 . . . . 0.0 109.482 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.46 143.96 55.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.176 0.512 . . . . 0.0 111.652 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -75.81 -29.89 58.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.343 0.657 . . . . 0.0 112.224 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -69.09 -36.41 77.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.658 0.663 . . . . 0.0 111.786 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -70.76 -33.76 71.12 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.59 0.632 . . . . 0.0 109.756 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 58.6 t90 -75.32 -27.98 59.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 122.752 0.421 . . . . 0.0 110.902 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.5 tp -85.81 -37.0 19.71 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.74 0.416 . . . . 0.0 111.312 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -61.63 -32.31 72.44 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.788 0.267 . . . . 0.0 110.344 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -75.56 -22.42 57.04 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.993 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.08 -36.79 75.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.775 0.716 . . . . 0.0 109.5 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.87 -38.74 57.6 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.0 p -78.24 -29.78 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 118.271 0.487 . . . . 0.0 110.801 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -75.28 -23.83 57.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.994 0.361 . . . . 0.0 110.159 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.8 m -79.17 -31.42 43.91 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.76 -29.83 62.44 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 117.56 0.164 . . . . 0.0 110.647 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -80.4 -28.6 37.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 119.444 -0.313 . . . . 0.0 110.999 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -17.26 35.23 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.58 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -74.72 -41.09 60.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.285 -0.259 . . . . 0.0 110.949 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.8 mt -79.94 -26.51 40.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.772 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.3 p -81.31 -23.21 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 CA-C-N 118.757 0.708 . . . . 0.0 110.315 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.96 -14.13 59.39 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -114.7 -19.65 10.98 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 122.486 0.315 . . . . 0.0 111.286 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.07 -21.97 47.32 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -109.44 11.18 25.16 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.542 0.671 . . . . 0.0 111.713 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -122.82 4.59 9.43 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.79 0.836 . . . . 0.0 110.935 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 38.2 tp -126.51 -13.56 5.97 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.812 0.445 . . . . 0.0 111.227 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.5 1.06 17.64 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.811 -0.555 . . . . 0.0 111.72 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.75 -7.67 59.62 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.763 0.425 . . . . 0.0 110.528 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.95 142.69 48.65 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -52.25 151.85 16.44 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.518 2.812 . . . . 0.0 111.913 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.6 mmt-85 -70.36 159.81 33.45 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.1 0.476 . . . . 0.0 111.392 -175.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.58 -8.01 77.15 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.7 t -156.02 138.39 14.84 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 117.695 0.747 . . . . 0.0 109.735 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 49.14 24.3 0.92 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.627 0.771 . . . . 0.0 112.845 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -84.01 2.4 39.21 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -76.34 149.51 37.0 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.382 0.273 . . . . 0.0 110.395 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -153.19 165.05 36.9 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.962 0.505 . . . . 0.0 110.682 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -100.56 151.11 21.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.888 0.475 . . . . 0.0 109.817 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 52.1 t60 . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.656 -1.164 . . . . 0.0 110.413 -178.126 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 120.368 0.128 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.2 m -69.88 169.18 13.67 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.075 0.55 . . . . 0.0 111.329 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -70.33 163.57 26.3 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -78.56 0.19 27.18 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.512 0.325 . . . . 0.0 111.858 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.4 mt -129.73 155.17 46.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.88 0.872 . . . . 0.0 109.124 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.9 m -139.93 173.5 11.46 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.594 0.758 . . . . 0.0 109.303 -176.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -55.29 -17.33 4.48 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.454 0.701 . . . . 0.0 112.046 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -67.04 -51.58 52.97 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 122.016 -0.428 . . . . 0.0 110.3 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.59 -26.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 122.993 0.517 . . . . 0.0 110.73 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -69.05 -29.02 67.06 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.02 -0.425 . . . . 0.0 110.532 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.5 t -82.31 -28.78 9.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 118.565 0.621 . . . . 0.0 110.105 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.32 -35.48 68.62 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.571 -0.706 . . . . 0.0 110.433 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -69.97 -37.29 75.75 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.311 0.244 . . . . 0.0 111.347 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 m -73.44 -23.76 19.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 121.771 -0.581 . . . . 0.0 111.078 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -78.38 -16.25 57.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.273 0.229 . . . . 0.0 110.576 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -91.91 3.91 54.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.67 0.788 . . . . 0.0 111.764 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.15 1.64 51.32 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.977 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.88 83.98 4.09 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.851 0.826 . . . . 0.0 109.442 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -67.11 -18.09 65.16 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.982 0.513 . . . . 0.0 110.675 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -60.75 -25.38 66.45 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.582 0.353 . . . . 0.0 110.69 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.12 -18.81 45.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.54 0.155 . . . . 0.0 111.056 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -76.7 -36.77 57.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.57 -40.59 97.34 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.83 -19.04 59.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.272 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.9 tp -83.51 -47.11 11.69 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.428 0.291 . . . . 0.0 111.242 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.04 -24.9 30.87 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.541 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.8 p -70.71 -26.98 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.32 0.964 . . . . 0.0 110.879 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -67.95 -31.62 71.5 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.84 -8.7 21.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -62.03 -29.2 70.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.334 0.515 . . . . 0.0 110.665 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -86.47 -30.53 21.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.044 -0.071 . . . . 0.0 110.955 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.29 -42.27 55.19 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 m -80.94 -25.32 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-N 118.306 0.503 . . . . 0.0 110.98 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.79 -22.09 62.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.083 0.402 . . . . 0.0 110.195 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -77.2 -41.63 40.68 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.87 -24.9 30.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -88.71 -19.38 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 118.343 0.519 . . . . 0.0 111.717 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.2 t -68.34 -9.37 47.43 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -90.32 -4.35 57.17 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.7 0.8 . . . . 0.0 111.66 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -122.4 -13.0 8.13 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.686 0.394 . . . . 0.0 111.864 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 m -144.0 154.53 58.4 Favored Pre-proline 0 N--CA 1.462 0.152 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.71 164.46 31.24 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.269 2.646 . . . . 0.0 111.08 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.8 p -66.34 -10.17 40.44 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.29 -17.95 56.36 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.175 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -116.37 -6.4 11.77 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 117.423 0.611 . . . . 0.0 111.691 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.413 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 9.9 p -66.34 -33.52 6.82 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 117.587 -1.197 . . . . 0.0 113.428 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 95.5 Cg_endo -76.13 -25.25 10.34 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 CA-C-N 122.212 1.826 . . . . 0.0 111.4 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -81.96 -29.42 32.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.631 0.253 . . . . 0.0 110.381 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.5 t -78.4 -26.94 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.1 t -71.74 -34.95 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 118.419 0.554 . . . . 0.0 109.531 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -72.96 -43.07 62.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -67.73 -26.49 66.17 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.234 0.47 . . . . 0.0 110.156 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.78 -29.32 63.19 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.58 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -85.14 -28.72 25.35 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.575 0.625 . . . . 0.0 111.113 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.6 mt -73.03 -37.92 54.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -75.41 -32.28 60.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.789 0.436 . . . . 0.0 110.613 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.85 -44.51 76.97 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.104 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -60.87 -37.15 81.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.587 0.63 . . . . 0.0 111.621 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -72.87 -25.26 61.03 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.758 0.423 . . . . 0.0 111.047 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.18 -11.03 28.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.144 0.577 . . . . 0.0 111.278 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.96 -23.64 55.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.228 0.611 . . . . 0.0 110.201 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.25 -11.07 56.51 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.261 0.224 . . . . 0.0 110.552 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -110.91 3.18 18.64 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.639 0.776 . . . . 0.0 111.672 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -74.38 141.27 45.13 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -136.07 7.62 3.17 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -175.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.63 14.85 82.07 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.43 -0.65 . . . . 0.0 113.677 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -70.75 -6.87 40.72 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.287 1.043 . . . . 0.0 111.295 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.2 t -150.87 164.4 36.37 Favored 'General case' 0 N--CA 1.458 -0.075 0 C-N-CA 124.321 1.049 . . . . 0.0 108.473 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.55 145.99 55.01 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -66.86 -33.72 76.22 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.304 -0.248 . . . . 0.0 111.605 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -69.41 -38.04 77.74 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.544 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.7 m -69.62 -37.96 77.05 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.8 t90 -69.05 -31.2 69.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.741 -0.208 . . . . 0.0 110.993 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.6 tp -83.22 -35.15 25.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.576 0.35 . . . . 0.0 111.313 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -63.01 -26.8 69.02 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.005 0.366 . . . . 0.0 110.209 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.64 -27.03 61.04 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 122.8 0.44 . . . . 0.0 111.318 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.2 mm -72.05 -36.25 56.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.94 -36.34 56.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -78.83 -28.87 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.475 0.579 . . . . 0.0 111.274 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.91 -25.28 52.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.152 0.433 . . . . 0.0 110.407 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.2 m -80.63 -28.14 37.03 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 122.448 -0.158 . . . . 0.0 110.597 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.16 -32.84 56.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.087 0.403 . . . . 0.0 111.205 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.45 -26.19 51.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -78.42 -23.49 46.63 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.454 0.302 . . . . 0.0 110.327 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -77.79 -35.37 51.6 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.612 0.365 . . . . 0.0 111.057 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.0 mt -75.63 -31.15 59.75 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 119.467 -0.301 . . . . 0.0 111.782 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.7 m -78.34 -22.03 13.35 Favored 'Isoleucine or valine' 0 C--N 1.337 0.052 0 CA-C-N 118.653 0.66 . . . . 0.0 110.402 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.19 -23.91 67.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -95.2 -27.4 15.55 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.82 0.448 . . . . 0.0 110.222 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.32 -4.96 65.55 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.88 -0.4 . . . . 0.0 112.194 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -124.87 10.72 8.3 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.538 0.669 . . . . 0.0 112.229 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -136.99 -22.61 1.18 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 122.826 0.451 . . . . 0.0 111.919 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.7 mt -128.37 10.69 6.27 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.24 0.616 . . . . 0.0 111.052 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -83.35 -19.36 36.26 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.604 0.362 . . . . 0.0 110.653 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 63.4 mt 53.73 19.37 1.82 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.166 1.387 . . . . 0.0 114.652 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.0 m -81.84 150.94 66.76 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 118.576 0.625 . . . . 0.0 110.531 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.74 167.66 26.7 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.922 3.081 . . . . 0.0 110.942 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -133.28 162.41 31.87 Favored 'General case' 0 C--N 1.338 0.076 0 C-N-CA 123.804 0.841 . . . . 0.0 110.06 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.73 0.9 89.92 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.3 m -102.56 2.44 36.19 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.24 0.616 . . . . 0.0 111.066 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -87.12 162.38 17.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.634 0.774 . . . . 0.0 110.836 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -142.41 11.9 1.93 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.915 0.486 . . . . 0.0 111.223 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 54.81 21.2 3.44 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.82 0.848 . . . . 0.0 112.802 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -147.1 154.73 41.5 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.326 0.651 . . . . 0.0 110.27 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -152.21 159.89 43.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.179 0.592 . . . . 0.0 110.07 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 14.3 p80 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.946 -179.065 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 120.579 0.228 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -142.01 25.35 1.94 Allowed 'General case' 0 C--N 1.339 0.132 0 CA-C-O 121.091 0.472 . . . . 0.0 111.012 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -78.24 -9.13 59.08 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.865 -0.522 . . . . 0.0 111.459 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 54.51 -172.65 0.05 OUTLIER 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.885 1.274 . . . . 0.0 112.843 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 43.2 mt -94.57 156.55 16.39 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.194 0.598 . . . . 0.0 110.665 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.1 m -140.07 172.96 12.01 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.734 0.814 . . . . 0.0 109.363 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -55.28 -17.34 4.44 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.164 0.585 . . . . 0.0 112.385 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -66.23 -53.18 40.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.111 -0.368 . . . . 0.0 110.418 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -84.48 -26.13 7.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.779 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -69.69 -28.99 66.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.642 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.1 t -82.26 -28.22 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 118.839 0.745 . . . . 0.0 109.894 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.85 -37.63 70.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.641 -0.662 . . . . 0.0 110.368 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -69.57 -36.16 76.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 122.057 -0.402 . . . . 0.0 111.76 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -73.62 -23.78 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.038 0 CA-C-N 118.299 0.5 . . . . 0.0 111.205 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -79.69 -14.64 58.62 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.408 0.283 . . . . 0.0 110.335 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -93.18 3.2 56.08 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.632 0.773 . . . . 0.0 112.028 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.54 1.24 43.5 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 119.75 -0.472 . . . . 0.0 113.345 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -92.69 84.24 4.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.025 0.912 . . . . 0.0 109.558 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -65.09 -20.11 66.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.655 0.382 . . . . 0.0 110.659 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -61.72 -24.54 66.86 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.142 0.577 . . . . 0.0 111.007 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.36 -18.79 40.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 119.62 -0.228 . . . . 0.0 110.873 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -77.38 -36.83 53.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.51 -41.95 98.07 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.9 mt -76.53 -18.41 58.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.628 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 tp -81.97 -42.87 18.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.713 0.233 . . . . 0.0 110.659 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 m -69.83 -27.03 31.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.538 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -66.23 -26.86 39.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 CA-C-N 119.859 1.209 . . . . 0.0 111.129 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -69.44 -33.27 72.7 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.016 0.436 . . . . 0.0 109.919 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -100.27 -8.71 23.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.349 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -61.55 -30.08 70.42 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.234 0.613 . . . . 0.0 110.824 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -86.75 -29.5 22.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 121.994 0.118 . . . . 0.0 111.084 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -76.35 -41.22 49.0 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 m -82.79 -24.86 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 118.062 0.392 . . . . 0.0 111.064 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.15 -25.23 63.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -76.81 -46.27 25.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.834 0.35 . . . . 0.0 110.817 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.06 -24.62 59.53 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.595 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.8 -19.95 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 118.139 0.427 . . . . 0.0 112.146 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.3 m -66.6 -9.93 40.41 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.36 0.527 . . . . 0.0 112.245 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -95.11 -3.75 47.46 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.229 0.468 . . . . 0.0 111.671 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -111.03 -20.63 12.34 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.854 0.462 . . . . 0.0 110.997 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -141.83 152.63 62.93 Favored Pre-proline 0 C--N 1.34 0.176 0 C-N-CA 124.057 0.943 . . . . 0.0 109.541 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.54 167.43 24.17 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.716 2.944 . . . . 0.0 111.249 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.7 m -65.58 -11.77 47.09 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.054 0.542 . . . . 0.0 112.418 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.81 -18.86 53.6 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.609 -0.55 . . . . 0.0 112.795 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.47 -6.98 11.71 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 117.808 0.804 . . . . 0.0 112.035 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.415 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 7.6 p -66.25 -36.04 11.95 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 83.2 Cg_endo -73.68 -24.37 15.88 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 CA-C-N 121.697 1.642 . . . . 0.0 111.246 -172.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.5 -30.49 29.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.07 -30.2 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 122.556 0.342 . . . . 0.0 110.133 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -72.16 -33.53 47.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -72.5 -42.9 64.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -65.59 -30.71 71.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.418 0.554 . . . . 0.0 109.595 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.57 -29.3 66.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 117.746 0.248 . . . . 0.0 110.952 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -85.18 -28.92 25.14 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.299 0.5 . . . . 0.0 111.385 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 99.2 mt -72.93 -36.87 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -77.76 -31.07 51.82 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.445 0.698 . . . . 0.0 111.015 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.67 -42.47 74.13 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.121 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -62.05 -38.33 88.34 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.536 0.607 . . . . 0.0 111.485 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.23 -25.78 62.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.622 0.369 . . . . 0.0 111.166 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.34 -10.53 29.86 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.967 0.507 . . . . 0.0 111.395 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.5 tp -75.24 -24.53 57.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.972 0.509 . . . . 0.0 110.249 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.09 -10.25 52.47 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.454 0.302 . . . . 0.0 110.473 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.0 m -110.83 0.75 17.36 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.647 0.779 . . . . 0.0 111.662 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -74.06 146.38 43.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.103 0.561 . . . . 0.0 109.68 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -134.74 4.81 3.35 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.4 15.67 80.22 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 118.169 0.441 . . . . 0.0 112.5 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -69.0 -11.01 60.39 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.65 0.725 . . . . 0.0 110.961 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 81.3 p -147.95 170.05 18.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.518 1.127 . . . . 0.0 108.928 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.06 145.0 54.85 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -66.21 -35.12 79.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.28 -0.262 . . . . 0.0 111.676 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -68.88 -37.15 78.86 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.737 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.0 m -69.41 -39.61 77.82 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -67.37 -32.96 74.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.95 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.3 tp -81.12 -34.11 32.77 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.726 0.41 . . . . 0.0 111.515 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.4 m-30 -64.0 -27.37 69.07 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.074 -0.391 . . . . 0.0 110.431 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -75.68 -25.04 56.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.165 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.5 mm -70.29 -39.25 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-N 118.296 0.498 . . . . 0.0 109.726 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.56 -37.06 57.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.06 -30.66 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-N 118.469 0.577 . . . . 0.0 111.43 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -76.07 -24.55 55.1 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.969 -0.457 . . . . 0.0 110.167 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.7 m -77.34 -29.37 53.4 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.08 62.5 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.877 0.308 . . . . 0.0 110.973 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.44 -29.7 57.08 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -83.63 -16.61 44.53 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.828 -0.169 . . . . 0.0 110.615 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -78.27 -36.42 46.81 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.904 -0.497 . . . . 0.0 110.394 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.0 mt -81.35 -17.68 48.29 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.8 p -85.77 -25.31 6.62 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 CA-C-N 118.675 0.671 . . . . 0.0 110.051 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.11 -26.96 60.65 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.456 -0.153 . . . . 0.0 110.921 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -103.04 -11.68 17.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.064 0.545 . . . . 0.0 110.091 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.69 -9.04 69.27 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.097 177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 -126.8 159.22 34.48 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.831 0.853 . . . . 0.0 110.084 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 -137.68 155.05 49.54 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 124.703 1.201 . . . . 0.0 108.314 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.0 mt 51.62 33.16 10.22 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.077 0.551 . . . . 0.0 110.241 -173.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -139.56 172.62 12.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.709 1.204 . . . . 0.0 109.018 -172.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.8 tp 61.67 28.9 17.91 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.926 0.891 . . . . 0.0 110.786 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.4 156.17 73.17 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 124.718 1.207 . . . . 0.0 108.956 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.63 158.71 48.68 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.821 2.348 . . . . 0.0 110.936 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.7 mmt-85 -120.86 162.6 19.55 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.764 0.826 . . . . 0.0 110.138 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.45 9.01 81.46 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.83 -0.428 . . . . 0.0 112.417 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.5 p -117.01 14.16 14.97 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.776 0.83 . . . . 0.0 111.393 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -115.98 161.8 18.32 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.245 0.618 . . . . 0.0 110.769 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -131.43 2.75 4.2 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.843 0.457 . . . . 0.0 111.674 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -151.54 167.02 29.37 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.547 0.739 . . . . 0.0 109.406 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.7 m80 55.11 -168.26 0.08 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.72 0.808 . . . . 0.0 111.64 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -138.22 155.19 48.89 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.796 0.438 . . . . 0.0 110.177 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.8 m80 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 117.393 -1.289 . . . . 0.0 110.227 -176.939 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 tpp . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 t -141.84 8.19 1.89 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.043 0.537 . . . . 0.0 111.327 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 55.63 13.79 1.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.327 1.051 . . . . 0.0 113.768 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 60.95 27.09 16.98 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.236 0.614 . . . . 0.0 111.304 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.2 mt -110.2 160.31 16.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.085 0.954 . . . . 0.0 109.786 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 m -139.79 173.12 11.85 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.746 0.818 . . . . 0.0 109.476 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -55.52 -17.67 5.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.154 0.582 . . . . 0.0 112.222 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.69 -52.81 40.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -85.94 -25.9 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 122.85 0.46 . . . . 0.0 110.882 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mp -69.44 -28.18 65.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.909 -0.494 . . . . 0.0 110.515 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.3 t -81.14 -28.54 10.9 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 CA-C-N 118.398 0.545 . . . . 0.0 109.839 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.458 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 38.8 mt-10 -72.45 -34.7 67.94 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.824 -0.547 . . . . 0.0 110.271 174.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -68.98 -39.79 79.2 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.688 0.395 . . . . 0.0 111.257 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 m -72.94 -24.16 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 117.698 0.226 . . . . 0.0 111.054 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -78.67 -20.5 50.07 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.887 0.312 . . . . 0.0 110.301 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -81.42 -5.22 57.68 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.328 0.651 . . . . 0.0 111.799 174.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.88 0.38 34.05 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.487 -0.618 . . . . 0.0 112.79 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -87.68 83.96 7.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.008 0.904 . . . . 0.0 109.471 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -66.39 -20.6 66.11 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.683 0.393 . . . . 0.0 110.6 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -60.77 -24.92 66.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.998 0.519 . . . . 0.0 110.834 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.26 -18.77 41.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 119.583 -0.246 . . . . 0.0 111.07 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -76.51 -36.85 57.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -62.49 -40.76 97.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.74 -18.76 59.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.521 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.0 tp -83.7 -47.81 10.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.39 0.276 . . . . 0.0 110.885 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.89 -25.08 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.383 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.3 p -70.37 -26.63 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 119.329 0.968 . . . . 0.0 110.681 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -68.65 -33.13 73.47 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -99.66 -8.91 23.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.352 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -62.62 -27.2 69.04 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.4 0.545 . . . . 0.0 110.609 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -86.12 -30.82 22.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -76.9 -42.23 40.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.3 m -81.59 -25.36 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 118.158 0.435 . . . . 0.0 110.911 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.86 -22.89 62.25 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.177 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.0 t -76.53 -43.38 39.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.3 -25.22 36.66 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 p -87.35 -18.45 8.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.089 0 CA-C-N 118.094 0.406 . . . . 0.0 111.226 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.2 t -68.21 -9.51 47.62 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 174.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -90.86 -3.87 57.03 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.659 0.784 . . . . 0.0 111.484 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.35 -14.45 8.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.75 0.42 . . . . 0.0 111.807 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.41 153.46 59.08 Favored Pre-proline 0 N--CA 1.462 0.148 0 C-N-CA 123.953 0.901 . . . . 0.0 109.466 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.72 164.5 31.07 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.559 2.839 . . . . 0.0 110.756 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.3 p -66.61 -10.11 42.41 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.06 -18.33 56.07 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 118.262 0.483 . . . . 0.0 112.093 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.36 -5.09 11.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.427 0.613 . . . . 0.0 111.451 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.425 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 5.2 p -67.3 -33.08 5.21 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 117.707 -1.139 . . . . 0.0 113.368 -177.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 97.0 Cg_endo -76.84 -25.25 9.28 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 CA-C-N 122.12 1.793 . . . . 0.0 111.687 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.4 -29.79 30.59 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -78.06 -25.84 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.97 -37.07 59.71 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -71.31 -42.85 68.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -67.83 -26.45 66.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.233 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.41 -27.9 61.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.668 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -85.26 -29.67 24.43 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.531 0.605 . . . . 0.0 111.069 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.99 -37.46 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 175.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -75.58 -32.93 60.54 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.197 0.599 . . . . 0.0 110.538 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.72 -42.75 77.21 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 119.141 -0.456 . . . . 0.0 110.733 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -62.49 -37.62 86.68 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.906 0.776 . . . . 0.0 111.255 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -71.53 -25.12 62.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.679 0.392 . . . . 0.0 111.014 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.98 -11.77 27.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.132 0.573 . . . . 0.0 111.508 176.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -74.72 -24.53 58.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 110.264 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.56 -10.79 58.0 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.276 0.23 . . . . 0.0 110.506 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -109.43 1.92 20.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.649 0.78 . . . . 0.0 111.722 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -74.45 147.66 41.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.092 0.557 . . . . 0.0 109.732 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -137.83 2.97 2.44 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.49 18.0 78.37 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.698 -0.501 . . . . 0.0 112.519 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -66.55 -11.74 54.43 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.051 0.926 . . . . 0.0 110.933 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.9 p -151.2 170.23 19.96 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.606 1.162 . . . . 0.0 109.054 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.17 147.76 52.84 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -67.49 -33.55 75.33 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -69.03 -37.64 78.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.67 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -69.65 -37.25 76.67 Favored 'General case' 0 C--O 1.227 -0.095 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -70.22 -32.18 69.93 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 122.246 0.218 . . . . 0.0 110.953 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.9 tp -81.89 -34.78 29.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.644 0.378 . . . . 0.0 111.319 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -63.63 -28.0 69.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -72.82 -26.04 61.35 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 122.817 0.447 . . . . 0.0 111.527 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mm -72.84 -38.38 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.159 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.85 -35.44 59.94 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 p -77.41 -31.87 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 118.344 0.52 . . . . 0.0 111.245 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -77.87 -23.96 48.67 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.038 0.381 . . . . 0.0 110.649 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.6 m -77.3 -30.45 54.17 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.44 -32.41 62.62 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.726 0.239 . . . . 0.0 111.415 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.53 -30.89 61.94 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -78.23 -26.33 47.3 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -72.4 -39.5 67.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 122.261 -0.274 . . . . 0.0 111.29 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -78.05 -29.16 49.13 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.16 -20.97 17.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 CA-C-N 118.95 0.796 . . . . 0.0 110.133 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.16 -14.78 61.43 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 119.486 -0.293 . . . . 0.0 111.045 175.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -101.08 -32.43 10.59 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.088 0.404 . . . . 0.0 111.39 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.68 -10.75 69.52 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.287 -0.73 . . . . 0.0 113.638 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -105.41 11.38 32.73 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.271 1.035 . . . . 0.0 112.701 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -74.95 131.53 40.75 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.6 mp 52.05 30.4 7.43 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.112 0.965 . . . . 0.0 111.686 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -66.77 -3.18 6.13 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.48 -10.61 59.78 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.114 0.415 . . . . 0.0 110.99 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.4 m -141.36 153.92 66.58 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 123.42 0.688 . . . . 0.0 110.378 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.09 -18.7 16.25 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.309 2.673 . . . . 0.0 110.97 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -157.05 150.08 23.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.123 0.969 . . . . 0.0 108.409 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.87 146.2 50.22 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.5 p -155.12 168.45 26.98 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 122.992 0.517 . . . . 0.0 110.615 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -135.5 14.29 3.45 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.278 0.631 . . . . 0.0 111.276 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.488 ' CG ' ' H ' ' A' ' 103' ' ' HIS . 11.9 t60 58.98 176.57 0.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.5 1.12 . . . . 0.0 112.392 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.488 ' H ' ' CG ' ' A' ' 102' ' ' HIS . 32.0 t-80 -146.29 160.42 42.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.898 0.479 . . . . 0.0 110.537 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -144.75 164.48 30.88 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.138 0.575 . . . . 0.0 110.726 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -127.9 4.54 5.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.883 0.473 . . . . 0.0 111.953 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.045 -1.455 . . . . 0.0 110.097 179.521 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.461 0.172 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -105.09 161.16 14.48 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.86 0.464 . . . . 0.0 110.792 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -147.78 151.54 36.19 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 122.944 0.498 . . . . 0.0 110.197 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -148.11 163.92 35.46 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.055 0.542 . . . . 0.0 109.919 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.7 mt -107.02 154.37 21.21 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.621 0.768 . . . . 0.0 110.901 -173.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.9 m -138.41 174.14 10.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.963 0.905 . . . . 0.0 109.299 -174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -54.94 -18.87 5.55 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.103 0.561 . . . . 0.0 112.284 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -65.79 -52.28 52.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 p -85.68 -25.6 6.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 122.795 0.438 . . . . 0.0 110.923 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 mp -71.67 -28.34 63.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.783 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.4 t -81.86 -28.97 9.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 118.442 0.565 . . . . 0.0 110.055 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.92 -37.15 72.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.719 -0.613 . . . . 0.0 110.206 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -69.82 -37.88 76.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.494 0.318 . . . . 0.0 111.532 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.21 -23.98 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 O-C-N 121.901 -0.499 . . . . 0.0 110.907 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -80.44 -14.62 58.14 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.21 -0.306 . . . . 0.0 110.398 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -93.13 3.65 55.34 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.623 0.769 . . . . 0.0 111.709 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.47 2.79 47.34 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.168 172.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -95.92 84.02 3.79 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.04 0.92 . . . . 0.0 110.086 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -65.58 -20.34 66.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.276 0.63 . . . . 0.0 110.966 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -61.02 -23.81 65.7 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 122.883 0.473 . . . . 0.0 110.871 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.87 -19.03 41.78 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.583 -0.246 . . . . 0.0 110.835 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -76.57 -37.23 56.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.5 -41.86 97.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -76.62 -18.49 58.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.451 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.2 tp -81.0 -43.04 20.22 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.253 -0.279 . . . . 0.0 110.805 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.07 -27.1 31.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.459 -175.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -65.72 -27.3 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 119.97 1.259 . . . . 0.0 111.216 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -70.56 -32.29 69.64 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.121 0.419 . . . . 0.0 109.954 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -100.02 -8.65 23.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.381 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -62.69 -27.97 69.61 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.421 0.689 . . . . 0.0 110.446 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -86.31 -29.67 22.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.475 -0.141 . . . . 0.0 110.859 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -76.67 -43.04 39.51 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -80.92 -25.89 10.84 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 O-C-N 121.928 -0.483 . . . . 0.0 111.145 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.55 -22.16 61.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.049 0.386 . . . . 0.0 110.104 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 t -76.51 -41.62 46.27 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.123 0.169 . . . . 0.0 110.58 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.96 -25.29 30.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 p -88.25 -18.95 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.036 0 CA-C-N 118.165 0.439 . . . . 0.0 111.55 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.5 t -68.61 -8.88 45.98 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 173.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -90.91 -3.87 56.99 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.033 0.933 . . . . 0.0 111.289 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -121.37 -17.5 7.59 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.831 0.452 . . . . 0.0 111.458 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.4 m -141.09 153.19 66.69 Favored Pre-proline 0 N--CA 1.463 0.176 0 C-N-CA 123.406 0.682 . . . . 0.0 109.441 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.82 165.62 29.12 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.718 2.946 . . . . 0.0 111.17 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.7 m -64.87 -11.02 32.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.09 -18.09 56.47 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.272 0.487 . . . . 0.0 112.07 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -116.64 -6.11 11.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.223 0.511 . . . . 0.0 111.642 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.423 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 6.0 p -67.66 -33.18 5.03 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.592 -1.195 . . . . 0.0 113.462 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 98.2 Cg_endo -76.51 -25.5 9.53 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 CA-C-N 122.23 1.832 . . . . 0.0 111.511 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.43 -30.39 30.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.415 -0.178 . . . . 0.0 110.593 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -77.15 -27.02 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.3 t -72.27 -35.44 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -72.05 -42.61 66.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.03 -28.04 67.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.24 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.99 -28.4 63.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.458 -0.305 . . . . 0.0 110.793 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -85.08 -29.97 24.44 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.576 0.625 . . . . 0.0 111.216 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 99.0 mt -72.05 -37.23 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -76.64 -32.37 57.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.118 0.567 . . . . 0.0 110.98 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.71 75.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.32 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -61.58 -38.7 88.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.383 0.538 . . . . 0.0 111.419 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -71.53 -26.12 62.52 Favored 'General case' 0 C--O 1.228 -0.05 0 C-N-CA 122.779 0.431 . . . . 0.0 111.175 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.8 -11.29 31.6 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.063 0.545 . . . . 0.0 111.462 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.1 tp -75.74 -25.81 56.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.689 0.396 . . . . 0.0 110.45 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.86 -10.7 59.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.511 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.6 m -113.37 0.08 14.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.796 0.838 . . . . 0.0 111.213 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.415 ' CZ ' ' HA2' ' A' ' 66' ' ' GLY . 25.4 t80 -72.91 147.35 45.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -121.23 -4.36 9.46 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.415 ' HA2' ' CZ ' ' A' ' 64' ' ' PHE . . . 69.27 17.33 72.12 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 118.092 0.405 . . . . 0.0 112.489 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.34 -8.31 45.14 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.712 0.756 . . . . 0.0 111.189 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.1 t -145.7 170.23 16.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.521 1.128 . . . . 0.0 108.027 176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.24 146.76 54.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.873 -0.517 . . . . 0.0 110.28 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -65.28 -34.09 77.52 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.507 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -68.59 -35.74 77.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.97 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.8 m -70.86 -37.84 73.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -70.47 -32.21 69.66 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.249 0.22 . . . . 0.0 111.016 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.8 tp -81.33 -34.77 31.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.602 0.361 . . . . 0.0 111.516 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.2 m-30 -63.52 -28.4 69.92 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 122.086 -0.383 . . . . 0.0 110.109 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -74.01 -25.08 59.69 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.552 0.341 . . . . 0.0 111.363 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.67 -38.24 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.02 -36.26 59.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -174.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.2 p -78.21 -31.23 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-N 118.329 0.513 . . . . 0.0 111.471 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.86 -24.02 52.65 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.137 0.426 . . . . 0.0 110.091 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.5 m -78.73 -29.64 45.43 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.77 -32.97 66.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.876 0.307 . . . . 0.0 110.906 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.24 -30.13 57.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.347 -0.22 . . . . 0.0 110.477 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -79.23 -24.68 42.91 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.674 0.274 . . . . 0.0 110.513 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -74.46 -35.39 63.3 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.431 0.292 . . . . 0.0 110.906 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.3 mt -77.43 -25.23 50.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.84 -19.0 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 118.922 0.783 . . . . 0.0 111.113 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.27 -12.57 60.31 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.09 -0.381 . . . . 0.0 111.073 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -118.05 -17.69 9.6 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.753 0.421 . . . . 0.0 111.284 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.38 -21.3 62.61 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -88.69 8.18 29.97 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.471 0.709 . . . . 0.0 111.054 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -92.98 -13.9 28.16 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.265 0.626 . . . . 0.0 110.579 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 93.7 mt -125.46 4.39 7.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.626 0.77 . . . . 0.0 111.286 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -137.15 147.54 46.03 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.0 tp 56.36 9.48 0.53 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.436 1.094 . . . . 0.0 112.371 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.44 135.32 14.81 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.13 163.76 37.38 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.441 2.761 . . . . 0.0 111.507 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -145.96 166.37 26.23 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.307 0.643 . . . . 0.0 110.68 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.66 -174.84 41.69 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.9 t -146.39 158.27 43.87 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 122.788 0.435 . . . . 0.0 110.39 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -149.94 163.12 38.92 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.418 0.687 . . . . 0.0 109.678 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -81.96 1.12 36.89 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -143.95 155.89 44.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.694 0.798 . . . . 0.0 109.92 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -152.35 163.93 38.48 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.784 0.433 . . . . 0.0 110.764 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -76.11 166.98 22.68 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.075 0.55 . . . . 0.0 111.103 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 . . . . . 0 C--O 1.252 1.222 0 CA-C-O 117.993 -1.003 . . . . 0.0 111.345 179.733 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.7 mtp . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.3 p -146.71 166.78 25.57 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.109 0.564 . . . . 0.0 110.472 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -134.27 19.63 3.69 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.132 0.573 . . . . 0.0 111.322 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -130.75 176.39 8.24 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.263 0.554 . . . . 0.0 110.499 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.3 mt -91.18 153.73 19.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.198 0.599 . . . . 0.0 111.107 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.4 m -138.26 173.79 11.24 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.926 0.891 . . . . 0.0 108.92 -175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -55.6 -17.1 4.87 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 123.384 0.673 . . . . 0.0 112.182 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.0 tp60 -66.36 -52.76 43.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 121.825 -0.547 . . . . 0.0 110.159 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 p -85.02 -25.79 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 C-N-CA 122.626 0.37 . . . . 0.0 110.9 -177.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.96 -28.54 64.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.079 -0.388 . . . . 0.0 110.841 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.2 t -82.44 -29.18 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 CA-C-N 118.683 0.674 . . . . 0.0 109.771 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.6 -40.92 76.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.514 -0.741 . . . . 0.0 109.971 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -68.39 -36.9 79.83 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.051 0.54 . . . . 0.0 112.204 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -70.47 -22.56 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.051 0 O-C-N 121.489 -0.757 . . . . 0.0 110.43 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -81.03 -14.56 57.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 119.592 -0.242 . . . . 0.0 110.67 174.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -80.41 -6.4 58.0 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.156 0.435 . . . . 0.0 110.759 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.61 4.02 52.57 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.6 0.619 . . . . 0.0 112.187 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -89.6 84.06 6.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.802 0.801 . . . . 0.0 109.487 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -65.68 -19.27 65.84 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.73 0.412 . . . . 0.0 110.774 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -60.32 -24.99 65.44 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 122.753 0.421 . . . . 0.0 110.977 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.57 -18.59 40.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.595 -0.24 . . . . 0.0 110.9 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -77.66 -37.38 50.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -61.32 -41.22 96.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.8 mt -76.94 -18.32 58.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.6 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.1 tp -82.13 -41.9 19.83 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.995 -0.441 . . . . 0.0 110.637 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.8 -26.76 28.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.587 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.4 m -66.58 -27.21 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.933 1.242 . . . . 0.0 111.253 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -70.84 -31.85 68.69 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -100.27 -8.73 23.13 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.376 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -62.95 -28.15 69.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.195 0.598 . . . . 0.0 110.514 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -86.61 -29.42 22.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.448 0.165 . . . . 0.0 110.749 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -77.39 -42.39 36.51 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -80.82 -26.69 11.04 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 118.127 0.421 . . . . 0.0 110.988 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.59 -22.53 62.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 t -77.78 -41.99 35.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.413 0.149 . . . . 0.0 110.668 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.6 -24.97 36.11 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.4 -18.8 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.18 0.446 . . . . 0.0 111.407 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -67.28 -11.09 56.62 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.986 -0.446 . . . . 0.0 110.043 173.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -86.7 -6.46 58.84 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.594 0.758 . . . . 0.0 111.535 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -122.66 -13.09 8.01 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -143.32 153.07 58.93 Favored Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 123.642 0.777 . . . . 0.0 109.211 173.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.08 164.0 33.72 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.66 2.907 . . . . 0.0 110.997 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.0 m -64.84 -10.64 29.78 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.06 -19.17 54.24 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 118.147 0.43 . . . . 0.0 112.166 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.18 -4.92 11.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.501 0.651 . . . . 0.0 111.619 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.423 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 5.3 p -67.43 -32.76 4.79 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.4 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 96.7 Cg_endo -76.78 -24.87 9.73 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 CA-C-N 122.095 1.784 . . . . 0.0 111.79 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.76 -30.8 32.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.289 -0.257 . . . . 0.0 110.528 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.1 t -77.98 -25.49 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.8 t -73.25 -35.42 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.38 -42.22 68.69 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -66.03 -30.84 71.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.78 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.1 -28.39 65.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.477 -0.296 . . . . 0.0 110.932 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -85.38 -28.73 24.97 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.519 0.6 . . . . 0.0 111.386 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.3 mt -72.7 -37.69 56.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -76.91 -32.81 57.66 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.105 0.562 . . . . 0.0 110.92 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.49 -42.16 79.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.279 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -61.82 -39.29 91.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.601 0.637 . . . . 0.0 111.542 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -70.82 -25.12 62.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.73 0.412 . . . . 0.0 111.289 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.22 -11.93 27.18 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.23 0.612 . . . . 0.0 111.419 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.0 tp -74.94 -24.82 58.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.005 0.522 . . . . 0.0 110.444 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.85 -10.75 51.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.271 0.228 . . . . 0.0 110.676 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.3 m -110.93 2.27 18.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.535 0.734 . . . . 0.0 111.7 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -72.65 143.82 48.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -136.43 7.9 3.1 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -175.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.55 14.61 79.51 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.611 -0.549 . . . . 0.0 112.868 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.5 -14.63 63.14 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.15 0.975 . . . . 0.0 110.842 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.6 m -142.77 164.93 28.76 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.914 1.286 . . . . 0.0 108.937 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.13 147.08 53.88 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -66.59 -34.73 78.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -175.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -69.56 -36.67 76.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.479 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.2 m -70.4 -34.23 72.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 62.0 t90 -76.21 -26.83 56.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 122.908 0.483 . . . . 0.0 111.325 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.8 tp -86.25 -35.19 20.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.22 -0.3 . . . . 0.0 111.289 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -63.91 -30.63 71.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -74.49 -22.17 59.21 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 117.999 0.363 . . . . 0.0 111.817 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.4 mm -70.26 -37.61 71.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.716 0.689 . . . . 0.0 109.504 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.97 -37.38 55.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 p -78.91 -29.35 14.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 CA-C-N 118.45 0.568 . . . . 0.0 111.336 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -76.13 -24.82 54.92 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.884 -0.51 . . . . 0.0 109.975 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.8 m -80.1 -30.74 39.21 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 122.206 -0.309 . . . . 0.0 110.246 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.56 -34.63 65.24 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.13 0.423 . . . . 0.0 111.016 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.44 -27.77 52.27 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -80.33 -25.91 39.04 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -72.64 -38.68 67.64 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.742 0.417 . . . . 0.0 111.135 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.3 mt -79.01 -26.42 43.26 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.1 m -84.64 -20.88 8.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 CA-C-N 119.038 0.835 . . . . 0.0 111.163 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.61 -10.3 59.77 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 122.25 -0.281 . . . . 0.0 111.287 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -118.63 -23.11 7.2 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.422 0.289 . . . . 0.0 111.337 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -98.82 -12.19 44.35 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.672 -0.515 . . . . 0.0 113.069 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -131.84 18.42 4.65 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 118.037 0.918 . . . . 0.0 111.896 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -61.91 -16.56 51.7 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.011 0.524 . . . . 0.0 111.919 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.0 mt -109.55 9.33 25.28 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.219 0.608 . . . . 0.0 112.212 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -142.19 -20.27 0.71 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 44.8 tp -100.96 -19.34 15.91 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.213 0.46 . . . . 0.0 111.11 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.409 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 59.8 t -86.88 -46.84 0.52 Allowed Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.21 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 96' ' ' VAL . 78.0 Cg_endo -77.42 -3.56 13.77 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.345 2.03 . . . . 0.0 111.344 174.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 52.37 29.96 7.53 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.542 1.137 . . . . 0.0 112.412 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.92 179.65 43.46 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.2 t -81.08 -12.34 59.31 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.678 0.391 . . . . 0.0 111.512 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.7 t60 52.72 28.53 6.38 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.829 0.852 . . . . 0.0 112.24 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -144.34 160.14 41.52 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.506 0.722 . . . . 0.0 110.098 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -140.44 164.14 30.94 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 122.978 0.511 . . . . 0.0 110.808 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -145.43 171.08 15.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.41 0.684 . . . . 0.0 110.512 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -135.69 160.91 37.07 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 123.02 0.528 . . . . 0.0 110.644 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.71 -179.123 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttp . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.644 -0.132 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.2 p -154.94 163.39 40.37 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.87 0.468 . . . . 0.0 110.736 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -149.9 149.92 31.14 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -150.38 171.05 17.62 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.173 0.511 . . . . 0.0 111.272 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 69.7 mt -109.82 155.61 21.41 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.369 1.067 . . . . 0.0 109.917 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.7 m -138.26 173.17 11.9 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.381 0.672 . . . . 0.0 109.692 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -55.18 -17.38 4.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.498 0.719 . . . . 0.0 112.11 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.44 -53.25 37.62 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.101 -0.375 . . . . 0.0 110.144 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 p -85.08 -26.14 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.965 0.506 . . . . 0.0 110.781 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.78 -28.66 64.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.758 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.7 t -82.22 -28.78 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 118.791 0.723 . . . . 0.0 110.013 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.93 -37.65 72.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.584 -0.697 . . . . 0.0 110.401 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -71.64 -35.4 70.38 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.133 -0.354 . . . . 0.0 111.952 -175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -73.24 -23.88 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.174 0.443 . . . . 0.0 111.036 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -80.13 -14.96 58.07 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -92.39 3.32 55.68 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.47 0.708 . . . . 0.0 111.922 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.06 0.11 41.42 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.583 -0.565 . . . . 0.0 113.471 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -93.95 84.15 4.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.164 0.982 . . . . 0.0 109.294 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.2 tm0? -65.66 -19.91 66.09 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.82 0.448 . . . . 0.0 110.438 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -62.57 -22.44 66.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.102 0.561 . . . . 0.0 111.119 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.66 -18.78 43.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.842 0.292 . . . . 0.0 110.494 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -76.88 -36.11 56.97 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -61.98 -40.39 95.43 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.96 -19.07 59.04 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.292 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 tp -83.67 -48.08 10.55 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 119.634 -0.222 . . . . 0.0 111.126 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -66.72 -25.04 33.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.616 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.28 -26.74 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 119.399 1.0 . . . . 0.0 111.083 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -68.72 -31.68 70.93 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -101.52 -9.01 21.4 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -62.08 -28.38 69.57 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.389 0.54 . . . . 0.0 110.332 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -86.69 -31.39 21.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.716 -0.105 . . . . 0.0 110.716 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -75.74 -42.17 51.26 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -80.84 -25.22 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 O-C-N 121.739 -0.601 . . . . 0.0 110.873 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.39 -23.43 63.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.115 0.416 . . . . 0.0 110.149 176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -76.27 -44.47 37.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 pp -79.05 -25.21 43.2 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 p -88.51 -17.95 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 118.108 0.413 . . . . 0.0 111.626 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.7 t -67.17 -9.36 39.17 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.941 -0.474 . . . . 0.0 110.009 173.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -86.71 -7.65 58.11 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.346 0.659 . . . . 0.0 111.501 176.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -120.9 -13.8 8.58 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 m -144.42 154.23 56.54 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 124.152 0.981 . . . . 0.0 109.182 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.62 164.45 33.0 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.368 2.712 . . . . 0.0 110.881 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -66.51 -9.96 39.96 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.11 -19.14 54.21 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.05 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -116.35 -5.2 11.79 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.554 0.677 . . . . 0.0 111.621 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.427 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 5.0 p -66.39 -32.69 5.63 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.67 -1.157 . . . . 0.0 113.703 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 91.4 Cg_endo -76.75 -25.46 9.2 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 CA-C-N 121.989 1.746 . . . . 0.0 111.458 -176.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.06 -30.39 31.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.132 -0.355 . . . . 0.0 110.57 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.2 t -75.53 -27.21 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.92 -35.74 55.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -71.85 -43.17 65.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -67.28 -27.91 67.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.089 0.404 . . . . 0.0 110.18 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.62 -27.17 61.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.7 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -84.58 -31.32 24.39 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.538 0.608 . . . . 0.0 110.918 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.9 mt -70.08 -36.94 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -78.03 -33.75 50.9 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.443 0.297 . . . . 0.0 110.921 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.29 -39.85 89.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.585 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -64.94 -36.77 85.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.521 0.601 . . . . 0.0 111.07 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -71.58 -17.74 62.27 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.943 0.497 . . . . 0.0 110.78 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.28 -10.8 17.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.137 0.575 . . . . 0.0 111.439 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.1 tp -76.06 -23.95 55.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.279 0.631 . . . . 0.0 110.155 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.62 -9.12 47.82 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.663 0.385 . . . . 0.0 110.463 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.1 m -113.17 4.8 16.72 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.114 0.966 . . . . 0.0 111.528 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -71.53 145.36 49.17 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -132.58 -0.45 3.55 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.34 15.25 80.3 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.666 -0.519 . . . . 0.0 113.378 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -69.39 -8.18 44.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.297 1.049 . . . . 0.0 111.12 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.3 p -148.26 166.72 27.12 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.663 1.185 . . . . 0.0 108.661 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 147.89 51.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 122.124 -0.36 . . . . 0.0 110.266 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -66.2 -33.83 76.64 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -175.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -69.76 -36.51 75.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.705 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.3 m -70.78 -34.31 71.66 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -74.23 -28.84 61.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.061 0.544 . . . . 0.0 110.947 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.7 tp -86.24 -35.36 20.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.558 0.343 . . . . 0.0 111.387 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -62.74 -33.62 75.51 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -74.86 -21.86 59.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.678 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.8 mm -68.71 -39.91 80.89 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 118.836 0.744 . . . . 0.0 109.231 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.04 -34.47 64.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.65 -30.92 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.082 0 CA-C-N 118.713 0.688 . . . . 0.0 111.05 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -78.51 -19.02 53.89 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.979 -0.451 . . . . 0.0 110.522 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 81.4 m -78.64 -31.45 46.89 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.66 -35.55 62.81 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.743 0.247 . . . . 0.0 111.188 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -77.67 -24.03 49.45 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -86.8 -18.76 30.24 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.361 -0.212 . . . . 0.0 111.111 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -78.23 -36.55 46.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.002 -0.436 . . . . 0.0 110.818 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.7 mt -82.4 -25.86 33.35 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.0 p -79.95 -28.25 12.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 CA-C-N 118.447 0.567 . . . . 0.0 110.125 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.51 -17.12 60.2 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 122.5 -0.125 . . . . 0.0 111.029 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -111.11 -8.32 14.43 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.751 0.42 . . . . 0.0 110.586 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -93.78 -14.59 52.21 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.45 -0.639 . . . . 0.0 112.045 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -112.53 -15.69 13.01 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 117.987 0.894 . . . . 0.0 112.502 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtp85 -96.11 131.31 42.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.159 0.436 . . . . 0.0 110.323 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.3 mp 52.43 33.33 12.89 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.921 0.888 . . . . 0.0 111.795 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -126.0 144.85 50.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.174 0.59 . . . . 0.0 110.062 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.3 mp -97.44 48.79 1.03 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.085 0.954 . . . . 0.0 110.66 -175.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.98 133.66 89.92 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.4 5.95 3.87 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.13 3.22 . . . . 0.0 112.804 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -139.83 148.48 42.19 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 123.072 0.549 . . . . 0.0 110.212 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.52 154.27 6.42 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 123.76 0.695 . . . . 0.0 111.542 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.3 p -154.82 172.69 17.58 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.818 0.447 . . . . 0.0 110.595 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -112.69 157.25 21.51 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.214 0.606 . . . . 0.0 110.279 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -150.32 167.63 26.45 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.63 0.372 . . . . 0.0 110.504 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -93.37 5.66 50.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.048 0.539 . . . . 0.0 112.417 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -139.18 163.27 32.89 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.021 0.528 . . . . 0.0 110.465 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -82.42 167.53 18.38 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.581 0.352 . . . . 0.0 111.411 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 117.727 -1.13 . . . . 0.0 110.3 -179.944 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -140.24 156.31 46.54 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.236 0.614 . . . . 0.0 110.262 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -152.82 169.49 22.66 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.981 0.42 . . . . 0.0 110.693 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -131.19 8.43 4.71 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.23 0.612 . . . . 0.0 111.627 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.8 mt -127.28 156.15 42.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.953 0.501 . . . . 0.0 109.817 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.4 m -139.89 172.76 12.3 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.929 0.892 . . . . 0.0 109.788 -175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -55.29 -17.13 4.13 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.988 0.515 . . . . 0.0 112.165 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -66.96 -51.2 58.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.111 -0.368 . . . . 0.0 110.226 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.57 -26.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 122.772 0.429 . . . . 0.0 110.818 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.64 -29.16 67.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.252 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.66 -28.66 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 118.611 0.641 . . . . 0.0 110.154 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.94 -35.07 69.5 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.598 -0.689 . . . . 0.0 110.269 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -70.6 -37.37 73.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.451 0.3 . . . . 0.0 111.647 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -73.09 -23.69 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 118.139 0.427 . . . . 0.0 111.291 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -79.64 -16.42 55.81 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.362 0.265 . . . . 0.0 110.608 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -91.72 3.36 55.27 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.939 0.896 . . . . 0.0 111.88 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.25 3.11 48.03 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.782 -0.454 . . . . 0.0 113.28 173.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -97.99 83.64 3.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 117.923 0.862 . . . . 0.0 109.526 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 tm0? -67.01 -17.73 65.05 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.158 0.583 . . . . 0.0 110.62 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -60.67 -24.6 65.72 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.85 0.46 . . . . 0.0 110.927 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.0 -18.92 41.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 119.639 -0.22 . . . . 0.0 110.892 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -76.76 -37.22 56.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.26 -39.85 94.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.823 0.344 . . . . 0.0 110.282 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.4 -18.95 58.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.808 0.443 . . . . 0.0 111.335 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -83.48 -47.09 11.74 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.775 0.43 . . . . 0.0 111.008 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -69.5 -24.44 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.881 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.47 -26.27 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 119.231 0.923 . . . . 0.0 110.62 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -67.78 -33.93 75.8 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -97.7 -8.93 27.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.41 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -63.58 -29.49 70.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.357 -0.839 . . . . 0.0 110.479 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -86.81 -32.04 20.53 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -83.87 -32.16 25.35 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.32 -38.41 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.24 -25.78 68.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.919 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.3 t -72.9 -48.04 40.63 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.007 0.367 . . . . 0.0 110.942 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 pp -79.34 -27.17 42.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.553 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 p -84.93 -15.35 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 117.715 0.234 . . . . 0.0 111.463 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.4 t -68.34 -11.86 60.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.977 -0.452 . . . . 0.0 109.973 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -84.8 -6.76 59.36 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.963 0.505 . . . . 0.0 111.686 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -122.31 -12.52 8.23 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 m -146.31 153.96 48.95 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 123.509 0.723 . . . . 0.0 109.118 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.19 162.76 36.99 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.469 2.779 . . . . 0.0 111.07 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.3 p -65.08 -10.14 27.95 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.18 -19.04 54.46 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.194 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -116.15 -5.03 11.9 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.591 0.696 . . . . 0.0 111.224 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.419 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 6.3 p -66.85 -32.3 4.83 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -176.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 85.0 Cg_endo -78.17 -22.81 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 CA-C-N 121.789 1.674 . . . . 0.0 111.162 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -81.56 -28.82 33.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.526 0.203 . . . . 0.0 110.499 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.97 -27.79 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.58 -37.06 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -70.18 -42.91 71.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.3 -27.25 65.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.23 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -35.45 70.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -74.98 -33.7 61.9 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 118.256 0.48 . . . . 0.0 111.788 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.3 mt -70.23 -38.73 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -74.38 -31.95 62.55 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.144 0.578 . . . . 0.0 110.462 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.32 -44.85 70.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.249 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -61.36 -37.14 82.29 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.913 0.779 . . . . 0.0 111.329 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -71.65 -25.88 62.32 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 122.663 0.385 . . . . 0.0 110.989 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.23 -11.18 28.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.145 0.578 . . . . 0.0 111.393 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.9 tp -75.36 -24.45 57.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.243 0.617 . . . . 0.0 110.277 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.99 -10.77 53.12 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 173.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.7 m -108.22 3.76 24.0 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.668 0.787 . . . . 0.0 111.856 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -78.03 147.43 34.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.11 0.564 . . . . 0.0 109.994 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -135.07 3.97 3.2 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.34 15.37 78.94 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.678 -0.512 . . . . 0.0 112.556 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.17 -9.53 58.23 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.956 0.878 . . . . 0.0 110.75 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.1 p -147.04 169.37 19.38 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.571 1.149 . . . . 0.0 109.1 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.68 144.69 52.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.16 -0.337 . . . . 0.0 110.276 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -67.21 -33.59 75.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -69.72 -34.89 74.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.037 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 88.5 m -76.03 -32.66 59.45 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 57.3 t90 -72.92 -28.0 62.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.56 0.344 . . . . 0.0 110.66 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.5 tp -85.87 -37.45 19.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.394 0.277 . . . . 0.0 111.167 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -69.33 -20.6 63.87 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.942 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -77.94 -21.89 50.38 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.445 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.9 mm -71.63 -37.42 63.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.82 -39.64 66.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.56 -29.01 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 118.181 0.446 . . . . 0.0 111.07 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -76.46 -23.62 53.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.172 -0.33 . . . . 0.0 110.479 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.5 m -80.16 -29.12 38.73 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.27 -33.14 61.22 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.322 -0.236 . . . . 0.0 111.22 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -75.98 -28.58 57.92 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -76.41 -22.26 54.93 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 174.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -78.33 -36.23 46.61 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.073 -0.392 . . . . 0.0 110.783 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.5 mt -72.57 -24.68 61.14 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.398 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.7 -18.9 8.06 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 CA-C-N 118.906 0.775 . . . . 0.0 111.052 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.42 -27.19 62.18 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.124 0.42 . . . . 0.0 110.267 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -100.93 -24.67 14.3 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.962 0.505 . . . . 0.0 110.62 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.14 -24.01 74.6 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -90.27 4.21 51.33 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.94 0.496 . . . . 0.0 111.379 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp-105 -120.6 12.01 11.4 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.904 0.882 . . . . 0.0 109.92 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.4 tp -144.9 13.28 1.47 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.383 1.073 . . . . 0.0 110.037 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -68.18 -21.93 64.86 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.746 -0.596 . . . . 0.0 112.051 -174.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.9 tp -150.17 -30.68 0.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.225 -0.297 . . . . 0.0 111.28 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.3 p -152.4 137.43 10.93 Favored Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.56 129.19 18.43 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.763 2.309 . . . . 0.0 110.882 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 51.63 17.88 0.64 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.607 1.163 . . . . 0.0 113.958 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -119.62 -1.04 13.69 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 118.052 0.387 . . . . 0.0 112.329 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.5 t -84.79 158.19 20.77 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.599 0.699 . . . . 0.0 111.045 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -148.57 160.57 42.98 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.502 0.721 . . . . 0.0 110.267 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -137.38 15.06 2.98 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.116 0.566 . . . . 0.0 111.146 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -78.82 158.95 28.06 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.957 0.503 . . . . 0.0 110.805 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -134.52 12.95 3.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.459 0.704 . . . . 0.0 111.423 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -72.55 155.97 39.5 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.782 0.433 . . . . 0.0 110.733 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 79.0 t60 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 117.107 -1.425 . . . . 0.0 110.293 -179.256 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 ttp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.8 p -135.83 -1.35 2.48 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.904 0.481 . . . . 0.0 111.903 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 47.58 25.77 0.71 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.486 1.514 . . . . 0.0 114.261 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -144.84 170.64 15.73 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-O 121.229 0.538 . . . . 0.0 111.499 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.2 mt -96.27 154.12 17.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.828 0.851 . . . . 0.0 109.665 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.3 m -138.84 172.81 12.31 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.588 0.755 . . . . 0.0 109.39 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -55.27 -17.21 4.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.087 0.555 . . . . 0.0 112.261 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -65.21 -53.52 43.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.725 0.298 . . . . 0.0 110.203 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 p -85.5 -26.23 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 123.038 0.535 . . . . 0.0 111.006 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.02 -28.83 64.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 122.065 -0.397 . . . . 0.0 110.957 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.7 t -82.58 -28.19 8.63 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 CA-C-N 118.562 0.619 . . . . 0.0 110.153 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 42.9 mt-10 -71.37 -35.74 71.2 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.561 -0.712 . . . . 0.0 110.36 175.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -71.22 -38.78 71.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.654 0.382 . . . . 0.0 111.637 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.05 -24.22 22.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 O-C-N 121.92 -0.488 . . . . 0.0 110.81 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -78.39 -18.78 54.56 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -79.12 -5.84 55.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.336 0.654 . . . . 0.0 111.21 172.135 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.95 2.54 48.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 123.235 0.445 . . . . 0.0 112.61 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.88 83.99 7.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 117.915 0.858 . . . . 0.0 109.505 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -64.98 -19.87 66.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.911 0.484 . . . . 0.0 110.714 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -60.27 -25.05 65.41 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.865 0.466 . . . . 0.0 111.096 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.89 -18.93 38.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.285 -0.259 . . . . 0.0 111.078 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -77.17 -36.93 54.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.74 -42.14 96.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.4 mt -76.2 -18.32 59.12 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.9 tp -82.27 -41.6 19.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.906 0.321 . . . . 0.0 111.009 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.2 m -72.26 -24.7 22.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.739 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.26 -26.87 37.23 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-N 119.915 1.234 . . . . 0.0 110.884 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -69.91 -31.7 69.61 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -99.49 -8.76 24.21 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.328 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -62.98 -29.7 71.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.186 -0.946 . . . . 0.0 110.853 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -86.87 -32.09 20.42 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.379 0.14 . . . . 0.0 111.379 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -81.06 -33.69 33.26 Favored 'General case' 0 CA--C 1.527 0.082 0 O-C-N 122.037 -0.414 . . . . 0.0 111.995 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -74.88 -37.18 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.513 0.725 . . . . 0.0 109.415 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.47 -27.22 69.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.531 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -73.67 -49.41 26.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.945 0.339 . . . . 0.0 111.191 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.23 -25.02 57.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.151 -0.343 . . . . 0.0 111.211 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.415 ' CG1' HG23 ' A' ' 46' ' ' VAL . 1.4 p -86.76 -16.86 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.2 m -66.41 -12.4 56.82 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.807 -0.558 . . . . 0.0 111.669 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -92.87 -3.68 54.2 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.673 0.67 . . . . 0.0 111.941 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -113.11 -19.52 11.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.714 0.406 . . . . 0.0 111.419 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 m -142.65 152.87 60.8 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 123.472 0.709 . . . . 0.0 109.485 173.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.15 168.82 20.95 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.614 2.876 . . . . 0.0 111.446 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.9 m -65.14 -11.65 42.49 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.106 0.562 . . . . 0.0 112.404 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.8 -19.31 51.99 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.832 -0.427 . . . . 0.0 112.986 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -116.22 -5.64 11.85 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.601 0.701 . . . . 0.0 112.122 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.425 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 4.0 p -64.7 -34.73 11.34 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 87.5 Cg_endo -73.9 -25.52 14.2 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 CA-C-N 121.738 1.656 . . . . 0.0 111.33 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.03 -27.68 28.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 122.449 -0.157 . . . . 0.0 110.735 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.4 t -80.45 -29.98 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.0 t -69.25 -35.96 70.33 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.84 -44.03 70.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -67.44 -30.3 69.99 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.834 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.34 -34.84 76.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -75.96 -34.41 59.83 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.105 0.412 . . . . 0.0 111.764 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.5 mt -71.01 -36.35 63.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -77.1 -33.29 56.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.248 0.619 . . . . 0.0 110.333 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.54 82.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 119.323 -0.37 . . . . 0.0 110.16 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -63.34 -37.71 88.33 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.66 0.664 . . . . 0.0 111.262 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -70.57 -20.07 62.82 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 122.862 0.465 . . . . 0.0 111.358 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 -10.43 18.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.01 0.524 . . . . 0.0 111.106 177.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.07 -24.06 58.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.282 0.633 . . . . 0.0 110.159 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.06 -9.8 43.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.4 m -111.8 1.43 16.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.76 0.824 . . . . 0.0 111.454 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -74.26 147.54 42.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -146.45 13.67 1.23 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.07 16.4 80.6 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-O 119.654 -0.526 . . . . 0.0 113.119 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -67.17 -13.71 62.22 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.235 1.018 . . . . 0.0 110.555 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.3 p -151.92 169.49 22.17 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.615 1.166 . . . . 0.0 108.907 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.21 144.22 56.1 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -65.09 -33.53 76.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 119.577 -0.249 . . . . 0.0 111.664 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -69.96 -37.61 75.85 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.379 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.1 m -70.39 -37.84 74.58 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -68.77 -33.43 73.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.87 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.8 tp -79.09 -35.91 41.59 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.178 0.191 . . . . 0.0 111.198 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -69.43 -20.28 63.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.215 -0.303 . . . . 0.0 111.593 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -74.0 -26.44 60.44 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.4 mm -73.76 -36.1 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.08 -36.91 64.32 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 p -81.35 -28.74 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 118.119 0.418 . . . . 0.0 110.93 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -76.7 -25.41 53.57 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 117.817 0.28 . . . . 0.0 110.359 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.3 m -79.21 -29.73 42.98 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.92 -33.5 63.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.259 -0.276 . . . . 0.0 111.369 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -76.39 -31.07 57.76 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -74.91 -24.42 58.52 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -76.66 -37.12 56.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.484 0.314 . . . . 0.0 111.046 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.5 mt -72.31 -23.74 61.22 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.884 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.3 m -89.43 -21.89 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-N 118.783 0.72 . . . . 0.0 111.336 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.14 -22.06 60.59 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.064 0.393 . . . . 0.0 111.331 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -111.23 -12.8 14.06 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.112 0.565 . . . . 0.0 110.277 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.18 -2.29 64.24 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 119.561 -0.577 . . . . 0.0 112.665 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -116.39 1.21 12.98 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 118.128 0.964 . . . . 0.0 112.458 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -70.14 129.44 39.41 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 52.6 23.02 2.42 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.733 0.813 . . . . 0.0 111.888 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -134.39 2.13 3.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.931 0.492 . . . . 0.0 111.086 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 45.7 tp -128.59 -16.09 4.36 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.07 0.548 . . . . 0.0 110.894 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.2 p -153.0 136.11 9.72 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.21 1.44 7.27 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.935 3.09 . . . . 0.0 112.899 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -122.52 21.0 10.29 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.901 0.88 . . . . 0.0 110.966 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.9 173.51 30.99 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 112.136 -0.385 . . . . 0.0 112.136 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 63.4 p -151.88 173.77 14.4 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.696 0.798 . . . . 0.0 109.979 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -95.6 -3.86 45.61 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.779 0.432 . . . . 0.0 111.664 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -150.57 152.09 33.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.317 0.647 . . . . 0.0 109.965 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 49.3 t60 53.39 26.6 5.52 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.43 0.692 . . . . 0.0 111.52 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -84.95 6.78 23.64 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.996 0.919 . . . . 0.0 112.038 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -138.33 153.66 48.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.434 0.694 . . . . 0.0 110.002 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 48.4 m80 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.53 -176.494 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 110.689 -0.115 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -148.26 162.16 40.05 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.369 0.668 . . . . 0.0 110.351 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -108.7 0.43 20.56 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.252 0.621 . . . . 0.0 111.42 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -95.83 176.87 5.97 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.509 0.724 . . . . 0.0 110.135 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.0 mt -116.57 151.61 35.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.002 0.43 . . . . 0.0 110.89 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.3 m -139.85 173.78 11.18 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 124.286 1.034 . . . . 0.0 109.278 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -55.29 -18.04 5.64 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.257 0.623 . . . . 0.0 112.437 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -65.85 -52.45 50.22 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.82 -0.55 . . . . 0.0 110.041 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -85.22 -26.03 6.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 C-N-CA 122.704 0.402 . . . . 0.0 111.022 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.73 -27.99 64.38 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.887 -0.508 . . . . 0.0 110.803 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.0 t -81.84 -28.63 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.04 0 CA-C-N 118.833 0.742 . . . . 0.0 110.077 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.72 -36.66 70.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.707 -0.62 . . . . 0.0 110.461 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -71.15 -35.89 71.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -72.71 -25.05 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 118.098 0.408 . . . . 0.0 110.945 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -79.49 -14.81 58.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.172 0.189 . . . . 0.0 110.521 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -92.74 3.23 56.01 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.908 0.883 . . . . 0.0 112.143 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.81 -0.49 39.07 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.558 172.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -93.47 84.06 4.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.107 0.953 . . . . 0.0 109.633 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -66.33 -19.98 65.96 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.52 0.328 . . . . 0.0 110.467 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -62.26 -23.08 66.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.218 0.607 . . . . 0.0 111.137 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.83 -18.92 42.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 117.786 0.266 . . . . 0.0 110.533 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -77.46 -36.63 52.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -61.45 -41.18 96.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -76.92 -18.54 58.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.593 0.357 . . . . 0.0 111.507 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.8 tp -81.41 -42.71 20.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 122.328 -0.232 . . . . 0.0 110.593 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.4 m -71.77 -24.39 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.863 -176.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.6 -26.45 35.45 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 119.944 1.247 . . . . 0.0 111.012 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -69.9 -31.73 69.68 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -99.03 -8.85 24.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.343 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -63.07 -30.06 71.3 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.254 -0.904 . . . . 0.0 110.786 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -86.92 -31.73 20.54 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -81.27 -35.43 31.14 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.138 -0.351 . . . . 0.0 111.808 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.1 t -72.39 -38.57 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.493 0.717 . . . . 0.0 109.175 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.49 -24.48 67.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.195 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.2 t -73.97 -45.7 48.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.297 -0.252 . . . . 0.0 111.088 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 pp -81.61 -28.29 33.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.726 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -83.78 -15.88 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 117.954 0.343 . . . . 0.0 111.552 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -68.89 -11.61 60.75 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.922 -0.486 . . . . 0.0 109.802 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -86.01 -4.72 59.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.245 0.618 . . . . 0.0 111.409 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.84 -16.12 7.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.008 0.523 . . . . 0.0 112.295 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.76 154.51 62.65 Favored Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 123.671 0.789 . . . . 0.0 109.517 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.72 164.01 32.98 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.671 2.914 . . . . 0.0 111.013 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.0 p -66.05 -10.33 39.04 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.56 -19.13 55.46 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.629 -0.54 . . . . 0.0 111.987 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.45 -5.08 11.74 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.68 0.74 . . . . 0.0 111.53 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.43 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 5.5 p -67.08 -32.8 5.1 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 75.3 Cg_endo -78.18 -22.8 9.52 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.699 1.643 . . . . 0.0 111.384 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.48 -28.65 31.06 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.308 -0.245 . . . . 0.0 110.492 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.9 t -77.94 -28.68 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.02 -36.85 75.87 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -71.27 -43.4 67.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.47 -27.59 66.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.142 0.428 . . . . 0.0 110.266 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.4 69.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -72.22 -35.37 68.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.491 0.587 . . . . 0.0 111.493 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.0 -40.99 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -76.7 -28.85 56.03 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.552 0.341 . . . . 0.0 111.143 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.95 -40.66 75.3 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 119.25 -0.405 . . . . 0.0 110.006 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.58 -38.22 89.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.846 0.748 . . . . 0.0 111.295 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.03 -24.65 62.4 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.977 0.511 . . . . 0.0 111.027 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.82 -11.26 27.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.025 0.53 . . . . 0.0 111.393 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.6 tp -75.29 -24.29 57.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.217 0.607 . . . . 0.0 110.138 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.15 -11.1 56.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.79 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.0 m -110.36 4.56 20.81 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.559 0.744 . . . . 0.0 111.615 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -73.99 145.07 44.89 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.85 3.25 3.2 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.84 13.99 81.92 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.457 -0.635 . . . . 0.0 113.46 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -72.28 -5.55 36.87 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.32 1.06 . . . . 0.0 111.13 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.4 p -149.82 168.68 23.04 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.322 1.049 . . . . 0.0 109.022 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.83 146.5 51.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.125 -0.359 . . . . 0.0 110.154 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -66.37 -33.37 75.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -70.41 -36.86 74.28 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.421 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.0 m -71.84 -33.23 68.28 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -75.46 -27.25 58.82 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.381 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 tp -86.02 -35.94 20.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.377 0.271 . . . . 0.0 111.293 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -70.21 -20.64 63.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.083 -0.386 . . . . 0.0 111.745 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -76.63 -24.19 53.37 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.494 0.588 . . . . 0.0 110.56 172.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.8 mm -70.69 -41.2 77.63 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.7 74.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.67 -29.91 16.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 118.193 0.452 . . . . 0.0 110.791 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.65 -19.14 53.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.844 -0.535 . . . . 0.0 110.409 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -83.1 -26.73 30.75 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.069 0.395 . . . . 0.0 110.034 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.12 -36.13 64.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.94 -0.475 . . . . 0.0 110.333 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -74.03 -28.59 61.5 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -74.89 -29.85 61.12 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.961 0.904 . . . . 0.0 111.065 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -77.47 -35.07 54.11 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.424 0.29 . . . . 0.0 111.102 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -79.42 -24.26 42.63 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.3 m -88.8 -22.09 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 118.952 0.796 . . . . 0.0 111.014 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.93 -13.38 60.88 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.17 -0.331 . . . . 0.0 110.625 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -117.55 -19.49 9.41 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.123 0.569 . . . . 0.0 110.773 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.24 -22.83 56.28 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -81.27 1.89 30.42 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 117.686 0.743 . . . . 0.0 111.264 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -99.08 -2.21 37.64 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.371 0.668 . . . . 0.0 111.621 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.73 13.17 2.3 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.867 0.467 . . . . 0.0 111.864 -177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -123.03 14.14 9.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.577 0.751 . . . . 0.0 110.312 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.2 tp 57.23 21.38 6.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.46 1.104 . . . . 0.0 112.833 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.14 135.79 57.89 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.73 161.43 45.44 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.145 2.563 . . . . 0.0 111.612 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 53.68 22.54 3.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.486 1.114 . . . . 0.0 112.831 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.6 -13.17 83.21 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -153.87 171.56 18.77 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.862 0.865 . . . . 0.0 109.877 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -142.3 157.45 44.8 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.569 0.347 . . . . 0.0 110.101 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -136.85 20.27 3.05 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.112 0.565 . . . . 0.0 111.33 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 54.8 t60 56.33 23.1 6.91 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.675 0.79 . . . . 0.0 111.984 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -77.32 166.64 22.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.197 0.599 . . . . 0.0 111.114 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -147.76 166.88 26.16 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.309 0.644 . . . . 0.0 110.506 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.1 m80 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.592 -1.194 . . . . 0.0 110.371 -179.348 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.1 p -84.5 4.81 30.11 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.235 0.614 . . . . 0.0 112.432 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -146.52 161.02 41.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.16 0.584 . . . . 0.0 109.623 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 58.65 178.36 0.07 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.997 1.319 . . . . 0.0 112.366 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.0 mt -127.72 154.51 45.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.026 0.531 . . . . 0.0 110.648 -175.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.6 m -139.37 173.92 11.05 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.937 0.895 . . . . 0.0 108.896 -176.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -56.08 -17.73 7.82 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.663 0.385 . . . . 0.0 111.942 -178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -62.82 -53.44 54.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 p -86.0 -26.38 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.146 0.578 . . . . 0.0 110.896 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.0 -28.7 64.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 119.086 -0.483 . . . . 0.0 110.964 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.1 t -82.64 -30.74 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 CA-C-N 118.862 0.756 . . . . 0.0 109.97 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.1 -41.62 81.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.812 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -69.66 -35.44 75.17 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.2 m -71.31 -22.19 22.22 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-N 118.554 0.616 . . . . 0.0 110.441 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -80.46 -14.79 57.98 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.858 0.299 . . . . 0.0 110.385 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -80.45 -8.04 59.39 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 122.006 -0.434 . . . . 0.0 110.908 172.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.86 2.47 45.97 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.464 0.554 . . . . 0.0 112.826 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.48 84.17 7.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.042 0.921 . . . . 0.0 109.505 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.97 -21.41 66.48 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.825 0.45 . . . . 0.0 110.417 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -61.72 -24.62 66.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.918 0.487 . . . . 0.0 111.239 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.19 -18.79 41.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.363 -0.211 . . . . 0.0 110.682 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -77.79 -35.57 51.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -62.56 -41.03 98.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.29 -19.0 59.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.201 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -83.68 -46.82 11.88 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.137 -0.352 . . . . 0.0 111.528 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.3 m -67.63 -25.49 33.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 118.654 -0.689 . . . . 0.0 111.34 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.7 -26.41 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 119.337 0.971 . . . . 0.0 110.893 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -68.62 -32.31 72.09 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -100.83 -8.66 22.42 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -63.07 -28.01 69.79 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 118.421 0.555 . . . . 0.0 110.758 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -85.83 -30.14 23.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -76.38 -43.25 41.49 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 m -81.35 -26.01 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.18 0.445 . . . . 0.0 111.24 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.53 -22.5 62.61 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 t -76.8 -43.14 37.88 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.594 0.235 . . . . 0.0 110.754 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.46 -25.1 39.06 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 p -87.58 -18.54 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-N 118.007 0.367 . . . . 0.0 111.169 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -63.23 -13.55 39.1 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 171.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -89.32 -3.94 58.3 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.799 0.84 . . . . 0.0 111.78 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -122.51 -17.73 6.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.779 0.432 . . . . 0.0 111.815 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.27 153.68 66.62 Favored Pre-proline 0 N--CA 1.462 0.146 0 C-N-CA 123.353 0.661 . . . . 0.0 110.055 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.21 164.01 35.62 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.584 2.856 . . . . 0.0 110.755 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -66.29 -10.29 41.04 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.14 -18.61 57.33 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -116.52 -6.69 11.68 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.216 0.607 . . . . 0.0 111.258 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.425 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 4.5 p -66.78 -33.11 5.72 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 117.811 -1.09 . . . . 0.0 113.772 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 86.8 Cg_endo -77.11 -25.01 9.12 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 122.004 1.752 . . . . 0.0 111.518 -175.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -81.97 -29.55 32.1 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.235 -0.29 . . . . 0.0 110.341 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.4 t -77.85 -27.52 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.3 -33.91 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -72.97 -42.52 63.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -66.13 -29.05 69.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.785 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.67 -29.53 64.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.755 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -85.04 -28.97 25.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.278 0.49 . . . . 0.0 111.362 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.4 mt -72.13 -38.42 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -75.01 -32.51 61.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.215 0.606 . . . . 0.0 110.652 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.94 -46.86 67.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.208 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -59.69 -37.19 78.14 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.613 0.642 . . . . 0.0 111.508 -175.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -72.66 -25.7 61.37 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.907 0.483 . . . . 0.0 111.253 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.18 -13.52 28.3 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.077 0.551 . . . . 0.0 111.548 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.8 tp -76.71 -25.81 53.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.293 0.637 . . . . 0.0 110.819 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.4 -12.74 61.91 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -112.48 -0.4 15.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.664 0.786 . . . . 0.0 111.909 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -72.55 130.87 41.62 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HA ' ' HE ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -126.37 -0.21 6.97 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -173.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.92 -40.25 36.34 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 49.23 17.72 0.21 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.649 1.58 . . . . 0.0 114.51 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.1 m -141.81 0.59 1.43 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.344 0.52 . . . . 0.0 111.977 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.25 54.69 1.45 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.935 0.398 . . . . 0.0 110.552 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -67.51 -32.78 73.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -70.52 -43.62 69.27 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 118.505 0.593 . . . . 0.0 111.651 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -68.69 -33.2 73.55 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -72.82 -28.46 62.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.925 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.0 tp -85.89 -37.85 18.68 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.846 0.458 . . . . 0.0 111.034 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -60.09 -32.0 70.55 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.616 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -77.07 -21.3 54.62 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.107 -0.473 . . . . 0.0 111.951 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.72 -38.3 75.85 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.942 0.792 . . . . 0.0 109.492 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.62 -38.96 58.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.5 p -76.4 -31.84 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.064 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -75.88 -20.88 57.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.035 -0.416 . . . . 0.0 110.552 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 m -78.68 -30.46 46.16 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.99 -29.78 63.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 122.263 -0.273 . . . . 0.0 110.319 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -79.51 -28.94 41.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.332 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.37 -16.6 39.33 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.771 0.714 . . . . 0.0 110.644 175.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -77.62 -37.7 49.6 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 122.428 -0.17 . . . . 0.0 110.973 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.13 -25.96 33.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 p -81.12 -26.16 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.073 0 CA-C-N 118.899 0.772 . . . . 0.0 110.266 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.61 -16.98 61.22 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 121.372 -0.131 . . . . 0.0 110.879 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -111.05 -17.55 13.24 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.759 0.424 . . . . 0.0 110.947 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.68 -14.93 76.94 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -109.03 3.24 21.89 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.259 0.623 . . . . 0.0 111.265 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -79.67 -21.79 44.28 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.026 0.53 . . . . 0.0 111.187 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.1 tp -89.23 -15.16 34.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.913 0.485 . . . . 0.0 110.558 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -82.69 2.15 35.03 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.121 0.568 . . . . 0.0 111.24 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.37 -7.06 59.42 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.933 0.493 . . . . 0.0 111.466 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.9 m -139.23 152.26 69.19 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 123.594 0.758 . . . . 0.0 110.391 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.27 -7.14 16.0 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.792 2.995 . . . . 0.0 111.526 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -85.04 165.84 17.19 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.278 0.631 . . . . 0.0 111.161 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.32 1.03 87.95 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.414 -0.659 . . . . 0.0 112.893 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 63.0 m -142.87 149.16 38.15 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.969 0.885 . . . . 0.0 110.679 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -156.93 160.03 38.69 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.556 0.742 . . . . 0.0 109.622 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -150.47 167.4 27.27 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.962 0.411 . . . . 0.0 110.896 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -142.44 28.8 1.63 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.282 0.633 . . . . 0.0 110.07 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.6 m80 58.31 178.15 0.06 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.53 1.132 . . . . 0.0 112.809 -175.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -134.71 17.07 3.58 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.334 0.654 . . . . 0.0 111.4 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 117.778 -1.106 . . . . 0.0 111.051 -178.851 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -142.1 163.16 33.63 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.326 0.65 . . . . 0.0 110.556 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.95 7.03 4.32 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.107 0.563 . . . . 0.0 111.774 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -144.59 158.89 43.57 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.452 0.701 . . . . 0.0 110.314 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.7 mt -70.02 157.79 36.85 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.962 0.905 . . . . 0.0 111.506 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 t -140.55 178.42 7.33 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.372 1.069 . . . . 0.0 109.966 -175.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -59.86 -17.01 33.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.058 0.543 . . . . 0.0 110.763 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -69.94 -52.27 25.84 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.539 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.2 -26.65 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 122.673 0.389 . . . . 0.0 110.934 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 mp -70.04 -30.08 67.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.841 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.9 t -80.59 -28.01 11.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-N 118.623 0.647 . . . . 0.0 110.0 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.32 -36.44 68.88 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.627 -0.671 . . . . 0.0 110.188 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -69.95 -37.13 75.75 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.506 0.322 . . . . 0.0 111.497 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.5 m -73.46 -23.62 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.06 0 CA-C-N 118.117 0.417 . . . . 0.0 111.224 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -79.95 -15.76 56.61 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.534 0.334 . . . . 0.0 110.72 174.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -92.23 4.34 53.47 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.728 0.811 . . . . 0.0 111.99 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.28 2.38 51.03 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 119.8 -0.445 . . . . 0.0 113.128 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -97.26 83.88 3.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.001 0.901 . . . . 0.0 109.771 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -66.95 -18.35 65.34 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -60.79 -23.96 65.43 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.73 0.412 . . . . 0.0 110.824 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.77 -18.61 43.55 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.378 -0.201 . . . . 0.0 110.849 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -77.48 -36.98 52.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -61.85 -40.11 94.21 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.46 -19.07 58.42 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.442 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.6 tp -83.62 -46.46 12.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.691 0.396 . . . . 0.0 111.008 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.87 -24.55 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.546 -175.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.48 -27.13 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.157 0.89 . . . . 0.0 110.674 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -67.39 -32.77 73.91 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -98.67 -9.08 25.17 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -62.86 -28.82 70.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.474 -0.766 . . . . 0.0 110.48 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -86.91 -32.51 20.13 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -82.0 -33.03 30.3 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 122.054 -0.404 . . . . 0.0 111.998 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.8 t -74.23 -38.33 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.85 -23.95 67.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.934 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.7 t -74.64 -46.07 40.65 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.944 0.338 . . . . 0.0 111.019 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.88 -29.47 39.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.181 -0.325 . . . . 0.0 111.473 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.4 -15.71 11.41 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.056 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.4 t -67.7 -11.72 58.94 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.858 -0.526 . . . . 0.0 109.887 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -84.7 -6.54 59.36 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.042 0.537 . . . . 0.0 111.644 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -122.5 -13.44 8.0 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.27 154.8 57.79 Favored Pre-proline 0 C--O 1.231 0.123 0 C-N-CA 123.923 0.889 . . . . 0.0 109.567 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.27 162.94 38.26 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.455 2.77 . . . . 0.0 110.758 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.4 p -65.88 -10.61 40.0 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.13 -18.89 54.9 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.81 -0.439 . . . . 0.0 112.05 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -116.35 -4.78 11.81 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.384 0.592 . . . . 0.0 111.677 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.424 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 5.7 p -66.51 -32.12 4.95 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 117.79 -1.1 . . . . 0.0 113.719 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 74.5 Cg_endo -78.18 -23.28 9.11 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 CA-C-N 121.904 1.716 . . . . 0.0 111.266 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -81.74 -27.74 33.69 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.96 -27.42 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.5 -34.59 62.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.67 -42.92 66.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -67.5 -28.58 67.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.383 0.538 . . . . 0.0 109.99 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.42 -36.42 74.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.2 -33.18 61.37 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.371 0.532 . . . . 0.0 111.967 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.57 -38.89 75.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -75.22 -31.72 60.94 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.081 0.552 . . . . 0.0 110.555 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.73 -43.93 71.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.236 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -61.28 -37.91 84.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.863 0.756 . . . . 0.0 111.36 -176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -71.68 -25.39 62.09 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.552 0.341 . . . . 0.0 111.062 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.93 -10.76 27.91 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.28 0.632 . . . . 0.0 111.441 176.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.4 tp -74.93 -23.84 58.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.104 0.562 . . . . 0.0 110.119 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.35 -11.48 51.36 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.509 0.324 . . . . 0.0 110.544 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -110.39 2.68 19.16 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.722 0.809 . . . . 0.0 111.851 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.22 144.81 46.62 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -135.65 6.16 3.2 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.27 15.04 76.84 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.759 -0.467 . . . . 0.0 112.82 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.84 -10.46 59.63 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.764 0.782 . . . . 0.0 110.921 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.7 t -149.36 165.73 31.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.252 1.021 . . . . 0.0 108.854 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.32 145.38 56.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -67.5 -32.57 73.47 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -175.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -70.39 -36.57 74.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.62 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -72.02 -36.28 69.65 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 64.5 t90 -70.28 -32.88 70.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.678 -0.201 . . . . 0.0 110.747 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.0 tp -80.23 -37.15 33.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.597 0.359 . . . . 0.0 111.292 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -68.67 -20.27 64.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.133 -0.354 . . . . 0.0 111.63 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -74.69 -26.75 60.04 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.186 0.448 . . . . 0.0 110.323 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.76 -36.88 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.98 -40.08 63.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.63 -32.04 15.9 Favored 'Isoleucine or valine' 0 C--N 1.337 0.043 0 O-C-N 121.993 -0.442 . . . . 0.0 111.268 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -74.61 -24.33 58.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.014 -0.429 . . . . 0.0 110.3 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.1 m -78.08 -30.45 49.63 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 117.741 0.246 . . . . 0.0 110.44 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.29 -29.46 62.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.316 -0.24 . . . . 0.0 110.496 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.05 -31.05 55.9 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.75 -15.92 43.39 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.837 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -76.77 -39.59 51.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.632 0.196 . . . . 0.0 111.253 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -81.93 -25.21 35.09 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-O 119.122 -0.466 . . . . 0.0 112.19 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.9 p -80.98 -25.62 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.048 0 CA-C-N 119.067 0.849 . . . . 0.0 110.44 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.56 -12.32 59.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.463 -0.148 . . . . 0.0 111.072 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -118.29 -4.16 10.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.128 0.571 . . . . 0.0 110.581 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -108.2 -7.05 31.21 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.565 -0.575 . . . . 0.0 112.409 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -129.44 3.99 5.12 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 117.768 0.784 . . . . 0.0 111.925 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -140.09 6.45 2.17 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.893 0.477 . . . . 0.0 112.065 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.8 tp -146.66 0.89 0.78 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.195 0.452 . . . . 0.0 111.875 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -70.3 156.47 39.24 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.562 -0.711 . . . . 0.0 110.904 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.87 -17.06 28.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.807 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.1 t -144.58 132.91 10.83 Favored Pre-proline 0 CA--C 1.528 0.116 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.08 158.96 51.22 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.399 2.733 . . . . 0.0 110.66 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.3 ptt-85 -149.88 152.13 34.58 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 122.489 0.316 . . . . 0.0 111.397 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.67 166.51 19.59 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 91.0 p -152.63 166.64 31.46 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 122.648 0.379 . . . . 0.0 110.896 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -130.79 11.36 5.18 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.44 0.696 . . . . 0.0 111.633 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -120.16 8.97 11.0 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.304 0.641 . . . . 0.0 111.191 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -134.61 4.29 3.35 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.32 0.648 . . . . 0.0 110.958 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -139.53 163.24 33.08 Favored 'General case' 0 CA--C 1.526 0.052 0 C-N-CA 123.596 0.758 . . . . 0.0 110.101 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 46.3 m80 54.61 21.45 3.42 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.794 0.838 . . . . 0.0 112.912 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.197 -1.382 . . . . 0.0 110.328 -179.36 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttp . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 119.918 -0.086 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -142.62 156.71 45.11 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.899 0.48 . . . . 0.0 110.148 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -134.69 -1.46 2.77 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.203 0.601 . . . . 0.0 111.612 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 55.64 4.53 0.11 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.639 1.575 . . . . 0.0 115.069 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.2 mt -141.42 155.33 45.89 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.838 0.855 . . . . 0.0 109.154 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.8 m -140.35 173.12 11.82 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.788 0.835 . . . . 0.0 109.456 -177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -55.26 -18.19 5.81 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.005 0.522 . . . . 0.0 111.937 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -65.17 -51.37 61.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.238 -0.289 . . . . 0.0 110.453 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 p -84.06 -25.8 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 122.594 0.357 . . . . 0.0 110.631 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.89 -30.14 67.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.095 -0.378 . . . . 0.0 110.634 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.9 t -81.74 -28.48 9.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 CA-C-N 118.634 0.652 . . . . 0.0 110.029 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.05 -40.8 71.45 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.066 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -69.06 -34.35 75.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -70.49 -23.01 24.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 118.702 0.683 . . . . 0.0 110.398 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -81.15 -14.98 57.11 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 119.503 -0.284 . . . . 0.0 110.92 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.62 -7.0 59.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.287 0.494 . . . . 0.0 110.752 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.48 3.12 47.28 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.479 0.562 . . . . 0.0 112.779 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.81 83.98 5.33 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 117.954 0.877 . . . . 0.0 108.991 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -64.48 -17.73 64.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.091 0.557 . . . . 0.0 110.643 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -60.82 -25.62 66.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.991 0.516 . . . . 0.0 110.794 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.34 -18.99 43.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.781 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -76.54 -36.97 57.36 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -61.82 -39.8 93.04 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.8 mt -76.79 -18.98 58.09 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.352 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.6 tp -83.3 -47.36 11.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.554 0.342 . . . . 0.0 111.308 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.8 m -68.13 -25.69 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.222 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.56 -26.92 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.326 0.966 . . . . 0.0 110.915 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -67.82 -33.05 74.03 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -100.85 -8.73 22.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.308 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -62.16 -28.78 69.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.357 0.526 . . . . 0.0 110.42 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -86.1 -28.94 23.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 121.977 0.111 . . . . 0.0 110.763 174.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -78.4 -40.64 35.41 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 m -83.85 -23.53 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 O-C-N 121.966 -0.459 . . . . 0.0 110.835 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.63 -22.09 61.0 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.5 t -79.37 -40.23 30.67 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -81.38 -24.56 36.93 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 119.242 -0.409 . . . . 0.0 112.081 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.16 -21.08 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.674 0.67 . . . . 0.0 112.212 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -69.27 -10.53 58.24 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.845 -0.534 . . . . 0.0 111.611 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -92.28 -4.01 54.61 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 121.805 -0.56 . . . . 0.0 111.642 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -110.16 -23.57 11.19 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.644 0.378 . . . . 0.0 111.304 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.13 155.73 74.21 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 123.433 0.693 . . . . 0.0 109.461 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.42 170.59 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.515 2.81 . . . . 0.0 111.339 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.0 m -63.41 -11.91 26.76 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.118 0.567 . . . . 0.0 112.132 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.68 -16.28 58.61 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.593 -0.559 . . . . 0.0 112.598 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -116.3 -10.86 11.33 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 117.938 0.869 . . . . 0.0 111.801 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.415 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 8.0 p -62.89 -34.34 13.75 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 117.78 -1.105 . . . . 0.0 112.929 -177.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 94.7 Cg_endo -77.5 -25.42 8.16 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 CA-C-N 121.927 1.724 . . . . 0.0 112.135 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.38 -33.11 23.87 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.191 0.45 . . . . 0.0 111.098 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.5 t -78.17 -25.39 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.16 -34.68 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -71.44 -42.05 68.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -66.36 -29.64 69.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.29 0.496 . . . . 0.0 110.0 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.01 -28.38 64.38 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 119.478 -0.296 . . . . 0.0 110.837 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -85.2 -29.33 24.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.523 0.601 . . . . 0.0 111.232 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -72.42 -37.86 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -76.54 -32.29 58.13 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.224 0.61 . . . . 0.0 110.804 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.92 77.65 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.463 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -62.06 -38.35 88.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.755 0.707 . . . . 0.0 111.329 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -71.36 -24.94 62.18 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.599 0.36 . . . . 0.0 111.336 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.7 -11.74 28.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.972 0.509 . . . . 0.0 111.454 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.0 tp -75.68 -24.24 56.29 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.951 0.5 . . . . 0.0 110.538 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.95 -10.37 57.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.468 0.307 . . . . 0.0 110.741 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.4 m -109.63 3.03 20.64 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.682 0.793 . . . . 0.0 111.442 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -71.61 151.85 43.4 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.144 0.578 . . . . 0.0 109.817 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -133.3 -6.71 2.97 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.3 13.63 81.32 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.584 -0.565 . . . . 0.0 111.978 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -71.74 -5.89 37.29 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.117 0.958 . . . . 0.0 111.215 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.9 t -149.88 165.83 31.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.514 1.126 . . . . 0.0 108.466 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.29 146.53 54.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.128 -0.357 . . . . 0.0 110.457 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -68.35 -33.26 73.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.275 -0.266 . . . . 0.0 111.691 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -69.72 -37.41 76.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.838 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.6 m -70.58 -33.78 71.47 Favored 'General case' 0 CA--C 1.527 0.068 0 O-C-N 121.895 -0.503 . . . . 0.0 109.757 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -73.96 -28.64 61.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.968 0.507 . . . . 0.0 110.881 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.7 tp -86.01 -36.0 20.03 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.804 0.442 . . . . 0.0 111.297 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -61.87 -32.57 72.94 Favored 'General case' 0 C--O 1.23 0.077 0 O-C-N 122.201 -0.312 . . . . 0.0 110.599 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -76.54 -21.24 55.95 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.075 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.3 mm -68.01 -38.83 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 118.979 0.809 . . . . 0.0 109.216 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.01 -38.38 53.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.26 -28.01 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 CA-C-N 118.919 0.781 . . . . 0.0 111.171 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -75.42 -24.76 57.15 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.105 0.411 . . . . 0.0 110.101 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.2 m -79.05 -29.97 43.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 176.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.83 -33.77 66.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.049 0.386 . . . . 0.0 111.025 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -77.96 -29.0 49.6 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -76.12 -28.3 57.41 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -74.02 -35.9 64.42 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 122.588 0.355 . . . . 0.0 110.984 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.1 mt -78.13 -18.9 55.04 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.8 m -91.75 -18.79 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.037 0 CA-C-N 119.053 0.842 . . . . 0.0 110.988 175.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.39 -23.02 46.97 Favored 'General case' 0 CA--C 1.527 0.065 0 O-C-N 122.043 -0.411 . . . . 0.0 111.252 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -109.79 -17.88 13.56 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.98 0.512 . . . . 0.0 110.394 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -80.7 -22.21 62.35 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -93.76 14.11 20.28 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.483 0.713 . . . . 0.0 110.767 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -117.8 8.17 12.63 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.811 0.844 . . . . 0.0 111.261 -176.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 pp -144.96 15.01 1.53 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.665 0.786 . . . . 0.0 111.824 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -65.87 -28.07 68.69 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.714 0.406 . . . . 0.0 111.836 -174.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.9 mt -139.73 -35.88 0.52 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 122.803 0.441 . . . . 0.0 110.315 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.3 m -143.96 151.52 52.81 Favored Pre-proline 0 N--CA 1.456 -0.14 0 C-N-CA 124.099 0.96 . . . . 0.0 108.501 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.89 13.59 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.318 3.345 . . . . 0.0 113.283 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -130.1 -2.69 4.54 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.478 0.711 . . . . 0.0 112.207 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.86 -158.46 29.14 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 m 52.19 35.09 15.83 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.679 0.792 . . . . 0.0 113.01 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -143.65 165.34 27.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.735 0.414 . . . . 0.0 110.24 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -136.42 157.36 46.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.055 0.542 . . . . 0.0 110.589 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -73.07 -5.78 41.27 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.062 0.545 . . . . 0.0 111.844 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -133.26 16.73 4.09 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.647 0.779 . . . . 0.0 110.388 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 58.3 177.7 0.06 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.675 1.19 . . . . 0.0 112.576 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.568 -1.206 . . . . 0.0 110.364 -179.839 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.3 mtp . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 110.61 -0.144 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.1 m 52.91 27.92 6.01 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.703 0.801 . . . . 0.0 112.746 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -147.11 156.45 43.01 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.132 0.573 . . . . 0.0 109.821 -177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -123.59 -179.42 4.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.507 0.723 . . . . 0.0 110.299 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.72 149.44 43.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.203 0.525 . . . . 0.0 110.94 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 47.0 m -140.0 174.48 10.48 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.125 0.97 . . . . 0.0 109.08 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -55.69 -16.93 4.81 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.18 0.592 . . . . 0.0 112.479 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -67.25 -51.43 53.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 117.917 0.326 . . . . 0.0 110.127 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.66 -25.67 6.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 122.449 0.3 . . . . 0.0 110.981 -176.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -68.56 -30.13 68.84 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.276 -0.265 . . . . 0.0 110.439 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.8 t -81.58 -28.43 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 118.316 0.507 . . . . 0.0 110.215 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.63 -35.11 70.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.574 -0.704 . . . . 0.0 111.357 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -83.6 -25.41 30.88 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.454 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.07 -23.06 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 119.16 0.891 . . . . 0.0 109.358 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -78.86 -25.54 43.96 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.282 0.233 . . . . 0.0 110.68 174.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -89.33 -7.26 55.68 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.84 -3.52 8.0 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 118.835 -0.98 . . . . 0.0 114.889 170.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -86.61 83.72 7.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.331 1.566 . . . . 0.0 109.961 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -66.38 -21.79 66.24 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.39 -24.58 66.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.536 0.734 . . . . 0.0 110.897 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.69 -19.2 35.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 119.579 -0.248 . . . . 0.0 110.742 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -76.97 -35.89 56.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -63.22 -40.81 98.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.41 -18.81 59.83 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.154 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.9 tp -83.41 -47.09 11.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.521 0.328 . . . . 0.0 111.044 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.4 m -69.32 -24.53 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.717 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.5 p -69.24 -27.32 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 119.146 0.884 . . . . 0.0 110.771 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -67.11 -33.1 74.74 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -98.4 -8.92 26.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.102 0.561 . . . . 0.0 112.326 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -63.32 -30.44 71.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.503 -0.748 . . . . 0.0 110.633 -174.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -87.03 -32.05 20.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -81.43 -34.74 31.32 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -71.28 -38.86 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.56 -24.21 67.71 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.095 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.2 t -73.85 -48.16 33.13 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.851 0.296 . . . . 0.0 110.734 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 pp -79.98 -27.82 39.6 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.479 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 p -83.5 -15.74 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.334 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 t -68.92 -9.65 53.01 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.825 -0.547 . . . . 0.0 110.28 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -88.8 -3.91 58.64 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.408 0.683 . . . . 0.0 111.427 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.31 -16.2 7.45 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.2 m -143.17 153.78 60.34 Favored Pre-proline 0 C--N 1.338 0.069 0 C-N-CA 124.168 0.987 . . . . 0.0 109.613 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.28 164.25 33.15 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.483 2.788 . . . . 0.0 111.062 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.2 p -65.92 -10.25 37.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.43 -18.03 55.96 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -116.44 -5.64 11.74 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.527 0.664 . . . . 0.0 111.481 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.426 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 5.8 p -67.28 -32.03 4.27 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 117.755 -1.117 . . . . 0.0 114.001 -176.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 81.2 Cg_endo -78.12 -23.53 8.98 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 CA-C-N 121.758 1.664 . . . . 0.0 111.308 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.84 -29.24 32.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.5 t -77.09 -28.54 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.4 t -69.72 -35.71 66.79 Favored 'Isoleucine or valine' 0 C--N 1.337 0.063 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -70.95 -42.83 69.27 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -67.31 -28.77 68.28 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.731 -0.606 . . . . 0.0 109.873 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.23 -36.13 74.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -75.39 -32.65 60.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.353 0.524 . . . . 0.0 112.204 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -71.33 -38.16 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -76.22 -31.37 58.35 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.015 0.526 . . . . 0.0 110.458 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.27 -44.0 72.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.187 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -61.19 -38.1 85.32 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.812 0.733 . . . . 0.0 111.366 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -71.45 -25.32 62.25 Favored 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 122.596 0.358 . . . . 0.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.08 -10.74 27.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.184 0.594 . . . . 0.0 111.266 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.42 -23.97 57.04 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.999 0.52 . . . . 0.0 110.3 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.02 -11.47 48.35 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.335 0.254 . . . . 0.0 110.508 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.4 m -110.8 -2.24 16.25 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.622 0.769 . . . . 0.0 112.034 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -72.24 134.79 45.8 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.417 ' HA ' ' HE ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -124.78 4.25 8.14 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -173.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.31 17.62 77.64 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.322 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -70.93 -8.16 51.09 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.066 0.933 . . . . 0.0 111.196 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.5 t -151.81 168.6 24.58 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.953 0.901 . . . . 0.0 108.751 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.24 146.84 53.76 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.051 -0.406 . . . . 0.0 110.072 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -67.78 -33.14 74.25 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -175.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -69.51 -36.97 76.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.863 -0.523 . . . . 0.0 110.708 -176.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.2 m -72.7 -36.43 67.85 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -69.39 -33.27 72.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -78.94 -36.62 41.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.557 0.343 . . . . 0.0 111.578 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -69.17 -20.09 64.0 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.078 -0.388 . . . . 0.0 111.574 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -74.6 -25.9 59.56 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 117.965 0.348 . . . . 0.0 110.283 173.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.4 mm -73.23 -35.74 47.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.11 -39.52 60.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.3 p -79.05 -30.63 14.39 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 O-C-N 122.26 -0.275 . . . . 0.0 110.979 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -76.3 -23.04 54.32 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.053 0.388 . . . . 0.0 110.623 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.5 m -80.21 -28.49 38.59 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.7 -33.26 66.36 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.209 0.459 . . . . 0.0 110.284 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.39 -25.82 54.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -86.09 -19.21 30.57 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.464 0.306 . . . . 0.0 110.711 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -77.04 -36.98 55.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 121.977 -0.452 . . . . 0.0 110.334 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.6 mt -82.52 -22.78 34.9 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.3 p -82.94 -25.92 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-N 118.716 0.689 . . . . 0.0 109.892 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.59 -18.95 61.0 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -108.21 -15.66 14.44 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.307 0.643 . . . . 0.0 111.1 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.03 -26.62 36.56 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -90.49 14.38 13.24 Favored 'General case' 0 N--CA 1.458 -0.064 0 C-N-CA 123.225 0.61 . . . . 0.0 111.146 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -94.4 -14.99 24.71 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.674 0.79 . . . . 0.0 110.291 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.4 mt -126.96 -2.81 6.49 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.951 0.9 . . . . 0.0 111.077 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -135.0 160.38 38.49 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.432 1.093 . . . . 0.0 108.419 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.2 tp 57.19 27.48 13.61 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.42 0.688 . . . . 0.0 111.408 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.81 152.76 70.18 Favored Pre-proline 0 N--CA 1.456 -0.14 0 C-N-CA 124.109 0.963 . . . . 0.0 109.507 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.8 -11.56 32.21 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.576 2.851 . . . . 0.0 112.54 -176.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -93.38 -2.05 55.15 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.004 0.366 . . . . 0.0 111.796 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.17 -12.36 81.66 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.1 t -82.91 -9.05 59.5 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.455 0.627 . . . . 0.0 110.93 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -98.96 5.16 47.36 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.305 0.642 . . . . 0.0 111.299 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 55.69 18.31 2.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.411 1.084 . . . . 0.0 113.226 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 55.9 -176.22 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.61 1.164 . . . . 0.0 112.979 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.59 ' CG ' ' H ' ' A' ' 105' ' ' HIS . 19.2 t-80 57.07 -175.74 0.06 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.37 1.068 . . . . 0.0 112.045 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.59 ' H ' ' CG ' ' A' ' 104' ' ' HIS . 88.0 m-70 57.29 -179.03 0.05 Allowed 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.558 1.143 . . . . 0.0 112.602 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.1 t60 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 116.692 -1.623 . . . . 0.0 111.79 -179.286 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptm . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.523 0.201 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m 56.09 5.68 0.19 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -159.65 -26.25 0.07 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.449 0.568 . . . . 0.0 110.578 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -146.38 159.96 42.69 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.556 0.742 . . . . 0.0 109.507 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 26.9 mt -61.54 151.87 31.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.276 1.03 . . . . 0.0 111.795 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.5 m -139.26 174.13 10.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.481 1.113 . . . . 0.0 108.918 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -56.02 -17.31 6.52 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -66.67 -53.5 33.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 122.148 -0.345 . . . . 0.0 110.391 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 p -83.63 -25.41 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 122.676 0.39 . . . . 0.0 110.782 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.88 -27.92 64.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.847 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -82.6 -28.45 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.058 0 CA-C-N 118.899 0.772 . . . . 0.0 109.909 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 44.3 mt-10 -72.51 -35.95 68.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.498 -0.751 . . . . 0.0 110.322 176.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -71.28 -37.12 71.89 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.53 -23.87 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 118.155 0.434 . . . . 0.0 110.749 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -78.27 -17.39 56.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.759 0.254 . . . . 0.0 110.438 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -82.54 -5.86 59.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.219 0.608 . . . . 0.0 111.695 172.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.36 0.63 37.81 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.322 -0.71 . . . . 0.0 113.098 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -85.52 84.16 7.7 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.304 1.052 . . . . 0.0 109.071 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -64.38 -20.91 66.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.548 0.339 . . . . 0.0 110.87 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -62.48 -23.95 67.19 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.575 0.75 . . . . 0.0 111.168 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.34 -19.2 39.79 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.614 0.188 . . . . 0.0 110.784 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -77.77 -36.64 50.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -60.75 -42.79 98.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.57 -18.47 59.74 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.571 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.0 tp -81.47 -43.1 19.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.214 -0.304 . . . . 0.0 110.931 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.7 m -70.92 -24.58 24.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.874 -175.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.86 -26.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 119.685 1.13 . . . . 0.0 110.706 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -70.15 -31.2 68.59 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -99.76 -9.01 23.51 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.481 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -62.69 -30.27 71.27 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.189 -0.944 . . . . 0.0 110.499 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -86.56 -32.84 20.46 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.475 0.31 . . . . 0.0 111.601 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -80.67 -36.37 32.5 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.0 t -71.21 -38.86 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.47 -23.38 67.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.934 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 t -74.47 -45.93 42.9 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.019 -0.426 . . . . 0.0 111.112 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.409 HD23 ' CD1' ' A' ' 75' ' ' TYR . 3.8 pp -82.61 -26.43 32.27 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.432 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 p -85.45 -16.91 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 118.131 0.423 . . . . 0.0 111.761 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.8 t -69.67 -9.07 52.82 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -89.29 -4.42 58.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.47 0.708 . . . . 0.0 111.221 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -122.76 -15.21 7.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.891 0.476 . . . . 0.0 112.245 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -143.1 153.84 60.65 Favored Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 123.721 0.808 . . . . 0.0 109.541 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -68.59 164.85 31.42 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.551 2.834 . . . . 0.0 111.062 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -65.76 -10.3 35.89 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.49 -18.02 55.87 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 118.094 0.407 . . . . 0.0 112.333 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -116.58 -5.78 11.66 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 117.561 0.681 . . . . 0.0 111.605 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.42 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 6.0 p -67.37 -32.63 4.73 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 77.9 Cg_endo -77.86 -23.85 9.05 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 CA-C-N 121.844 1.694 . . . . 0.0 111.437 -176.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.4 -28.74 34.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -79.03 -27.91 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.64 -36.01 68.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.14 -43.09 68.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -67.84 -28.99 68.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.427 0.558 . . . . 0.0 109.765 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.22 73.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -75.61 -33.73 60.56 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 118.272 0.487 . . . . 0.0 112.203 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -71.41 -37.26 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -77.18 -32.86 56.42 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.909 0.483 . . . . 0.0 110.586 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.47 -44.92 81.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -61.55 -36.71 81.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.508 0.595 . . . . 0.0 111.215 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -72.05 -20.72 61.63 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 122.694 0.397 . . . . 0.0 111.281 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.85 -11.83 18.74 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.94 0.496 . . . . 0.0 111.109 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.2 tp -76.26 -25.71 55.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.583 0.753 . . . . 0.0 110.617 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.94 -13.18 62.28 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.376 0.27 . . . . 0.0 110.651 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.9 m -113.45 0.9 14.87 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.592 0.757 . . . . 0.0 111.785 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -72.61 119.11 16.37 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.963 -0.46 . . . . 0.0 110.454 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.73 25.31 1.47 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.015 1.326 . . . . 0.0 109.749 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.77 -6.13 49.38 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.157 -0.802 . . . . 0.0 113.58 -173.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 51.67 28.87 5.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.299 1.049 . . . . 0.0 111.532 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.3 m -128.84 176.2 8.03 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.153 0.981 . . . . 0.0 109.96 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.44 148.11 52.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.175 0.512 . . . . 0.0 111.249 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -75.54 -30.5 59.76 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.393 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -67.73 -37.83 82.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.303 0.501 . . . . 0.0 111.984 -174.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.7 m -70.72 -37.7 73.53 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -69.27 -34.02 74.12 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.7 -0.191 . . . . 0.0 110.798 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.8 tp -77.09 -36.53 55.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.716 0.406 . . . . 0.0 111.199 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.409 ' CD1' HD23 ' A' ' 36' ' ' LEU . 20.9 m-85 -69.56 -20.03 63.67 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.804 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -76.1 -23.98 54.98 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.087 0.403 . . . . 0.0 110.456 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.2 mm -73.55 -35.94 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.44 -39.69 62.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.71 -29.66 13.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 O-C-N 122.086 -0.384 . . . . 0.0 111.402 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -75.74 -23.21 56.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.821 -0.55 . . . . 0.0 110.618 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.2 m -82.94 -28.93 29.5 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 119.556 -0.259 . . . . 0.0 110.339 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.09 -32.78 61.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.093 0.406 . . . . 0.0 110.932 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.37 -29.68 53.43 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -76.27 -24.67 54.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -75.87 -36.86 59.39 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.499 0.32 . . . . 0.0 110.808 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.7 mt -76.84 -21.22 55.35 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.51 -20.61 6.87 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 CA-C-N 119.076 0.853 . . . . 0.0 111.286 176.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.21 -28.55 53.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.971 0.35 . . . . 0.0 111.014 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -101.97 -16.33 16.53 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.843 0.457 . . . . 0.0 110.498 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.48 -14.92 67.29 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 119.741 -0.477 . . . . 0.0 112.023 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -119.78 11.71 11.97 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-N 117.604 0.702 . . . . 0.0 111.572 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -68.11 -9.71 48.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.675 0.79 . . . . 0.0 111.304 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.0 tp -118.03 -1.21 11.48 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.641 0.777 . . . . 0.0 110.746 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -99.61 -35.63 9.78 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.688 -0.632 . . . . 0.0 110.65 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.49 -23.67 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.451 2.3 . . . . 0.0 116.341 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 m -145.97 157.62 50.14 Favored Pre-proline 0 CA--C 1.526 0.052 0 CA-C-N 119.786 1.175 . . . . 0.0 110.598 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -67.7 149.93 79.12 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.99 2.46 . . . . 0.0 109.658 173.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -141.57 162.24 35.96 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 122.894 0.477 . . . . 0.0 110.702 -176.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.78 177.58 46.69 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 t -149.58 160.17 43.71 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.7 0.4 . . . . 0.0 110.477 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -139.12 15.96 2.62 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.615 0.766 . . . . 0.0 110.864 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -139.99 167.62 21.71 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.272 0.629 . . . . 0.0 110.755 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -74.33 0.65 13.69 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.386 0.674 . . . . 0.0 111.538 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.4 p80 49.91 22.41 0.86 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.675 1.59 . . . . 0.0 113.621 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -147.17 158.51 43.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.432 0.693 . . . . 0.0 109.816 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 52.9 t60 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 116.68 -1.629 . . . . 0.0 111.776 -178.225 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.421 0.153 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 m -71.78 161.6 30.72 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.069 0.461 . . . . 0.0 111.162 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.78 -5.2 58.82 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.032 0.533 . . . . 0.0 111.581 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 56.88 7.25 0.38 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.281 1.432 . . . . 0.0 114.376 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 98.0 mt -140.32 155.09 46.94 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.408 0.683 . . . . 0.0 109.369 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.4 m -140.28 173.33 11.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.559 0.744 . . . . 0.0 109.805 -176.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -55.34 -17.29 4.55 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.982 0.513 . . . . 0.0 111.87 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -65.88 -51.51 58.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 p -85.81 -26.48 6.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 122.734 0.413 . . . . 0.0 110.952 -176.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.72 -29.92 68.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 122.136 -0.352 . . . . 0.0 110.34 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.8 t -84.23 -27.35 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.186 0.448 . . . . 0.0 110.296 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.37 -35.68 65.98 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.51 -0.744 . . . . 0.0 109.998 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -70.81 -34.9 72.22 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.0 m -74.75 -24.09 18.08 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 CA-C-N 118.108 0.413 . . . . 0.0 111.228 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -77.13 -16.14 59.28 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 174.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.36 2.26 56.75 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.723 0.809 . . . . 0.0 112.161 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.23 44.18 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.55 -0.583 . . . . 0.0 113.554 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -91.81 83.97 5.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.413 1.107 . . . . 0.0 109.31 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.69 -20.2 66.18 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.727 0.411 . . . . 0.0 110.435 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -62.08 -24.52 67.16 Favored 'General case' 0 N--CA 1.458 -0.041 0 C-N-CA 122.863 0.465 . . . . 0.0 111.441 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.44 -18.75 44.25 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.792 0.269 . . . . 0.0 110.574 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -77.8 -37.14 49.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -61.73 -40.22 94.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.43 -19.22 58.3 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.401 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.4 tp -83.47 -46.9 11.96 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.426 0.29 . . . . 0.0 111.245 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.65 -25.09 29.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 CA-C-O 118.578 -0.725 . . . . 0.0 111.479 -175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.4 p -69.7 -26.64 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 119.32 0.964 . . . . 0.0 110.693 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.9 mtp85 -68.54 -34.54 76.02 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -97.35 -8.73 28.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.282 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -63.33 -28.35 69.94 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 118.453 0.57 . . . . 0.0 110.8 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -85.07 -30.17 24.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -77.05 -43.47 34.38 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 m -79.78 -25.32 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 O-C-N 121.971 -0.456 . . . . 0.0 110.885 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.03 -22.75 63.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.149 0.432 . . . . 0.0 110.436 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -76.31 -42.3 45.7 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.43 -24.85 31.7 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -87.94 -19.44 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 118.326 0.512 . . . . 0.0 111.467 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.4 t -67.26 -9.26 38.88 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.878 -0.514 . . . . 0.0 109.854 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -90.45 -3.92 57.33 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.7 0.8 . . . . 0.0 111.438 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -122.18 -15.38 7.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.985 0.514 . . . . 0.0 111.884 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 m -142.42 153.32 62.32 Favored Pre-proline 0 N--CA 1.463 0.176 0 C-N-CA 123.829 0.852 . . . . 0.0 109.229 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.38 165.33 29.27 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.385 2.723 . . . . 0.0 110.959 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -65.38 -12.54 53.13 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.782 0.433 . . . . 0.0 112.132 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.02 -19.58 59.03 Favored Glycine 0 CA--C 1.527 0.83 0 O-C-N 121.928 -0.483 . . . . 0.0 112.192 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -116.55 -5.67 11.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.633 0.716 . . . . 0.0 111.681 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.418 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 5.9 p -66.58 -33.32 6.25 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.782 -1.104 . . . . 0.0 113.7 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 93.7 Cg_endo -76.68 -25.88 8.88 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 122.084 1.78 . . . . 0.0 111.774 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -82.7 -28.84 30.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.227 -0.296 . . . . 0.0 110.408 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.2 t -77.76 -27.63 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -71.72 -35.59 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -72.27 -43.2 64.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -67.45 -27.35 66.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.784 -0.572 . . . . 0.0 110.208 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.48 -28.51 62.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.683 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.31 -29.81 24.25 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.411 0.551 . . . . 0.0 110.89 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.66 -37.11 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -78.74 -31.64 46.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.865 0.466 . . . . 0.0 111.016 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.94 -42.46 85.25 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.165 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -62.76 -36.5 83.27 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 118.63 0.65 . . . . 0.0 111.211 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -71.64 -17.68 62.25 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 122.501 0.32 . . . . 0.0 111.122 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.49 -11.51 16.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.863 0.465 . . . . 0.0 111.066 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.2 tp -73.77 -23.22 59.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.472 0.709 . . . . 0.0 110.099 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.48 -13.13 37.46 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.445 0.298 . . . . 0.0 110.673 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.2 t -113.48 4.44 16.24 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -71.14 126.47 29.69 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.509 -0.744 . . . . 0.0 109.503 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -140.17 13.71 2.42 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.995 0.918 . . . . 0.0 110.513 -175.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.93 -35.31 54.37 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 47.97 22.01 0.35 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.857 1.263 . . . . 0.0 113.813 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 77.9 p -157.77 -8.78 0.08 Allowed 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.24 54.82 1.45 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.338 0.517 . . . . 0.0 111.611 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -68.91 -34.86 76.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.187 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -69.69 -40.4 76.36 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.042 0.383 . . . . 0.0 111.297 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -70.78 -35.11 72.44 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -69.53 -31.02 68.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.5 tp -82.92 -36.15 25.49 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.586 0.354 . . . . 0.0 111.629 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -62.44 -29.13 70.29 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.129 -0.357 . . . . 0.0 110.387 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -73.33 -25.29 60.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.489 0.315 . . . . 0.0 111.48 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mm -71.53 -39.76 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.035 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.56 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.41 -36.11 68.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -174.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -75.64 -29.25 20.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.378 0.536 . . . . 0.0 110.775 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -79.07 -20.54 48.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.266 -0.271 . . . . 0.0 110.609 177.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 79.1 m -79.85 -33.37 40.2 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 122.014 -0.429 . . . . 0.0 109.963 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.96 69.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.281 -0.262 . . . . 0.0 110.928 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -75.17 -28.64 60.14 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -78.81 -30.03 45.18 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.128 0.171 . . . . 0.0 110.99 177.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -69.88 -37.09 75.93 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.138 0.575 . . . . 0.0 111.091 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.6 mt -76.56 -29.22 56.56 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.33 -19.79 7.57 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 CA-C-N 118.558 0.617 . . . . 0.0 111.415 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.04 -10.24 59.24 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.151 -0.343 . . . . 0.0 111.311 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -117.1 -19.19 9.82 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.364 0.266 . . . . 0.0 111.18 177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.75 -16.88 64.76 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.834 -0.426 . . . . 0.0 112.073 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -100.4 8.89 43.33 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 117.675 0.738 . . . . 0.0 112.436 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -92.64 -0.94 57.23 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.3 tp -141.16 -7.78 1.03 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.52 0.328 . . . . 0.0 111.238 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -93.28 126.99 38.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.94 -0.475 . . . . 0.0 109.776 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.7 mt -135.65 10.89 3.43 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.244 1.018 . . . . 0.0 110.717 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.15 154.85 81.38 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 123.714 0.806 . . . . 0.0 110.181 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.97 167.2 25.41 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.589 2.859 . . . . 0.0 111.412 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -121.37 7.31 10.14 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.608 0.763 . . . . 0.0 111.05 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.73 -162.74 41.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.0 t -140.89 163.06 33.96 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.867 0.467 . . . . 0.0 110.52 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -84.29 0.24 49.82 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.654 0.781 . . . . 0.0 111.62 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -141.94 154.03 44.77 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.165 0.586 . . . . 0.0 110.295 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -153.22 161.8 42.0 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.148 0.579 . . . . 0.0 110.109 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -145.84 158.38 43.86 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.958 0.503 . . . . 0.0 110.506 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 55.9 -176.14 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.362 1.065 . . . . 0.0 112.234 -175.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.101 -1.428 . . . . 0.0 110.731 -179.479 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.911 0 CA-C-O 120.481 0.182 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 m -142.38 162.78 34.58 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.293 0.637 . . . . 0.0 110.468 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -75.31 136.85 40.85 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.554 0.216 . . . . 0.0 110.45 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -158.57 -176.48 5.91 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.157 0.583 . . . . 0.0 111.07 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.401 ' CD2' ' H ' ' A' ' 5' ' ' LEU . 1.2 mm? -74.01 151.05 40.35 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.277 1.031 . . . . 0.0 109.804 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.5 m -139.73 172.33 12.94 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.229 0.612 . . . . 0.0 109.526 -175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -55.17 -16.81 3.44 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.319 0.648 . . . . 0.0 111.822 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -65.76 -54.12 31.37 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 122.107 -0.37 . . . . 0.0 110.032 176.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.52 -25.44 6.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.756 0.423 . . . . 0.0 111.031 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 mp -70.1 -31.72 69.42 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 119.299 -0.381 . . . . 0.0 110.338 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.0 t -80.17 -27.91 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 118.62 0.645 . . . . 0.0 110.15 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.02 -39.37 75.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.815 -0.553 . . . . 0.0 111.373 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -82.19 -25.1 34.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.74 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.41 -24.25 23.61 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 CA-C-N 118.755 0.707 . . . . 0.0 109.695 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -78.78 -21.66 47.49 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.674 0.389 . . . . 0.0 110.293 174.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -89.43 -7.3 55.42 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.368 0.667 . . . . 0.0 111.818 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.69 0.58 17.81 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.932 -0.927 . . . . 0.0 114.16 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -87.32 83.71 7.31 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.213 1.507 . . . . 0.0 109.761 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -65.88 -23.77 66.72 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -59.69 -24.35 63.86 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.425 0.69 . . . . 0.0 111.048 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.37 -20.12 32.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 119.777 -0.154 . . . . 0.0 111.26 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -76.45 -35.12 58.66 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.06 -40.63 98.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.0 mt -75.01 -19.02 60.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.672 0.389 . . . . 0.0 111.396 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 tp -83.55 -46.75 12.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.899 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 m -68.77 -24.34 28.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.646 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.9 p -69.88 -26.76 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 119.239 0.927 . . . . 0.0 110.756 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -68.1 -30.67 69.9 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -101.09 -8.89 21.87 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.75 -30.22 71.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.134 -0.979 . . . . 0.0 110.551 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -86.87 -32.47 20.21 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -79.29 -36.39 39.76 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -71.7 -39.01 68.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 123.449 0.7 . . . . 0.0 109.316 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.46 -23.09 67.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.235 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 t -75.02 -45.62 40.55 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.145 -0.347 . . . . 0.0 111.126 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 pp -82.02 -28.12 32.71 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.56 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 p -83.55 -16.92 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 118.219 0.463 . . . . 0.0 111.515 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -67.96 -11.99 59.88 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.103 0.478 . . . . 0.0 109.786 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -86.01 -4.26 59.13 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.341 0.656 . . . . 0.0 111.346 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -122.78 -16.44 7.15 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.938 0.495 . . . . 0.0 112.289 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -142.74 154.48 62.69 Favored Pre-proline 0 N--CA 1.462 0.166 0 C-N-CA 123.587 0.755 . . . . 0.0 109.353 175.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.96 164.21 30.77 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.423 2.748 . . . . 0.0 111.009 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.5 p -66.43 -9.5 34.54 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.05 54.35 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.818 -0.435 . . . . 0.0 112.05 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -116.18 -6.01 11.88 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 117.518 0.659 . . . . 0.0 111.453 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.424 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 8.1 p -66.45 -32.76 5.65 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 117.774 -1.108 . . . . 0.0 113.853 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 78.9 Cg_endo -77.96 -23.07 9.6 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 CA-C-N 121.834 1.691 . . . . 0.0 111.056 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.86 -29.39 32.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.95 -28.91 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.78 -35.8 66.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -71.11 -42.77 68.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -67.98 -29.89 69.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.22 0.464 . . . . 0.0 109.855 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.09 -36.56 77.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 119.55 -0.262 . . . . 0.0 110.297 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -74.69 -33.57 62.47 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.245 0.475 . . . . 0.0 112.024 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.54 -39.17 75.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -75.37 -30.84 60.31 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.812 0.445 . . . . 0.0 110.638 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.53 -44.67 67.06 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.344 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -59.6 -39.23 83.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.61 0.641 . . . . 0.0 111.38 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -72.19 -28.46 63.21 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.512 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 -12.01 40.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.803 0.441 . . . . 0.0 111.351 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.7 tp -75.55 -28.06 58.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.349 0.659 . . . . 0.0 110.721 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -71.38 -6.26 38.79 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.1 m -113.4 4.15 16.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.83 0.852 . . . . 0.0 111.198 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.451 ' CZ ' ' HA2' ' A' ' 66' ' ' GLY . 25.6 t80 -84.68 150.02 25.41 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.973 0.509 . . . . 0.0 110.14 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.01 -2.78 9.15 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -175.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 64' ' ' PHE . . . 70.49 17.64 74.74 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.314 0.507 . . . . 0.0 112.489 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.57 -10.69 57.43 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 117.842 0.821 . . . . 0.0 111.063 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.0 m -139.95 172.65 12.46 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.972 1.309 . . . . 0.0 108.689 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.79 146.06 53.22 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.781 -0.574 . . . . 0.0 110.35 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -67.85 -32.11 72.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -176.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -70.07 -37.41 75.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.817 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -71.28 -33.79 70.08 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 56.9 t90 -73.75 -28.23 61.57 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.483 0.313 . . . . 0.0 110.846 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -85.63 -36.66 20.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.929 0.331 . . . . 0.0 111.029 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -69.36 -21.03 63.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.989 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -78.27 -21.87 49.13 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.908 0.776 . . . . 0.0 110.61 173.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mm -70.44 -34.33 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.95 -41.24 52.18 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.35 -29.03 13.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 O-C-N 121.997 -0.44 . . . . 0.0 111.356 -178.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -75.69 -24.22 56.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.152 -0.343 . . . . 0.0 110.287 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -81.73 -26.98 34.12 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.201 -0.312 . . . . 0.0 110.363 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.91 -32.64 63.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.423 0.556 . . . . 0.0 110.72 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.33 -25.74 46.57 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -83.56 -17.36 42.02 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.447 0.165 . . . . 0.0 110.701 175.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -79.86 -34.76 39.03 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.855 -0.528 . . . . 0.0 110.274 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.5 mt -81.42 -22.44 38.21 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.92 -24.48 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 118.44 0.564 . . . . 0.0 110.151 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.31 -20.64 61.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.223 -0.298 . . . . 0.0 110.99 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -108.9 -15.42 14.38 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.992 0.517 . . . . 0.0 111.028 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.73 -16.83 71.99 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.7 mmm-85 -101.89 -10.58 19.71 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 123.795 0.838 . . . . 0.0 110.762 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 46.59 43.29 12.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.632 0.773 . . . . 0.0 112.664 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.54 24.98 12.55 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.893 0.877 . . . . 0.0 112.597 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -65.59 -19.95 66.12 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.722 0.809 . . . . 0.0 110.565 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.0 tp -107.32 12.01 28.56 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.765 0.826 . . . . 0.0 110.922 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.6 136.54 28.85 Favored Pre-proline 0 CA--C 1.53 0.211 0 C-N-CA 123.111 0.564 . . . . 0.0 109.803 -176.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -70.87 160.85 48.06 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.393 2.728 . . . . 0.0 111.301 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 -100.22 -9.0 22.9 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.253 0.621 . . . . 0.0 111.394 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -68.72 165.63 47.63 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.3 t -150.45 156.3 41.19 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 122.961 0.505 . . . . 0.0 110.355 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -89.9 1.2 56.5 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.539 0.736 . . . . 0.0 111.318 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -124.77 19.37 8.59 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.587 0.755 . . . . 0.0 111.094 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.404 ' CG ' ' H ' ' A' ' 104' ' ' HIS . 6.5 t60 -136.47 173.37 11.78 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.112 0.565 . . . . 0.0 110.342 -178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.404 ' H ' ' CG ' ' A' ' 103' ' ' HIS . 89.6 m-70 58.98 16.73 4.85 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.422 1.089 . . . . 0.0 113.104 -177.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -91.12 -2.16 57.62 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.687 0.395 . . . . 0.0 111.24 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 16.3 p80 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.544 -179.344 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 110.588 -0.153 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.6 m -133.85 7.94 3.79 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.952 0.501 . . . . 0.0 111.347 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -150.47 154.18 37.21 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.117 0.567 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -140.37 157.38 45.63 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.921 0.488 . . . . 0.0 110.391 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.9 mt -77.33 154.73 32.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.482 1.113 . . . . 0.0 111.623 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.0 m -139.87 173.93 11.03 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.131 0.973 . . . . 0.0 108.894 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -55.16 -17.14 3.79 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -66.41 -53.05 40.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.056 -0.402 . . . . 0.0 110.257 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -85.34 -25.75 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 122.906 0.482 . . . . 0.0 110.559 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.8 mp -70.85 -28.65 64.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.154 -0.451 . . . . 0.0 110.974 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.8 t -82.54 -28.12 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 118.858 0.754 . . . . 0.0 110.024 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.439 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 44.1 mt-10 -72.11 -36.61 69.49 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.762 -0.586 . . . . 0.0 110.504 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -70.58 -36.67 73.72 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 m -73.13 -23.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 118.298 0.499 . . . . 0.0 110.827 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -78.0 -18.16 56.26 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -80.99 -5.93 58.16 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.297 0.639 . . . . 0.0 111.863 172.494 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.72 2.13 46.36 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 119.559 -0.578 . . . . 0.0 112.876 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -85.86 84.19 7.62 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.19 0.995 . . . . 0.0 109.349 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -64.36 -19.65 65.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.419 0.288 . . . . 0.0 110.624 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -61.48 -25.5 67.29 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.94 0.496 . . . . 0.0 111.121 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.88 -18.8 38.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.74 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -77.91 -36.16 49.78 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -61.84 -41.07 97.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -76.83 -18.41 58.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 tp -82.08 -41.66 20.25 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 122.139 -0.351 . . . . 0.0 110.74 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.6 m -72.16 -24.28 22.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.885 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -67.74 -26.33 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 119.866 1.212 . . . . 0.0 110.887 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -69.74 -32.13 70.49 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -99.34 -9.08 23.97 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.411 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -62.77 -30.4 71.42 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.206 -0.934 . . . . 0.0 110.751 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -86.99 -32.36 20.09 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 176.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -80.24 -36.37 34.74 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.96 -38.44 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.96 -23.27 67.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 t -74.68 -45.19 46.16 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.047 0.385 . . . . 0.0 111.012 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -82.92 -27.03 30.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.498 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 p -84.97 -16.71 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 118.117 0.417 . . . . 0.0 111.478 -178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -68.35 -11.77 60.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.21 0.529 . . . . 0.0 109.845 172.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -85.83 -5.98 59.16 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.425 0.69 . . . . 0.0 111.312 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -122.6 -16.51 7.22 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.799 0.44 . . . . 0.0 112.164 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 m -141.34 153.76 66.46 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 123.462 0.705 . . . . 0.0 109.443 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.9 164.97 29.61 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.656 2.904 . . . . 0.0 110.984 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -65.87 -10.75 41.1 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -175.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.41 -17.98 56.09 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.082 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -116.49 -5.85 11.71 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 117.726 0.763 . . . . 0.0 111.538 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.423 ' N ' ' CD ' ' A' ' 47' ' ' PRO . 6.8 p -67.35 -32.02 4.21 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 117.785 -1.102 . . . . 0.0 113.722 -176.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 82.4 Cg_endo -78.41 -23.11 8.93 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 121.804 1.68 . . . . 0.0 111.076 -177.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -82.4 -28.21 31.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.343 -0.223 . . . . 0.0 110.62 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.4 t -79.36 -28.61 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -69.15 -35.85 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -70.36 -43.24 70.55 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -68.17 -29.16 67.97 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.736 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.63 -35.47 75.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.987 0.358 . . . . 0.0 110.2 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.46 -33.62 60.86 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.076 0.398 . . . . 0.0 111.72 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.04 -38.46 71.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -75.39 -32.35 60.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.04 0.536 . . . . 0.0 110.579 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.27 77.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.098 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -61.14 -37.8 84.13 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.769 0.713 . . . . 0.0 111.287 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -71.81 -24.72 61.77 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.709 0.404 . . . . 0.0 111.059 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.11 -11.85 25.67 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.167 0.587 . . . . 0.0 111.442 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.2 tp -75.63 -24.06 56.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.26 0.624 . . . . 0.0 110.376 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.56 -11.33 57.83 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.422 0.289 . . . . 0.0 110.604 174.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.2 m -109.46 0.23 19.21 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.754 0.822 . . . . 0.0 111.65 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -79.45 134.32 36.54 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.125 0.57 . . . . 0.0 110.196 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -124.73 6.17 8.14 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -176.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.12 16.99 77.68 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.395 -0.669 . . . . 0.0 113.28 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -68.93 -10.69 58.54 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.267 1.033 . . . . 0.0 111.107 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.4 m -146.04 166.41 26.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.542 1.137 . . . . 0.0 108.676 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.37 144.49 56.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -67.47 -33.22 74.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -69.84 -38.81 76.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.839 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.2 m -70.45 -35.66 73.47 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -69.28 -33.59 73.44 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 122.379 -0.201 . . . . 0.0 110.74 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.2 tp -79.8 -35.91 37.77 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.261 0.225 . . . . 0.0 111.18 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -69.18 -20.25 64.0 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.787 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.5 mtm105 -75.51 -23.76 56.75 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.412 0.551 . . . . 0.0 110.517 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.54 -33.72 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.23 -39.13 55.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -173.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -80.52 -29.65 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 O-C-N 122.126 -0.359 . . . . 0.0 111.409 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -75.88 -23.92 55.65 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 122.208 -0.307 . . . . 0.0 110.309 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.3 m -81.67 -29.59 33.02 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.177 -0.327 . . . . 0.0 110.399 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.84 -35.28 67.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.207 0.458 . . . . 0.0 110.877 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -76.87 -28.27 55.34 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -78.94 -26.52 43.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.261 0.224 . . . . 0.0 110.595 176.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -73.55 -36.49 65.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.834 0.453 . . . . 0.0 111.195 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.6 mt -79.59 -26.25 41.31 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.07 -22.21 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 119.088 0.858 . . . . 0.0 111.005 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.41 -11.81 59.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.279 0.231 . . . . 0.0 111.278 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -118.8 -16.78 9.29 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 122.502 0.321 . . . . 0.0 110.778 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.89 -19.15 61.9 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -106.47 0.01 24.39 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.324 0.65 . . . . 0.0 111.148 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.47 128.03 35.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.919 0.488 . . . . 0.0 110.302 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.1 mp 52.36 17.19 0.71 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.373 1.069 . . . . 0.0 113.278 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -96.06 -16.42 21.61 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.966 -0.459 . . . . 0.0 110.202 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.3 pp -141.86 15.98 2.12 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.415 0.686 . . . . 0.0 111.284 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.2 t 50.06 75.6 0.64 Allowed Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.324 1.049 . . . . 0.0 110.393 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.86 148.43 76.69 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.186 2.591 . . . . 0.0 110.829 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 52.27 20.51 1.38 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.941 0.896 . . . . 0.0 112.801 -177.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.73 169.01 53.83 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.3 p -144.32 4.33 1.21 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.105 0.562 . . . . 0.0 111.93 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -148.59 150.89 34.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.805 0.442 . . . . 0.0 110.535 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -144.9 160.61 41.04 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.709 0.804 . . . . 0.0 109.901 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -138.86 11.05 2.65 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.898 0.479 . . . . 0.0 111.131 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -82.26 -2.18 51.71 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.178 0.591 . . . . 0.0 111.842 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -150.03 165.62 32.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.651 0.78 . . . . 0.0 110.363 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 80.5 t60 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 117.252 -1.356 . . . . 0.0 110.304 -179.998 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 7' ' ' ASP . 27.4 m . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.472 ' N ' HG22 ' A' ' 6' ' ' THR . 3.7 p30 -55.11 -17.55 4.25 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.157 0.583 . . . . 0.0 112.21 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -66.0 -51.98 53.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.99 -0.444 . . . . 0.0 110.251 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.89 -25.58 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 122.396 0.278 . . . . 0.0 110.611 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.84 -28.74 64.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.154 -0.341 . . . . 0.0 110.703 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.1 t -82.17 -28.45 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 118.534 0.606 . . . . 0.0 109.876 176.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.469 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 39.8 mt-10 -70.9 -37.02 72.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.69 -0.631 . . . . 0.0 110.345 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -71.7 -36.42 70.54 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.44 -24.6 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.032 0 CA-C-N 118.338 0.517 . . . . 0.0 110.956 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -78.77 -18.26 54.45 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -83.16 -5.18 59.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.446 0.699 . . . . 0.0 111.898 174.274 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.52 0.14 34.75 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.614 -0.548 . . . . 0.0 113.351 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -88.77 84.29 6.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.232 1.016 . . . . 0.0 109.547 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -63.7 -20.61 65.86 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.711 0.405 . . . . 0.0 110.831 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -62.85 -23.23 67.19 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.095 0.558 . . . . 0.0 111.294 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.52 -18.7 44.14 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.378 -0.202 . . . . 0.0 110.674 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -77.1 -36.51 55.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -62.52 -41.11 98.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -75.19 -18.95 60.05 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.288 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.5 tp -83.54 -47.34 11.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 122.405 0.282 . . . . 0.0 111.238 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 m -67.61 -24.69 31.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.399 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.68 -26.97 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 119.133 0.878 . . . . 0.0 110.891 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -67.93 -32.17 72.45 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -101.49 -8.63 21.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -62.73 -27.6 69.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.342 0.519 . . . . 0.0 110.503 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -86.59 -30.56 21.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.339 -0.226 . . . . 0.0 110.512 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -76.83 -41.87 42.5 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -82.18 -25.5 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.074 0 CA-C-N 118.0 0.364 . . . . 0.0 110.997 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.18 -23.64 63.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.179 0.445 . . . . 0.0 110.193 176.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 t -76.19 -44.22 38.89 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -80.04 -24.94 40.39 Favored 'General case' 0 C--O 1.227 -0.093 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 46' ' ' VAL . 3.2 p -86.76 -17.64 8.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 CA-C-N 118.104 0.411 . . . . 0.0 111.145 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.9 t -67.75 -9.18 41.68 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 122.046 -0.409 . . . . 0.0 110.197 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -88.42 -5.84 58.03 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.033 0.533 . . . . 0.0 111.713 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -122.18 -12.42 8.29 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.56 154.02 59.28 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.813 0.845 . . . . 0.0 109.1 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.18 163.69 35.13 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.363 2.708 . . . . 0.0 110.611 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.0 p -65.61 -10.63 37.42 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.82 -19.54 53.53 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.05 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -116.31 -3.41 11.95 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 117.718 0.759 . . . . 0.0 111.618 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.525 HG23 HG13 ' A' ' 37' ' ' VAL . 5.9 p -67.02 -32.85 5.19 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 117.615 -1.183 . . . . 0.0 113.381 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 95.6 Cg_endo -77.75 -25.17 8.04 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 122.093 1.783 . . . . 0.0 111.492 -177.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -79.73 -29.67 40.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.586 0.232 . . . . 0.0 110.449 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -80.57 -25.89 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -70.79 -36.23 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -72.02 -40.98 68.06 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.895 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -66.24 -29.73 70.03 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.98 -27.8 63.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 122.243 -0.286 . . . . 0.0 110.728 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -85.32 -31.4 23.04 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.278 0.49 . . . . 0.0 111.597 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.3 mt -71.29 -37.13 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -75.58 -32.61 60.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.948 0.499 . . . . 0.0 110.471 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.59 -45.17 69.23 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 119.456 -0.306 . . . . 0.0 110.336 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -60.51 -37.78 82.24 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.594 0.634 . . . . 0.0 111.609 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -72.31 -25.83 61.72 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.826 0.45 . . . . 0.0 111.148 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.22 -12.91 29.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.06 0.544 . . . . 0.0 111.576 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 tp -76.78 -25.84 53.81 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.143 0.577 . . . . 0.0 110.792 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.32 -14.92 63.34 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.307 0.243 . . . . 0.0 110.408 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.0 p -112.94 8.14 18.46 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.241 0.616 . . . . 0.0 111.789 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 t80 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-N 118.025 0.375 . . . . 0.0 110.639 177.364 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.3 t80 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -69.09 -36.41 77.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.658 0.663 . . . . 0.0 111.786 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -70.76 -33.76 71.12 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.59 0.632 . . . . 0.0 109.756 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 58.6 t90 -75.32 -27.98 59.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 122.752 0.421 . . . . 0.0 110.902 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.5 tp -85.81 -37.0 19.71 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.74 0.416 . . . . 0.0 111.312 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -61.63 -32.31 72.44 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.788 0.267 . . . . 0.0 110.344 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -75.56 -22.42 57.04 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.993 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.08 -36.79 75.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.775 0.716 . . . . 0.0 109.5 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.87 -38.74 57.6 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.0 p -78.24 -29.78 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 118.271 0.487 . . . . 0.0 110.801 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -75.28 -23.83 57.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.994 0.361 . . . . 0.0 110.159 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.8 m -79.17 -31.42 43.91 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.76 -29.83 62.44 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 117.56 0.164 . . . . 0.0 110.647 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -80.4 -28.6 37.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 119.444 -0.313 . . . . 0.0 110.999 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.171 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.58 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 7' ' ' ASP . 29.9 m . . . . . 0 CA--C 1.526 0.055 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.493 ' H ' HG22 ' A' ' 6' ' ' THR . 3.1 p30 -55.29 -17.33 4.48 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.454 0.701 . . . . 0.0 112.046 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -67.04 -51.58 52.97 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 122.016 -0.428 . . . . 0.0 110.3 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.59 -26.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 122.993 0.517 . . . . 0.0 110.73 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -69.05 -29.02 67.06 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.02 -0.425 . . . . 0.0 110.532 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.5 t -82.31 -28.78 9.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 118.565 0.621 . . . . 0.0 110.105 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.32 -35.48 68.62 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.571 -0.706 . . . . 0.0 110.433 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -69.97 -37.29 75.75 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.311 0.244 . . . . 0.0 111.347 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 m -73.44 -23.76 19.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 121.771 -0.581 . . . . 0.0 111.078 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -78.38 -16.25 57.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.273 0.229 . . . . 0.0 110.576 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -91.91 3.91 54.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.67 0.788 . . . . 0.0 111.764 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.15 1.64 51.32 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.977 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.88 83.98 4.09 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.851 0.826 . . . . 0.0 109.442 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -67.11 -18.09 65.16 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.982 0.513 . . . . 0.0 110.675 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -60.75 -25.38 66.45 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.582 0.353 . . . . 0.0 110.69 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.12 -18.81 45.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.54 0.155 . . . . 0.0 111.056 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -76.7 -36.77 57.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.57 -40.59 97.34 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.83 -19.04 59.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.272 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.9 tp -83.51 -47.11 11.69 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.428 0.291 . . . . 0.0 111.242 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.04 -24.9 30.87 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.541 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.8 p -70.71 -26.98 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.32 0.964 . . . . 0.0 110.879 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -67.95 -31.62 71.5 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.84 -8.7 21.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -62.03 -29.2 70.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.334 0.515 . . . . 0.0 110.665 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -86.47 -30.53 21.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.044 -0.071 . . . . 0.0 110.955 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.29 -42.27 55.19 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 m -80.94 -25.32 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-N 118.306 0.503 . . . . 0.0 110.98 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.79 -22.09 62.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.083 0.402 . . . . 0.0 110.195 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -77.2 -41.63 40.68 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.87 -24.9 30.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.554 HG13 HG23 ' A' ' 46' ' ' VAL . 2.3 p -88.71 -19.38 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 118.343 0.519 . . . . 0.0 111.717 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.2 t -68.34 -9.37 47.43 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -90.32 -4.35 57.17 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.7 0.8 . . . . 0.0 111.66 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -122.4 -13.0 8.13 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.686 0.394 . . . . 0.0 111.864 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 m -144.0 154.53 58.4 Favored Pre-proline 0 N--CA 1.462 0.152 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.71 164.46 31.24 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.269 2.646 . . . . 0.0 111.08 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.8 p -66.34 -10.17 40.44 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.29 -17.95 56.36 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.175 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -116.37 -6.4 11.77 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 117.423 0.611 . . . . 0.0 111.691 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.554 HG23 HG13 ' A' ' 37' ' ' VAL . 9.9 p -66.34 -33.52 6.82 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 117.587 -1.197 . . . . 0.0 113.428 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 95.5 Cg_endo -76.13 -25.25 10.34 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 CA-C-N 122.212 1.826 . . . . 0.0 111.4 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -81.96 -29.42 32.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.631 0.253 . . . . 0.0 110.381 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.5 t -78.4 -26.94 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.1 t -71.74 -34.95 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 118.419 0.554 . . . . 0.0 109.531 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -72.96 -43.07 62.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -67.73 -26.49 66.17 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.234 0.47 . . . . 0.0 110.156 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.78 -29.32 63.19 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.58 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -85.14 -28.72 25.35 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.575 0.625 . . . . 0.0 111.113 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.6 mt -73.03 -37.92 54.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -75.41 -32.28 60.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.789 0.436 . . . . 0.0 110.613 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.85 -44.51 76.97 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.104 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -60.87 -37.15 81.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.587 0.63 . . . . 0.0 111.621 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -72.87 -25.26 61.03 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.758 0.423 . . . . 0.0 111.047 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.18 -11.03 28.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.144 0.577 . . . . 0.0 111.278 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.96 -23.64 55.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.228 0.611 . . . . 0.0 110.201 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.25 -11.07 56.51 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.261 0.224 . . . . 0.0 110.552 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -110.91 3.18 18.64 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.639 0.776 . . . . 0.0 111.672 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.1 t80 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.506 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 73.7 t80 . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -69.41 -38.04 77.74 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.544 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.7 m -69.62 -37.96 77.05 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.8 t90 -69.05 -31.2 69.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.741 -0.208 . . . . 0.0 110.993 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.6 tp -83.22 -35.15 25.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.576 0.35 . . . . 0.0 111.313 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -63.01 -26.8 69.02 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.005 0.366 . . . . 0.0 110.209 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.64 -27.03 61.04 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 122.8 0.44 . . . . 0.0 111.318 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.2 mm -72.05 -36.25 56.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.94 -36.34 56.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -78.83 -28.87 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.475 0.579 . . . . 0.0 111.274 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.91 -25.28 52.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.152 0.433 . . . . 0.0 110.407 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.2 m -80.63 -28.14 37.03 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 122.448 -0.158 . . . . 0.0 110.597 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.16 -32.84 56.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.087 0.403 . . . . 0.0 111.205 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.45 -26.19 51.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t30 . . . . . 0 CA--C 1.533 0.291 0 C-N-CA 122.454 0.302 . . . . 0.0 110.327 174.601 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 7' ' ' ASP . 31.1 m . . . . . 0 CA--C 1.528 0.114 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 6' ' ' THR . 3.6 p30 -55.28 -17.34 4.44 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.164 0.585 . . . . 0.0 112.385 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -66.23 -53.18 40.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.111 -0.368 . . . . 0.0 110.418 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -84.48 -26.13 7.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.779 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -69.69 -28.99 66.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.642 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.1 t -82.26 -28.22 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 118.839 0.745 . . . . 0.0 109.894 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.85 -37.63 70.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.641 -0.662 . . . . 0.0 110.368 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -69.57 -36.16 76.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 122.057 -0.402 . . . . 0.0 111.76 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -73.62 -23.78 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.038 0 CA-C-N 118.299 0.5 . . . . 0.0 111.205 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -79.69 -14.64 58.62 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.408 0.283 . . . . 0.0 110.335 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -93.18 3.2 56.08 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.632 0.773 . . . . 0.0 112.028 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.54 1.24 43.5 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 119.75 -0.472 . . . . 0.0 113.345 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -92.69 84.24 4.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.025 0.912 . . . . 0.0 109.558 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -65.09 -20.11 66.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.655 0.382 . . . . 0.0 110.659 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -61.72 -24.54 66.86 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.142 0.577 . . . . 0.0 111.007 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.36 -18.79 40.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 119.62 -0.228 . . . . 0.0 110.873 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -77.38 -36.83 53.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.51 -41.95 98.07 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.9 mt -76.53 -18.41 58.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.628 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 tp -81.97 -42.87 18.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.713 0.233 . . . . 0.0 110.659 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 m -69.83 -27.03 31.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.538 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -66.23 -26.86 39.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 CA-C-N 119.859 1.209 . . . . 0.0 111.129 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -69.44 -33.27 72.7 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.016 0.436 . . . . 0.0 109.919 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -100.27 -8.71 23.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.349 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -61.55 -30.08 70.42 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.234 0.613 . . . . 0.0 110.824 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -86.75 -29.5 22.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 121.994 0.118 . . . . 0.0 111.084 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -76.35 -41.22 49.0 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 m -82.79 -24.86 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 118.062 0.392 . . . . 0.0 111.064 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.15 -25.23 63.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -76.81 -46.27 25.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.834 0.35 . . . . 0.0 110.817 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.06 -24.62 59.53 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.595 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 46' ' ' VAL . 2.4 p -88.8 -19.95 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 118.139 0.427 . . . . 0.0 112.146 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.3 m -66.6 -9.93 40.41 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.36 0.527 . . . . 0.0 112.245 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -95.11 -3.75 47.46 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.229 0.468 . . . . 0.0 111.671 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -111.03 -20.63 12.34 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.854 0.462 . . . . 0.0 110.997 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -141.83 152.63 62.93 Favored Pre-proline 0 C--N 1.34 0.176 0 C-N-CA 124.057 0.943 . . . . 0.0 109.541 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.54 167.43 24.17 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.716 2.944 . . . . 0.0 111.249 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.7 m -65.58 -11.77 47.09 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.054 0.542 . . . . 0.0 112.418 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.81 -18.86 53.6 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.609 -0.55 . . . . 0.0 112.795 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.47 -6.98 11.71 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 117.808 0.804 . . . . 0.0 112.035 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.531 HG23 HG13 ' A' ' 37' ' ' VAL . 7.6 p -66.25 -36.04 11.95 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 46' ' ' VAL . 83.2 Cg_endo -73.68 -24.37 15.88 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 CA-C-N 121.697 1.642 . . . . 0.0 111.246 -172.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.5 -30.49 29.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.07 -30.2 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 122.556 0.342 . . . . 0.0 110.133 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -72.16 -33.53 47.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -72.5 -42.9 64.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -65.59 -30.71 71.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.418 0.554 . . . . 0.0 109.595 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.57 -29.3 66.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 117.746 0.248 . . . . 0.0 110.952 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -85.18 -28.92 25.14 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.299 0.5 . . . . 0.0 111.385 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 99.2 mt -72.93 -36.87 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -77.76 -31.07 51.82 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.445 0.698 . . . . 0.0 111.015 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.67 -42.47 74.13 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.121 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -62.05 -38.33 88.34 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.536 0.607 . . . . 0.0 111.485 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.23 -25.78 62.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.622 0.369 . . . . 0.0 111.166 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.34 -10.53 29.86 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.967 0.507 . . . . 0.0 111.395 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.5 tp -75.24 -24.53 57.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.972 0.509 . . . . 0.0 110.249 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.09 -10.25 52.47 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.454 0.302 . . . . 0.0 110.473 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.0 m -110.83 0.75 17.36 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.647 0.779 . . . . 0.0 111.662 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.5 t80 . . . . . 0 N--CA 1.454 -0.269 0 C-N-CA 123.103 0.561 . . . . 0.0 109.68 176.962 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 N--CA 1.455 -0.222 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -68.88 -37.15 78.86 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.737 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.0 m -69.41 -39.61 77.82 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -67.37 -32.96 74.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.95 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.3 tp -81.12 -34.11 32.77 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.726 0.41 . . . . 0.0 111.515 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.4 m-30 -64.0 -27.37 69.07 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.074 -0.391 . . . . 0.0 110.431 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -75.68 -25.04 56.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.165 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.5 mm -70.29 -39.25 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-N 118.296 0.498 . . . . 0.0 109.726 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.56 -37.06 57.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.06 -30.66 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-N 118.469 0.577 . . . . 0.0 111.43 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -76.07 -24.55 55.1 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.969 -0.457 . . . . 0.0 110.167 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.7 m -77.34 -29.37 53.4 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.08 62.5 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.877 0.308 . . . . 0.0 110.973 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.44 -29.7 57.08 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.6 t30 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-N 116.828 -0.169 . . . . 0.0 110.615 176.524 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 7' ' ' ASP . 24.9 m . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.469 ' H ' HG22 ' A' ' 6' ' ' THR . 3.5 p30 -55.52 -17.67 5.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.154 0.582 . . . . 0.0 112.222 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.69 -52.81 40.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.8 p -85.94 -25.9 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 122.85 0.46 . . . . 0.0 110.882 -176.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mp -69.44 -28.18 65.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.909 -0.494 . . . . 0.0 110.515 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.3 t -81.14 -28.54 10.9 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 CA-C-N 118.398 0.545 . . . . 0.0 109.839 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 38.8 mt-10 -72.45 -34.7 67.94 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.824 -0.547 . . . . 0.0 110.271 174.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -68.98 -39.79 79.2 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.688 0.395 . . . . 0.0 111.257 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 m -72.94 -24.16 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 117.698 0.226 . . . . 0.0 111.054 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -78.67 -20.5 50.07 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.887 0.312 . . . . 0.0 110.301 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -81.42 -5.22 57.68 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.328 0.651 . . . . 0.0 111.799 174.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.88 0.38 34.05 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.487 -0.618 . . . . 0.0 112.79 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -87.68 83.96 7.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.008 0.904 . . . . 0.0 109.471 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -66.39 -20.6 66.11 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.683 0.393 . . . . 0.0 110.6 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -60.77 -24.92 66.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.998 0.519 . . . . 0.0 110.834 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.26 -18.77 41.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 119.583 -0.246 . . . . 0.0 111.07 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -76.51 -36.85 57.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -62.49 -40.76 97.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.74 -18.76 59.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.521 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.0 tp -83.7 -47.81 10.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.39 0.276 . . . . 0.0 110.885 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.89 -25.08 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.383 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.3 p -70.37 -26.63 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 119.329 0.968 . . . . 0.0 110.681 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -68.65 -33.13 73.47 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -99.66 -8.91 23.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.352 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -62.62 -27.2 69.04 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.4 0.545 . . . . 0.0 110.609 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -86.12 -30.82 22.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -76.9 -42.23 40.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.3 m -81.59 -25.36 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 118.158 0.435 . . . . 0.0 110.911 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.482 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.86 -22.89 62.25 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.177 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.0 t -76.53 -43.38 39.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.3 -25.22 36.66 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 46' ' ' VAL . 2.8 p -87.35 -18.45 8.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.089 0 CA-C-N 118.094 0.406 . . . . 0.0 111.226 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.2 t -68.21 -9.51 47.62 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 174.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -90.86 -3.87 57.03 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.659 0.784 . . . . 0.0 111.484 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.35 -14.45 8.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.75 0.42 . . . . 0.0 111.807 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.41 153.46 59.08 Favored Pre-proline 0 N--CA 1.462 0.148 0 C-N-CA 123.953 0.901 . . . . 0.0 109.466 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.72 164.5 31.07 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.559 2.839 . . . . 0.0 110.756 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.3 p -66.61 -10.11 42.41 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.06 -18.33 56.07 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 118.262 0.483 . . . . 0.0 112.093 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.36 -5.09 11.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.427 0.613 . . . . 0.0 111.451 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.525 HG23 HG13 ' A' ' 37' ' ' VAL . 5.2 p -67.3 -33.08 5.21 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 117.707 -1.139 . . . . 0.0 113.368 -177.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 97.0 Cg_endo -76.84 -25.25 9.28 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 CA-C-N 122.12 1.793 . . . . 0.0 111.687 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.4 -29.79 30.59 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -78.06 -25.84 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.97 -37.07 59.71 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -71.31 -42.85 68.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -67.83 -26.45 66.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.233 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.41 -27.9 61.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.668 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -85.26 -29.67 24.43 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.531 0.605 . . . . 0.0 111.069 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.99 -37.46 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 175.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -75.58 -32.93 60.54 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.197 0.599 . . . . 0.0 110.538 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.72 -42.75 77.21 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 119.141 -0.456 . . . . 0.0 110.733 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -62.49 -37.62 86.68 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.906 0.776 . . . . 0.0 111.255 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -71.53 -25.12 62.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.679 0.392 . . . . 0.0 111.014 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.98 -11.77 27.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.132 0.573 . . . . 0.0 111.508 176.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -74.72 -24.53 58.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 110.264 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.56 -10.79 58.0 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.276 0.23 . . . . 0.0 110.506 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -109.43 1.92 20.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.649 0.78 . . . . 0.0 111.722 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.5 t80 . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 123.092 0.557 . . . . 0.0 109.732 177.534 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.6 t80 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -69.03 -37.64 78.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.67 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -69.65 -37.25 76.67 Favored 'General case' 0 C--O 1.227 -0.095 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -70.22 -32.18 69.93 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 122.246 0.218 . . . . 0.0 110.953 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.9 tp -81.89 -34.78 29.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.644 0.378 . . . . 0.0 111.319 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -63.63 -28.0 69.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -72.82 -26.04 61.35 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 122.817 0.447 . . . . 0.0 111.527 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mm -72.84 -38.38 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.159 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.85 -35.44 59.94 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 p -77.41 -31.87 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 118.344 0.52 . . . . 0.0 111.245 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -77.87 -23.96 48.67 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.038 0.381 . . . . 0.0 110.649 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.6 m -77.3 -30.45 54.17 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.44 -32.41 62.62 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.726 0.239 . . . . 0.0 111.415 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.53 -30.89 61.94 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.9 t30 . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 176.917 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 7' ' ' ASP . 29.9 m . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 6' ' ' THR . 3.7 p30 -54.94 -18.87 5.55 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.103 0.561 . . . . 0.0 112.284 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -65.79 -52.28 52.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 9' ' ' VAL . 2.9 p -85.68 -25.6 6.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 122.795 0.438 . . . . 0.0 110.923 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 mp -71.67 -28.34 63.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.783 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.4 t -81.86 -28.97 9.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 118.442 0.565 . . . . 0.0 110.055 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.92 -37.15 72.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.719 -0.613 . . . . 0.0 110.206 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -69.82 -37.88 76.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.494 0.318 . . . . 0.0 111.532 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.21 -23.98 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 O-C-N 121.901 -0.499 . . . . 0.0 110.907 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -80.44 -14.62 58.14 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.21 -0.306 . . . . 0.0 110.398 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -93.13 3.65 55.34 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.623 0.769 . . . . 0.0 111.709 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.47 2.79 47.34 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.168 172.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -95.92 84.02 3.79 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.04 0.92 . . . . 0.0 110.086 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -65.58 -20.34 66.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.276 0.63 . . . . 0.0 110.966 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -61.02 -23.81 65.7 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 122.883 0.473 . . . . 0.0 110.871 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.87 -19.03 41.78 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.583 -0.246 . . . . 0.0 110.835 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -76.57 -37.23 56.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.5 -41.86 97.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -76.62 -18.49 58.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.451 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.2 tp -81.0 -43.04 20.22 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.253 -0.279 . . . . 0.0 110.805 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.07 -27.1 31.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.459 -175.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -65.72 -27.3 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 119.97 1.259 . . . . 0.0 111.216 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -70.56 -32.29 69.64 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.121 0.419 . . . . 0.0 109.954 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -100.02 -8.65 23.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.381 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -62.69 -27.97 69.61 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.421 0.689 . . . . 0.0 110.446 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -86.31 -29.67 22.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.475 -0.141 . . . . 0.0 110.859 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -76.67 -43.04 39.51 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -80.92 -25.89 10.84 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 O-C-N 121.928 -0.483 . . . . 0.0 111.145 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -71.55 -22.16 61.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.049 0.386 . . . . 0.0 110.104 176.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 t -76.51 -41.62 46.27 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.123 0.169 . . . . 0.0 110.58 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.96 -25.29 30.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.529 HG13 HG23 ' A' ' 46' ' ' VAL . 2.6 p -88.25 -18.95 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.036 0 CA-C-N 118.165 0.439 . . . . 0.0 111.55 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.5 t -68.61 -8.88 45.98 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 173.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -90.91 -3.87 56.99 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.033 0.933 . . . . 0.0 111.289 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -121.37 -17.5 7.59 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.831 0.452 . . . . 0.0 111.458 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.4 m -141.09 153.19 66.69 Favored Pre-proline 0 N--CA 1.463 0.176 0 C-N-CA 123.406 0.682 . . . . 0.0 109.441 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.82 165.62 29.12 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.718 2.946 . . . . 0.0 111.17 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.7 m -64.87 -11.02 32.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.09 -18.09 56.47 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.272 0.487 . . . . 0.0 112.07 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -116.64 -6.11 11.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.223 0.511 . . . . 0.0 111.642 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.529 HG23 HG13 ' A' ' 37' ' ' VAL . 6.0 p -67.66 -33.18 5.03 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.592 -1.195 . . . . 0.0 113.462 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 98.2 Cg_endo -76.51 -25.5 9.53 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 CA-C-N 122.23 1.832 . . . . 0.0 111.511 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.43 -30.39 30.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.415 -0.178 . . . . 0.0 110.593 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -77.15 -27.02 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.3 t -72.27 -35.44 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -72.05 -42.61 66.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.03 -28.04 67.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.24 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.99 -28.4 63.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.458 -0.305 . . . . 0.0 110.793 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -85.08 -29.97 24.44 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.576 0.625 . . . . 0.0 111.216 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 99.0 mt -72.05 -37.23 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -76.64 -32.37 57.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.118 0.567 . . . . 0.0 110.98 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.71 75.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.32 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -61.58 -38.7 88.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.383 0.538 . . . . 0.0 111.419 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -71.53 -26.12 62.52 Favored 'General case' 0 C--O 1.228 -0.05 0 C-N-CA 122.779 0.431 . . . . 0.0 111.175 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.8 -11.29 31.6 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.063 0.545 . . . . 0.0 111.462 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.1 tp -75.74 -25.81 56.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.689 0.396 . . . . 0.0 110.45 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.86 -10.7 59.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.511 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.6 m -113.37 0.08 14.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.796 0.838 . . . . 0.0 111.213 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.4 t80 . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.367 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 59.2 t80 . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -68.59 -35.74 77.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.97 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.8 m -70.86 -37.84 73.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -70.47 -32.21 69.66 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.249 0.22 . . . . 0.0 111.016 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.8 tp -81.33 -34.77 31.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.602 0.361 . . . . 0.0 111.516 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.2 m-30 -63.52 -28.4 69.92 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 122.086 -0.383 . . . . 0.0 110.109 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -74.01 -25.08 59.69 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.552 0.341 . . . . 0.0 111.363 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.67 -38.24 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.02 -36.26 59.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -174.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.2 p -78.21 -31.23 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-N 118.329 0.513 . . . . 0.0 111.471 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.86 -24.02 52.65 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.137 0.426 . . . . 0.0 110.091 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.5 m -78.73 -29.64 45.43 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.77 -32.97 66.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.876 0.307 . . . . 0.0 110.906 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.24 -30.13 57.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.347 -0.22 . . . . 0.0 110.477 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.5 t30 . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.674 0.274 . . . . 0.0 110.513 177.251 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 7' ' ' ASP . 32.4 m . . . . . 0 C--O 1.232 0.165 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.469 ' N ' HG22 ' A' ' 6' ' ' THR . 3.4 p30 -55.6 -17.1 4.87 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 123.384 0.673 . . . . 0.0 112.182 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.0 tp60 -66.36 -52.76 43.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 121.825 -0.547 . . . . 0.0 110.159 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.408 ' H ' HG12 ' A' ' 9' ' ' VAL . 3.0 p -85.02 -25.79 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 C-N-CA 122.626 0.37 . . . . 0.0 110.9 -177.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.96 -28.54 64.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.079 -0.388 . . . . 0.0 110.841 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.2 t -82.44 -29.18 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 CA-C-N 118.683 0.674 . . . . 0.0 109.771 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.6 -40.92 76.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.514 -0.741 . . . . 0.0 109.971 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -68.39 -36.9 79.83 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.051 0.54 . . . . 0.0 112.204 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -70.47 -22.56 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.051 0 O-C-N 121.489 -0.757 . . . . 0.0 110.43 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -81.03 -14.56 57.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 119.592 -0.242 . . . . 0.0 110.67 174.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -80.41 -6.4 58.0 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.156 0.435 . . . . 0.0 110.759 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.61 4.02 52.57 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.6 0.619 . . . . 0.0 112.187 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -89.6 84.06 6.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.802 0.801 . . . . 0.0 109.487 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -65.68 -19.27 65.84 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.73 0.412 . . . . 0.0 110.774 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -60.32 -24.99 65.44 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 122.753 0.421 . . . . 0.0 110.977 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.57 -18.59 40.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.595 -0.24 . . . . 0.0 110.9 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -77.66 -37.38 50.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -61.32 -41.22 96.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.8 mt -76.94 -18.32 58.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.6 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.1 tp -82.13 -41.9 19.83 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.995 -0.441 . . . . 0.0 110.637 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.8 -26.76 28.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.587 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.4 m -66.58 -27.21 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.933 1.242 . . . . 0.0 111.253 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -70.84 -31.85 68.69 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -100.27 -8.73 23.13 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.376 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -62.95 -28.15 69.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.195 0.598 . . . . 0.0 110.514 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -86.61 -29.42 22.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.448 0.165 . . . . 0.0 110.749 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -77.39 -42.39 36.51 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -80.82 -26.69 11.04 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 118.127 0.421 . . . . 0.0 110.988 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.59 -22.53 62.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 t -77.78 -41.99 35.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.413 0.149 . . . . 0.0 110.668 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.6 -24.97 36.11 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.515 HG13 HG23 ' A' ' 46' ' ' VAL . 2.7 p -88.4 -18.8 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.18 0.446 . . . . 0.0 111.407 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -67.28 -11.09 56.62 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.986 -0.446 . . . . 0.0 110.043 173.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -86.7 -6.46 58.84 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.594 0.758 . . . . 0.0 111.535 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -122.66 -13.09 8.01 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -143.32 153.07 58.93 Favored Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 123.642 0.777 . . . . 0.0 109.211 173.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.08 164.0 33.72 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.66 2.907 . . . . 0.0 110.997 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.0 m -64.84 -10.64 29.78 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.06 -19.17 54.24 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 118.147 0.43 . . . . 0.0 112.166 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.18 -4.92 11.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.501 0.651 . . . . 0.0 111.619 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.515 HG23 HG13 ' A' ' 37' ' ' VAL . 5.3 p -67.43 -32.76 4.79 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.4 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 96.7 Cg_endo -76.78 -24.87 9.73 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 CA-C-N 122.095 1.784 . . . . 0.0 111.79 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.76 -30.8 32.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.289 -0.257 . . . . 0.0 110.528 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.1 t -77.98 -25.49 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.8 t -73.25 -35.42 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.38 -42.22 68.69 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -66.03 -30.84 71.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.78 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.1 -28.39 65.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.477 -0.296 . . . . 0.0 110.932 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -85.38 -28.73 24.97 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.519 0.6 . . . . 0.0 111.386 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.3 mt -72.7 -37.69 56.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -76.91 -32.81 57.66 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.105 0.562 . . . . 0.0 110.92 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.49 -42.16 79.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.279 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -61.82 -39.29 91.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.601 0.637 . . . . 0.0 111.542 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -70.82 -25.12 62.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.73 0.412 . . . . 0.0 111.289 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.22 -11.93 27.18 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.23 0.612 . . . . 0.0 111.419 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.0 tp -74.94 -24.82 58.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.005 0.522 . . . . 0.0 110.444 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.85 -10.75 51.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.271 0.228 . . . . 0.0 110.676 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.3 m -110.93 2.27 18.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.535 0.734 . . . . 0.0 111.7 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 t80 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.655 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.6 t80 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -69.56 -36.67 76.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.479 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.2 m -70.4 -34.23 72.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 62.0 t90 -76.21 -26.83 56.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 122.908 0.483 . . . . 0.0 111.325 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.8 tp -86.25 -35.19 20.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.22 -0.3 . . . . 0.0 111.289 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -63.91 -30.63 71.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -74.49 -22.17 59.21 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 117.999 0.363 . . . . 0.0 111.817 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.4 mm -70.26 -37.61 71.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.716 0.689 . . . . 0.0 109.504 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.97 -37.38 55.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 p -78.91 -29.35 14.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 CA-C-N 118.45 0.568 . . . . 0.0 111.336 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -76.13 -24.82 54.92 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.884 -0.51 . . . . 0.0 109.975 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.8 m -80.1 -30.74 39.21 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 122.206 -0.309 . . . . 0.0 110.246 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.56 -34.63 65.24 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.13 0.423 . . . . 0.0 111.016 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.44 -27.77 52.27 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.5 t30 . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 176.648 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 7' ' ' ASP . 32.7 m . . . . . 0 C--O 1.23 0.075 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.469 ' N ' HG22 ' A' ' 6' ' ' THR . 3.7 p30 -55.18 -17.38 4.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.498 0.719 . . . . 0.0 112.11 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.44 -53.25 37.62 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.101 -0.375 . . . . 0.0 110.144 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 p -85.08 -26.14 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.965 0.506 . . . . 0.0 110.781 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.78 -28.66 64.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.758 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.7 t -82.22 -28.78 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 118.791 0.723 . . . . 0.0 110.013 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.93 -37.65 72.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.584 -0.697 . . . . 0.0 110.401 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -71.64 -35.4 70.38 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.133 -0.354 . . . . 0.0 111.952 -175.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -73.24 -23.88 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.174 0.443 . . . . 0.0 111.036 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -80.13 -14.96 58.07 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -92.39 3.32 55.68 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.47 0.708 . . . . 0.0 111.922 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.06 0.11 41.42 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.583 -0.565 . . . . 0.0 113.471 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -93.95 84.15 4.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.164 0.982 . . . . 0.0 109.294 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.2 tm0? -65.66 -19.91 66.09 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.82 0.448 . . . . 0.0 110.438 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -62.57 -22.44 66.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.102 0.561 . . . . 0.0 111.119 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.66 -18.78 43.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.842 0.292 . . . . 0.0 110.494 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -76.88 -36.11 56.97 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -61.98 -40.39 95.43 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.96 -19.07 59.04 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.292 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 tp -83.67 -48.08 10.55 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 119.634 -0.222 . . . . 0.0 111.126 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -66.72 -25.04 33.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.616 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.28 -26.74 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 119.399 1.0 . . . . 0.0 111.083 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -68.72 -31.68 70.93 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -101.52 -9.01 21.4 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -62.08 -28.38 69.57 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.389 0.54 . . . . 0.0 110.332 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -86.69 -31.39 21.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.716 -0.105 . . . . 0.0 110.716 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -75.74 -42.17 51.26 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -80.84 -25.22 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 O-C-N 121.739 -0.601 . . . . 0.0 110.873 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.458 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -69.39 -23.43 63.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.115 0.416 . . . . 0.0 110.149 176.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -76.27 -44.47 37.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 pp -79.05 -25.21 43.2 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.513 HG13 HG23 ' A' ' 46' ' ' VAL . 3.2 p -88.51 -17.95 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 118.108 0.413 . . . . 0.0 111.626 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.7 t -67.17 -9.36 39.17 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.941 -0.474 . . . . 0.0 110.009 173.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -86.71 -7.65 58.11 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.346 0.659 . . . . 0.0 111.501 176.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -120.9 -13.8 8.58 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 m -144.42 154.23 56.54 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 124.152 0.981 . . . . 0.0 109.182 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.62 164.45 33.0 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.368 2.712 . . . . 0.0 110.881 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -66.51 -9.96 39.96 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.11 -19.14 54.21 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.05 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -116.35 -5.2 11.79 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.554 0.677 . . . . 0.0 111.621 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.513 HG23 HG13 ' A' ' 37' ' ' VAL . 5.0 p -66.39 -32.69 5.63 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.67 -1.157 . . . . 0.0 113.703 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 91.4 Cg_endo -76.75 -25.46 9.2 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 CA-C-N 121.989 1.746 . . . . 0.0 111.458 -176.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.06 -30.39 31.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.132 -0.355 . . . . 0.0 110.57 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.2 t -75.53 -27.21 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.92 -35.74 55.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -71.85 -43.17 65.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -67.28 -27.91 67.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.089 0.404 . . . . 0.0 110.18 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.62 -27.17 61.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.7 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -84.58 -31.32 24.39 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.538 0.608 . . . . 0.0 110.918 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.9 mt -70.08 -36.94 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -78.03 -33.75 50.9 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.443 0.297 . . . . 0.0 110.921 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.29 -39.85 89.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.585 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -64.94 -36.77 85.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.521 0.601 . . . . 0.0 111.07 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -71.58 -17.74 62.27 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.943 0.497 . . . . 0.0 110.78 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.28 -10.8 17.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.137 0.575 . . . . 0.0 111.439 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.1 tp -76.06 -23.95 55.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.279 0.631 . . . . 0.0 110.155 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.62 -9.12 47.82 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.663 0.385 . . . . 0.0 110.463 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.1 m -113.17 4.8 16.72 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.114 0.966 . . . . 0.0 111.528 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.3 t80 . . . . . 0 C--O 1.233 0.186 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.232 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.0 t80 . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -69.76 -36.51 75.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.705 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.3 m -70.78 -34.31 71.66 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -74.23 -28.84 61.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.061 0.544 . . . . 0.0 110.947 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.7 tp -86.24 -35.36 20.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.558 0.343 . . . . 0.0 111.387 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -62.74 -33.62 75.51 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -74.86 -21.86 59.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.678 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.8 mm -68.71 -39.91 80.89 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 118.836 0.744 . . . . 0.0 109.231 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.04 -34.47 64.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.65 -30.92 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.082 0 CA-C-N 118.713 0.688 . . . . 0.0 111.05 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -78.51 -19.02 53.89 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.979 -0.451 . . . . 0.0 110.522 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 81.4 m -78.64 -31.45 46.89 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.66 -35.55 62.81 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.743 0.247 . . . . 0.0 111.188 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -77.67 -24.03 49.45 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.9 t30 . . . . . 0 CA--C 1.532 0.272 0 O-C-N 122.361 -0.212 . . . . 0.0 111.111 175.473 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 7' ' ' ASP . 23.4 m . . . . . 0 N--CA 1.461 0.124 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.471 ' N ' HG22 ' A' ' 6' ' ' THR . 3.2 p30 -55.29 -17.13 4.13 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.988 0.515 . . . . 0.0 112.165 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -66.96 -51.2 58.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.111 -0.368 . . . . 0.0 110.226 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.5 p -85.57 -26.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 122.772 0.429 . . . . 0.0 110.818 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.64 -29.16 67.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.252 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.66 -28.66 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 118.611 0.641 . . . . 0.0 110.154 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.94 -35.07 69.5 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.598 -0.689 . . . . 0.0 110.269 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -70.6 -37.37 73.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.451 0.3 . . . . 0.0 111.647 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -73.09 -23.69 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 118.139 0.427 . . . . 0.0 111.291 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -79.64 -16.42 55.81 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.362 0.265 . . . . 0.0 110.608 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -91.72 3.36 55.27 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.939 0.896 . . . . 0.0 111.88 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.25 3.11 48.03 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.782 -0.454 . . . . 0.0 113.28 173.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -97.99 83.64 3.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 117.923 0.862 . . . . 0.0 109.526 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 tm0? -67.01 -17.73 65.05 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.158 0.583 . . . . 0.0 110.62 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -60.67 -24.6 65.72 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.85 0.46 . . . . 0.0 110.927 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.0 -18.92 41.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 119.639 -0.22 . . . . 0.0 110.892 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -76.76 -37.22 56.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.26 -39.85 94.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.823 0.344 . . . . 0.0 110.282 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.4 -18.95 58.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.808 0.443 . . . . 0.0 111.335 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -83.48 -47.09 11.74 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.775 0.43 . . . . 0.0 111.008 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -69.5 -24.44 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.881 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.47 -26.27 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 119.231 0.923 . . . . 0.0 110.62 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -67.78 -33.93 75.8 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.444 ' HB3' HG23 ' A' ' 33' ' ' VAL . 78.1 m-85 -97.7 -8.93 27.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.41 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -63.58 -29.49 70.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.357 -0.839 . . . . 0.0 110.479 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -86.81 -32.04 20.53 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -83.87 -32.16 25.35 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 29' ' ' TYR . 61.3 t -73.32 -38.41 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -63.24 -25.78 68.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.919 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.3 t -72.9 -48.04 40.63 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.007 0.367 . . . . 0.0 110.942 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.417 HD21 ' CD1' ' A' ' 75' ' ' TYR . 3.7 pp -79.34 -27.17 42.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.553 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.584 HG13 HG23 ' A' ' 46' ' ' VAL . 2.1 p -84.93 -15.35 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 117.715 0.234 . . . . 0.0 111.463 -177.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.4 t -68.34 -11.86 60.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.977 -0.452 . . . . 0.0 109.973 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -84.8 -6.76 59.36 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.963 0.505 . . . . 0.0 111.686 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -122.31 -12.52 8.23 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 m -146.31 153.96 48.95 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 123.509 0.723 . . . . 0.0 109.118 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.19 162.76 36.99 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.469 2.779 . . . . 0.0 111.07 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.3 p -65.08 -10.14 27.95 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.18 -19.04 54.46 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.194 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -116.15 -5.03 11.9 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.591 0.696 . . . . 0.0 111.224 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.584 HG23 HG13 ' A' ' 37' ' ' VAL . 6.3 p -66.85 -32.3 4.83 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -176.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 85.0 Cg_endo -78.17 -22.81 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 CA-C-N 121.789 1.674 . . . . 0.0 111.162 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -81.56 -28.82 33.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.526 0.203 . . . . 0.0 110.499 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.97 -27.79 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.58 -37.06 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -70.18 -42.91 71.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.3 -27.25 65.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.23 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -35.45 70.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -74.98 -33.7 61.9 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 118.256 0.48 . . . . 0.0 111.788 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.3 mt -70.23 -38.73 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -74.38 -31.95 62.55 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.144 0.578 . . . . 0.0 110.462 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.32 -44.85 70.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.249 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -61.36 -37.14 82.29 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.913 0.779 . . . . 0.0 111.329 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -71.65 -25.88 62.32 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 122.663 0.385 . . . . 0.0 110.989 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.23 -11.18 28.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.145 0.578 . . . . 0.0 111.393 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.9 tp -75.36 -24.45 57.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.243 0.617 . . . . 0.0 110.277 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.99 -10.77 53.12 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 173.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.7 m -108.22 3.76 24.0 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.668 0.787 . . . . 0.0 111.856 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.2 t80 . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 123.11 0.564 . . . . 0.0 109.994 178.754 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 64.7 t80 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -69.72 -34.89 74.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.037 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 88.5 m -76.03 -32.66 59.45 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 57.3 t90 -72.92 -28.0 62.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.56 0.344 . . . . 0.0 110.66 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.5 tp -85.87 -37.45 19.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.394 0.277 . . . . 0.0 111.167 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.417 ' CD1' HD21 ' A' ' 36' ' ' LEU . 19.4 m-85 -69.33 -20.6 63.87 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.942 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -77.94 -21.89 50.38 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.445 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.9 mm -71.63 -37.42 63.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.82 -39.64 66.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.56 -29.01 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 118.181 0.446 . . . . 0.0 111.07 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -76.46 -23.62 53.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.172 -0.33 . . . . 0.0 110.479 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.5 m -80.16 -29.12 38.73 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.27 -33.14 61.22 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.322 -0.236 . . . . 0.0 111.22 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -75.98 -28.58 57.92 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.3 t30 . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 174.6 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 7' ' ' ASP . 26.3 m . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.458 ' H ' HG22 ' A' ' 6' ' ' THR . 3.3 p30 -55.27 -17.21 4.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.087 0.555 . . . . 0.0 112.261 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -65.21 -53.52 43.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.725 0.298 . . . . 0.0 110.203 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 p -85.5 -26.23 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 123.038 0.535 . . . . 0.0 111.006 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.02 -28.83 64.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 122.065 -0.397 . . . . 0.0 110.957 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.7 t -82.58 -28.19 8.63 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 CA-C-N 118.562 0.619 . . . . 0.0 110.153 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.435 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 42.9 mt-10 -71.37 -35.74 71.2 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.561 -0.712 . . . . 0.0 110.36 175.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -71.22 -38.78 71.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.654 0.382 . . . . 0.0 111.637 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.05 -24.22 22.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 O-C-N 121.92 -0.488 . . . . 0.0 110.81 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -78.39 -18.78 54.56 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -79.12 -5.84 55.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.336 0.654 . . . . 0.0 111.21 172.135 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.95 2.54 48.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 123.235 0.445 . . . . 0.0 112.61 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.88 83.99 7.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 117.915 0.858 . . . . 0.0 109.505 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -64.98 -19.87 66.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.911 0.484 . . . . 0.0 110.714 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -60.27 -25.05 65.41 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.865 0.466 . . . . 0.0 111.096 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.89 -18.93 38.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.285 -0.259 . . . . 0.0 111.078 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -77.17 -36.93 54.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.74 -42.14 96.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.4 mt -76.2 -18.32 59.12 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.9 tp -82.27 -41.6 19.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.906 0.321 . . . . 0.0 111.009 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.2 m -72.26 -24.7 22.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.739 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.26 -26.87 37.23 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-N 119.915 1.234 . . . . 0.0 110.884 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -69.91 -31.7 69.61 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.415 ' HB3' HG23 ' A' ' 33' ' ' VAL . 66.6 m-85 -99.49 -8.76 24.21 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.328 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -62.98 -29.7 71.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.186 -0.946 . . . . 0.0 110.853 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -86.87 -32.09 20.42 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.379 0.14 . . . . 0.0 111.379 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -81.06 -33.69 33.26 Favored 'General case' 0 CA--C 1.527 0.082 0 O-C-N 122.037 -0.414 . . . . 0.0 111.995 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 29' ' ' TYR . 53.8 t -74.88 -37.18 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.513 0.725 . . . . 0.0 109.415 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.47 -27.22 69.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.531 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -73.67 -49.41 26.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.945 0.339 . . . . 0.0 111.191 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.4 HD21 ' CD1' ' A' ' 75' ' ' TYR . 3.3 pp -75.23 -25.02 57.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.151 -0.343 . . . . 0.0 111.211 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.47 ' CG1' HG23 ' A' ' 46' ' ' VAL . 1.4 p -86.76 -16.86 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.2 m -66.41 -12.4 56.82 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.807 -0.558 . . . . 0.0 111.669 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -92.87 -3.68 54.2 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.673 0.67 . . . . 0.0 111.941 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -113.11 -19.52 11.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.714 0.406 . . . . 0.0 111.419 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 m -142.65 152.87 60.8 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 123.472 0.709 . . . . 0.0 109.485 173.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.15 168.82 20.95 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.614 2.876 . . . . 0.0 111.446 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.9 m -65.14 -11.65 42.49 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.106 0.562 . . . . 0.0 112.404 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.8 -19.31 51.99 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.832 -0.427 . . . . 0.0 112.986 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -116.22 -5.64 11.85 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.601 0.701 . . . . 0.0 112.122 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.47 HG23 ' CG1' ' A' ' 37' ' ' VAL . 4.0 p -64.7 -34.73 11.34 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 46' ' ' VAL . 87.5 Cg_endo -73.9 -25.52 14.2 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 CA-C-N 121.738 1.656 . . . . 0.0 111.33 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.03 -27.68 28.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 122.449 -0.157 . . . . 0.0 110.735 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.4 t -80.45 -29.98 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.0 t -69.25 -35.96 70.33 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.84 -44.03 70.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -67.44 -30.3 69.99 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.834 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.34 -34.84 76.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -75.96 -34.41 59.83 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.105 0.412 . . . . 0.0 111.764 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.5 mt -71.01 -36.35 63.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -77.1 -33.29 56.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.248 0.619 . . . . 0.0 110.333 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.54 82.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 119.323 -0.37 . . . . 0.0 110.16 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -63.34 -37.71 88.33 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.66 0.664 . . . . 0.0 111.262 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -70.57 -20.07 62.82 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 122.862 0.465 . . . . 0.0 111.358 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 -10.43 18.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.01 0.524 . . . . 0.0 111.106 177.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.07 -24.06 58.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.282 0.633 . . . . 0.0 110.159 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.06 -9.8 43.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.4 m -111.8 1.43 16.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.76 0.824 . . . . 0.0 111.454 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 86.3 t80 . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.511 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.4 t80 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 119.577 -0.249 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -69.96 -37.61 75.85 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.379 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.1 m -70.39 -37.84 74.58 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -68.77 -33.43 73.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.87 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.8 tp -79.09 -35.91 41.59 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.178 0.191 . . . . 0.0 111.198 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.4 ' CD1' HD21 ' A' ' 36' ' ' LEU . 21.8 m-30 -69.43 -20.28 63.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.215 -0.303 . . . . 0.0 111.593 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -74.0 -26.44 60.44 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.4 mm -73.76 -36.1 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.08 -36.91 64.32 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 p -81.35 -28.74 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 118.119 0.418 . . . . 0.0 110.93 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -76.7 -25.41 53.57 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 117.817 0.28 . . . . 0.0 110.359 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.3 m -79.21 -29.73 42.98 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.92 -33.5 63.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.259 -0.276 . . . . 0.0 111.369 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -76.39 -31.07 57.76 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.1 t30 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 175.966 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 7' ' ' ASP . 27.3 m . . . . . 0 CA--C 1.524 -0.025 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 6' ' ' THR . 3.1 p30 -55.29 -18.04 5.64 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.257 0.623 . . . . 0.0 112.437 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -65.85 -52.45 50.22 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.82 -0.55 . . . . 0.0 110.041 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.409 ' H ' HG12 ' A' ' 9' ' ' VAL . 2.7 p -85.22 -26.03 6.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 C-N-CA 122.704 0.402 . . . . 0.0 111.022 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.73 -27.99 64.38 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.887 -0.508 . . . . 0.0 110.803 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.0 t -81.84 -28.63 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.04 0 CA-C-N 118.833 0.742 . . . . 0.0 110.077 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.72 -36.66 70.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.707 -0.62 . . . . 0.0 110.461 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -71.15 -35.89 71.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -72.71 -25.05 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 118.098 0.408 . . . . 0.0 110.945 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -79.49 -14.81 58.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.172 0.189 . . . . 0.0 110.521 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -92.74 3.23 56.01 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.908 0.883 . . . . 0.0 112.143 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.81 -0.49 39.07 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.558 172.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -93.47 84.06 4.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.107 0.953 . . . . 0.0 109.633 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -66.33 -19.98 65.96 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.52 0.328 . . . . 0.0 110.467 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -62.26 -23.08 66.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.218 0.607 . . . . 0.0 111.137 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.83 -18.92 42.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 117.786 0.266 . . . . 0.0 110.533 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -77.46 -36.63 52.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -61.45 -41.18 96.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -76.92 -18.54 58.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.593 0.357 . . . . 0.0 111.507 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.8 tp -81.41 -42.71 20.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 122.328 -0.232 . . . . 0.0 110.593 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.4 m -71.77 -24.39 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.863 -176.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.6 -26.45 35.45 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 119.944 1.247 . . . . 0.0 111.012 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -69.9 -31.73 69.68 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.432 ' HB3' HG23 ' A' ' 33' ' ' VAL . 60.8 m-85 -99.03 -8.85 24.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.343 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -63.07 -30.06 71.3 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.254 -0.904 . . . . 0.0 110.786 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -86.92 -31.73 20.54 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -81.27 -35.43 31.14 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.138 -0.351 . . . . 0.0 111.808 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 29' ' ' TYR . 61.1 t -72.39 -38.57 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.493 0.717 . . . . 0.0 109.175 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.482 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.49 -24.48 67.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.195 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.2 t -73.97 -45.7 48.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.297 -0.252 . . . . 0.0 111.088 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 pp -81.61 -28.29 33.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.726 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.568 HG13 HG23 ' A' ' 46' ' ' VAL . 2.3 p -83.78 -15.88 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 117.954 0.343 . . . . 0.0 111.552 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -68.89 -11.61 60.75 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.922 -0.486 . . . . 0.0 109.802 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -86.01 -4.72 59.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.245 0.618 . . . . 0.0 111.409 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.84 -16.12 7.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.008 0.523 . . . . 0.0 112.295 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.76 154.51 62.65 Favored Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 123.671 0.789 . . . . 0.0 109.517 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.72 164.01 32.98 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.671 2.914 . . . . 0.0 111.013 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.0 p -66.05 -10.33 39.04 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.56 -19.13 55.46 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.629 -0.54 . . . . 0.0 111.987 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.45 -5.08 11.74 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.68 0.74 . . . . 0.0 111.53 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.568 HG23 HG13 ' A' ' 37' ' ' VAL . 5.5 p -67.08 -32.8 5.1 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 75.3 Cg_endo -78.18 -22.8 9.52 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.699 1.643 . . . . 0.0 111.384 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.48 -28.65 31.06 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.308 -0.245 . . . . 0.0 110.492 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.9 t -77.94 -28.68 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.02 -36.85 75.87 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -71.27 -43.4 67.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.47 -27.59 66.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.142 0.428 . . . . 0.0 110.266 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.4 69.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -72.22 -35.37 68.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.491 0.587 . . . . 0.0 111.493 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.0 -40.99 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -76.7 -28.85 56.03 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.552 0.341 . . . . 0.0 111.143 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.95 -40.66 75.3 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 119.25 -0.405 . . . . 0.0 110.006 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.58 -38.22 89.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.846 0.748 . . . . 0.0 111.295 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.03 -24.65 62.4 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.977 0.511 . . . . 0.0 111.027 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.82 -11.26 27.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.025 0.53 . . . . 0.0 111.393 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.6 tp -75.29 -24.29 57.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.217 0.607 . . . . 0.0 110.138 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.15 -11.1 56.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.79 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.0 m -110.36 4.56 20.81 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.559 0.744 . . . . 0.0 111.615 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.1 t80 . . . . . 0 C--O 1.235 0.323 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.237 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.2 t80 . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -70.41 -36.86 74.28 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.421 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.0 m -71.84 -33.23 68.28 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -75.46 -27.25 58.82 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.381 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 tp -86.02 -35.94 20.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.377 0.271 . . . . 0.0 111.293 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -70.21 -20.64 63.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.083 -0.386 . . . . 0.0 111.745 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -76.63 -24.19 53.37 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.494 0.588 . . . . 0.0 110.56 172.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.8 mm -70.69 -41.2 77.63 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.7 74.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.67 -29.91 16.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 118.193 0.452 . . . . 0.0 110.791 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.65 -19.14 53.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.844 -0.535 . . . . 0.0 110.409 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -83.1 -26.73 30.75 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.069 0.395 . . . . 0.0 110.034 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.12 -36.13 64.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.94 -0.475 . . . . 0.0 110.333 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -74.03 -28.59 61.5 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 123.961 0.904 . . . . 0.0 111.065 177.236 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 7' ' ' ASP . 25.6 m . . . . . 0 CA--C 1.528 0.123 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.483 ' H ' HG22 ' A' ' 6' ' ' THR . 3.8 p30 -56.08 -17.73 7.82 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.663 0.385 . . . . 0.0 111.942 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -62.82 -53.44 54.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.6 p -86.0 -26.38 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.146 0.578 . . . . 0.0 110.896 -176.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.0 -28.7 64.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 119.086 -0.483 . . . . 0.0 110.964 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.1 t -82.64 -30.74 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 CA-C-N 118.862 0.756 . . . . 0.0 109.97 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.1 -41.62 81.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.812 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -69.66 -35.44 75.17 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.2 m -71.31 -22.19 22.22 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-N 118.554 0.616 . . . . 0.0 110.441 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -80.46 -14.79 57.98 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.858 0.299 . . . . 0.0 110.385 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -80.45 -8.04 59.39 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 122.006 -0.434 . . . . 0.0 110.908 172.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.86 2.47 45.97 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.464 0.554 . . . . 0.0 112.826 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.48 84.17 7.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.042 0.921 . . . . 0.0 109.505 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.97 -21.41 66.48 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.825 0.45 . . . . 0.0 110.417 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -61.72 -24.62 66.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.918 0.487 . . . . 0.0 111.239 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.19 -18.79 41.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.363 -0.211 . . . . 0.0 110.682 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -77.79 -35.57 51.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -62.56 -41.03 98.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.29 -19.0 59.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.201 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -83.68 -46.82 11.88 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.137 -0.352 . . . . 0.0 111.528 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.3 m -67.63 -25.49 33.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 118.654 -0.689 . . . . 0.0 111.34 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.7 -26.41 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 119.337 0.971 . . . . 0.0 110.893 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -68.62 -32.31 72.09 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -100.83 -8.66 22.42 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -63.07 -28.01 69.79 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 118.421 0.555 . . . . 0.0 110.758 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -85.83 -30.14 23.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -76.38 -43.25 41.49 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 m -81.35 -26.01 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.18 0.445 . . . . 0.0 111.24 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.53 -22.5 62.61 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 t -76.8 -43.14 37.88 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.594 0.235 . . . . 0.0 110.754 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.46 -25.1 39.06 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 46' ' ' VAL . 3.8 p -87.58 -18.54 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-N 118.007 0.367 . . . . 0.0 111.169 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -63.23 -13.55 39.1 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 171.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -89.32 -3.94 58.3 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.799 0.84 . . . . 0.0 111.78 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -122.51 -17.73 6.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.779 0.432 . . . . 0.0 111.815 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.27 153.68 66.62 Favored Pre-proline 0 N--CA 1.462 0.146 0 C-N-CA 123.353 0.661 . . . . 0.0 110.055 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.21 164.01 35.62 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.584 2.856 . . . . 0.0 110.755 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -66.29 -10.29 41.04 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.14 -18.61 57.33 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -116.52 -6.69 11.68 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.216 0.607 . . . . 0.0 111.258 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 37' ' ' VAL . 4.5 p -66.78 -33.11 5.72 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 117.811 -1.09 . . . . 0.0 113.772 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 86.8 Cg_endo -77.11 -25.01 9.12 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 122.004 1.752 . . . . 0.0 111.518 -175.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -81.97 -29.55 32.1 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.235 -0.29 . . . . 0.0 110.341 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.4 t -77.85 -27.52 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.3 -33.91 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -72.97 -42.52 63.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -66.13 -29.05 69.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.785 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.67 -29.53 64.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.755 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -85.04 -28.97 25.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.278 0.49 . . . . 0.0 111.362 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.4 mt -72.13 -38.42 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -75.01 -32.51 61.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.215 0.606 . . . . 0.0 110.652 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.94 -46.86 67.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.208 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -59.69 -37.19 78.14 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.613 0.642 . . . . 0.0 111.508 -175.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -72.66 -25.7 61.37 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.907 0.483 . . . . 0.0 111.253 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.18 -13.52 28.3 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.077 0.551 . . . . 0.0 111.548 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.8 tp -76.71 -25.81 53.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.293 0.637 . . . . 0.0 110.819 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.4 -12.74 61.91 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -112.48 -0.4 15.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.664 0.786 . . . . 0.0 111.909 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.9 t80 . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.35 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.0 t80 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -70.52 -43.62 69.27 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 118.505 0.593 . . . . 0.0 111.651 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -68.69 -33.2 73.55 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -72.82 -28.46 62.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.925 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.0 tp -85.89 -37.85 18.68 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.846 0.458 . . . . 0.0 111.034 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -60.09 -32.0 70.55 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.616 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -77.07 -21.3 54.62 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.107 -0.473 . . . . 0.0 111.951 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.72 -38.3 75.85 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.942 0.792 . . . . 0.0 109.492 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.62 -38.96 58.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.5 p -76.4 -31.84 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.064 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -75.88 -20.88 57.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.035 -0.416 . . . . 0.0 110.552 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 m -78.68 -30.46 46.16 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.99 -29.78 63.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 122.263 -0.273 . . . . 0.0 110.319 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -79.51 -28.94 41.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.332 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-N 118.771 0.714 . . . . 0.0 110.644 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 8' ' ' GLN . 5.8 t . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -59.86 -17.01 33.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.058 0.543 . . . . 0.0 110.763 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.485 ' H ' HG23 ' A' ' 6' ' ' THR . 19.2 tp60 -69.94 -52.27 25.84 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.539 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.2 -26.65 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 122.673 0.389 . . . . 0.0 110.934 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 mp -70.04 -30.08 67.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.841 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.9 t -80.59 -28.01 11.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-N 118.623 0.647 . . . . 0.0 110.0 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.32 -36.44 68.88 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.627 -0.671 . . . . 0.0 110.188 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -69.95 -37.13 75.75 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.506 0.322 . . . . 0.0 111.497 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.5 m -73.46 -23.62 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.06 0 CA-C-N 118.117 0.417 . . . . 0.0 111.224 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -79.95 -15.76 56.61 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.534 0.334 . . . . 0.0 110.72 174.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -92.23 4.34 53.47 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.728 0.811 . . . . 0.0 111.99 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.28 2.38 51.03 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 119.8 -0.445 . . . . 0.0 113.128 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -97.26 83.88 3.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.001 0.901 . . . . 0.0 109.771 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -66.95 -18.35 65.34 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -60.79 -23.96 65.43 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.73 0.412 . . . . 0.0 110.824 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.77 -18.61 43.55 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.378 -0.201 . . . . 0.0 110.849 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -77.48 -36.98 52.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -61.85 -40.11 94.21 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.46 -19.07 58.42 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.442 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.6 tp -83.62 -46.46 12.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.691 0.396 . . . . 0.0 111.008 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.87 -24.55 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.546 -175.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.48 -27.13 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.157 0.89 . . . . 0.0 110.674 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -67.39 -32.77 73.91 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.44 ' HB3' HG23 ' A' ' 33' ' ' VAL . 67.0 m-85 -98.67 -9.08 25.17 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -62.86 -28.82 70.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.474 -0.766 . . . . 0.0 110.48 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -86.91 -32.51 20.13 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -82.0 -33.03 30.3 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 122.054 -0.404 . . . . 0.0 111.998 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 29' ' ' TYR . 56.8 t -74.23 -38.33 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.85 -23.95 67.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.934 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.7 t -74.64 -46.07 40.65 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.944 0.338 . . . . 0.0 111.019 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.88 -29.47 39.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.181 -0.325 . . . . 0.0 111.473 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.565 HG13 HG23 ' A' ' 46' ' ' VAL . 2.4 p -83.4 -15.71 11.41 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.056 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.4 t -67.7 -11.72 58.94 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.858 -0.526 . . . . 0.0 109.887 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -84.7 -6.54 59.36 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.042 0.537 . . . . 0.0 111.644 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -122.5 -13.44 8.0 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.27 154.8 57.79 Favored Pre-proline 0 C--O 1.231 0.123 0 C-N-CA 123.923 0.889 . . . . 0.0 109.567 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.27 162.94 38.26 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.455 2.77 . . . . 0.0 110.758 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.4 p -65.88 -10.61 40.0 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.13 -18.89 54.9 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.81 -0.439 . . . . 0.0 112.05 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -116.35 -4.78 11.81 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.384 0.592 . . . . 0.0 111.677 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.565 HG23 HG13 ' A' ' 37' ' ' VAL . 5.7 p -66.51 -32.12 4.95 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 117.79 -1.1 . . . . 0.0 113.719 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 74.5 Cg_endo -78.18 -23.28 9.11 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 CA-C-N 121.904 1.716 . . . . 0.0 111.266 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -81.74 -27.74 33.69 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.96 -27.42 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.5 -34.59 62.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.67 -42.92 66.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -67.5 -28.58 67.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.383 0.538 . . . . 0.0 109.99 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.42 -36.42 74.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.2 -33.18 61.37 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.371 0.532 . . . . 0.0 111.967 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.57 -38.89 75.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -75.22 -31.72 60.94 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.081 0.552 . . . . 0.0 110.555 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.73 -43.93 71.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.236 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -61.28 -37.91 84.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.863 0.756 . . . . 0.0 111.36 -176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -71.68 -25.39 62.09 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.552 0.341 . . . . 0.0 111.062 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.93 -10.76 27.91 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.28 0.632 . . . . 0.0 111.441 176.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.4 tp -74.93 -23.84 58.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.104 0.562 . . . . 0.0 110.119 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.35 -11.48 51.36 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.509 0.324 . . . . 0.0 110.544 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -110.39 2.68 19.16 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.722 0.809 . . . . 0.0 111.851 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 t80 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.553 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.5 t80 . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -70.39 -36.57 74.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.62 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -72.02 -36.28 69.65 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 64.5 t90 -70.28 -32.88 70.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.678 -0.201 . . . . 0.0 110.747 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.0 tp -80.23 -37.15 33.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.597 0.359 . . . . 0.0 111.292 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -68.67 -20.27 64.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.133 -0.354 . . . . 0.0 111.63 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -74.69 -26.75 60.04 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.186 0.448 . . . . 0.0 110.323 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.76 -36.88 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.98 -40.08 63.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.63 -32.04 15.9 Favored 'Isoleucine or valine' 0 C--N 1.337 0.043 0 O-C-N 121.993 -0.442 . . . . 0.0 111.268 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -74.61 -24.33 58.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.014 -0.429 . . . . 0.0 110.3 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.1 m -78.08 -30.45 49.63 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 117.741 0.246 . . . . 0.0 110.44 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.29 -29.46 62.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.316 -0.24 . . . . 0.0 110.496 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.05 -31.05 55.9 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.339 0.137 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.837 176.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 7' ' ' ASP . 26.8 m . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 6' ' ' THR . 3.1 p30 -55.26 -18.19 5.81 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.005 0.522 . . . . 0.0 111.937 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -65.17 -51.37 61.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.238 -0.289 . . . . 0.0 110.453 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 p -84.06 -25.8 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 122.594 0.357 . . . . 0.0 110.631 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.89 -30.14 67.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.095 -0.378 . . . . 0.0 110.634 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.9 t -81.74 -28.48 9.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 CA-C-N 118.634 0.652 . . . . 0.0 110.029 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.05 -40.8 71.45 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.066 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -69.06 -34.35 75.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -70.49 -23.01 24.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 118.702 0.683 . . . . 0.0 110.398 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -81.15 -14.98 57.11 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 119.503 -0.284 . . . . 0.0 110.92 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.62 -7.0 59.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.287 0.494 . . . . 0.0 110.752 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.48 3.12 47.28 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.479 0.562 . . . . 0.0 112.779 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.81 83.98 5.33 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 117.954 0.877 . . . . 0.0 108.991 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -64.48 -17.73 64.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.091 0.557 . . . . 0.0 110.643 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -60.82 -25.62 66.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.991 0.516 . . . . 0.0 110.794 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.34 -18.99 43.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.781 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -76.54 -36.97 57.36 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -61.82 -39.8 93.04 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.8 mt -76.79 -18.98 58.09 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.352 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.6 tp -83.3 -47.36 11.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.554 0.342 . . . . 0.0 111.308 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.8 m -68.13 -25.69 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.222 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.56 -26.92 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.326 0.966 . . . . 0.0 110.915 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -67.82 -33.05 74.03 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -100.85 -8.73 22.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.308 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -62.16 -28.78 69.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.357 0.526 . . . . 0.0 110.42 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -86.1 -28.94 23.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 121.977 0.111 . . . . 0.0 110.763 174.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -78.4 -40.64 35.41 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 m -83.85 -23.53 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 O-C-N 121.966 -0.459 . . . . 0.0 110.835 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.63 -22.09 61.0 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.5 t -79.37 -40.23 30.67 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -81.38 -24.56 36.93 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 119.242 -0.409 . . . . 0.0 112.081 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.16 -21.08 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.674 0.67 . . . . 0.0 112.212 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -69.27 -10.53 58.24 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.845 -0.534 . . . . 0.0 111.611 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -92.28 -4.01 54.61 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 121.805 -0.56 . . . . 0.0 111.642 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -110.16 -23.57 11.19 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.644 0.378 . . . . 0.0 111.304 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.441 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 26.9 m -138.13 155.73 74.21 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 123.433 0.693 . . . . 0.0 109.461 175.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 94.2 Cg_endo -71.42 170.59 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.515 2.81 . . . . 0.0 111.339 -176.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.0 m -63.41 -11.91 26.76 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.118 0.567 . . . . 0.0 112.132 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.68 -16.28 58.61 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.593 -0.559 . . . . 0.0 112.598 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -116.3 -10.86 11.33 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 117.938 0.869 . . . . 0.0 111.801 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.416 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 8.0 p -62.89 -34.34 13.75 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 117.78 -1.105 . . . . 0.0 112.929 -177.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 46' ' ' VAL . 94.7 Cg_endo -77.5 -25.42 8.16 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 CA-C-N 121.927 1.724 . . . . 0.0 112.135 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.38 -33.11 23.87 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.191 0.45 . . . . 0.0 111.098 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.5 t -78.17 -25.39 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.16 -34.68 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -71.44 -42.05 68.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -66.36 -29.64 69.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.29 0.496 . . . . 0.0 110.0 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.01 -28.38 64.38 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 119.478 -0.296 . . . . 0.0 110.837 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -85.2 -29.33 24.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.523 0.601 . . . . 0.0 111.232 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -72.42 -37.86 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -76.54 -32.29 58.13 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.224 0.61 . . . . 0.0 110.804 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.92 77.65 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.463 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -62.06 -38.35 88.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.755 0.707 . . . . 0.0 111.329 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -71.36 -24.94 62.18 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.599 0.36 . . . . 0.0 111.336 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.7 -11.74 28.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.972 0.509 . . . . 0.0 111.454 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.0 tp -75.68 -24.24 56.29 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.951 0.5 . . . . 0.0 110.538 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.95 -10.37 57.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.468 0.307 . . . . 0.0 110.741 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.4 m -109.63 3.03 20.64 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.682 0.793 . . . . 0.0 111.442 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 t80 . . . . . 0 CA--C 1.531 0.224 0 C-N-CA 123.144 0.578 . . . . 0.0 109.817 178.023 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.0 t80 . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -69.72 -37.41 76.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.838 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.6 m -70.58 -33.78 71.47 Favored 'General case' 0 CA--C 1.527 0.068 0 O-C-N 121.895 -0.503 . . . . 0.0 109.757 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -73.96 -28.64 61.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.968 0.507 . . . . 0.0 110.881 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.7 tp -86.01 -36.0 20.03 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.804 0.442 . . . . 0.0 111.297 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -61.87 -32.57 72.94 Favored 'General case' 0 C--O 1.23 0.077 0 O-C-N 122.201 -0.312 . . . . 0.0 110.599 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -76.54 -21.24 55.95 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.075 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.3 mm -68.01 -38.83 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 118.979 0.809 . . . . 0.0 109.216 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.01 -38.38 53.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.26 -28.01 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 CA-C-N 118.919 0.781 . . . . 0.0 111.171 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -75.42 -24.76 57.15 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.105 0.411 . . . . 0.0 110.101 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.2 m -79.05 -29.97 43.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 176.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.83 -33.77 66.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.049 0.386 . . . . 0.0 111.025 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -77.96 -29.0 49.6 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.6 t30 . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.955 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 7' ' ' ASP . 47.0 m . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.499 ' N ' HG22 ' A' ' 6' ' ' THR . 3.1 p30 -55.69 -16.93 4.81 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.18 0.592 . . . . 0.0 112.479 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -67.25 -51.43 53.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 117.917 0.326 . . . . 0.0 110.127 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.5 p -85.66 -25.67 6.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 122.449 0.3 . . . . 0.0 110.981 -176.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -68.56 -30.13 68.84 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.276 -0.265 . . . . 0.0 110.439 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.8 t -81.58 -28.43 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 118.316 0.507 . . . . 0.0 110.215 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.63 -35.11 70.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.574 -0.704 . . . . 0.0 111.357 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -83.6 -25.41 30.88 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.454 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.07 -23.06 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 119.16 0.891 . . . . 0.0 109.358 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -78.86 -25.54 43.96 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.282 0.233 . . . . 0.0 110.68 174.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -89.33 -7.26 55.68 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.84 -3.52 8.0 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 118.835 -0.98 . . . . 0.0 114.889 170.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -86.61 83.72 7.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.331 1.566 . . . . 0.0 109.961 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -66.38 -21.79 66.24 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.39 -24.58 66.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.536 0.734 . . . . 0.0 110.897 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.69 -19.2 35.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 119.579 -0.248 . . . . 0.0 110.742 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -76.97 -35.89 56.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -63.22 -40.81 98.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.41 -18.81 59.83 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.154 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.9 tp -83.41 -47.09 11.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.521 0.328 . . . . 0.0 111.044 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.4 m -69.32 -24.53 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.717 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.5 p -69.24 -27.32 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 119.146 0.884 . . . . 0.0 110.771 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -67.11 -33.1 74.74 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.448 ' HB3' HG23 ' A' ' 33' ' ' VAL . 73.2 m-85 -98.4 -8.92 26.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.102 0.561 . . . . 0.0 112.326 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -63.32 -30.44 71.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.503 -0.748 . . . . 0.0 110.633 -174.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -87.03 -32.05 20.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -81.43 -34.74 31.32 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 29' ' ' TYR . 60.4 t -71.28 -38.86 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -63.56 -24.21 67.71 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.095 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.2 t -73.85 -48.16 33.13 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.851 0.296 . . . . 0.0 110.734 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 pp -79.98 -27.82 39.6 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.479 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.577 HG13 HG23 ' A' ' 46' ' ' VAL . 2.2 p -83.5 -15.74 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.334 -178.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 t -68.92 -9.65 53.01 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.825 -0.547 . . . . 0.0 110.28 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -88.8 -3.91 58.64 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.408 0.683 . . . . 0.0 111.427 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.31 -16.2 7.45 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.2 m -143.17 153.78 60.34 Favored Pre-proline 0 C--N 1.338 0.069 0 C-N-CA 124.168 0.987 . . . . 0.0 109.613 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.28 164.25 33.15 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.483 2.788 . . . . 0.0 111.062 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.2 p -65.92 -10.25 37.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.43 -18.03 55.96 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -116.44 -5.64 11.74 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.527 0.664 . . . . 0.0 111.481 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.577 HG23 HG13 ' A' ' 37' ' ' VAL . 5.8 p -67.28 -32.03 4.27 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 117.755 -1.117 . . . . 0.0 114.001 -176.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 81.2 Cg_endo -78.12 -23.53 8.98 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 CA-C-N 121.758 1.664 . . . . 0.0 111.308 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.84 -29.24 32.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.5 t -77.09 -28.54 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.4 t -69.72 -35.71 66.79 Favored 'Isoleucine or valine' 0 C--N 1.337 0.063 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -70.95 -42.83 69.27 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -67.31 -28.77 68.28 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.731 -0.606 . . . . 0.0 109.873 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.23 -36.13 74.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -75.39 -32.65 60.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.353 0.524 . . . . 0.0 112.204 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -71.33 -38.16 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -76.22 -31.37 58.35 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.015 0.526 . . . . 0.0 110.458 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.27 -44.0 72.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.187 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -61.19 -38.1 85.32 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.812 0.733 . . . . 0.0 111.366 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -71.45 -25.32 62.25 Favored 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 122.596 0.358 . . . . 0.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.08 -10.74 27.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.184 0.594 . . . . 0.0 111.266 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.42 -23.97 57.04 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.999 0.52 . . . . 0.0 110.3 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.02 -11.47 48.35 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.335 0.254 . . . . 0.0 110.508 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.4 m -110.8 -2.24 16.25 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.622 0.769 . . . . 0.0 112.034 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.6 t80 . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.404 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.0 t80 . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -69.51 -36.97 76.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.863 -0.523 . . . . 0.0 110.708 -176.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.2 m -72.7 -36.43 67.85 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -69.39 -33.27 72.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -78.94 -36.62 41.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.557 0.343 . . . . 0.0 111.578 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -69.17 -20.09 64.0 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.078 -0.388 . . . . 0.0 111.574 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -74.6 -25.9 59.56 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 117.965 0.348 . . . . 0.0 110.283 173.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.4 mm -73.23 -35.74 47.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.11 -39.52 60.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.3 p -79.05 -30.63 14.39 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 O-C-N 122.26 -0.275 . . . . 0.0 110.979 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -76.3 -23.04 54.32 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.053 0.388 . . . . 0.0 110.623 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.5 m -80.21 -28.49 38.59 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.7 -33.26 66.36 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.209 0.459 . . . . 0.0 110.284 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.39 -25.82 54.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.9 t30 . . . . . 0 CA--C 1.531 0.249 0 C-N-CA 122.464 0.306 . . . . 0.0 110.711 177.132 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 7' ' ' ASP . 28.5 m . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 6' ' ' THR . 3.8 p30 -56.02 -17.31 6.52 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -66.67 -53.5 33.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 122.148 -0.345 . . . . 0.0 110.391 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 p -83.63 -25.41 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 122.676 0.39 . . . . 0.0 110.782 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.88 -27.92 64.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.847 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -82.6 -28.45 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.058 0 CA-C-N 118.899 0.772 . . . . 0.0 109.909 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.442 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 44.3 mt-10 -72.51 -35.95 68.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.498 -0.751 . . . . 0.0 110.322 176.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -71.28 -37.12 71.89 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.53 -23.87 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 118.155 0.434 . . . . 0.0 110.749 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -78.27 -17.39 56.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.759 0.254 . . . . 0.0 110.438 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -82.54 -5.86 59.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.219 0.608 . . . . 0.0 111.695 172.806 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.36 0.63 37.81 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.322 -0.71 . . . . 0.0 113.098 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -85.52 84.16 7.7 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.304 1.052 . . . . 0.0 109.071 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -64.38 -20.91 66.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.548 0.339 . . . . 0.0 110.87 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -62.48 -23.95 67.19 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.575 0.75 . . . . 0.0 111.168 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.34 -19.2 39.79 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.614 0.188 . . . . 0.0 110.784 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -77.77 -36.64 50.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -60.75 -42.79 98.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.57 -18.47 59.74 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.571 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.0 tp -81.47 -43.1 19.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.214 -0.304 . . . . 0.0 110.931 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.7 m -70.92 -24.58 24.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.874 -175.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.86 -26.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 119.685 1.13 . . . . 0.0 110.706 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -70.15 -31.2 68.59 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.433 ' HB3' HG23 ' A' ' 33' ' ' VAL . 69.7 m-85 -99.76 -9.01 23.51 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.481 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -62.69 -30.27 71.27 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.189 -0.944 . . . . 0.0 110.499 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -86.56 -32.84 20.46 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.475 0.31 . . . . 0.0 111.601 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -80.67 -36.37 32.5 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 29' ' ' TYR . 62.0 t -71.21 -38.86 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.47 -23.38 67.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.934 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 t -74.47 -45.93 42.9 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.019 -0.426 . . . . 0.0 111.112 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.424 HD21 ' CD1' ' A' ' 75' ' ' TYR . 3.8 pp -82.61 -26.43 32.27 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.432 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.566 HG13 HG23 ' A' ' 46' ' ' VAL . 1.9 p -85.45 -16.91 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 118.131 0.423 . . . . 0.0 111.761 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.8 t -69.67 -9.07 52.82 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -89.29 -4.42 58.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.47 0.708 . . . . 0.0 111.221 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -122.76 -15.21 7.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.891 0.476 . . . . 0.0 112.245 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -143.1 153.84 60.65 Favored Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 123.721 0.808 . . . . 0.0 109.541 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -68.59 164.85 31.42 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.551 2.834 . . . . 0.0 111.062 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -65.76 -10.3 35.89 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.49 -18.02 55.87 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 118.094 0.407 . . . . 0.0 112.333 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -116.58 -5.78 11.66 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 117.561 0.681 . . . . 0.0 111.605 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.566 HG23 HG13 ' A' ' 37' ' ' VAL . 6.0 p -67.37 -32.63 4.73 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 77.9 Cg_endo -77.86 -23.85 9.05 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 CA-C-N 121.844 1.694 . . . . 0.0 111.437 -176.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.4 -28.74 34.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -79.03 -27.91 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.64 -36.01 68.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.14 -43.09 68.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -67.84 -28.99 68.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.427 0.558 . . . . 0.0 109.765 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.22 73.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -75.61 -33.73 60.56 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 118.272 0.487 . . . . 0.0 112.203 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -71.41 -37.26 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -77.18 -32.86 56.42 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.909 0.483 . . . . 0.0 110.586 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.47 -44.92 81.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -61.55 -36.71 81.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.508 0.595 . . . . 0.0 111.215 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -72.05 -20.72 61.63 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 122.694 0.397 . . . . 0.0 111.281 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.85 -11.83 18.74 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.94 0.496 . . . . 0.0 111.109 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.2 tp -76.26 -25.71 55.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.583 0.753 . . . . 0.0 110.617 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.94 -13.18 62.28 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.376 0.27 . . . . 0.0 110.651 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.9 m -113.45 0.9 14.87 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.592 0.757 . . . . 0.0 111.785 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.9 t80 . . . . . 0 N--CA 1.453 -0.286 0 O-C-N 121.963 -0.46 . . . . 0.0 110.454 179.95 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.5 t80 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -67.73 -37.83 82.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.303 0.501 . . . . 0.0 111.984 -174.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.7 m -70.72 -37.7 73.53 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -69.27 -34.02 74.12 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.7 -0.191 . . . . 0.0 110.798 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.8 tp -77.09 -36.53 55.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.716 0.406 . . . . 0.0 111.199 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.424 ' CD1' HD21 ' A' ' 36' ' ' LEU . 20.9 m-85 -69.56 -20.03 63.67 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.804 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -76.1 -23.98 54.98 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.087 0.403 . . . . 0.0 110.456 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.2 mm -73.55 -35.94 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.44 -39.69 62.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.71 -29.66 13.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 O-C-N 122.086 -0.384 . . . . 0.0 111.402 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -75.74 -23.21 56.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.821 -0.55 . . . . 0.0 110.618 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.2 m -82.94 -28.93 29.5 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 119.556 -0.259 . . . . 0.0 110.339 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.09 -32.78 61.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.093 0.406 . . . . 0.0 110.932 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.37 -29.68 53.43 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t30 . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 175.889 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 7' ' ' ASP . 25.4 m . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 6' ' ' THR . 3.5 p30 -55.34 -17.29 4.55 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.982 0.513 . . . . 0.0 111.87 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -65.88 -51.51 58.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.3 p -85.81 -26.48 6.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 122.734 0.413 . . . . 0.0 110.952 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.72 -29.92 68.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 122.136 -0.352 . . . . 0.0 110.34 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.8 t -84.23 -27.35 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.186 0.448 . . . . 0.0 110.296 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.37 -35.68 65.98 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.51 -0.744 . . . . 0.0 109.998 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -70.81 -34.9 72.22 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.0 m -74.75 -24.09 18.08 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 CA-C-N 118.108 0.413 . . . . 0.0 111.228 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -77.13 -16.14 59.28 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 174.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.36 2.26 56.75 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.723 0.809 . . . . 0.0 112.161 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.23 44.18 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.55 -0.583 . . . . 0.0 113.554 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -91.81 83.97 5.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.413 1.107 . . . . 0.0 109.31 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.69 -20.2 66.18 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.727 0.411 . . . . 0.0 110.435 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -62.08 -24.52 67.16 Favored 'General case' 0 N--CA 1.458 -0.041 0 C-N-CA 122.863 0.465 . . . . 0.0 111.441 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.44 -18.75 44.25 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.792 0.269 . . . . 0.0 110.574 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -77.8 -37.14 49.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -61.73 -40.22 94.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.43 -19.22 58.3 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.401 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.4 tp -83.47 -46.9 11.96 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.426 0.29 . . . . 0.0 111.245 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.65 -25.09 29.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 CA-C-O 118.578 -0.725 . . . . 0.0 111.479 -175.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.4 p -69.7 -26.64 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 119.32 0.964 . . . . 0.0 110.693 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.9 mtp85 -68.54 -34.54 76.02 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -97.35 -8.73 28.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.282 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -63.33 -28.35 69.94 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 118.453 0.57 . . . . 0.0 110.8 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -85.07 -30.17 24.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -77.05 -43.47 34.38 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 m -79.78 -25.32 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 O-C-N 121.971 -0.456 . . . . 0.0 110.885 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.03 -22.75 63.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.149 0.432 . . . . 0.0 110.436 176.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -76.31 -42.3 45.7 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.43 -24.85 31.7 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.524 HG13 HG23 ' A' ' 46' ' ' VAL . 2.7 p -87.94 -19.44 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 118.326 0.512 . . . . 0.0 111.467 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.4 t -67.26 -9.26 38.88 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.878 -0.514 . . . . 0.0 109.854 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -90.45 -3.92 57.33 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.7 0.8 . . . . 0.0 111.438 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -122.18 -15.38 7.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.985 0.514 . . . . 0.0 111.884 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 m -142.42 153.32 62.32 Favored Pre-proline 0 N--CA 1.463 0.176 0 C-N-CA 123.829 0.852 . . . . 0.0 109.229 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.38 165.33 29.27 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.385 2.723 . . . . 0.0 110.959 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -65.38 -12.54 53.13 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.782 0.433 . . . . 0.0 112.132 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.02 -19.58 59.03 Favored Glycine 0 CA--C 1.527 0.83 0 O-C-N 121.928 -0.483 . . . . 0.0 112.192 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -116.55 -5.67 11.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.633 0.716 . . . . 0.0 111.681 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.524 HG23 HG13 ' A' ' 37' ' ' VAL . 5.9 p -66.58 -33.32 6.25 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.782 -1.104 . . . . 0.0 113.7 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 93.7 Cg_endo -76.68 -25.88 8.88 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 122.084 1.78 . . . . 0.0 111.774 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -82.7 -28.84 30.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.227 -0.296 . . . . 0.0 110.408 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.2 t -77.76 -27.63 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -71.72 -35.59 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -72.27 -43.2 64.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -67.45 -27.35 66.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.784 -0.572 . . . . 0.0 110.208 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.48 -28.51 62.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.683 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.31 -29.81 24.25 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.411 0.551 . . . . 0.0 110.89 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.66 -37.11 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -78.74 -31.64 46.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.865 0.466 . . . . 0.0 111.016 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.94 -42.46 85.25 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.165 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -62.76 -36.5 83.27 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 118.63 0.65 . . . . 0.0 111.211 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -71.64 -17.68 62.25 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 122.501 0.32 . . . . 0.0 111.122 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.49 -11.51 16.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.863 0.465 . . . . 0.0 111.066 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.2 tp -73.77 -23.22 59.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.472 0.709 . . . . 0.0 110.099 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.48 -13.13 37.46 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.445 0.298 . . . . 0.0 110.673 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.2 t -113.48 4.44 16.24 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.6 t80 . . . . . 0 C--N 1.339 0.11 0 O-C-N 121.509 -0.744 . . . . 0.0 109.503 177.286 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.8 t80 . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 119.701 -0.19 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -69.69 -40.4 76.36 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.042 0.383 . . . . 0.0 111.297 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -70.78 -35.11 72.44 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -69.53 -31.02 68.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.5 tp -82.92 -36.15 25.49 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.586 0.354 . . . . 0.0 111.629 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -62.44 -29.13 70.29 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.129 -0.357 . . . . 0.0 110.387 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -73.33 -25.29 60.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.489 0.315 . . . . 0.0 111.48 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mm -71.53 -39.76 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.035 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.56 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.41 -36.11 68.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -174.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -75.64 -29.25 20.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.378 0.536 . . . . 0.0 110.775 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -79.07 -20.54 48.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.266 -0.271 . . . . 0.0 110.609 177.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 79.1 m -79.85 -33.37 40.2 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 122.014 -0.429 . . . . 0.0 109.963 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.96 69.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.281 -0.262 . . . . 0.0 110.928 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -75.17 -28.64 60.14 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 t30 . . . . . 0 N--CA 1.455 -0.195 0 C-N-CA 122.128 0.171 . . . . 0.0 110.99 177.154 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.475 HG22 ' N ' ' A' ' 7' ' ' ASP . 29.5 m . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.475 ' N ' HG22 ' A' ' 6' ' ' THR . 3.3 p30 -55.17 -16.81 3.44 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.319 0.648 . . . . 0.0 111.822 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -65.76 -54.12 31.37 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 122.107 -0.37 . . . . 0.0 110.032 176.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.52 -25.44 6.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.756 0.423 . . . . 0.0 111.031 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 mp -70.1 -31.72 69.42 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 119.299 -0.381 . . . . 0.0 110.338 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.0 t -80.17 -27.91 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 118.62 0.645 . . . . 0.0 110.15 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.02 -39.37 75.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.815 -0.553 . . . . 0.0 111.373 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -82.19 -25.1 34.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.74 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.41 -24.25 23.61 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 CA-C-N 118.755 0.707 . . . . 0.0 109.695 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -78.78 -21.66 47.49 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.674 0.389 . . . . 0.0 110.293 174.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -89.43 -7.3 55.42 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.368 0.667 . . . . 0.0 111.818 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.69 0.58 17.81 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.932 -0.927 . . . . 0.0 114.16 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -87.32 83.71 7.31 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.213 1.507 . . . . 0.0 109.761 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -65.88 -23.77 66.72 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -59.69 -24.35 63.86 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.425 0.69 . . . . 0.0 111.048 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.37 -20.12 32.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 119.777 -0.154 . . . . 0.0 111.26 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -76.45 -35.12 58.66 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.06 -40.63 98.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.0 mt -75.01 -19.02 60.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.672 0.389 . . . . 0.0 111.396 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 tp -83.55 -46.75 12.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.899 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 m -68.77 -24.34 28.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.646 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.9 p -69.88 -26.76 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 119.239 0.927 . . . . 0.0 110.756 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -68.1 -30.67 69.9 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.44 ' HB3' HG23 ' A' ' 33' ' ' VAL . 70.1 m-85 -101.09 -8.89 21.87 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.75 -30.22 71.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.134 -0.979 . . . . 0.0 110.551 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -86.87 -32.47 20.21 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -79.29 -36.39 39.76 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 29' ' ' TYR . 59.0 t -71.7 -39.01 68.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 123.449 0.7 . . . . 0.0 109.316 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.488 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.46 -23.09 67.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.235 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 t -75.02 -45.62 40.55 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.145 -0.347 . . . . 0.0 111.126 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 pp -82.02 -28.12 32.71 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.56 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.582 HG13 HG23 ' A' ' 46' ' ' VAL . 2.1 p -83.55 -16.92 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 118.219 0.463 . . . . 0.0 111.515 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -67.96 -11.99 59.88 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.103 0.478 . . . . 0.0 109.786 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -86.01 -4.26 59.13 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.341 0.656 . . . . 0.0 111.346 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -122.78 -16.44 7.15 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.938 0.495 . . . . 0.0 112.289 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -142.74 154.48 62.69 Favored Pre-proline 0 N--CA 1.462 0.166 0 C-N-CA 123.587 0.755 . . . . 0.0 109.353 175.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.96 164.21 30.77 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.423 2.748 . . . . 0.0 111.009 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.5 p -66.43 -9.5 34.54 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.05 54.35 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.818 -0.435 . . . . 0.0 112.05 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -116.18 -6.01 11.88 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 117.518 0.659 . . . . 0.0 111.453 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.582 HG23 HG13 ' A' ' 37' ' ' VAL . 8.1 p -66.45 -32.76 5.65 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 117.774 -1.108 . . . . 0.0 113.853 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 78.9 Cg_endo -77.96 -23.07 9.6 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 CA-C-N 121.834 1.691 . . . . 0.0 111.056 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.86 -29.39 32.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.95 -28.91 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.78 -35.8 66.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -71.11 -42.77 68.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -67.98 -29.89 69.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.22 0.464 . . . . 0.0 109.855 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.09 -36.56 77.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 119.55 -0.262 . . . . 0.0 110.297 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -74.69 -33.57 62.47 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.245 0.475 . . . . 0.0 112.024 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.54 -39.17 75.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -75.37 -30.84 60.31 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.812 0.445 . . . . 0.0 110.638 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.53 -44.67 67.06 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.344 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -59.6 -39.23 83.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.61 0.641 . . . . 0.0 111.38 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -72.19 -28.46 63.21 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.512 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 -12.01 40.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.803 0.441 . . . . 0.0 111.351 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.7 tp -75.55 -28.06 58.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.349 0.659 . . . . 0.0 110.721 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -71.38 -6.26 38.79 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.1 m -113.4 4.15 16.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.83 0.852 . . . . 0.0 111.198 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.6 t80 . . . . . 0 CA--C 1.531 0.248 0 C-N-CA 122.973 0.509 . . . . 0.0 110.14 179.549 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.3 t80 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -70.07 -37.41 75.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.817 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -71.28 -33.79 70.08 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 56.9 t90 -73.75 -28.23 61.57 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.483 0.313 . . . . 0.0 110.846 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -85.63 -36.66 20.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.929 0.331 . . . . 0.0 111.029 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -69.36 -21.03 63.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.989 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -78.27 -21.87 49.13 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.908 0.776 . . . . 0.0 110.61 173.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mm -70.44 -34.33 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.95 -41.24 52.18 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.35 -29.03 13.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 O-C-N 121.997 -0.44 . . . . 0.0 111.356 -178.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -75.69 -24.22 56.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.152 -0.343 . . . . 0.0 110.287 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -81.73 -26.98 34.12 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.201 -0.312 . . . . 0.0 110.363 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.91 -32.64 63.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.423 0.556 . . . . 0.0 110.72 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.33 -25.74 46.57 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.4 t30 . . . . . 0 CA--C 1.531 0.245 0 CA-C-O 120.447 0.165 . . . . 0.0 110.701 175.154 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.49 HG22 ' H ' ' A' ' 7' ' ' ASP . 28.0 m . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.49 ' H ' HG22 ' A' ' 6' ' ' THR . 3.4 p30 -55.16 -17.14 3.79 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -66.41 -53.05 40.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.056 -0.402 . . . . 0.0 110.257 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.413 ' H ' HG12 ' A' ' 9' ' ' VAL . 2.8 p -85.34 -25.75 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 122.906 0.482 . . . . 0.0 110.559 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.8 mp -70.85 -28.65 64.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.154 -0.451 . . . . 0.0 110.974 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.8 t -82.54 -28.12 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 118.858 0.754 . . . . 0.0 110.024 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.442 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 44.1 mt-10 -72.11 -36.61 69.49 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.762 -0.586 . . . . 0.0 110.504 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -70.58 -36.67 73.72 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 m -73.13 -23.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 118.298 0.499 . . . . 0.0 110.827 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -78.0 -18.16 56.26 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -80.99 -5.93 58.16 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.297 0.639 . . . . 0.0 111.863 172.494 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.72 2.13 46.36 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 119.559 -0.578 . . . . 0.0 112.876 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -85.86 84.19 7.62 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.19 0.995 . . . . 0.0 109.349 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -64.36 -19.65 65.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.419 0.288 . . . . 0.0 110.624 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -61.48 -25.5 67.29 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.94 0.496 . . . . 0.0 111.121 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.88 -18.8 38.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.74 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -77.91 -36.16 49.78 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -61.84 -41.07 97.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -76.83 -18.41 58.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 tp -82.08 -41.66 20.25 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 122.139 -0.351 . . . . 0.0 110.74 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.6 m -72.16 -24.28 22.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.885 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -67.74 -26.33 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 119.866 1.212 . . . . 0.0 110.887 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -69.74 -32.13 70.49 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.43 ' HB3' HG23 ' A' ' 33' ' ' VAL . 64.6 m-85 -99.34 -9.08 23.97 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.411 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -62.77 -30.4 71.42 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.206 -0.934 . . . . 0.0 110.751 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -86.99 -32.36 20.09 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 176.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -80.24 -36.37 34.74 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' A' ' 29' ' ' TYR . 61.6 t -70.96 -38.44 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.96 -23.27 67.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 t -74.68 -45.19 46.16 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.047 0.385 . . . . 0.0 111.012 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.413 HD21 ' CD1' ' A' ' 75' ' ' TYR . 3.8 pp -82.92 -27.03 30.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.498 -177.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.571 HG13 HG23 ' A' ' 46' ' ' VAL . 1.8 p -84.97 -16.71 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 118.117 0.417 . . . . 0.0 111.478 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -68.35 -11.77 60.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.21 0.529 . . . . 0.0 109.845 172.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -85.83 -5.98 59.16 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.425 0.69 . . . . 0.0 111.312 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -122.6 -16.51 7.22 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.799 0.44 . . . . 0.0 112.164 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 m -141.34 153.76 66.46 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 123.462 0.705 . . . . 0.0 109.443 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.9 164.97 29.61 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.656 2.904 . . . . 0.0 110.984 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -65.87 -10.75 41.1 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -175.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.41 -17.98 56.09 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.082 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -116.49 -5.85 11.71 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 117.726 0.763 . . . . 0.0 111.538 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.571 HG23 HG13 ' A' ' 37' ' ' VAL . 6.8 p -67.35 -32.02 4.21 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 117.785 -1.102 . . . . 0.0 113.722 -176.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 82.4 Cg_endo -78.41 -23.11 8.93 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 121.804 1.68 . . . . 0.0 111.076 -177.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -82.4 -28.21 31.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.343 -0.223 . . . . 0.0 110.62 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.4 t -79.36 -28.61 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -69.15 -35.85 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -70.36 -43.24 70.55 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -68.17 -29.16 67.97 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.736 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.63 -35.47 75.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.987 0.358 . . . . 0.0 110.2 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.46 -33.62 60.86 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.076 0.398 . . . . 0.0 111.72 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.04 -38.46 71.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -75.39 -32.35 60.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.04 0.536 . . . . 0.0 110.579 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.27 77.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.098 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -61.14 -37.8 84.13 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.769 0.713 . . . . 0.0 111.287 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -71.81 -24.72 61.77 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.709 0.404 . . . . 0.0 111.059 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.11 -11.85 25.67 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.167 0.587 . . . . 0.0 111.442 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.2 tp -75.63 -24.06 56.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.26 0.624 . . . . 0.0 110.376 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.56 -11.33 57.83 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.422 0.289 . . . . 0.0 110.604 174.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.2 m -109.46 0.23 19.21 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.754 0.822 . . . . 0.0 111.65 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.6 t80 . . . . . 0 N--CA 1.455 -0.179 0 C-N-CA 123.125 0.57 . . . . 0.0 110.196 178.026 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -69.84 -38.81 76.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.839 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.2 m -70.45 -35.66 73.47 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -69.28 -33.59 73.44 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 122.379 -0.201 . . . . 0.0 110.74 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.2 tp -79.8 -35.91 37.77 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.261 0.225 . . . . 0.0 111.18 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.413 ' CD1' HD21 ' A' ' 36' ' ' LEU . 20.5 m-85 -69.18 -20.25 64.0 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.787 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.5 mtm105 -75.51 -23.76 56.75 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.412 0.551 . . . . 0.0 110.517 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.54 -33.72 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.23 -39.13 55.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -173.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -80.52 -29.65 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 O-C-N 122.126 -0.359 . . . . 0.0 111.409 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -75.88 -23.92 55.65 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 122.208 -0.307 . . . . 0.0 110.309 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.3 m -81.67 -29.59 33.02 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.177 -0.327 . . . . 0.0 110.399 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.84 -35.28 67.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.207 0.458 . . . . 0.0 110.877 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -76.87 -28.27 55.34 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 t30 . . . . . 0 N--CA 1.455 -0.198 0 C-N-CA 122.261 0.224 . . . . 0.0 110.595 176.79 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.277 0.084 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -141.04 160.98 38.93 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.051 0.54 . . . . 0.0 110.387 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -84.49 161.13 20.37 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.778 0.431 . . . . 0.0 110.663 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -89.1 -3.75 58.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.641 0.376 . . . . 0.0 111.719 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.429 ' N ' HD22 ' A' ' 5' ' ' LEU . 2.0 mm? -119.93 148.17 43.85 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 7' ' ' ASP . 27.4 m -139.43 172.54 12.67 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.497 0.719 . . . . 0.0 109.352 -175.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.472 ' N ' HG22 ' A' ' 6' ' ' THR . 3.7 p30 -55.11 -17.55 4.25 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.157 0.583 . . . . 0.0 112.21 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -66.0 -51.98 53.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.99 -0.444 . . . . 0.0 110.251 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.89 -25.58 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 122.396 0.278 . . . . 0.0 110.611 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.84 -28.74 64.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.154 -0.341 . . . . 0.0 110.703 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.1 t -82.17 -28.45 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 118.534 0.606 . . . . 0.0 109.876 176.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.469 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 39.8 mt-10 -70.9 -37.02 72.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.69 -0.631 . . . . 0.0 110.345 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -71.7 -36.42 70.54 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.44 -24.6 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.032 0 CA-C-N 118.338 0.517 . . . . 0.0 110.956 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -78.77 -18.26 54.45 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -83.16 -5.18 59.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.446 0.699 . . . . 0.0 111.898 174.274 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.52 0.14 34.75 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.614 -0.548 . . . . 0.0 113.351 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -88.77 84.29 6.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.232 1.016 . . . . 0.0 109.547 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -63.7 -20.61 65.86 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.711 0.405 . . . . 0.0 110.831 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -62.85 -23.23 67.19 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.095 0.558 . . . . 0.0 111.294 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.52 -18.7 44.14 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.378 -0.202 . . . . 0.0 110.674 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -77.1 -36.51 55.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -62.52 -41.11 98.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -75.19 -18.95 60.05 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.288 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.5 tp -83.54 -47.34 11.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 122.405 0.282 . . . . 0.0 111.238 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 m -67.61 -24.69 31.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.399 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.68 -26.97 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 119.133 0.878 . . . . 0.0 110.891 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -67.93 -32.17 72.45 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -101.49 -8.63 21.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -62.73 -27.6 69.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.342 0.519 . . . . 0.0 110.503 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -86.59 -30.56 21.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.339 -0.226 . . . . 0.0 110.512 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -76.83 -41.87 42.5 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -82.18 -25.5 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.074 0 CA-C-N 118.0 0.364 . . . . 0.0 110.997 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.18 -23.64 63.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.179 0.445 . . . . 0.0 110.193 176.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 t -76.19 -44.22 38.89 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -80.04 -24.94 40.39 Favored 'General case' 0 C--O 1.227 -0.093 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 46' ' ' VAL . 3.2 p -86.76 -17.64 8.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 CA-C-N 118.104 0.411 . . . . 0.0 111.145 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.9 t -67.75 -9.18 41.68 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 122.046 -0.409 . . . . 0.0 110.197 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -88.42 -5.84 58.03 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.033 0.533 . . . . 0.0 111.713 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -122.18 -12.42 8.29 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.56 154.02 59.28 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.813 0.845 . . . . 0.0 109.1 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.18 163.69 35.13 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.363 2.708 . . . . 0.0 110.611 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.0 p -65.61 -10.63 37.42 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.82 -19.54 53.53 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.05 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -116.31 -3.41 11.95 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 117.718 0.759 . . . . 0.0 111.618 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.525 HG23 HG13 ' A' ' 37' ' ' VAL . 5.9 p -67.02 -32.85 5.19 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 117.615 -1.183 . . . . 0.0 113.381 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 95.6 Cg_endo -77.75 -25.17 8.04 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 122.093 1.783 . . . . 0.0 111.492 -177.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -79.73 -29.67 40.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.586 0.232 . . . . 0.0 110.449 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -80.57 -25.89 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -70.79 -36.23 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -72.02 -40.98 68.06 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.895 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -66.24 -29.73 70.03 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.98 -27.8 63.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 122.243 -0.286 . . . . 0.0 110.728 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -85.32 -31.4 23.04 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.278 0.49 . . . . 0.0 111.597 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.3 mt -71.29 -37.13 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -75.58 -32.61 60.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.948 0.499 . . . . 0.0 110.471 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.59 -45.17 69.23 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 119.456 -0.306 . . . . 0.0 110.336 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -60.51 -37.78 82.24 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.594 0.634 . . . . 0.0 111.609 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -72.31 -25.83 61.72 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.826 0.45 . . . . 0.0 111.148 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.22 -12.91 29.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.06 0.544 . . . . 0.0 111.576 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 tp -76.78 -25.84 53.81 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.143 0.577 . . . . 0.0 110.792 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.32 -14.92 63.34 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.307 0.243 . . . . 0.0 110.408 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.0 p -112.94 8.14 18.46 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.241 0.616 . . . . 0.0 111.789 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -87.23 113.05 22.62 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.025 0.375 . . . . 0.0 110.639 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -139.21 29.71 2.22 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.388 1.075 . . . . 0.0 109.07 176.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.2 -5.62 42.58 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.135 0.874 . . . . 0.0 113.816 -173.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.9 t70 52.0 31.04 8.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.27 1.035 . . . . 0.0 111.431 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 t -129.1 177.01 7.45 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.965 0.906 . . . . 0.0 109.482 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.46 143.96 55.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.176 0.512 . . . . 0.0 111.652 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -75.81 -29.89 58.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.343 0.657 . . . . 0.0 112.224 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -69.09 -36.41 77.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.658 0.663 . . . . 0.0 111.786 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -70.76 -33.76 71.12 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.59 0.632 . . . . 0.0 109.756 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 58.6 t90 -75.32 -27.98 59.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 122.752 0.421 . . . . 0.0 110.902 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.5 tp -85.81 -37.0 19.71 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.74 0.416 . . . . 0.0 111.312 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -61.63 -32.31 72.44 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.788 0.267 . . . . 0.0 110.344 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -75.56 -22.42 57.04 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.993 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.08 -36.79 75.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.775 0.716 . . . . 0.0 109.5 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.87 -38.74 57.6 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.0 p -78.24 -29.78 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 118.271 0.487 . . . . 0.0 110.801 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -75.28 -23.83 57.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.994 0.361 . . . . 0.0 110.159 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.8 m -79.17 -31.42 43.91 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.76 -29.83 62.44 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 117.56 0.164 . . . . 0.0 110.647 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -80.4 -28.6 37.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 119.444 -0.313 . . . . 0.0 110.999 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -17.26 35.23 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.58 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -74.72 -41.09 60.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.285 -0.259 . . . . 0.0 110.949 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.8 mt -79.94 -26.51 40.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.772 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.3 p -81.31 -23.21 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 CA-C-N 118.757 0.708 . . . . 0.0 110.315 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.96 -14.13 59.39 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -114.7 -19.65 10.98 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 122.486 0.315 . . . . 0.0 111.286 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.07 -21.97 47.32 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -109.44 11.18 25.16 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.542 0.671 . . . . 0.0 111.713 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -122.82 4.59 9.43 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.79 0.836 . . . . 0.0 110.935 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 38.2 tp -126.51 -13.56 5.97 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.812 0.445 . . . . 0.0 111.227 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.5 1.06 17.64 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.811 -0.555 . . . . 0.0 111.72 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 95' ' ' LEU . 2.9 mm? -81.75 -7.67 59.62 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.763 0.425 . . . . 0.0 110.528 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.95 142.69 48.65 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -52.25 151.85 16.44 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.518 2.812 . . . . 0.0 111.913 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.6 mmt-85 -70.36 159.81 33.45 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.1 0.476 . . . . 0.0 111.392 -175.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.58 -8.01 77.15 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.7 t -156.02 138.39 14.84 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 117.695 0.747 . . . . 0.0 109.735 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 49.14 24.3 0.92 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.627 0.771 . . . . 0.0 112.845 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -84.01 2.4 39.21 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -76.34 149.51 37.0 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.382 0.273 . . . . 0.0 110.395 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -153.19 165.05 36.9 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.962 0.505 . . . . 0.0 110.682 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -100.56 151.11 21.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.888 0.475 . . . . 0.0 109.817 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 52.1 t60 . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.656 -1.164 . . . . 0.0 110.413 -178.126 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 120.368 0.128 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.2 m -69.88 169.18 13.67 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.075 0.55 . . . . 0.0 111.329 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -70.33 163.57 26.3 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -78.56 0.19 27.18 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.512 0.325 . . . . 0.0 111.858 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.4 mt -129.73 155.17 46.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.88 0.872 . . . . 0.0 109.124 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 7' ' ' ASP . 29.9 m -139.93 173.5 11.46 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.594 0.758 . . . . 0.0 109.303 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.493 ' H ' HG22 ' A' ' 6' ' ' THR . 3.1 p30 -55.29 -17.33 4.48 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.454 0.701 . . . . 0.0 112.046 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -67.04 -51.58 52.97 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 122.016 -0.428 . . . . 0.0 110.3 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.59 -26.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 122.993 0.517 . . . . 0.0 110.73 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -69.05 -29.02 67.06 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.02 -0.425 . . . . 0.0 110.532 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.5 t -82.31 -28.78 9.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 118.565 0.621 . . . . 0.0 110.105 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.32 -35.48 68.62 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.571 -0.706 . . . . 0.0 110.433 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -69.97 -37.29 75.75 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.311 0.244 . . . . 0.0 111.347 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 m -73.44 -23.76 19.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 121.771 -0.581 . . . . 0.0 111.078 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -78.38 -16.25 57.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.273 0.229 . . . . 0.0 110.576 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -91.91 3.91 54.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.67 0.788 . . . . 0.0 111.764 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.15 1.64 51.32 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.977 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.88 83.98 4.09 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.851 0.826 . . . . 0.0 109.442 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -67.11 -18.09 65.16 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.982 0.513 . . . . 0.0 110.675 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -60.75 -25.38 66.45 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.582 0.353 . . . . 0.0 110.69 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.12 -18.81 45.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.54 0.155 . . . . 0.0 111.056 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -76.7 -36.77 57.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.57 -40.59 97.34 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.83 -19.04 59.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.272 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.9 tp -83.51 -47.11 11.69 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.428 0.291 . . . . 0.0 111.242 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.04 -24.9 30.87 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.541 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.8 p -70.71 -26.98 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.32 0.964 . . . . 0.0 110.879 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -67.95 -31.62 71.5 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.84 -8.7 21.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -62.03 -29.2 70.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.334 0.515 . . . . 0.0 110.665 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -86.47 -30.53 21.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.044 -0.071 . . . . 0.0 110.955 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.29 -42.27 55.19 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 m -80.94 -25.32 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-N 118.306 0.503 . . . . 0.0 110.98 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.79 -22.09 62.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.083 0.402 . . . . 0.0 110.195 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -77.2 -41.63 40.68 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.87 -24.9 30.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.554 HG13 HG23 ' A' ' 46' ' ' VAL . 2.3 p -88.71 -19.38 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 118.343 0.519 . . . . 0.0 111.717 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.2 t -68.34 -9.37 47.43 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -90.32 -4.35 57.17 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.7 0.8 . . . . 0.0 111.66 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -122.4 -13.0 8.13 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.686 0.394 . . . . 0.0 111.864 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 m -144.0 154.53 58.4 Favored Pre-proline 0 N--CA 1.462 0.152 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.71 164.46 31.24 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.269 2.646 . . . . 0.0 111.08 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.8 p -66.34 -10.17 40.44 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.29 -17.95 56.36 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.175 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -116.37 -6.4 11.77 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 117.423 0.611 . . . . 0.0 111.691 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.554 HG23 HG13 ' A' ' 37' ' ' VAL . 9.9 p -66.34 -33.52 6.82 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 117.587 -1.197 . . . . 0.0 113.428 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 95.5 Cg_endo -76.13 -25.25 10.34 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 CA-C-N 122.212 1.826 . . . . 0.0 111.4 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -81.96 -29.42 32.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.631 0.253 . . . . 0.0 110.381 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.5 t -78.4 -26.94 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.1 t -71.74 -34.95 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 118.419 0.554 . . . . 0.0 109.531 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -72.96 -43.07 62.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -67.73 -26.49 66.17 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.234 0.47 . . . . 0.0 110.156 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.78 -29.32 63.19 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.58 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -85.14 -28.72 25.35 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.575 0.625 . . . . 0.0 111.113 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.6 mt -73.03 -37.92 54.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -75.41 -32.28 60.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.789 0.436 . . . . 0.0 110.613 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.85 -44.51 76.97 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.104 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -60.87 -37.15 81.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.587 0.63 . . . . 0.0 111.621 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -72.87 -25.26 61.03 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.758 0.423 . . . . 0.0 111.047 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.18 -11.03 28.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.144 0.577 . . . . 0.0 111.278 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.96 -23.64 55.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.228 0.611 . . . . 0.0 110.201 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.25 -11.07 56.51 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.261 0.224 . . . . 0.0 110.552 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -110.91 3.18 18.64 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.639 0.776 . . . . 0.0 111.672 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -74.38 141.27 45.13 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -136.07 7.62 3.17 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -175.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.63 14.85 82.07 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.43 -0.65 . . . . 0.0 113.677 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -70.75 -6.87 40.72 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.287 1.043 . . . . 0.0 111.295 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.2 t -150.87 164.4 36.37 Favored 'General case' 0 N--CA 1.458 -0.075 0 C-N-CA 124.321 1.049 . . . . 0.0 108.473 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.55 145.99 55.01 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -66.86 -33.72 76.22 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.304 -0.248 . . . . 0.0 111.605 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -69.41 -38.04 77.74 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.544 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.7 m -69.62 -37.96 77.05 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.8 t90 -69.05 -31.2 69.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.741 -0.208 . . . . 0.0 110.993 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.6 tp -83.22 -35.15 25.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.576 0.35 . . . . 0.0 111.313 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -63.01 -26.8 69.02 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.005 0.366 . . . . 0.0 110.209 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.64 -27.03 61.04 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 122.8 0.44 . . . . 0.0 111.318 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.2 mm -72.05 -36.25 56.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.94 -36.34 56.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -78.83 -28.87 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.475 0.579 . . . . 0.0 111.274 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.91 -25.28 52.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.152 0.433 . . . . 0.0 110.407 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.2 m -80.63 -28.14 37.03 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 122.448 -0.158 . . . . 0.0 110.597 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.16 -32.84 56.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.087 0.403 . . . . 0.0 111.205 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.45 -26.19 51.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -78.42 -23.49 46.63 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.454 0.302 . . . . 0.0 110.327 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -77.79 -35.37 51.6 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.612 0.365 . . . . 0.0 111.057 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.0 mt -75.63 -31.15 59.75 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 119.467 -0.301 . . . . 0.0 111.782 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.7 m -78.34 -22.03 13.35 Favored 'Isoleucine or valine' 0 C--N 1.337 0.052 0 CA-C-N 118.653 0.66 . . . . 0.0 110.402 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.19 -23.91 67.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -95.2 -27.4 15.55 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.82 0.448 . . . . 0.0 110.222 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.32 -4.96 65.55 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.88 -0.4 . . . . 0.0 112.194 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -124.87 10.72 8.3 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.538 0.669 . . . . 0.0 112.229 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -136.99 -22.61 1.18 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 122.826 0.451 . . . . 0.0 111.919 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.7 mt -128.37 10.69 6.27 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.24 0.616 . . . . 0.0 111.052 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -83.35 -19.36 36.26 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.604 0.362 . . . . 0.0 110.653 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 63.4 mt 53.73 19.37 1.82 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.166 1.387 . . . . 0.0 114.652 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.0 m -81.84 150.94 66.76 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 118.576 0.625 . . . . 0.0 110.531 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.74 167.66 26.7 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.922 3.081 . . . . 0.0 110.942 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -133.28 162.41 31.87 Favored 'General case' 0 C--N 1.338 0.076 0 C-N-CA 123.804 0.841 . . . . 0.0 110.06 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.73 0.9 89.92 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.3 m -102.56 2.44 36.19 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.24 0.616 . . . . 0.0 111.066 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -87.12 162.38 17.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.634 0.774 . . . . 0.0 110.836 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -142.41 11.9 1.93 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.915 0.486 . . . . 0.0 111.223 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 54.81 21.2 3.44 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.82 0.848 . . . . 0.0 112.802 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -147.1 154.73 41.5 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.326 0.651 . . . . 0.0 110.27 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -152.21 159.89 43.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.179 0.592 . . . . 0.0 110.07 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 14.3 p80 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.946 -179.065 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 120.579 0.228 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -142.01 25.35 1.94 Allowed 'General case' 0 C--N 1.339 0.132 0 CA-C-O 121.091 0.472 . . . . 0.0 111.012 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -78.24 -9.13 59.08 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.865 -0.522 . . . . 0.0 111.459 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 54.51 -172.65 0.05 OUTLIER 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.885 1.274 . . . . 0.0 112.843 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 43.2 mt -94.57 156.55 16.39 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.194 0.598 . . . . 0.0 110.665 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 7' ' ' ASP . 31.1 m -140.07 172.96 12.01 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.734 0.814 . . . . 0.0 109.363 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 6' ' ' THR . 3.6 p30 -55.28 -17.34 4.44 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.164 0.585 . . . . 0.0 112.385 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -66.23 -53.18 40.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.111 -0.368 . . . . 0.0 110.418 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -84.48 -26.13 7.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.779 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -69.69 -28.99 66.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.642 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.1 t -82.26 -28.22 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 118.839 0.745 . . . . 0.0 109.894 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.85 -37.63 70.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.641 -0.662 . . . . 0.0 110.368 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -69.57 -36.16 76.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 122.057 -0.402 . . . . 0.0 111.76 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -73.62 -23.78 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.038 0 CA-C-N 118.299 0.5 . . . . 0.0 111.205 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -79.69 -14.64 58.62 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.408 0.283 . . . . 0.0 110.335 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -93.18 3.2 56.08 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.632 0.773 . . . . 0.0 112.028 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.54 1.24 43.5 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 119.75 -0.472 . . . . 0.0 113.345 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -92.69 84.24 4.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.025 0.912 . . . . 0.0 109.558 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -65.09 -20.11 66.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.655 0.382 . . . . 0.0 110.659 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -61.72 -24.54 66.86 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.142 0.577 . . . . 0.0 111.007 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.36 -18.79 40.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 119.62 -0.228 . . . . 0.0 110.873 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -77.38 -36.83 53.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.51 -41.95 98.07 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.9 mt -76.53 -18.41 58.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.628 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 tp -81.97 -42.87 18.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.713 0.233 . . . . 0.0 110.659 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 m -69.83 -27.03 31.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.538 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -66.23 -26.86 39.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 CA-C-N 119.859 1.209 . . . . 0.0 111.129 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -69.44 -33.27 72.7 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.016 0.436 . . . . 0.0 109.919 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -100.27 -8.71 23.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.349 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -61.55 -30.08 70.42 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.234 0.613 . . . . 0.0 110.824 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -86.75 -29.5 22.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 121.994 0.118 . . . . 0.0 111.084 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -76.35 -41.22 49.0 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 m -82.79 -24.86 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 118.062 0.392 . . . . 0.0 111.064 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.15 -25.23 63.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -76.81 -46.27 25.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.834 0.35 . . . . 0.0 110.817 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.06 -24.62 59.53 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.595 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 46' ' ' VAL . 2.4 p -88.8 -19.95 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 118.139 0.427 . . . . 0.0 112.146 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.3 m -66.6 -9.93 40.41 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.36 0.527 . . . . 0.0 112.245 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -95.11 -3.75 47.46 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.229 0.468 . . . . 0.0 111.671 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -111.03 -20.63 12.34 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.854 0.462 . . . . 0.0 110.997 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -141.83 152.63 62.93 Favored Pre-proline 0 C--N 1.34 0.176 0 C-N-CA 124.057 0.943 . . . . 0.0 109.541 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.54 167.43 24.17 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.716 2.944 . . . . 0.0 111.249 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.7 m -65.58 -11.77 47.09 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.054 0.542 . . . . 0.0 112.418 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.81 -18.86 53.6 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.609 -0.55 . . . . 0.0 112.795 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.47 -6.98 11.71 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 117.808 0.804 . . . . 0.0 112.035 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.531 HG23 HG13 ' A' ' 37' ' ' VAL . 7.6 p -66.25 -36.04 11.95 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 46' ' ' VAL . 83.2 Cg_endo -73.68 -24.37 15.88 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 CA-C-N 121.697 1.642 . . . . 0.0 111.246 -172.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.5 -30.49 29.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.07 -30.2 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 122.556 0.342 . . . . 0.0 110.133 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -72.16 -33.53 47.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -72.5 -42.9 64.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -65.59 -30.71 71.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.418 0.554 . . . . 0.0 109.595 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.57 -29.3 66.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 117.746 0.248 . . . . 0.0 110.952 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -85.18 -28.92 25.14 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.299 0.5 . . . . 0.0 111.385 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 99.2 mt -72.93 -36.87 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -77.76 -31.07 51.82 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.445 0.698 . . . . 0.0 111.015 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.67 -42.47 74.13 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.121 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -62.05 -38.33 88.34 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.536 0.607 . . . . 0.0 111.485 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.23 -25.78 62.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.622 0.369 . . . . 0.0 111.166 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.34 -10.53 29.86 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.967 0.507 . . . . 0.0 111.395 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.5 tp -75.24 -24.53 57.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.972 0.509 . . . . 0.0 110.249 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.09 -10.25 52.47 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.454 0.302 . . . . 0.0 110.473 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.0 m -110.83 0.75 17.36 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.647 0.779 . . . . 0.0 111.662 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -74.06 146.38 43.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.103 0.561 . . . . 0.0 109.68 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -134.74 4.81 3.35 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.4 15.67 80.22 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 118.169 0.441 . . . . 0.0 112.5 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -69.0 -11.01 60.39 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.65 0.725 . . . . 0.0 110.961 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 81.3 p -147.95 170.05 18.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.518 1.127 . . . . 0.0 108.928 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.06 145.0 54.85 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -66.21 -35.12 79.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.28 -0.262 . . . . 0.0 111.676 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -68.88 -37.15 78.86 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.737 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.0 m -69.41 -39.61 77.82 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -67.37 -32.96 74.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.95 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.3 tp -81.12 -34.11 32.77 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.726 0.41 . . . . 0.0 111.515 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.4 m-30 -64.0 -27.37 69.07 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.074 -0.391 . . . . 0.0 110.431 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -75.68 -25.04 56.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.165 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.5 mm -70.29 -39.25 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-N 118.296 0.498 . . . . 0.0 109.726 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.56 -37.06 57.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.06 -30.66 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-N 118.469 0.577 . . . . 0.0 111.43 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -76.07 -24.55 55.1 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.969 -0.457 . . . . 0.0 110.167 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.7 m -77.34 -29.37 53.4 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.08 62.5 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.877 0.308 . . . . 0.0 110.973 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.44 -29.7 57.08 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.412 ' HA ' HG12 ' A' ' 87' ' ' VAL . 16.6 t30 -83.63 -16.61 44.53 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.828 -0.169 . . . . 0.0 110.615 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -78.27 -36.42 46.81 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.904 -0.497 . . . . 0.0 110.394 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.0 mt -81.35 -17.68 48.29 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 84' ' ' ASN . 3.8 p -85.77 -25.31 6.62 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 CA-C-N 118.675 0.671 . . . . 0.0 110.051 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.11 -26.96 60.65 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.456 -0.153 . . . . 0.0 110.921 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -103.04 -11.68 17.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.064 0.545 . . . . 0.0 110.091 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.69 -9.04 69.27 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.097 177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 -126.8 159.22 34.48 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.831 0.853 . . . . 0.0 110.084 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 -137.68 155.05 49.54 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 124.703 1.201 . . . . 0.0 108.314 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.0 mt 51.62 33.16 10.22 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.077 0.551 . . . . 0.0 110.241 -173.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -139.56 172.62 12.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.709 1.204 . . . . 0.0 109.018 -172.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.8 tp 61.67 28.9 17.91 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.926 0.891 . . . . 0.0 110.786 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.4 156.17 73.17 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 124.718 1.207 . . . . 0.0 108.956 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.63 158.71 48.68 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.821 2.348 . . . . 0.0 110.936 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.7 mmt-85 -120.86 162.6 19.55 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.764 0.826 . . . . 0.0 110.138 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.45 9.01 81.46 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.83 -0.428 . . . . 0.0 112.417 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.5 p -117.01 14.16 14.97 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.776 0.83 . . . . 0.0 111.393 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -115.98 161.8 18.32 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.245 0.618 . . . . 0.0 110.769 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -131.43 2.75 4.2 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.843 0.457 . . . . 0.0 111.674 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -151.54 167.02 29.37 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.547 0.739 . . . . 0.0 109.406 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.7 m80 55.11 -168.26 0.08 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.72 0.808 . . . . 0.0 111.64 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -138.22 155.19 48.89 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.796 0.438 . . . . 0.0 110.177 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.8 m80 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 117.393 -1.289 . . . . 0.0 110.227 -176.939 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 tpp . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 t -141.84 8.19 1.89 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.043 0.537 . . . . 0.0 111.327 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 55.63 13.79 1.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.327 1.051 . . . . 0.0 113.768 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 60.95 27.09 16.98 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.236 0.614 . . . . 0.0 111.304 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.2 mt -110.2 160.31 16.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.085 0.954 . . . . 0.0 109.786 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 7' ' ' ASP . 24.9 m -139.79 173.12 11.85 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.746 0.818 . . . . 0.0 109.476 -175.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.469 ' H ' HG22 ' A' ' 6' ' ' THR . 3.5 p30 -55.52 -17.67 5.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.154 0.582 . . . . 0.0 112.222 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.69 -52.81 40.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.8 p -85.94 -25.9 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 122.85 0.46 . . . . 0.0 110.882 -176.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mp -69.44 -28.18 65.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.909 -0.494 . . . . 0.0 110.515 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.3 t -81.14 -28.54 10.9 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 CA-C-N 118.398 0.545 . . . . 0.0 109.839 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 38.8 mt-10 -72.45 -34.7 67.94 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.824 -0.547 . . . . 0.0 110.271 174.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -68.98 -39.79 79.2 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.688 0.395 . . . . 0.0 111.257 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 m -72.94 -24.16 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 117.698 0.226 . . . . 0.0 111.054 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -78.67 -20.5 50.07 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.887 0.312 . . . . 0.0 110.301 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -81.42 -5.22 57.68 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.328 0.651 . . . . 0.0 111.799 174.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.88 0.38 34.05 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.487 -0.618 . . . . 0.0 112.79 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -87.68 83.96 7.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.008 0.904 . . . . 0.0 109.471 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -66.39 -20.6 66.11 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.683 0.393 . . . . 0.0 110.6 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -60.77 -24.92 66.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.998 0.519 . . . . 0.0 110.834 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.26 -18.77 41.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 119.583 -0.246 . . . . 0.0 111.07 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -76.51 -36.85 57.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -62.49 -40.76 97.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.74 -18.76 59.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.521 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.0 tp -83.7 -47.81 10.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.39 0.276 . . . . 0.0 110.885 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.89 -25.08 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.383 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.3 p -70.37 -26.63 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 119.329 0.968 . . . . 0.0 110.681 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -68.65 -33.13 73.47 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -99.66 -8.91 23.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.352 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -62.62 -27.2 69.04 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.4 0.545 . . . . 0.0 110.609 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -86.12 -30.82 22.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -76.9 -42.23 40.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.3 m -81.59 -25.36 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 118.158 0.435 . . . . 0.0 110.911 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.482 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.86 -22.89 62.25 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.177 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.0 t -76.53 -43.38 39.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.3 -25.22 36.66 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 46' ' ' VAL . 2.8 p -87.35 -18.45 8.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.089 0 CA-C-N 118.094 0.406 . . . . 0.0 111.226 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.2 t -68.21 -9.51 47.62 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 174.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -90.86 -3.87 57.03 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.659 0.784 . . . . 0.0 111.484 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.35 -14.45 8.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.75 0.42 . . . . 0.0 111.807 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.41 153.46 59.08 Favored Pre-proline 0 N--CA 1.462 0.148 0 C-N-CA 123.953 0.901 . . . . 0.0 109.466 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.72 164.5 31.07 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.559 2.839 . . . . 0.0 110.756 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.3 p -66.61 -10.11 42.41 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.06 -18.33 56.07 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 118.262 0.483 . . . . 0.0 112.093 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.36 -5.09 11.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.427 0.613 . . . . 0.0 111.451 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.525 HG23 HG13 ' A' ' 37' ' ' VAL . 5.2 p -67.3 -33.08 5.21 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 117.707 -1.139 . . . . 0.0 113.368 -177.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 97.0 Cg_endo -76.84 -25.25 9.28 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 CA-C-N 122.12 1.793 . . . . 0.0 111.687 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.4 -29.79 30.59 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -78.06 -25.84 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.97 -37.07 59.71 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -71.31 -42.85 68.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -67.83 -26.45 66.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.233 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.41 -27.9 61.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.668 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -85.26 -29.67 24.43 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.531 0.605 . . . . 0.0 111.069 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.99 -37.46 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 175.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -75.58 -32.93 60.54 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.197 0.599 . . . . 0.0 110.538 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.72 -42.75 77.21 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 119.141 -0.456 . . . . 0.0 110.733 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -62.49 -37.62 86.68 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.906 0.776 . . . . 0.0 111.255 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -71.53 -25.12 62.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.679 0.392 . . . . 0.0 111.014 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.98 -11.77 27.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.132 0.573 . . . . 0.0 111.508 176.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -74.72 -24.53 58.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 110.264 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.56 -10.79 58.0 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.276 0.23 . . . . 0.0 110.506 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -109.43 1.92 20.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.649 0.78 . . . . 0.0 111.722 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -74.45 147.66 41.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.092 0.557 . . . . 0.0 109.732 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -137.83 2.97 2.44 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.49 18.0 78.37 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.698 -0.501 . . . . 0.0 112.519 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -66.55 -11.74 54.43 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.051 0.926 . . . . 0.0 110.933 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.9 p -151.2 170.23 19.96 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.606 1.162 . . . . 0.0 109.054 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.17 147.76 52.84 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -67.49 -33.55 75.33 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -69.03 -37.64 78.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.67 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -69.65 -37.25 76.67 Favored 'General case' 0 C--O 1.227 -0.095 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -70.22 -32.18 69.93 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 122.246 0.218 . . . . 0.0 110.953 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.9 tp -81.89 -34.78 29.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.644 0.378 . . . . 0.0 111.319 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -63.63 -28.0 69.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -72.82 -26.04 61.35 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 122.817 0.447 . . . . 0.0 111.527 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mm -72.84 -38.38 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.159 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.85 -35.44 59.94 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 p -77.41 -31.87 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 118.344 0.52 . . . . 0.0 111.245 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -77.87 -23.96 48.67 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.038 0.381 . . . . 0.0 110.649 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.6 m -77.3 -30.45 54.17 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.44 -32.41 62.62 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.726 0.239 . . . . 0.0 111.415 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.53 -30.89 61.94 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -78.23 -26.33 47.3 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -72.4 -39.5 67.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 122.261 -0.274 . . . . 0.0 111.29 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -78.05 -29.16 49.13 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.16 -20.97 17.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 CA-C-N 118.95 0.796 . . . . 0.0 110.133 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.16 -14.78 61.43 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 119.486 -0.293 . . . . 0.0 111.045 175.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -101.08 -32.43 10.59 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.088 0.404 . . . . 0.0 111.39 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.68 -10.75 69.52 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.287 -0.73 . . . . 0.0 113.638 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -105.41 11.38 32.73 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.271 1.035 . . . . 0.0 112.701 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -74.95 131.53 40.75 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 93' ' ' LEU . 7.6 mp 52.05 30.4 7.43 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.112 0.965 . . . . 0.0 111.686 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -66.77 -3.18 6.13 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 95' ' ' LEU . 3.0 mm? -78.48 -10.61 59.78 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.114 0.415 . . . . 0.0 110.99 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.4 m -141.36 153.92 66.58 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 123.42 0.688 . . . . 0.0 110.378 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.09 -18.7 16.25 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.309 2.673 . . . . 0.0 110.97 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -157.05 150.08 23.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.123 0.969 . . . . 0.0 108.409 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.87 146.2 50.22 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.5 p -155.12 168.45 26.98 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 122.992 0.517 . . . . 0.0 110.615 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -135.5 14.29 3.45 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.278 0.631 . . . . 0.0 111.276 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.445 ' CG ' ' H ' ' A' ' 103' ' ' HIS . 11.9 t60 58.98 176.57 0.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.5 1.12 . . . . 0.0 112.392 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.445 ' H ' ' CG ' ' A' ' 102' ' ' HIS . 32.0 t-80 -146.29 160.42 42.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.898 0.479 . . . . 0.0 110.537 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -144.75 164.48 30.88 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.138 0.575 . . . . 0.0 110.726 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -127.9 4.54 5.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.883 0.473 . . . . 0.0 111.953 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.045 -1.455 . . . . 0.0 110.097 179.521 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.461 0.172 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -105.09 161.16 14.48 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.86 0.464 . . . . 0.0 110.792 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -147.78 151.54 36.19 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 122.944 0.498 . . . . 0.0 110.197 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -148.11 163.92 35.46 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.055 0.542 . . . . 0.0 109.919 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.7 mt -107.02 154.37 21.21 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.621 0.768 . . . . 0.0 110.901 -173.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 7' ' ' ASP . 29.9 m -138.41 174.14 10.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.963 0.905 . . . . 0.0 109.299 -174.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 6' ' ' THR . 3.7 p30 -54.94 -18.87 5.55 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.103 0.561 . . . . 0.0 112.284 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -65.79 -52.28 52.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 9' ' ' VAL . 2.9 p -85.68 -25.6 6.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 122.795 0.438 . . . . 0.0 110.923 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 mp -71.67 -28.34 63.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.783 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.4 t -81.86 -28.97 9.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 118.442 0.565 . . . . 0.0 110.055 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.92 -37.15 72.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.719 -0.613 . . . . 0.0 110.206 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -69.82 -37.88 76.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.494 0.318 . . . . 0.0 111.532 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.21 -23.98 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 O-C-N 121.901 -0.499 . . . . 0.0 110.907 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -80.44 -14.62 58.14 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.21 -0.306 . . . . 0.0 110.398 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -93.13 3.65 55.34 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.623 0.769 . . . . 0.0 111.709 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.47 2.79 47.34 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.168 172.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -95.92 84.02 3.79 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.04 0.92 . . . . 0.0 110.086 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -65.58 -20.34 66.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.276 0.63 . . . . 0.0 110.966 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -61.02 -23.81 65.7 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 122.883 0.473 . . . . 0.0 110.871 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.87 -19.03 41.78 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.583 -0.246 . . . . 0.0 110.835 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -76.57 -37.23 56.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.5 -41.86 97.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -76.62 -18.49 58.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.451 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.2 tp -81.0 -43.04 20.22 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.253 -0.279 . . . . 0.0 110.805 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.07 -27.1 31.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.459 -175.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -65.72 -27.3 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 119.97 1.259 . . . . 0.0 111.216 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -70.56 -32.29 69.64 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.121 0.419 . . . . 0.0 109.954 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -100.02 -8.65 23.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.381 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -62.69 -27.97 69.61 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.421 0.689 . . . . 0.0 110.446 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -86.31 -29.67 22.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.475 -0.141 . . . . 0.0 110.859 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -76.67 -43.04 39.51 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -80.92 -25.89 10.84 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 O-C-N 121.928 -0.483 . . . . 0.0 111.145 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -71.55 -22.16 61.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.049 0.386 . . . . 0.0 110.104 176.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 t -76.51 -41.62 46.27 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.123 0.169 . . . . 0.0 110.58 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.96 -25.29 30.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.529 HG13 HG23 ' A' ' 46' ' ' VAL . 2.6 p -88.25 -18.95 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.036 0 CA-C-N 118.165 0.439 . . . . 0.0 111.55 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.5 t -68.61 -8.88 45.98 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 173.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -90.91 -3.87 56.99 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.033 0.933 . . . . 0.0 111.289 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -121.37 -17.5 7.59 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.831 0.452 . . . . 0.0 111.458 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.4 m -141.09 153.19 66.69 Favored Pre-proline 0 N--CA 1.463 0.176 0 C-N-CA 123.406 0.682 . . . . 0.0 109.441 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.82 165.62 29.12 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.718 2.946 . . . . 0.0 111.17 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.7 m -64.87 -11.02 32.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.09 -18.09 56.47 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.272 0.487 . . . . 0.0 112.07 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -116.64 -6.11 11.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.223 0.511 . . . . 0.0 111.642 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.529 HG23 HG13 ' A' ' 37' ' ' VAL . 6.0 p -67.66 -33.18 5.03 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.592 -1.195 . . . . 0.0 113.462 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 98.2 Cg_endo -76.51 -25.5 9.53 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 CA-C-N 122.23 1.832 . . . . 0.0 111.511 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.43 -30.39 30.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.415 -0.178 . . . . 0.0 110.593 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -77.15 -27.02 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.3 t -72.27 -35.44 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -72.05 -42.61 66.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.03 -28.04 67.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.24 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.99 -28.4 63.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.458 -0.305 . . . . 0.0 110.793 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -85.08 -29.97 24.44 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.576 0.625 . . . . 0.0 111.216 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 99.0 mt -72.05 -37.23 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -76.64 -32.37 57.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.118 0.567 . . . . 0.0 110.98 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.71 75.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.32 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -61.58 -38.7 88.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.383 0.538 . . . . 0.0 111.419 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -71.53 -26.12 62.52 Favored 'General case' 0 C--O 1.228 -0.05 0 C-N-CA 122.779 0.431 . . . . 0.0 111.175 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.8 -11.29 31.6 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.063 0.545 . . . . 0.0 111.462 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.1 tp -75.74 -25.81 56.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.689 0.396 . . . . 0.0 110.45 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.86 -10.7 59.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.511 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.6 m -113.37 0.08 14.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.796 0.838 . . . . 0.0 111.213 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.407 ' CZ ' ' HA2' ' A' ' 66' ' ' GLY . 25.4 t80 -72.91 147.35 45.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -121.23 -4.36 9.46 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.407 ' HA2' ' CZ ' ' A' ' 64' ' ' PHE . . . 69.27 17.33 72.12 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 118.092 0.405 . . . . 0.0 112.489 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.34 -8.31 45.14 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.712 0.756 . . . . 0.0 111.189 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.1 t -145.7 170.23 16.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.521 1.128 . . . . 0.0 108.027 176.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.24 146.76 54.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.873 -0.517 . . . . 0.0 110.28 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -65.28 -34.09 77.52 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.507 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -68.59 -35.74 77.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.97 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.8 m -70.86 -37.84 73.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -70.47 -32.21 69.66 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.249 0.22 . . . . 0.0 111.016 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.8 tp -81.33 -34.77 31.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.602 0.361 . . . . 0.0 111.516 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.2 m-30 -63.52 -28.4 69.92 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 122.086 -0.383 . . . . 0.0 110.109 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -74.01 -25.08 59.69 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.552 0.341 . . . . 0.0 111.363 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.67 -38.24 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.02 -36.26 59.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -174.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.2 p -78.21 -31.23 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-N 118.329 0.513 . . . . 0.0 111.471 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.86 -24.02 52.65 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.137 0.426 . . . . 0.0 110.091 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.5 m -78.73 -29.64 45.43 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.77 -32.97 66.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.876 0.307 . . . . 0.0 110.906 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.24 -30.13 57.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.347 -0.22 . . . . 0.0 110.477 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -79.23 -24.68 42.91 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.674 0.274 . . . . 0.0 110.513 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -74.46 -35.39 63.3 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.431 0.292 . . . . 0.0 110.906 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.3 mt -77.43 -25.23 50.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.84 -19.0 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 118.922 0.783 . . . . 0.0 111.113 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.27 -12.57 60.31 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.09 -0.381 . . . . 0.0 111.073 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -118.05 -17.69 9.6 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.753 0.421 . . . . 0.0 111.284 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.38 -21.3 62.61 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -88.69 8.18 29.97 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.471 0.709 . . . . 0.0 111.054 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -92.98 -13.9 28.16 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.265 0.626 . . . . 0.0 110.579 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 93.7 mt -125.46 4.39 7.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.626 0.77 . . . . 0.0 111.286 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -137.15 147.54 46.03 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.0 tp 56.36 9.48 0.53 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.436 1.094 . . . . 0.0 112.371 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.44 135.32 14.81 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.13 163.76 37.38 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.441 2.761 . . . . 0.0 111.507 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -145.96 166.37 26.23 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.307 0.643 . . . . 0.0 110.68 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.66 -174.84 41.69 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.9 t -146.39 158.27 43.87 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 122.788 0.435 . . . . 0.0 110.39 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -149.94 163.12 38.92 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.418 0.687 . . . . 0.0 109.678 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -81.96 1.12 36.89 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -143.95 155.89 44.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.694 0.798 . . . . 0.0 109.92 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -152.35 163.93 38.48 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.784 0.433 . . . . 0.0 110.764 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -76.11 166.98 22.68 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.075 0.55 . . . . 0.0 111.103 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 . . . . . 0 C--O 1.252 1.222 0 CA-C-O 117.993 -1.003 . . . . 0.0 111.345 179.733 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.7 mtp . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.3 p -146.71 166.78 25.57 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.109 0.564 . . . . 0.0 110.472 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -134.27 19.63 3.69 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.132 0.573 . . . . 0.0 111.322 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -130.75 176.39 8.24 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.263 0.554 . . . . 0.0 110.499 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.3 mt -91.18 153.73 19.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.198 0.599 . . . . 0.0 111.107 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 7' ' ' ASP . 32.4 m -138.26 173.79 11.24 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.926 0.891 . . . . 0.0 108.92 -175.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.469 ' N ' HG22 ' A' ' 6' ' ' THR . 3.4 p30 -55.6 -17.1 4.87 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 123.384 0.673 . . . . 0.0 112.182 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.0 tp60 -66.36 -52.76 43.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 121.825 -0.547 . . . . 0.0 110.159 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' H ' HG12 ' A' ' 9' ' ' VAL . 3.0 p -85.02 -25.79 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 C-N-CA 122.626 0.37 . . . . 0.0 110.9 -177.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.96 -28.54 64.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.079 -0.388 . . . . 0.0 110.841 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.2 t -82.44 -29.18 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 CA-C-N 118.683 0.674 . . . . 0.0 109.771 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.6 -40.92 76.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.514 -0.741 . . . . 0.0 109.971 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -68.39 -36.9 79.83 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.051 0.54 . . . . 0.0 112.204 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -70.47 -22.56 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.051 0 O-C-N 121.489 -0.757 . . . . 0.0 110.43 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -81.03 -14.56 57.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 119.592 -0.242 . . . . 0.0 110.67 174.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -80.41 -6.4 58.0 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.156 0.435 . . . . 0.0 110.759 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.61 4.02 52.57 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.6 0.619 . . . . 0.0 112.187 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -89.6 84.06 6.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.802 0.801 . . . . 0.0 109.487 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -65.68 -19.27 65.84 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.73 0.412 . . . . 0.0 110.774 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -60.32 -24.99 65.44 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 122.753 0.421 . . . . 0.0 110.977 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.57 -18.59 40.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.595 -0.24 . . . . 0.0 110.9 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -77.66 -37.38 50.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -61.32 -41.22 96.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.8 mt -76.94 -18.32 58.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.6 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.1 tp -82.13 -41.9 19.83 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.995 -0.441 . . . . 0.0 110.637 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.8 -26.76 28.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.587 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.4 m -66.58 -27.21 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.933 1.242 . . . . 0.0 111.253 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -70.84 -31.85 68.69 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -100.27 -8.73 23.13 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.376 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -62.95 -28.15 69.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.195 0.598 . . . . 0.0 110.514 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -86.61 -29.42 22.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.448 0.165 . . . . 0.0 110.749 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -77.39 -42.39 36.51 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -80.82 -26.69 11.04 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 118.127 0.421 . . . . 0.0 110.988 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.59 -22.53 62.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 t -77.78 -41.99 35.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.413 0.149 . . . . 0.0 110.668 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.6 -24.97 36.11 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.515 HG13 HG23 ' A' ' 46' ' ' VAL . 2.7 p -88.4 -18.8 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.18 0.446 . . . . 0.0 111.407 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -67.28 -11.09 56.62 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.986 -0.446 . . . . 0.0 110.043 173.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -86.7 -6.46 58.84 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.594 0.758 . . . . 0.0 111.535 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -122.66 -13.09 8.01 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -143.32 153.07 58.93 Favored Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 123.642 0.777 . . . . 0.0 109.211 173.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.08 164.0 33.72 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.66 2.907 . . . . 0.0 110.997 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.0 m -64.84 -10.64 29.78 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.06 -19.17 54.24 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 118.147 0.43 . . . . 0.0 112.166 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.18 -4.92 11.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.501 0.651 . . . . 0.0 111.619 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.515 HG23 HG13 ' A' ' 37' ' ' VAL . 5.3 p -67.43 -32.76 4.79 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.4 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 96.7 Cg_endo -76.78 -24.87 9.73 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 CA-C-N 122.095 1.784 . . . . 0.0 111.79 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.76 -30.8 32.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.289 -0.257 . . . . 0.0 110.528 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.1 t -77.98 -25.49 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.8 t -73.25 -35.42 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.38 -42.22 68.69 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -66.03 -30.84 71.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.78 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.1 -28.39 65.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.477 -0.296 . . . . 0.0 110.932 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -85.38 -28.73 24.97 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.519 0.6 . . . . 0.0 111.386 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.3 mt -72.7 -37.69 56.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -76.91 -32.81 57.66 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.105 0.562 . . . . 0.0 110.92 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.49 -42.16 79.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.279 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -61.82 -39.29 91.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.601 0.637 . . . . 0.0 111.542 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -70.82 -25.12 62.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.73 0.412 . . . . 0.0 111.289 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.22 -11.93 27.18 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.23 0.612 . . . . 0.0 111.419 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.0 tp -74.94 -24.82 58.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.005 0.522 . . . . 0.0 110.444 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.85 -10.75 51.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.271 0.228 . . . . 0.0 110.676 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.3 m -110.93 2.27 18.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.535 0.734 . . . . 0.0 111.7 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -72.65 143.82 48.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -136.43 7.9 3.1 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -175.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.55 14.61 79.51 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.611 -0.549 . . . . 0.0 112.868 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.5 -14.63 63.14 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.15 0.975 . . . . 0.0 110.842 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.6 m -142.77 164.93 28.76 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.914 1.286 . . . . 0.0 108.937 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.13 147.08 53.88 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -66.59 -34.73 78.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -175.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -69.56 -36.67 76.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.479 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.2 m -70.4 -34.23 72.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 62.0 t90 -76.21 -26.83 56.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 122.908 0.483 . . . . 0.0 111.325 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.8 tp -86.25 -35.19 20.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.22 -0.3 . . . . 0.0 111.289 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -63.91 -30.63 71.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -74.49 -22.17 59.21 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 117.999 0.363 . . . . 0.0 111.817 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.4 mm -70.26 -37.61 71.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.716 0.689 . . . . 0.0 109.504 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.97 -37.38 55.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 p -78.91 -29.35 14.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 CA-C-N 118.45 0.568 . . . . 0.0 111.336 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -76.13 -24.82 54.92 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.884 -0.51 . . . . 0.0 109.975 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.8 m -80.1 -30.74 39.21 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 122.206 -0.309 . . . . 0.0 110.246 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.56 -34.63 65.24 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.13 0.423 . . . . 0.0 111.016 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.44 -27.77 52.27 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -80.33 -25.91 39.04 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -72.64 -38.68 67.64 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.742 0.417 . . . . 0.0 111.135 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.3 mt -79.01 -26.42 43.26 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.1 m -84.64 -20.88 8.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 CA-C-N 119.038 0.835 . . . . 0.0 111.163 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.61 -10.3 59.77 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 122.25 -0.281 . . . . 0.0 111.287 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -118.63 -23.11 7.2 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.422 0.289 . . . . 0.0 111.337 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -98.82 -12.19 44.35 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.672 -0.515 . . . . 0.0 113.069 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -131.84 18.42 4.65 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 118.037 0.918 . . . . 0.0 111.896 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -61.91 -16.56 51.7 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.011 0.524 . . . . 0.0 111.919 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.0 mt -109.55 9.33 25.28 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.219 0.608 . . . . 0.0 112.212 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -142.19 -20.27 0.71 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 44.8 tp -100.96 -19.34 15.91 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.213 0.46 . . . . 0.0 111.11 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.439 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 59.8 t -86.88 -46.84 0.52 Allowed Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.21 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 96' ' ' VAL . 78.0 Cg_endo -77.42 -3.56 13.77 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.345 2.03 . . . . 0.0 111.344 174.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 52.37 29.96 7.53 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.542 1.137 . . . . 0.0 112.412 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.92 179.65 43.46 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.2 t -81.08 -12.34 59.31 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.678 0.391 . . . . 0.0 111.512 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.7 t60 52.72 28.53 6.38 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.829 0.852 . . . . 0.0 112.24 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -144.34 160.14 41.52 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.506 0.722 . . . . 0.0 110.098 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -140.44 164.14 30.94 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 122.978 0.511 . . . . 0.0 110.808 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -145.43 171.08 15.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.41 0.684 . . . . 0.0 110.512 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -135.69 160.91 37.07 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 123.02 0.528 . . . . 0.0 110.644 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.71 -179.123 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttp . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.644 -0.132 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.2 p -154.94 163.39 40.37 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.87 0.468 . . . . 0.0 110.736 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -149.9 149.92 31.14 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -150.38 171.05 17.62 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.173 0.511 . . . . 0.0 111.272 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 69.7 mt -109.82 155.61 21.41 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.369 1.067 . . . . 0.0 109.917 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 7' ' ' ASP . 32.7 m -138.26 173.17 11.9 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.381 0.672 . . . . 0.0 109.692 -175.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.469 ' N ' HG22 ' A' ' 6' ' ' THR . 3.7 p30 -55.18 -17.38 4.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.498 0.719 . . . . 0.0 112.11 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.44 -53.25 37.62 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.101 -0.375 . . . . 0.0 110.144 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 p -85.08 -26.14 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.965 0.506 . . . . 0.0 110.781 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.78 -28.66 64.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.758 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.7 t -82.22 -28.78 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 118.791 0.723 . . . . 0.0 110.013 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.93 -37.65 72.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.584 -0.697 . . . . 0.0 110.401 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -71.64 -35.4 70.38 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.133 -0.354 . . . . 0.0 111.952 -175.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -73.24 -23.88 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.174 0.443 . . . . 0.0 111.036 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -80.13 -14.96 58.07 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -92.39 3.32 55.68 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.47 0.708 . . . . 0.0 111.922 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.06 0.11 41.42 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.583 -0.565 . . . . 0.0 113.471 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -93.95 84.15 4.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.164 0.982 . . . . 0.0 109.294 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.2 tm0? -65.66 -19.91 66.09 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.82 0.448 . . . . 0.0 110.438 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -62.57 -22.44 66.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.102 0.561 . . . . 0.0 111.119 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.66 -18.78 43.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.842 0.292 . . . . 0.0 110.494 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -76.88 -36.11 56.97 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -61.98 -40.39 95.43 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.96 -19.07 59.04 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.292 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 tp -83.67 -48.08 10.55 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 119.634 -0.222 . . . . 0.0 111.126 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -66.72 -25.04 33.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.616 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.28 -26.74 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 119.399 1.0 . . . . 0.0 111.083 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -68.72 -31.68 70.93 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -101.52 -9.01 21.4 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -62.08 -28.38 69.57 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.389 0.54 . . . . 0.0 110.332 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -86.69 -31.39 21.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.716 -0.105 . . . . 0.0 110.716 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -75.74 -42.17 51.26 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -80.84 -25.22 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 O-C-N 121.739 -0.601 . . . . 0.0 110.873 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.458 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -69.39 -23.43 63.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.115 0.416 . . . . 0.0 110.149 176.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -76.27 -44.47 37.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 pp -79.05 -25.21 43.2 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.513 HG13 HG23 ' A' ' 46' ' ' VAL . 3.2 p -88.51 -17.95 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 118.108 0.413 . . . . 0.0 111.626 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.7 t -67.17 -9.36 39.17 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.941 -0.474 . . . . 0.0 110.009 173.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -86.71 -7.65 58.11 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.346 0.659 . . . . 0.0 111.501 176.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -120.9 -13.8 8.58 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 m -144.42 154.23 56.54 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 124.152 0.981 . . . . 0.0 109.182 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.62 164.45 33.0 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.368 2.712 . . . . 0.0 110.881 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -66.51 -9.96 39.96 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.11 -19.14 54.21 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.05 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -116.35 -5.2 11.79 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.554 0.677 . . . . 0.0 111.621 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.513 HG23 HG13 ' A' ' 37' ' ' VAL . 5.0 p -66.39 -32.69 5.63 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.67 -1.157 . . . . 0.0 113.703 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 91.4 Cg_endo -76.75 -25.46 9.2 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 CA-C-N 121.989 1.746 . . . . 0.0 111.458 -176.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.06 -30.39 31.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.132 -0.355 . . . . 0.0 110.57 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.2 t -75.53 -27.21 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.92 -35.74 55.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -71.85 -43.17 65.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -67.28 -27.91 67.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.089 0.404 . . . . 0.0 110.18 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.62 -27.17 61.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.7 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -84.58 -31.32 24.39 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.538 0.608 . . . . 0.0 110.918 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.9 mt -70.08 -36.94 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -78.03 -33.75 50.9 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.443 0.297 . . . . 0.0 110.921 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.29 -39.85 89.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.585 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -64.94 -36.77 85.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.521 0.601 . . . . 0.0 111.07 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -71.58 -17.74 62.27 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.943 0.497 . . . . 0.0 110.78 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.28 -10.8 17.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.137 0.575 . . . . 0.0 111.439 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.1 tp -76.06 -23.95 55.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.279 0.631 . . . . 0.0 110.155 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.62 -9.12 47.82 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.663 0.385 . . . . 0.0 110.463 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.1 m -113.17 4.8 16.72 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.114 0.966 . . . . 0.0 111.528 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -71.53 145.36 49.17 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -132.58 -0.45 3.55 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.34 15.25 80.3 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.666 -0.519 . . . . 0.0 113.378 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -69.39 -8.18 44.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.297 1.049 . . . . 0.0 111.12 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.3 p -148.26 166.72 27.12 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.663 1.185 . . . . 0.0 108.661 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 147.89 51.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 122.124 -0.36 . . . . 0.0 110.266 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -66.2 -33.83 76.64 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -175.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -69.76 -36.51 75.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.705 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.3 m -70.78 -34.31 71.66 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -74.23 -28.84 61.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.061 0.544 . . . . 0.0 110.947 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.7 tp -86.24 -35.36 20.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.558 0.343 . . . . 0.0 111.387 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -62.74 -33.62 75.51 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -74.86 -21.86 59.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.678 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.8 mm -68.71 -39.91 80.89 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 118.836 0.744 . . . . 0.0 109.231 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.04 -34.47 64.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.65 -30.92 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.082 0 CA-C-N 118.713 0.688 . . . . 0.0 111.05 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -78.51 -19.02 53.89 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.979 -0.451 . . . . 0.0 110.522 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 81.4 m -78.64 -31.45 46.89 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.66 -35.55 62.81 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.743 0.247 . . . . 0.0 111.188 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -77.67 -24.03 49.45 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.482 ' HA ' HG12 ' A' ' 87' ' ' VAL . 17.9 t30 -86.8 -18.76 30.24 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.361 -0.212 . . . . 0.0 111.111 175.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -78.23 -36.55 46.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.002 -0.436 . . . . 0.0 110.818 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.7 mt -82.4 -25.86 33.35 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.482 HG12 ' HA ' ' A' ' 84' ' ' ASN . 7.0 p -79.95 -28.25 12.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 CA-C-N 118.447 0.567 . . . . 0.0 110.125 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.51 -17.12 60.2 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 122.5 -0.125 . . . . 0.0 111.029 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -111.11 -8.32 14.43 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.751 0.42 . . . . 0.0 110.586 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -93.78 -14.59 52.21 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.45 -0.639 . . . . 0.0 112.045 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -112.53 -15.69 13.01 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 117.987 0.894 . . . . 0.0 112.502 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtp85 -96.11 131.31 42.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.159 0.436 . . . . 0.0 110.323 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.3 mp 52.43 33.33 12.89 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.921 0.888 . . . . 0.0 111.795 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -126.0 144.85 50.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.174 0.59 . . . . 0.0 110.062 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.3 mp -97.44 48.79 1.03 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.085 0.954 . . . . 0.0 110.66 -175.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 98' ' ' ARG . 21.4 t -59.98 133.66 89.92 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.4 5.95 3.87 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.13 3.22 . . . . 0.0 112.804 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.417 ' H ' HG12 ' A' ' 96' ' ' VAL . 73.3 ttp85 -139.83 148.48 42.19 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 123.072 0.549 . . . . 0.0 110.212 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.52 154.27 6.42 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 123.76 0.695 . . . . 0.0 111.542 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.3 p -154.82 172.69 17.58 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.818 0.447 . . . . 0.0 110.595 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -112.69 157.25 21.51 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.214 0.606 . . . . 0.0 110.279 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -150.32 167.63 26.45 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.63 0.372 . . . . 0.0 110.504 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -93.37 5.66 50.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.048 0.539 . . . . 0.0 112.417 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -139.18 163.27 32.89 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.021 0.528 . . . . 0.0 110.465 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -82.42 167.53 18.38 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.581 0.352 . . . . 0.0 111.411 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 117.727 -1.13 . . . . 0.0 110.3 -179.944 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -140.24 156.31 46.54 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.236 0.614 . . . . 0.0 110.262 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -152.82 169.49 22.66 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.981 0.42 . . . . 0.0 110.693 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -131.19 8.43 4.71 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.23 0.612 . . . . 0.0 111.627 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.8 mt -127.28 156.15 42.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.953 0.501 . . . . 0.0 109.817 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 7' ' ' ASP . 23.4 m -139.89 172.76 12.3 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.929 0.892 . . . . 0.0 109.788 -175.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.471 ' N ' HG22 ' A' ' 6' ' ' THR . 3.2 p30 -55.29 -17.13 4.13 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.988 0.515 . . . . 0.0 112.165 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -66.96 -51.2 58.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.111 -0.368 . . . . 0.0 110.226 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.5 p -85.57 -26.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 122.772 0.429 . . . . 0.0 110.818 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.64 -29.16 67.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.252 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.66 -28.66 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 118.611 0.641 . . . . 0.0 110.154 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.94 -35.07 69.5 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.598 -0.689 . . . . 0.0 110.269 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -70.6 -37.37 73.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.451 0.3 . . . . 0.0 111.647 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -73.09 -23.69 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 118.139 0.427 . . . . 0.0 111.291 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -79.64 -16.42 55.81 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.362 0.265 . . . . 0.0 110.608 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -91.72 3.36 55.27 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.939 0.896 . . . . 0.0 111.88 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.25 3.11 48.03 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.782 -0.454 . . . . 0.0 113.28 173.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -97.99 83.64 3.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 117.923 0.862 . . . . 0.0 109.526 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 tm0? -67.01 -17.73 65.05 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.158 0.583 . . . . 0.0 110.62 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -60.67 -24.6 65.72 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.85 0.46 . . . . 0.0 110.927 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.0 -18.92 41.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 119.639 -0.22 . . . . 0.0 110.892 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -76.76 -37.22 56.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.26 -39.85 94.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.823 0.344 . . . . 0.0 110.282 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.4 -18.95 58.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.808 0.443 . . . . 0.0 111.335 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -83.48 -47.09 11.74 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.775 0.43 . . . . 0.0 111.008 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -69.5 -24.44 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.881 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.47 -26.27 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 119.231 0.923 . . . . 0.0 110.62 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -67.78 -33.93 75.8 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.444 ' HB3' HG23 ' A' ' 33' ' ' VAL . 78.1 m-85 -97.7 -8.93 27.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.41 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -63.58 -29.49 70.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.357 -0.839 . . . . 0.0 110.479 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -86.81 -32.04 20.53 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -83.87 -32.16 25.35 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 29' ' ' TYR . 61.3 t -73.32 -38.41 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -63.24 -25.78 68.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.919 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.3 t -72.9 -48.04 40.63 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.007 0.367 . . . . 0.0 110.942 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.417 HD21 ' CD1' ' A' ' 75' ' ' TYR . 3.7 pp -79.34 -27.17 42.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.553 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.584 HG13 HG23 ' A' ' 46' ' ' VAL . 2.1 p -84.93 -15.35 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 117.715 0.234 . . . . 0.0 111.463 -177.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.4 t -68.34 -11.86 60.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.977 -0.452 . . . . 0.0 109.973 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -84.8 -6.76 59.36 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.963 0.505 . . . . 0.0 111.686 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -122.31 -12.52 8.23 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 m -146.31 153.96 48.95 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 123.509 0.723 . . . . 0.0 109.118 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.19 162.76 36.99 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.469 2.779 . . . . 0.0 111.07 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.3 p -65.08 -10.14 27.95 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.18 -19.04 54.46 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.194 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -116.15 -5.03 11.9 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.591 0.696 . . . . 0.0 111.224 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.584 HG23 HG13 ' A' ' 37' ' ' VAL . 6.3 p -66.85 -32.3 4.83 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -176.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 85.0 Cg_endo -78.17 -22.81 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 CA-C-N 121.789 1.674 . . . . 0.0 111.162 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -81.56 -28.82 33.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.526 0.203 . . . . 0.0 110.499 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.97 -27.79 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.58 -37.06 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -70.18 -42.91 71.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.3 -27.25 65.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.23 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -35.45 70.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -74.98 -33.7 61.9 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 118.256 0.48 . . . . 0.0 111.788 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.3 mt -70.23 -38.73 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -74.38 -31.95 62.55 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.144 0.578 . . . . 0.0 110.462 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.32 -44.85 70.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.249 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -61.36 -37.14 82.29 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.913 0.779 . . . . 0.0 111.329 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -71.65 -25.88 62.32 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 122.663 0.385 . . . . 0.0 110.989 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.23 -11.18 28.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.145 0.578 . . . . 0.0 111.393 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.9 tp -75.36 -24.45 57.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.243 0.617 . . . . 0.0 110.277 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.99 -10.77 53.12 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 173.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.7 m -108.22 3.76 24.0 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.668 0.787 . . . . 0.0 111.856 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -78.03 147.43 34.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.11 0.564 . . . . 0.0 109.994 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -135.07 3.97 3.2 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.34 15.37 78.94 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.678 -0.512 . . . . 0.0 112.556 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.17 -9.53 58.23 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.956 0.878 . . . . 0.0 110.75 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.1 p -147.04 169.37 19.38 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.571 1.149 . . . . 0.0 109.1 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.68 144.69 52.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.16 -0.337 . . . . 0.0 110.276 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -67.21 -33.59 75.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -69.72 -34.89 74.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.037 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 88.5 m -76.03 -32.66 59.45 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 57.3 t90 -72.92 -28.0 62.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.56 0.344 . . . . 0.0 110.66 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.5 tp -85.87 -37.45 19.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.394 0.277 . . . . 0.0 111.167 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.417 ' CD1' HD21 ' A' ' 36' ' ' LEU . 19.4 m-85 -69.33 -20.6 63.87 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.942 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -77.94 -21.89 50.38 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.445 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.9 mm -71.63 -37.42 63.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.82 -39.64 66.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.56 -29.01 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 118.181 0.446 . . . . 0.0 111.07 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -76.46 -23.62 53.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.172 -0.33 . . . . 0.0 110.479 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.5 m -80.16 -29.12 38.73 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.27 -33.14 61.22 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.322 -0.236 . . . . 0.0 111.22 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -75.98 -28.58 57.92 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -76.41 -22.26 54.93 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 174.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -78.33 -36.23 46.61 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.073 -0.392 . . . . 0.0 110.783 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.5 mt -72.57 -24.68 61.14 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.398 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.7 -18.9 8.06 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 CA-C-N 118.906 0.775 . . . . 0.0 111.052 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.42 -27.19 62.18 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.124 0.42 . . . . 0.0 110.267 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -100.93 -24.67 14.3 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.962 0.505 . . . . 0.0 110.62 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.14 -24.01 74.6 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -90.27 4.21 51.33 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.94 0.496 . . . . 0.0 111.379 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp-105 -120.6 12.01 11.4 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.904 0.882 . . . . 0.0 109.92 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.4 tp -144.9 13.28 1.47 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.383 1.073 . . . . 0.0 110.037 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -68.18 -21.93 64.86 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.746 -0.596 . . . . 0.0 112.051 -174.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.9 tp -150.17 -30.68 0.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.225 -0.297 . . . . 0.0 111.28 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.3 p -152.4 137.43 10.93 Favored Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.56 129.19 18.43 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.763 2.309 . . . . 0.0 110.882 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 51.63 17.88 0.64 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.607 1.163 . . . . 0.0 113.958 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -119.62 -1.04 13.69 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 118.052 0.387 . . . . 0.0 112.329 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.5 t -84.79 158.19 20.77 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.599 0.699 . . . . 0.0 111.045 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -148.57 160.57 42.98 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.502 0.721 . . . . 0.0 110.267 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -137.38 15.06 2.98 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.116 0.566 . . . . 0.0 111.146 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -78.82 158.95 28.06 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.957 0.503 . . . . 0.0 110.805 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -134.52 12.95 3.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.459 0.704 . . . . 0.0 111.423 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -72.55 155.97 39.5 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.782 0.433 . . . . 0.0 110.733 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 79.0 t60 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 117.107 -1.425 . . . . 0.0 110.293 -179.256 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 ttp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.8 p -135.83 -1.35 2.48 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.904 0.481 . . . . 0.0 111.903 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 47.58 25.77 0.71 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.486 1.514 . . . . 0.0 114.261 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -144.84 170.64 15.73 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-O 121.229 0.538 . . . . 0.0 111.499 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.2 mt -96.27 154.12 17.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.828 0.851 . . . . 0.0 109.665 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 7' ' ' ASP . 26.3 m -138.84 172.81 12.31 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.588 0.755 . . . . 0.0 109.39 -174.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.458 ' H ' HG22 ' A' ' 6' ' ' THR . 3.3 p30 -55.27 -17.21 4.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.087 0.555 . . . . 0.0 112.261 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -65.21 -53.52 43.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.725 0.298 . . . . 0.0 110.203 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 p -85.5 -26.23 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 123.038 0.535 . . . . 0.0 111.006 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.02 -28.83 64.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 122.065 -0.397 . . . . 0.0 110.957 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.7 t -82.58 -28.19 8.63 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 CA-C-N 118.562 0.619 . . . . 0.0 110.153 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.435 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 42.9 mt-10 -71.37 -35.74 71.2 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.561 -0.712 . . . . 0.0 110.36 175.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -71.22 -38.78 71.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.654 0.382 . . . . 0.0 111.637 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.05 -24.22 22.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 O-C-N 121.92 -0.488 . . . . 0.0 110.81 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -78.39 -18.78 54.56 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -79.12 -5.84 55.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.336 0.654 . . . . 0.0 111.21 172.135 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.95 2.54 48.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 123.235 0.445 . . . . 0.0 112.61 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.88 83.99 7.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 117.915 0.858 . . . . 0.0 109.505 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -64.98 -19.87 66.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.911 0.484 . . . . 0.0 110.714 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -60.27 -25.05 65.41 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.865 0.466 . . . . 0.0 111.096 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.89 -18.93 38.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.285 -0.259 . . . . 0.0 111.078 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -77.17 -36.93 54.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.74 -42.14 96.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.4 mt -76.2 -18.32 59.12 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.9 tp -82.27 -41.6 19.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.906 0.321 . . . . 0.0 111.009 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.2 m -72.26 -24.7 22.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.739 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.26 -26.87 37.23 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-N 119.915 1.234 . . . . 0.0 110.884 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -69.91 -31.7 69.61 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.415 ' HB3' HG23 ' A' ' 33' ' ' VAL . 66.6 m-85 -99.49 -8.76 24.21 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.328 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -62.98 -29.7 71.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.186 -0.946 . . . . 0.0 110.853 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -86.87 -32.09 20.42 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.379 0.14 . . . . 0.0 111.379 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -81.06 -33.69 33.26 Favored 'General case' 0 CA--C 1.527 0.082 0 O-C-N 122.037 -0.414 . . . . 0.0 111.995 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 29' ' ' TYR . 53.8 t -74.88 -37.18 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.513 0.725 . . . . 0.0 109.415 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.47 -27.22 69.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.531 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -73.67 -49.41 26.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.945 0.339 . . . . 0.0 111.191 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.4 HD21 ' CD1' ' A' ' 75' ' ' TYR . 3.3 pp -75.23 -25.02 57.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.151 -0.343 . . . . 0.0 111.211 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.47 ' CG1' HG23 ' A' ' 46' ' ' VAL . 1.4 p -86.76 -16.86 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.2 m -66.41 -12.4 56.82 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.807 -0.558 . . . . 0.0 111.669 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -92.87 -3.68 54.2 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.673 0.67 . . . . 0.0 111.941 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -113.11 -19.52 11.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.714 0.406 . . . . 0.0 111.419 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 m -142.65 152.87 60.8 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 123.472 0.709 . . . . 0.0 109.485 173.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.15 168.82 20.95 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.614 2.876 . . . . 0.0 111.446 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.9 m -65.14 -11.65 42.49 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.106 0.562 . . . . 0.0 112.404 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.8 -19.31 51.99 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.832 -0.427 . . . . 0.0 112.986 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -116.22 -5.64 11.85 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.601 0.701 . . . . 0.0 112.122 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.47 HG23 ' CG1' ' A' ' 37' ' ' VAL . 4.0 p -64.7 -34.73 11.34 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 46' ' ' VAL . 87.5 Cg_endo -73.9 -25.52 14.2 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 CA-C-N 121.738 1.656 . . . . 0.0 111.33 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.03 -27.68 28.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 122.449 -0.157 . . . . 0.0 110.735 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.4 t -80.45 -29.98 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.0 t -69.25 -35.96 70.33 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.84 -44.03 70.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -67.44 -30.3 69.99 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.834 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.34 -34.84 76.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -75.96 -34.41 59.83 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.105 0.412 . . . . 0.0 111.764 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.5 mt -71.01 -36.35 63.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -77.1 -33.29 56.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.248 0.619 . . . . 0.0 110.333 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.54 82.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 119.323 -0.37 . . . . 0.0 110.16 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -63.34 -37.71 88.33 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.66 0.664 . . . . 0.0 111.262 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -70.57 -20.07 62.82 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 122.862 0.465 . . . . 0.0 111.358 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 -10.43 18.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.01 0.524 . . . . 0.0 111.106 177.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.07 -24.06 58.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.282 0.633 . . . . 0.0 110.159 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.06 -9.8 43.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.4 m -111.8 1.43 16.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.76 0.824 . . . . 0.0 111.454 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -74.26 147.54 42.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -146.45 13.67 1.23 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.07 16.4 80.6 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-O 119.654 -0.526 . . . . 0.0 113.119 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -67.17 -13.71 62.22 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.235 1.018 . . . . 0.0 110.555 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.3 p -151.92 169.49 22.17 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.615 1.166 . . . . 0.0 108.907 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.21 144.22 56.1 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -65.09 -33.53 76.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 119.577 -0.249 . . . . 0.0 111.664 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -69.96 -37.61 75.85 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.379 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.1 m -70.39 -37.84 74.58 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -68.77 -33.43 73.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.87 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.8 tp -79.09 -35.91 41.59 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.178 0.191 . . . . 0.0 111.198 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.4 ' CD1' HD21 ' A' ' 36' ' ' LEU . 21.8 m-30 -69.43 -20.28 63.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.215 -0.303 . . . . 0.0 111.593 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -74.0 -26.44 60.44 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.4 mm -73.76 -36.1 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.08 -36.91 64.32 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 p -81.35 -28.74 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 118.119 0.418 . . . . 0.0 110.93 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -76.7 -25.41 53.57 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 117.817 0.28 . . . . 0.0 110.359 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.3 m -79.21 -29.73 42.98 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.92 -33.5 63.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.259 -0.276 . . . . 0.0 111.369 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -76.39 -31.07 57.76 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -74.91 -24.42 58.52 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -76.66 -37.12 56.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.484 0.314 . . . . 0.0 111.046 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.5 mt -72.31 -23.74 61.22 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.884 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.3 m -89.43 -21.89 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-N 118.783 0.72 . . . . 0.0 111.336 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.14 -22.06 60.59 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.064 0.393 . . . . 0.0 111.331 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -111.23 -12.8 14.06 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.112 0.565 . . . . 0.0 110.277 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.18 -2.29 64.24 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 119.561 -0.577 . . . . 0.0 112.665 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -116.39 1.21 12.98 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 118.128 0.964 . . . . 0.0 112.458 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -70.14 129.44 39.41 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 52.6 23.02 2.42 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.733 0.813 . . . . 0.0 111.888 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -134.39 2.13 3.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.931 0.492 . . . . 0.0 111.086 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 45.7 tp -128.59 -16.09 4.36 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.07 0.548 . . . . 0.0 110.894 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 98' ' ' ARG . 12.2 p -153.0 136.11 9.72 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.21 1.44 7.27 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.935 3.09 . . . . 0.0 112.899 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.406 ' H ' HG22 ' A' ' 96' ' ' VAL . 75.4 mtp85 -122.52 21.0 10.29 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.901 0.88 . . . . 0.0 110.966 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.9 173.51 30.99 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 112.136 -0.385 . . . . 0.0 112.136 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 63.4 p -151.88 173.77 14.4 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.696 0.798 . . . . 0.0 109.979 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -95.6 -3.86 45.61 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.779 0.432 . . . . 0.0 111.664 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -150.57 152.09 33.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.317 0.647 . . . . 0.0 109.965 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 49.3 t60 53.39 26.6 5.52 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.43 0.692 . . . . 0.0 111.52 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -84.95 6.78 23.64 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.996 0.919 . . . . 0.0 112.038 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -138.33 153.66 48.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.434 0.694 . . . . 0.0 110.002 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 48.4 m80 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.53 -176.494 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 110.689 -0.115 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -148.26 162.16 40.05 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.369 0.668 . . . . 0.0 110.351 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -108.7 0.43 20.56 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.252 0.621 . . . . 0.0 111.42 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -95.83 176.87 5.97 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.509 0.724 . . . . 0.0 110.135 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.0 mt -116.57 151.61 35.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.002 0.43 . . . . 0.0 110.89 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 7' ' ' ASP . 27.3 m -139.85 173.78 11.18 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 124.286 1.034 . . . . 0.0 109.278 -174.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 6' ' ' THR . 3.1 p30 -55.29 -18.04 5.64 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.257 0.623 . . . . 0.0 112.437 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -65.85 -52.45 50.22 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.82 -0.55 . . . . 0.0 110.041 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.409 ' H ' HG12 ' A' ' 9' ' ' VAL . 2.7 p -85.22 -26.03 6.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 C-N-CA 122.704 0.402 . . . . 0.0 111.022 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.73 -27.99 64.38 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.887 -0.508 . . . . 0.0 110.803 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.0 t -81.84 -28.63 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.04 0 CA-C-N 118.833 0.742 . . . . 0.0 110.077 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.72 -36.66 70.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.707 -0.62 . . . . 0.0 110.461 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -71.15 -35.89 71.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -72.71 -25.05 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 118.098 0.408 . . . . 0.0 110.945 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -79.49 -14.81 58.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.172 0.189 . . . . 0.0 110.521 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -92.74 3.23 56.01 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.908 0.883 . . . . 0.0 112.143 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.81 -0.49 39.07 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.558 172.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -93.47 84.06 4.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.107 0.953 . . . . 0.0 109.633 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -66.33 -19.98 65.96 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.52 0.328 . . . . 0.0 110.467 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -62.26 -23.08 66.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.218 0.607 . . . . 0.0 111.137 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.83 -18.92 42.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 117.786 0.266 . . . . 0.0 110.533 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -77.46 -36.63 52.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -61.45 -41.18 96.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -76.92 -18.54 58.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.593 0.357 . . . . 0.0 111.507 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.8 tp -81.41 -42.71 20.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 122.328 -0.232 . . . . 0.0 110.593 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.4 m -71.77 -24.39 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.863 -176.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.6 -26.45 35.45 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 119.944 1.247 . . . . 0.0 111.012 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -69.9 -31.73 69.68 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.432 ' HB3' HG23 ' A' ' 33' ' ' VAL . 60.8 m-85 -99.03 -8.85 24.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.343 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -63.07 -30.06 71.3 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.254 -0.904 . . . . 0.0 110.786 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -86.92 -31.73 20.54 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -81.27 -35.43 31.14 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.138 -0.351 . . . . 0.0 111.808 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 29' ' ' TYR . 61.1 t -72.39 -38.57 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.493 0.717 . . . . 0.0 109.175 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.482 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.49 -24.48 67.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.195 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.2 t -73.97 -45.7 48.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.297 -0.252 . . . . 0.0 111.088 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 pp -81.61 -28.29 33.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.726 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.568 HG13 HG23 ' A' ' 46' ' ' VAL . 2.3 p -83.78 -15.88 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 117.954 0.343 . . . . 0.0 111.552 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -68.89 -11.61 60.75 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.922 -0.486 . . . . 0.0 109.802 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -86.01 -4.72 59.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.245 0.618 . . . . 0.0 111.409 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.84 -16.12 7.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.008 0.523 . . . . 0.0 112.295 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.76 154.51 62.65 Favored Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 123.671 0.789 . . . . 0.0 109.517 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.72 164.01 32.98 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.671 2.914 . . . . 0.0 111.013 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.0 p -66.05 -10.33 39.04 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.56 -19.13 55.46 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.629 -0.54 . . . . 0.0 111.987 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.45 -5.08 11.74 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.68 0.74 . . . . 0.0 111.53 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.568 HG23 HG13 ' A' ' 37' ' ' VAL . 5.5 p -67.08 -32.8 5.1 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 75.3 Cg_endo -78.18 -22.8 9.52 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.699 1.643 . . . . 0.0 111.384 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.48 -28.65 31.06 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.308 -0.245 . . . . 0.0 110.492 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.9 t -77.94 -28.68 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.02 -36.85 75.87 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -71.27 -43.4 67.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.47 -27.59 66.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.142 0.428 . . . . 0.0 110.266 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.4 69.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -72.22 -35.37 68.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.491 0.587 . . . . 0.0 111.493 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.0 -40.99 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -76.7 -28.85 56.03 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.552 0.341 . . . . 0.0 111.143 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.95 -40.66 75.3 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 119.25 -0.405 . . . . 0.0 110.006 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.58 -38.22 89.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.846 0.748 . . . . 0.0 111.295 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.03 -24.65 62.4 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.977 0.511 . . . . 0.0 111.027 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.82 -11.26 27.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.025 0.53 . . . . 0.0 111.393 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.6 tp -75.29 -24.29 57.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.217 0.607 . . . . 0.0 110.138 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.15 -11.1 56.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.79 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.0 m -110.36 4.56 20.81 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.559 0.744 . . . . 0.0 111.615 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -73.99 145.07 44.89 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.85 3.25 3.2 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.84 13.99 81.92 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.457 -0.635 . . . . 0.0 113.46 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -72.28 -5.55 36.87 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.32 1.06 . . . . 0.0 111.13 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.4 p -149.82 168.68 23.04 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.322 1.049 . . . . 0.0 109.022 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.83 146.5 51.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.125 -0.359 . . . . 0.0 110.154 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -66.37 -33.37 75.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -70.41 -36.86 74.28 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.421 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.0 m -71.84 -33.23 68.28 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -75.46 -27.25 58.82 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.381 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 tp -86.02 -35.94 20.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.377 0.271 . . . . 0.0 111.293 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -70.21 -20.64 63.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.083 -0.386 . . . . 0.0 111.745 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -76.63 -24.19 53.37 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.494 0.588 . . . . 0.0 110.56 172.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.8 mm -70.69 -41.2 77.63 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.7 74.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.67 -29.91 16.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 118.193 0.452 . . . . 0.0 110.791 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.65 -19.14 53.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.844 -0.535 . . . . 0.0 110.409 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -83.1 -26.73 30.75 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.069 0.395 . . . . 0.0 110.034 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.12 -36.13 64.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.94 -0.475 . . . . 0.0 110.333 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -74.03 -28.59 61.5 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -74.89 -29.85 61.12 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.961 0.904 . . . . 0.0 111.065 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -77.47 -35.07 54.11 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.424 0.29 . . . . 0.0 111.102 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -79.42 -24.26 42.63 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.3 m -88.8 -22.09 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 118.952 0.796 . . . . 0.0 111.014 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.93 -13.38 60.88 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.17 -0.331 . . . . 0.0 110.625 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -117.55 -19.49 9.41 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.123 0.569 . . . . 0.0 110.773 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.24 -22.83 56.28 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -81.27 1.89 30.42 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 117.686 0.743 . . . . 0.0 111.264 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -99.08 -2.21 37.64 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.371 0.668 . . . . 0.0 111.621 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.73 13.17 2.3 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.867 0.467 . . . . 0.0 111.864 -177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -123.03 14.14 9.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.577 0.751 . . . . 0.0 110.312 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.2 tp 57.23 21.38 6.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.46 1.104 . . . . 0.0 112.833 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.14 135.79 57.89 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.73 161.43 45.44 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.145 2.563 . . . . 0.0 111.612 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 53.68 22.54 3.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.486 1.114 . . . . 0.0 112.831 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.6 -13.17 83.21 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -153.87 171.56 18.77 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.862 0.865 . . . . 0.0 109.877 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -142.3 157.45 44.8 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.569 0.347 . . . . 0.0 110.101 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -136.85 20.27 3.05 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.112 0.565 . . . . 0.0 111.33 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 54.8 t60 56.33 23.1 6.91 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.675 0.79 . . . . 0.0 111.984 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -77.32 166.64 22.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.197 0.599 . . . . 0.0 111.114 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -147.76 166.88 26.16 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.309 0.644 . . . . 0.0 110.506 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.1 m80 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.592 -1.194 . . . . 0.0 110.371 -179.348 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.1 p -84.5 4.81 30.11 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.235 0.614 . . . . 0.0 112.432 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -146.52 161.02 41.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.16 0.584 . . . . 0.0 109.623 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 58.65 178.36 0.07 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.997 1.319 . . . . 0.0 112.366 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.0 mt -127.72 154.51 45.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.026 0.531 . . . . 0.0 110.648 -175.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 7' ' ' ASP . 25.6 m -139.37 173.92 11.05 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.937 0.895 . . . . 0.0 108.896 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.483 ' H ' HG22 ' A' ' 6' ' ' THR . 3.8 p30 -56.08 -17.73 7.82 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.663 0.385 . . . . 0.0 111.942 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -62.82 -53.44 54.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.6 p -86.0 -26.38 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.146 0.578 . . . . 0.0 110.896 -176.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.0 -28.7 64.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 119.086 -0.483 . . . . 0.0 110.964 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.1 t -82.64 -30.74 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 CA-C-N 118.862 0.756 . . . . 0.0 109.97 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.1 -41.62 81.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.812 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -69.66 -35.44 75.17 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.2 m -71.31 -22.19 22.22 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-N 118.554 0.616 . . . . 0.0 110.441 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -80.46 -14.79 57.98 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.858 0.299 . . . . 0.0 110.385 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -80.45 -8.04 59.39 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 122.006 -0.434 . . . . 0.0 110.908 172.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.86 2.47 45.97 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.464 0.554 . . . . 0.0 112.826 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.48 84.17 7.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.042 0.921 . . . . 0.0 109.505 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.97 -21.41 66.48 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.825 0.45 . . . . 0.0 110.417 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -61.72 -24.62 66.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.918 0.487 . . . . 0.0 111.239 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.19 -18.79 41.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.363 -0.211 . . . . 0.0 110.682 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -77.79 -35.57 51.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -62.56 -41.03 98.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.29 -19.0 59.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.201 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -83.68 -46.82 11.88 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.137 -0.352 . . . . 0.0 111.528 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.3 m -67.63 -25.49 33.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 118.654 -0.689 . . . . 0.0 111.34 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.7 -26.41 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 119.337 0.971 . . . . 0.0 110.893 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -68.62 -32.31 72.09 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -100.83 -8.66 22.42 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -63.07 -28.01 69.79 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 118.421 0.555 . . . . 0.0 110.758 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -85.83 -30.14 23.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -76.38 -43.25 41.49 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 m -81.35 -26.01 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.18 0.445 . . . . 0.0 111.24 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.53 -22.5 62.61 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 t -76.8 -43.14 37.88 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.594 0.235 . . . . 0.0 110.754 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.46 -25.1 39.06 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 46' ' ' VAL . 3.8 p -87.58 -18.54 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-N 118.007 0.367 . . . . 0.0 111.169 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -63.23 -13.55 39.1 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 171.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -89.32 -3.94 58.3 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.799 0.84 . . . . 0.0 111.78 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -122.51 -17.73 6.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.779 0.432 . . . . 0.0 111.815 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.27 153.68 66.62 Favored Pre-proline 0 N--CA 1.462 0.146 0 C-N-CA 123.353 0.661 . . . . 0.0 110.055 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.21 164.01 35.62 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.584 2.856 . . . . 0.0 110.755 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -66.29 -10.29 41.04 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.14 -18.61 57.33 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -116.52 -6.69 11.68 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.216 0.607 . . . . 0.0 111.258 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 37' ' ' VAL . 4.5 p -66.78 -33.11 5.72 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 117.811 -1.09 . . . . 0.0 113.772 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 86.8 Cg_endo -77.11 -25.01 9.12 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 122.004 1.752 . . . . 0.0 111.518 -175.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -81.97 -29.55 32.1 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.235 -0.29 . . . . 0.0 110.341 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.4 t -77.85 -27.52 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.3 -33.91 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -72.97 -42.52 63.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -66.13 -29.05 69.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.785 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.67 -29.53 64.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.755 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -85.04 -28.97 25.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.278 0.49 . . . . 0.0 111.362 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.4 mt -72.13 -38.42 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -75.01 -32.51 61.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.215 0.606 . . . . 0.0 110.652 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.94 -46.86 67.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.208 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -59.69 -37.19 78.14 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.613 0.642 . . . . 0.0 111.508 -175.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -72.66 -25.7 61.37 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.907 0.483 . . . . 0.0 111.253 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.18 -13.52 28.3 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.077 0.551 . . . . 0.0 111.548 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.8 tp -76.71 -25.81 53.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.293 0.637 . . . . 0.0 110.819 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.4 -12.74 61.91 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -112.48 -0.4 15.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.664 0.786 . . . . 0.0 111.909 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -72.55 130.87 41.62 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HA ' ' HE ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -126.37 -0.21 6.97 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -173.594 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.92 -40.25 36.34 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 49.23 17.72 0.21 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.649 1.58 . . . . 0.0 114.51 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.1 m -141.81 0.59 1.43 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.344 0.52 . . . . 0.0 111.977 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.25 54.69 1.45 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.935 0.398 . . . . 0.0 110.552 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -67.51 -32.78 73.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -70.52 -43.62 69.27 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 118.505 0.593 . . . . 0.0 111.651 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -68.69 -33.2 73.55 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -72.82 -28.46 62.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.925 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.0 tp -85.89 -37.85 18.68 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.846 0.458 . . . . 0.0 111.034 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -60.09 -32.0 70.55 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.616 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -77.07 -21.3 54.62 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.107 -0.473 . . . . 0.0 111.951 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.72 -38.3 75.85 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.942 0.792 . . . . 0.0 109.492 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.62 -38.96 58.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.5 p -76.4 -31.84 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.064 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -75.88 -20.88 57.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.035 -0.416 . . . . 0.0 110.552 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 m -78.68 -30.46 46.16 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.99 -29.78 63.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 122.263 -0.273 . . . . 0.0 110.319 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -79.51 -28.94 41.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.332 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.435 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -85.37 -16.6 39.33 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.771 0.714 . . . . 0.0 110.644 175.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -77.62 -37.7 49.6 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 122.428 -0.17 . . . . 0.0 110.973 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.13 -25.96 33.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 84' ' ' ASN . 6.6 p -81.12 -26.16 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.073 0 CA-C-N 118.899 0.772 . . . . 0.0 110.266 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.61 -16.98 61.22 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 121.372 -0.131 . . . . 0.0 110.879 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -111.05 -17.55 13.24 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.759 0.424 . . . . 0.0 110.947 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.68 -14.93 76.94 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -109.03 3.24 21.89 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.259 0.623 . . . . 0.0 111.265 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -79.67 -21.79 44.28 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.026 0.53 . . . . 0.0 111.187 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.1 tp -89.23 -15.16 34.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.913 0.485 . . . . 0.0 110.558 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -82.69 2.15 35.03 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.121 0.568 . . . . 0.0 111.24 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.37 -7.06 59.42 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.933 0.493 . . . . 0.0 111.466 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.9 m -139.23 152.26 69.19 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 123.594 0.758 . . . . 0.0 110.391 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.27 -7.14 16.0 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.792 2.995 . . . . 0.0 111.526 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -85.04 165.84 17.19 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.278 0.631 . . . . 0.0 111.161 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.32 1.03 87.95 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.414 -0.659 . . . . 0.0 112.893 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 63.0 m -142.87 149.16 38.15 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.969 0.885 . . . . 0.0 110.679 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -156.93 160.03 38.69 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.556 0.742 . . . . 0.0 109.622 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -150.47 167.4 27.27 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.962 0.411 . . . . 0.0 110.896 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -142.44 28.8 1.63 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.282 0.633 . . . . 0.0 110.07 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.6 m80 58.31 178.15 0.06 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.53 1.132 . . . . 0.0 112.809 -175.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -134.71 17.07 3.58 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.334 0.654 . . . . 0.0 111.4 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 117.778 -1.106 . . . . 0.0 111.051 -178.851 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -142.1 163.16 33.63 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.326 0.65 . . . . 0.0 110.556 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.95 7.03 4.32 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.107 0.563 . . . . 0.0 111.774 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -144.59 158.89 43.57 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.452 0.701 . . . . 0.0 110.314 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.7 mt -70.02 157.79 36.85 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.962 0.905 . . . . 0.0 111.506 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 8' ' ' GLN . 5.8 t -140.55 178.42 7.33 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.372 1.069 . . . . 0.0 109.966 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -59.86 -17.01 33.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.058 0.543 . . . . 0.0 110.763 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.485 ' H ' HG23 ' A' ' 6' ' ' THR . 19.2 tp60 -69.94 -52.27 25.84 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.539 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.2 -26.65 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 122.673 0.389 . . . . 0.0 110.934 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 mp -70.04 -30.08 67.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.841 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.9 t -80.59 -28.01 11.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-N 118.623 0.647 . . . . 0.0 110.0 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.32 -36.44 68.88 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.627 -0.671 . . . . 0.0 110.188 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -69.95 -37.13 75.75 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.506 0.322 . . . . 0.0 111.497 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.5 m -73.46 -23.62 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.06 0 CA-C-N 118.117 0.417 . . . . 0.0 111.224 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -79.95 -15.76 56.61 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.534 0.334 . . . . 0.0 110.72 174.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -92.23 4.34 53.47 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.728 0.811 . . . . 0.0 111.99 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.28 2.38 51.03 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 119.8 -0.445 . . . . 0.0 113.128 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -97.26 83.88 3.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.001 0.901 . . . . 0.0 109.771 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -66.95 -18.35 65.34 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -60.79 -23.96 65.43 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.73 0.412 . . . . 0.0 110.824 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.77 -18.61 43.55 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.378 -0.201 . . . . 0.0 110.849 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -77.48 -36.98 52.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -61.85 -40.11 94.21 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.46 -19.07 58.42 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.442 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.6 tp -83.62 -46.46 12.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.691 0.396 . . . . 0.0 111.008 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.87 -24.55 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.546 -175.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.48 -27.13 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.157 0.89 . . . . 0.0 110.674 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -67.39 -32.77 73.91 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.44 ' HB3' HG23 ' A' ' 33' ' ' VAL . 67.0 m-85 -98.67 -9.08 25.17 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -62.86 -28.82 70.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.474 -0.766 . . . . 0.0 110.48 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -86.91 -32.51 20.13 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -82.0 -33.03 30.3 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 122.054 -0.404 . . . . 0.0 111.998 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 29' ' ' TYR . 56.8 t -74.23 -38.33 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.85 -23.95 67.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.934 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.7 t -74.64 -46.07 40.65 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.944 0.338 . . . . 0.0 111.019 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.88 -29.47 39.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.181 -0.325 . . . . 0.0 111.473 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.565 HG13 HG23 ' A' ' 46' ' ' VAL . 2.4 p -83.4 -15.71 11.41 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.056 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.4 t -67.7 -11.72 58.94 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.858 -0.526 . . . . 0.0 109.887 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -84.7 -6.54 59.36 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.042 0.537 . . . . 0.0 111.644 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -122.5 -13.44 8.0 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.27 154.8 57.79 Favored Pre-proline 0 C--O 1.231 0.123 0 C-N-CA 123.923 0.889 . . . . 0.0 109.567 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.27 162.94 38.26 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.455 2.77 . . . . 0.0 110.758 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.4 p -65.88 -10.61 40.0 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.13 -18.89 54.9 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.81 -0.439 . . . . 0.0 112.05 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -116.35 -4.78 11.81 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.384 0.592 . . . . 0.0 111.677 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.565 HG23 HG13 ' A' ' 37' ' ' VAL . 5.7 p -66.51 -32.12 4.95 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 117.79 -1.1 . . . . 0.0 113.719 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 74.5 Cg_endo -78.18 -23.28 9.11 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 CA-C-N 121.904 1.716 . . . . 0.0 111.266 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -81.74 -27.74 33.69 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.96 -27.42 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.5 -34.59 62.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.67 -42.92 66.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -67.5 -28.58 67.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.383 0.538 . . . . 0.0 109.99 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.42 -36.42 74.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.2 -33.18 61.37 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.371 0.532 . . . . 0.0 111.967 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.57 -38.89 75.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -75.22 -31.72 60.94 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.081 0.552 . . . . 0.0 110.555 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.73 -43.93 71.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.236 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -61.28 -37.91 84.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.863 0.756 . . . . 0.0 111.36 -176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -71.68 -25.39 62.09 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.552 0.341 . . . . 0.0 111.062 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.93 -10.76 27.91 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.28 0.632 . . . . 0.0 111.441 176.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.4 tp -74.93 -23.84 58.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.104 0.562 . . . . 0.0 110.119 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.35 -11.48 51.36 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.509 0.324 . . . . 0.0 110.544 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -110.39 2.68 19.16 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.722 0.809 . . . . 0.0 111.851 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.22 144.81 46.62 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -135.65 6.16 3.2 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.27 15.04 76.84 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.759 -0.467 . . . . 0.0 112.82 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.84 -10.46 59.63 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.764 0.782 . . . . 0.0 110.921 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.7 t -149.36 165.73 31.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.252 1.021 . . . . 0.0 108.854 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.32 145.38 56.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -67.5 -32.57 73.47 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -175.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -70.39 -36.57 74.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.62 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -72.02 -36.28 69.65 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 64.5 t90 -70.28 -32.88 70.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.678 -0.201 . . . . 0.0 110.747 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.0 tp -80.23 -37.15 33.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.597 0.359 . . . . 0.0 111.292 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -68.67 -20.27 64.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.133 -0.354 . . . . 0.0 111.63 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -74.69 -26.75 60.04 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.186 0.448 . . . . 0.0 110.323 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.76 -36.88 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.98 -40.08 63.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.63 -32.04 15.9 Favored 'Isoleucine or valine' 0 C--N 1.337 0.043 0 O-C-N 121.993 -0.442 . . . . 0.0 111.268 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -74.61 -24.33 58.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.014 -0.429 . . . . 0.0 110.3 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.1 m -78.08 -30.45 49.63 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 117.741 0.246 . . . . 0.0 110.44 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.29 -29.46 62.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.316 -0.24 . . . . 0.0 110.496 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.05 -31.05 55.9 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.75 -15.92 43.39 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.837 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -76.77 -39.59 51.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.632 0.196 . . . . 0.0 111.253 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -81.93 -25.21 35.09 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-O 119.122 -0.466 . . . . 0.0 112.19 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.9 p -80.98 -25.62 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.048 0 CA-C-N 119.067 0.849 . . . . 0.0 110.44 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.56 -12.32 59.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.463 -0.148 . . . . 0.0 111.072 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -118.29 -4.16 10.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.128 0.571 . . . . 0.0 110.581 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -108.2 -7.05 31.21 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.565 -0.575 . . . . 0.0 112.409 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -129.44 3.99 5.12 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 117.768 0.784 . . . . 0.0 111.925 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -140.09 6.45 2.17 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.893 0.477 . . . . 0.0 112.065 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.8 tp -146.66 0.89 0.78 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.195 0.452 . . . . 0.0 111.875 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 2.9 pm0 -70.3 156.47 39.24 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.562 -0.711 . . . . 0.0 110.904 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.87 -17.06 28.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.807 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.1 t -144.58 132.91 10.83 Favored Pre-proline 0 CA--C 1.528 0.116 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.08 158.96 51.22 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.399 2.733 . . . . 0.0 110.66 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.3 ptt-85 -149.88 152.13 34.58 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 122.489 0.316 . . . . 0.0 111.397 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.67 166.51 19.59 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 91.0 p -152.63 166.64 31.46 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 122.648 0.379 . . . . 0.0 110.896 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -130.79 11.36 5.18 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.44 0.696 . . . . 0.0 111.633 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -120.16 8.97 11.0 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.304 0.641 . . . . 0.0 111.191 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -134.61 4.29 3.35 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.32 0.648 . . . . 0.0 110.958 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -139.53 163.24 33.08 Favored 'General case' 0 CA--C 1.526 0.052 0 C-N-CA 123.596 0.758 . . . . 0.0 110.101 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 46.3 m80 54.61 21.45 3.42 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.794 0.838 . . . . 0.0 112.912 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.197 -1.382 . . . . 0.0 110.328 -179.36 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttp . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 119.918 -0.086 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -142.62 156.71 45.11 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.899 0.48 . . . . 0.0 110.148 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -134.69 -1.46 2.77 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.203 0.601 . . . . 0.0 111.612 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 55.64 4.53 0.11 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.639 1.575 . . . . 0.0 115.069 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.2 mt -141.42 155.33 45.89 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.838 0.855 . . . . 0.0 109.154 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 7' ' ' ASP . 26.8 m -140.35 173.12 11.82 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.788 0.835 . . . . 0.0 109.456 -177.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 6' ' ' THR . 3.1 p30 -55.26 -18.19 5.81 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.005 0.522 . . . . 0.0 111.937 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -65.17 -51.37 61.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.238 -0.289 . . . . 0.0 110.453 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 p -84.06 -25.8 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 122.594 0.357 . . . . 0.0 110.631 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.89 -30.14 67.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.095 -0.378 . . . . 0.0 110.634 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.9 t -81.74 -28.48 9.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 CA-C-N 118.634 0.652 . . . . 0.0 110.029 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.05 -40.8 71.45 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.066 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -69.06 -34.35 75.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -70.49 -23.01 24.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 118.702 0.683 . . . . 0.0 110.398 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -81.15 -14.98 57.11 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 119.503 -0.284 . . . . 0.0 110.92 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.62 -7.0 59.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.287 0.494 . . . . 0.0 110.752 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.48 3.12 47.28 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.479 0.562 . . . . 0.0 112.779 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.81 83.98 5.33 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 117.954 0.877 . . . . 0.0 108.991 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -64.48 -17.73 64.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.091 0.557 . . . . 0.0 110.643 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -60.82 -25.62 66.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.991 0.516 . . . . 0.0 110.794 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.34 -18.99 43.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.781 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -76.54 -36.97 57.36 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -61.82 -39.8 93.04 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.8 mt -76.79 -18.98 58.09 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.352 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.6 tp -83.3 -47.36 11.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.554 0.342 . . . . 0.0 111.308 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.8 m -68.13 -25.69 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.222 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.56 -26.92 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.326 0.966 . . . . 0.0 110.915 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -67.82 -33.05 74.03 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -100.85 -8.73 22.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.308 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -62.16 -28.78 69.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.357 0.526 . . . . 0.0 110.42 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -86.1 -28.94 23.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 121.977 0.111 . . . . 0.0 110.763 174.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -78.4 -40.64 35.41 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 m -83.85 -23.53 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 O-C-N 121.966 -0.459 . . . . 0.0 110.835 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.63 -22.09 61.0 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.5 t -79.37 -40.23 30.67 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -81.38 -24.56 36.93 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 119.242 -0.409 . . . . 0.0 112.081 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.16 -21.08 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.674 0.67 . . . . 0.0 112.212 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -69.27 -10.53 58.24 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.845 -0.534 . . . . 0.0 111.611 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -92.28 -4.01 54.61 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 121.805 -0.56 . . . . 0.0 111.642 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -110.16 -23.57 11.19 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.644 0.378 . . . . 0.0 111.304 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.441 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 26.9 m -138.13 155.73 74.21 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 123.433 0.693 . . . . 0.0 109.461 175.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 94.2 Cg_endo -71.42 170.59 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.515 2.81 . . . . 0.0 111.339 -176.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.0 m -63.41 -11.91 26.76 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.118 0.567 . . . . 0.0 112.132 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.68 -16.28 58.61 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.593 -0.559 . . . . 0.0 112.598 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -116.3 -10.86 11.33 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 117.938 0.869 . . . . 0.0 111.801 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.416 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 8.0 p -62.89 -34.34 13.75 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 117.78 -1.105 . . . . 0.0 112.929 -177.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 46' ' ' VAL . 94.7 Cg_endo -77.5 -25.42 8.16 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 CA-C-N 121.927 1.724 . . . . 0.0 112.135 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.38 -33.11 23.87 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.191 0.45 . . . . 0.0 111.098 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.5 t -78.17 -25.39 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.16 -34.68 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -71.44 -42.05 68.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -66.36 -29.64 69.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.29 0.496 . . . . 0.0 110.0 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.01 -28.38 64.38 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 119.478 -0.296 . . . . 0.0 110.837 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -85.2 -29.33 24.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.523 0.601 . . . . 0.0 111.232 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -72.42 -37.86 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -76.54 -32.29 58.13 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.224 0.61 . . . . 0.0 110.804 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.92 77.65 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.463 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -62.06 -38.35 88.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.755 0.707 . . . . 0.0 111.329 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -71.36 -24.94 62.18 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.599 0.36 . . . . 0.0 111.336 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.7 -11.74 28.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.972 0.509 . . . . 0.0 111.454 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.0 tp -75.68 -24.24 56.29 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.951 0.5 . . . . 0.0 110.538 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.95 -10.37 57.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.468 0.307 . . . . 0.0 110.741 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.4 m -109.63 3.03 20.64 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.682 0.793 . . . . 0.0 111.442 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -71.61 151.85 43.4 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.144 0.578 . . . . 0.0 109.817 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -133.3 -6.71 2.97 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.3 13.63 81.32 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.584 -0.565 . . . . 0.0 111.978 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -71.74 -5.89 37.29 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.117 0.958 . . . . 0.0 111.215 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.9 t -149.88 165.83 31.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.514 1.126 . . . . 0.0 108.466 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.29 146.53 54.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.128 -0.357 . . . . 0.0 110.457 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -68.35 -33.26 73.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.275 -0.266 . . . . 0.0 111.691 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -69.72 -37.41 76.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.838 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.6 m -70.58 -33.78 71.47 Favored 'General case' 0 CA--C 1.527 0.068 0 O-C-N 121.895 -0.503 . . . . 0.0 109.757 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -73.96 -28.64 61.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.968 0.507 . . . . 0.0 110.881 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.7 tp -86.01 -36.0 20.03 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.804 0.442 . . . . 0.0 111.297 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -61.87 -32.57 72.94 Favored 'General case' 0 C--O 1.23 0.077 0 O-C-N 122.201 -0.312 . . . . 0.0 110.599 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -76.54 -21.24 55.95 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.075 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.3 mm -68.01 -38.83 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 118.979 0.809 . . . . 0.0 109.216 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.01 -38.38 53.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.26 -28.01 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 CA-C-N 118.919 0.781 . . . . 0.0 111.171 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -75.42 -24.76 57.15 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.105 0.411 . . . . 0.0 110.101 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.2 m -79.05 -29.97 43.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 176.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.83 -33.77 66.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.049 0.386 . . . . 0.0 111.025 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -77.96 -29.0 49.6 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -76.12 -28.3 57.41 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -74.02 -35.9 64.42 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 122.588 0.355 . . . . 0.0 110.984 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.1 mt -78.13 -18.9 55.04 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.8 m -91.75 -18.79 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.037 0 CA-C-N 119.053 0.842 . . . . 0.0 110.988 175.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.39 -23.02 46.97 Favored 'General case' 0 CA--C 1.527 0.065 0 O-C-N 122.043 -0.411 . . . . 0.0 111.252 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -109.79 -17.88 13.56 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.98 0.512 . . . . 0.0 110.394 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -80.7 -22.21 62.35 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -93.76 14.11 20.28 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.483 0.713 . . . . 0.0 110.767 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -117.8 8.17 12.63 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.811 0.844 . . . . 0.0 111.261 -176.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 pp -144.96 15.01 1.53 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.665 0.786 . . . . 0.0 111.824 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -65.87 -28.07 68.69 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.714 0.406 . . . . 0.0 111.836 -174.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.9 mt -139.73 -35.88 0.52 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 122.803 0.441 . . . . 0.0 110.315 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.3 m -143.96 151.52 52.81 Favored Pre-proline 0 N--CA 1.456 -0.14 0 C-N-CA 124.099 0.96 . . . . 0.0 108.501 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.89 13.59 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.318 3.345 . . . . 0.0 113.283 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -130.1 -2.69 4.54 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.478 0.711 . . . . 0.0 112.207 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.86 -158.46 29.14 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 m 52.19 35.09 15.83 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.679 0.792 . . . . 0.0 113.01 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -143.65 165.34 27.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.735 0.414 . . . . 0.0 110.24 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -136.42 157.36 46.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.055 0.542 . . . . 0.0 110.589 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -73.07 -5.78 41.27 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.062 0.545 . . . . 0.0 111.844 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -133.26 16.73 4.09 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.647 0.779 . . . . 0.0 110.388 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 58.3 177.7 0.06 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.675 1.19 . . . . 0.0 112.576 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.568 -1.206 . . . . 0.0 110.364 -179.839 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.3 mtp . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 110.61 -0.144 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.1 m 52.91 27.92 6.01 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.703 0.801 . . . . 0.0 112.746 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -147.11 156.45 43.01 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.132 0.573 . . . . 0.0 109.821 -177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -123.59 -179.42 4.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.507 0.723 . . . . 0.0 110.299 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.72 149.44 43.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.203 0.525 . . . . 0.0 110.94 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 7' ' ' ASP . 47.0 m -140.0 174.48 10.48 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.125 0.97 . . . . 0.0 109.08 -176.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.499 ' N ' HG22 ' A' ' 6' ' ' THR . 3.1 p30 -55.69 -16.93 4.81 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.18 0.592 . . . . 0.0 112.479 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -67.25 -51.43 53.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 117.917 0.326 . . . . 0.0 110.127 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.5 p -85.66 -25.67 6.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 122.449 0.3 . . . . 0.0 110.981 -176.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -68.56 -30.13 68.84 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.276 -0.265 . . . . 0.0 110.439 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.8 t -81.58 -28.43 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 118.316 0.507 . . . . 0.0 110.215 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.63 -35.11 70.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.574 -0.704 . . . . 0.0 111.357 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -83.6 -25.41 30.88 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.454 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.07 -23.06 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 119.16 0.891 . . . . 0.0 109.358 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -78.86 -25.54 43.96 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.282 0.233 . . . . 0.0 110.68 174.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -89.33 -7.26 55.68 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.84 -3.52 8.0 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 118.835 -0.98 . . . . 0.0 114.889 170.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -86.61 83.72 7.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.331 1.566 . . . . 0.0 109.961 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -66.38 -21.79 66.24 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.39 -24.58 66.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.536 0.734 . . . . 0.0 110.897 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.69 -19.2 35.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 119.579 -0.248 . . . . 0.0 110.742 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -76.97 -35.89 56.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -63.22 -40.81 98.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.41 -18.81 59.83 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.154 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.9 tp -83.41 -47.09 11.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.521 0.328 . . . . 0.0 111.044 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.4 m -69.32 -24.53 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.717 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.5 p -69.24 -27.32 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 119.146 0.884 . . . . 0.0 110.771 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -67.11 -33.1 74.74 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.448 ' HB3' HG23 ' A' ' 33' ' ' VAL . 73.2 m-85 -98.4 -8.92 26.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.102 0.561 . . . . 0.0 112.326 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -63.32 -30.44 71.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.503 -0.748 . . . . 0.0 110.633 -174.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -87.03 -32.05 20.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -81.43 -34.74 31.32 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 29' ' ' TYR . 60.4 t -71.28 -38.86 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -63.56 -24.21 67.71 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.095 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.2 t -73.85 -48.16 33.13 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.851 0.296 . . . . 0.0 110.734 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 pp -79.98 -27.82 39.6 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.479 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.577 HG13 HG23 ' A' ' 46' ' ' VAL . 2.2 p -83.5 -15.74 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.334 -178.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 t -68.92 -9.65 53.01 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.825 -0.547 . . . . 0.0 110.28 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -88.8 -3.91 58.64 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.408 0.683 . . . . 0.0 111.427 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.31 -16.2 7.45 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.2 m -143.17 153.78 60.34 Favored Pre-proline 0 C--N 1.338 0.069 0 C-N-CA 124.168 0.987 . . . . 0.0 109.613 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.28 164.25 33.15 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.483 2.788 . . . . 0.0 111.062 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.2 p -65.92 -10.25 37.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.43 -18.03 55.96 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -116.44 -5.64 11.74 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.527 0.664 . . . . 0.0 111.481 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.577 HG23 HG13 ' A' ' 37' ' ' VAL . 5.8 p -67.28 -32.03 4.27 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 117.755 -1.117 . . . . 0.0 114.001 -176.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 81.2 Cg_endo -78.12 -23.53 8.98 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 CA-C-N 121.758 1.664 . . . . 0.0 111.308 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.84 -29.24 32.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.5 t -77.09 -28.54 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.4 t -69.72 -35.71 66.79 Favored 'Isoleucine or valine' 0 C--N 1.337 0.063 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -70.95 -42.83 69.27 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -67.31 -28.77 68.28 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.731 -0.606 . . . . 0.0 109.873 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.23 -36.13 74.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -75.39 -32.65 60.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.353 0.524 . . . . 0.0 112.204 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -71.33 -38.16 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -76.22 -31.37 58.35 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.015 0.526 . . . . 0.0 110.458 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.27 -44.0 72.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.187 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -61.19 -38.1 85.32 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.812 0.733 . . . . 0.0 111.366 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -71.45 -25.32 62.25 Favored 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 122.596 0.358 . . . . 0.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.08 -10.74 27.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.184 0.594 . . . . 0.0 111.266 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.42 -23.97 57.04 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.999 0.52 . . . . 0.0 110.3 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.02 -11.47 48.35 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.335 0.254 . . . . 0.0 110.508 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.4 m -110.8 -2.24 16.25 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.622 0.769 . . . . 0.0 112.034 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -72.24 134.79 45.8 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.407 ' HA ' ' HE ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -124.78 4.25 8.14 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -173.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.31 17.62 77.64 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.322 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -70.93 -8.16 51.09 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.066 0.933 . . . . 0.0 111.196 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.5 t -151.81 168.6 24.58 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.953 0.901 . . . . 0.0 108.751 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.24 146.84 53.76 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.051 -0.406 . . . . 0.0 110.072 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -67.78 -33.14 74.25 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -175.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -69.51 -36.97 76.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.863 -0.523 . . . . 0.0 110.708 -176.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.2 m -72.7 -36.43 67.85 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -69.39 -33.27 72.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -78.94 -36.62 41.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.557 0.343 . . . . 0.0 111.578 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -69.17 -20.09 64.0 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.078 -0.388 . . . . 0.0 111.574 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -74.6 -25.9 59.56 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 117.965 0.348 . . . . 0.0 110.283 173.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.4 mm -73.23 -35.74 47.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.11 -39.52 60.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.3 p -79.05 -30.63 14.39 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 O-C-N 122.26 -0.275 . . . . 0.0 110.979 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -76.3 -23.04 54.32 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.053 0.388 . . . . 0.0 110.623 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.5 m -80.21 -28.49 38.59 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.7 -33.26 66.36 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.209 0.459 . . . . 0.0 110.284 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.39 -25.82 54.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.487 ' HA ' HG12 ' A' ' 87' ' ' VAL . 14.9 t30 -86.09 -19.21 30.57 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.464 0.306 . . . . 0.0 110.711 177.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -77.04 -36.98 55.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 121.977 -0.452 . . . . 0.0 110.334 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.6 mt -82.52 -22.78 34.9 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 84' ' ' ASN . 3.3 p -82.94 -25.92 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-N 118.716 0.689 . . . . 0.0 109.892 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.59 -18.95 61.0 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -108.21 -15.66 14.44 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.307 0.643 . . . . 0.0 111.1 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.03 -26.62 36.56 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -90.49 14.38 13.24 Favored 'General case' 0 N--CA 1.458 -0.064 0 C-N-CA 123.225 0.61 . . . . 0.0 111.146 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -94.4 -14.99 24.71 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.674 0.79 . . . . 0.0 110.291 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.4 mt -126.96 -2.81 6.49 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.951 0.9 . . . . 0.0 111.077 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -135.0 160.38 38.49 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.432 1.093 . . . . 0.0 108.419 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.2 tp 57.19 27.48 13.61 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.42 0.688 . . . . 0.0 111.408 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.81 152.76 70.18 Favored Pre-proline 0 N--CA 1.456 -0.14 0 C-N-CA 124.109 0.963 . . . . 0.0 109.507 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.8 -11.56 32.21 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.576 2.851 . . . . 0.0 112.54 -176.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -93.38 -2.05 55.15 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.004 0.366 . . . . 0.0 111.796 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.17 -12.36 81.66 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.1 t -82.91 -9.05 59.5 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.455 0.627 . . . . 0.0 110.93 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -98.96 5.16 47.36 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.305 0.642 . . . . 0.0 111.299 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 55.69 18.31 2.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.411 1.084 . . . . 0.0 113.226 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 55.9 -176.22 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.61 1.164 . . . . 0.0 112.979 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.551 ' CG ' ' H ' ' A' ' 105' ' ' HIS . 19.2 t-80 57.07 -175.74 0.06 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.37 1.068 . . . . 0.0 112.045 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.551 ' H ' ' CG ' ' A' ' 104' ' ' HIS . 88.0 m-70 57.29 -179.03 0.05 Allowed 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.558 1.143 . . . . 0.0 112.602 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.1 t60 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 116.692 -1.623 . . . . 0.0 111.79 -179.286 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptm . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.523 0.201 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m 56.09 5.68 0.19 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -159.65 -26.25 0.07 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.449 0.568 . . . . 0.0 110.578 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -146.38 159.96 42.69 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.556 0.742 . . . . 0.0 109.507 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 26.9 mt -61.54 151.87 31.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.276 1.03 . . . . 0.0 111.795 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 7' ' ' ASP . 28.5 m -139.26 174.13 10.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.481 1.113 . . . . 0.0 108.918 -175.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 6' ' ' THR . 3.8 p30 -56.02 -17.31 6.52 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -66.67 -53.5 33.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 122.148 -0.345 . . . . 0.0 110.391 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 p -83.63 -25.41 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 122.676 0.39 . . . . 0.0 110.782 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.88 -27.92 64.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.847 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -82.6 -28.45 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.058 0 CA-C-N 118.899 0.772 . . . . 0.0 109.909 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.442 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 44.3 mt-10 -72.51 -35.95 68.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.498 -0.751 . . . . 0.0 110.322 176.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -71.28 -37.12 71.89 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.53 -23.87 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 118.155 0.434 . . . . 0.0 110.749 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -78.27 -17.39 56.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.759 0.254 . . . . 0.0 110.438 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -82.54 -5.86 59.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.219 0.608 . . . . 0.0 111.695 172.806 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.36 0.63 37.81 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.322 -0.71 . . . . 0.0 113.098 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -85.52 84.16 7.7 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.304 1.052 . . . . 0.0 109.071 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -64.38 -20.91 66.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.548 0.339 . . . . 0.0 110.87 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -62.48 -23.95 67.19 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.575 0.75 . . . . 0.0 111.168 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.34 -19.2 39.79 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.614 0.188 . . . . 0.0 110.784 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -77.77 -36.64 50.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -60.75 -42.79 98.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.57 -18.47 59.74 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.571 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.0 tp -81.47 -43.1 19.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.214 -0.304 . . . . 0.0 110.931 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.7 m -70.92 -24.58 24.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.874 -175.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.86 -26.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 119.685 1.13 . . . . 0.0 110.706 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -70.15 -31.2 68.59 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.433 ' HB3' HG23 ' A' ' 33' ' ' VAL . 69.7 m-85 -99.76 -9.01 23.51 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.481 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -62.69 -30.27 71.27 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.189 -0.944 . . . . 0.0 110.499 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -86.56 -32.84 20.46 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.475 0.31 . . . . 0.0 111.601 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -80.67 -36.37 32.5 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 29' ' ' TYR . 62.0 t -71.21 -38.86 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.47 -23.38 67.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.934 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 t -74.47 -45.93 42.9 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.019 -0.426 . . . . 0.0 111.112 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.424 HD21 ' CD1' ' A' ' 75' ' ' TYR . 3.8 pp -82.61 -26.43 32.27 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.432 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.566 HG13 HG23 ' A' ' 46' ' ' VAL . 1.9 p -85.45 -16.91 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 118.131 0.423 . . . . 0.0 111.761 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.8 t -69.67 -9.07 52.82 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -89.29 -4.42 58.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.47 0.708 . . . . 0.0 111.221 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -122.76 -15.21 7.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.891 0.476 . . . . 0.0 112.245 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -143.1 153.84 60.65 Favored Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 123.721 0.808 . . . . 0.0 109.541 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -68.59 164.85 31.42 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.551 2.834 . . . . 0.0 111.062 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -65.76 -10.3 35.89 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.49 -18.02 55.87 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 118.094 0.407 . . . . 0.0 112.333 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -116.58 -5.78 11.66 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 117.561 0.681 . . . . 0.0 111.605 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.566 HG23 HG13 ' A' ' 37' ' ' VAL . 6.0 p -67.37 -32.63 4.73 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 77.9 Cg_endo -77.86 -23.85 9.05 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 CA-C-N 121.844 1.694 . . . . 0.0 111.437 -176.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.4 -28.74 34.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -79.03 -27.91 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.64 -36.01 68.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.14 -43.09 68.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -67.84 -28.99 68.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.427 0.558 . . . . 0.0 109.765 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.22 73.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -75.61 -33.73 60.56 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 118.272 0.487 . . . . 0.0 112.203 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -71.41 -37.26 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -77.18 -32.86 56.42 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.909 0.483 . . . . 0.0 110.586 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.47 -44.92 81.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -61.55 -36.71 81.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.508 0.595 . . . . 0.0 111.215 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -72.05 -20.72 61.63 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 122.694 0.397 . . . . 0.0 111.281 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.85 -11.83 18.74 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.94 0.496 . . . . 0.0 111.109 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.2 tp -76.26 -25.71 55.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.583 0.753 . . . . 0.0 110.617 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.94 -13.18 62.28 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.376 0.27 . . . . 0.0 110.651 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.9 m -113.45 0.9 14.87 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.592 0.757 . . . . 0.0 111.785 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -72.61 119.11 16.37 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.963 -0.46 . . . . 0.0 110.454 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.73 25.31 1.47 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.015 1.326 . . . . 0.0 109.749 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.77 -6.13 49.38 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.157 -0.802 . . . . 0.0 113.58 -173.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 51.67 28.87 5.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.299 1.049 . . . . 0.0 111.532 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.3 m -128.84 176.2 8.03 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.153 0.981 . . . . 0.0 109.96 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.44 148.11 52.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.175 0.512 . . . . 0.0 111.249 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -75.54 -30.5 59.76 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.393 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -67.73 -37.83 82.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.303 0.501 . . . . 0.0 111.984 -174.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.7 m -70.72 -37.7 73.53 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -69.27 -34.02 74.12 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.7 -0.191 . . . . 0.0 110.798 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.8 tp -77.09 -36.53 55.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.716 0.406 . . . . 0.0 111.199 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.424 ' CD1' HD21 ' A' ' 36' ' ' LEU . 20.9 m-85 -69.56 -20.03 63.67 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.804 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -76.1 -23.98 54.98 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.087 0.403 . . . . 0.0 110.456 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.2 mm -73.55 -35.94 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.44 -39.69 62.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.71 -29.66 13.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 O-C-N 122.086 -0.384 . . . . 0.0 111.402 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -75.74 -23.21 56.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.821 -0.55 . . . . 0.0 110.618 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.2 m -82.94 -28.93 29.5 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 119.556 -0.259 . . . . 0.0 110.339 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.09 -32.78 61.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.093 0.406 . . . . 0.0 110.932 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.37 -29.68 53.43 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -76.27 -24.67 54.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -75.87 -36.86 59.39 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.499 0.32 . . . . 0.0 110.808 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.7 mt -76.84 -21.22 55.35 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.51 -20.61 6.87 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 CA-C-N 119.076 0.853 . . . . 0.0 111.286 176.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.21 -28.55 53.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.971 0.35 . . . . 0.0 111.014 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -101.97 -16.33 16.53 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.843 0.457 . . . . 0.0 110.498 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.48 -14.92 67.29 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 119.741 -0.477 . . . . 0.0 112.023 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -119.78 11.71 11.97 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-N 117.604 0.702 . . . . 0.0 111.572 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -68.11 -9.71 48.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.675 0.79 . . . . 0.0 111.304 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.0 tp -118.03 -1.21 11.48 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.641 0.777 . . . . 0.0 110.746 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -99.61 -35.63 9.78 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.688 -0.632 . . . . 0.0 110.65 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.49 -23.67 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.451 2.3 . . . . 0.0 116.341 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 m -145.97 157.62 50.14 Favored Pre-proline 0 CA--C 1.526 0.052 0 CA-C-N 119.786 1.175 . . . . 0.0 110.598 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -67.7 149.93 79.12 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.99 2.46 . . . . 0.0 109.658 173.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -141.57 162.24 35.96 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 122.894 0.477 . . . . 0.0 110.702 -176.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.78 177.58 46.69 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 t -149.58 160.17 43.71 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.7 0.4 . . . . 0.0 110.477 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -139.12 15.96 2.62 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.615 0.766 . . . . 0.0 110.864 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -139.99 167.62 21.71 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.272 0.629 . . . . 0.0 110.755 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -74.33 0.65 13.69 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.386 0.674 . . . . 0.0 111.538 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.4 p80 49.91 22.41 0.86 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.675 1.59 . . . . 0.0 113.621 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -147.17 158.51 43.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.432 0.693 . . . . 0.0 109.816 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 52.9 t60 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 116.68 -1.629 . . . . 0.0 111.776 -178.225 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.421 0.153 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 m -71.78 161.6 30.72 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.069 0.461 . . . . 0.0 111.162 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.78 -5.2 58.82 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.032 0.533 . . . . 0.0 111.581 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 56.88 7.25 0.38 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.281 1.432 . . . . 0.0 114.376 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 98.0 mt -140.32 155.09 46.94 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.408 0.683 . . . . 0.0 109.369 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 7' ' ' ASP . 25.4 m -140.28 173.33 11.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.559 0.744 . . . . 0.0 109.805 -176.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 6' ' ' THR . 3.5 p30 -55.34 -17.29 4.55 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.982 0.513 . . . . 0.0 111.87 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -65.88 -51.51 58.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.3 p -85.81 -26.48 6.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 122.734 0.413 . . . . 0.0 110.952 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.72 -29.92 68.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 122.136 -0.352 . . . . 0.0 110.34 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.8 t -84.23 -27.35 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.186 0.448 . . . . 0.0 110.296 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.37 -35.68 65.98 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.51 -0.744 . . . . 0.0 109.998 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -70.81 -34.9 72.22 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.0 m -74.75 -24.09 18.08 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 CA-C-N 118.108 0.413 . . . . 0.0 111.228 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -77.13 -16.14 59.28 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 174.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.36 2.26 56.75 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.723 0.809 . . . . 0.0 112.161 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.23 44.18 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.55 -0.583 . . . . 0.0 113.554 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -91.81 83.97 5.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.413 1.107 . . . . 0.0 109.31 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.69 -20.2 66.18 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.727 0.411 . . . . 0.0 110.435 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -62.08 -24.52 67.16 Favored 'General case' 0 N--CA 1.458 -0.041 0 C-N-CA 122.863 0.465 . . . . 0.0 111.441 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.44 -18.75 44.25 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.792 0.269 . . . . 0.0 110.574 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -77.8 -37.14 49.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -61.73 -40.22 94.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.43 -19.22 58.3 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.401 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.4 tp -83.47 -46.9 11.96 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.426 0.29 . . . . 0.0 111.245 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.65 -25.09 29.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 CA-C-O 118.578 -0.725 . . . . 0.0 111.479 -175.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.4 p -69.7 -26.64 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 119.32 0.964 . . . . 0.0 110.693 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.9 mtp85 -68.54 -34.54 76.02 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -97.35 -8.73 28.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.282 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -63.33 -28.35 69.94 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 118.453 0.57 . . . . 0.0 110.8 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -85.07 -30.17 24.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -77.05 -43.47 34.38 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 m -79.78 -25.32 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 O-C-N 121.971 -0.456 . . . . 0.0 110.885 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.03 -22.75 63.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.149 0.432 . . . . 0.0 110.436 176.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -76.31 -42.3 45.7 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.43 -24.85 31.7 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.524 HG13 HG23 ' A' ' 46' ' ' VAL . 2.7 p -87.94 -19.44 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 118.326 0.512 . . . . 0.0 111.467 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.4 t -67.26 -9.26 38.88 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.878 -0.514 . . . . 0.0 109.854 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -90.45 -3.92 57.33 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.7 0.8 . . . . 0.0 111.438 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -122.18 -15.38 7.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.985 0.514 . . . . 0.0 111.884 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 m -142.42 153.32 62.32 Favored Pre-proline 0 N--CA 1.463 0.176 0 C-N-CA 123.829 0.852 . . . . 0.0 109.229 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.38 165.33 29.27 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.385 2.723 . . . . 0.0 110.959 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -65.38 -12.54 53.13 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.782 0.433 . . . . 0.0 112.132 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.02 -19.58 59.03 Favored Glycine 0 CA--C 1.527 0.83 0 O-C-N 121.928 -0.483 . . . . 0.0 112.192 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -116.55 -5.67 11.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.633 0.716 . . . . 0.0 111.681 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.524 HG23 HG13 ' A' ' 37' ' ' VAL . 5.9 p -66.58 -33.32 6.25 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.782 -1.104 . . . . 0.0 113.7 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 93.7 Cg_endo -76.68 -25.88 8.88 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 122.084 1.78 . . . . 0.0 111.774 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -82.7 -28.84 30.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.227 -0.296 . . . . 0.0 110.408 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.2 t -77.76 -27.63 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -71.72 -35.59 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -72.27 -43.2 64.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -67.45 -27.35 66.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.784 -0.572 . . . . 0.0 110.208 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.48 -28.51 62.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.683 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.31 -29.81 24.25 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.411 0.551 . . . . 0.0 110.89 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.66 -37.11 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -78.74 -31.64 46.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.865 0.466 . . . . 0.0 111.016 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.94 -42.46 85.25 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.165 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -62.76 -36.5 83.27 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 118.63 0.65 . . . . 0.0 111.211 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -71.64 -17.68 62.25 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 122.501 0.32 . . . . 0.0 111.122 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.49 -11.51 16.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.863 0.465 . . . . 0.0 111.066 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.2 tp -73.77 -23.22 59.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.472 0.709 . . . . 0.0 110.099 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.48 -13.13 37.46 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.445 0.298 . . . . 0.0 110.673 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.2 t -113.48 4.44 16.24 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -71.14 126.47 29.69 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.509 -0.744 . . . . 0.0 109.503 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -140.17 13.71 2.42 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.995 0.918 . . . . 0.0 110.513 -175.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.93 -35.31 54.37 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 47.97 22.01 0.35 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.857 1.263 . . . . 0.0 113.813 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 77.9 p -157.77 -8.78 0.08 Allowed 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.24 54.82 1.45 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.338 0.517 . . . . 0.0 111.611 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -68.91 -34.86 76.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.187 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -69.69 -40.4 76.36 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.042 0.383 . . . . 0.0 111.297 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -70.78 -35.11 72.44 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -69.53 -31.02 68.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.5 tp -82.92 -36.15 25.49 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.586 0.354 . . . . 0.0 111.629 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -62.44 -29.13 70.29 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.129 -0.357 . . . . 0.0 110.387 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -73.33 -25.29 60.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.489 0.315 . . . . 0.0 111.48 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mm -71.53 -39.76 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.035 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.56 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.41 -36.11 68.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -174.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -75.64 -29.25 20.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.378 0.536 . . . . 0.0 110.775 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -79.07 -20.54 48.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.266 -0.271 . . . . 0.0 110.609 177.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 79.1 m -79.85 -33.37 40.2 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 122.014 -0.429 . . . . 0.0 109.963 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.96 69.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.281 -0.262 . . . . 0.0 110.928 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -75.17 -28.64 60.14 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -78.81 -30.03 45.18 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.128 0.171 . . . . 0.0 110.99 177.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -69.88 -37.09 75.93 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.138 0.575 . . . . 0.0 111.091 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.6 mt -76.56 -29.22 56.56 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.33 -19.79 7.57 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 CA-C-N 118.558 0.617 . . . . 0.0 111.415 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.04 -10.24 59.24 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.151 -0.343 . . . . 0.0 111.311 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -117.1 -19.19 9.82 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.364 0.266 . . . . 0.0 111.18 177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.75 -16.88 64.76 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.834 -0.426 . . . . 0.0 112.073 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -100.4 8.89 43.33 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 117.675 0.738 . . . . 0.0 112.436 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -92.64 -0.94 57.23 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.3 tp -141.16 -7.78 1.03 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.52 0.328 . . . . 0.0 111.238 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -93.28 126.99 38.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.94 -0.475 . . . . 0.0 109.776 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.7 mt -135.65 10.89 3.43 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.244 1.018 . . . . 0.0 110.717 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.15 154.85 81.38 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 123.714 0.806 . . . . 0.0 110.181 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.97 167.2 25.41 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.589 2.859 . . . . 0.0 111.412 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -121.37 7.31 10.14 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.608 0.763 . . . . 0.0 111.05 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.73 -162.74 41.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.0 t -140.89 163.06 33.96 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.867 0.467 . . . . 0.0 110.52 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -84.29 0.24 49.82 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.654 0.781 . . . . 0.0 111.62 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -141.94 154.03 44.77 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.165 0.586 . . . . 0.0 110.295 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -153.22 161.8 42.0 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.148 0.579 . . . . 0.0 110.109 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -145.84 158.38 43.86 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.958 0.503 . . . . 0.0 110.506 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 55.9 -176.14 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.362 1.065 . . . . 0.0 112.234 -175.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.101 -1.428 . . . . 0.0 110.731 -179.479 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.911 0 CA-C-O 120.481 0.182 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 m -142.38 162.78 34.58 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.293 0.637 . . . . 0.0 110.468 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -75.31 136.85 40.85 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.554 0.216 . . . . 0.0 110.45 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -158.57 -176.48 5.91 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.157 0.583 . . . . 0.0 111.07 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.545 ' N ' HD22 ' A' ' 5' ' ' LEU . 1.2 mm? -74.01 151.05 40.35 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.277 1.031 . . . . 0.0 109.804 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.475 HG22 ' N ' ' A' ' 7' ' ' ASP . 29.5 m -139.73 172.33 12.94 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.229 0.612 . . . . 0.0 109.526 -175.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.475 ' N ' HG22 ' A' ' 6' ' ' THR . 3.3 p30 -55.17 -16.81 3.44 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.319 0.648 . . . . 0.0 111.822 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -65.76 -54.12 31.37 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 122.107 -0.37 . . . . 0.0 110.032 176.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.52 -25.44 6.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.756 0.423 . . . . 0.0 111.031 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 mp -70.1 -31.72 69.42 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 119.299 -0.381 . . . . 0.0 110.338 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.0 t -80.17 -27.91 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 118.62 0.645 . . . . 0.0 110.15 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.02 -39.37 75.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.815 -0.553 . . . . 0.0 111.373 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -82.19 -25.1 34.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.74 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.41 -24.25 23.61 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 CA-C-N 118.755 0.707 . . . . 0.0 109.695 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -78.78 -21.66 47.49 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.674 0.389 . . . . 0.0 110.293 174.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -89.43 -7.3 55.42 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.368 0.667 . . . . 0.0 111.818 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.69 0.58 17.81 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.932 -0.927 . . . . 0.0 114.16 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -87.32 83.71 7.31 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.213 1.507 . . . . 0.0 109.761 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -65.88 -23.77 66.72 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -59.69 -24.35 63.86 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.425 0.69 . . . . 0.0 111.048 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.37 -20.12 32.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 119.777 -0.154 . . . . 0.0 111.26 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -76.45 -35.12 58.66 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.06 -40.63 98.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.0 mt -75.01 -19.02 60.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.672 0.389 . . . . 0.0 111.396 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 tp -83.55 -46.75 12.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.899 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 m -68.77 -24.34 28.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.646 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.9 p -69.88 -26.76 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 119.239 0.927 . . . . 0.0 110.756 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -68.1 -30.67 69.9 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.44 ' HB3' HG23 ' A' ' 33' ' ' VAL . 70.1 m-85 -101.09 -8.89 21.87 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.75 -30.22 71.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.134 -0.979 . . . . 0.0 110.551 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -86.87 -32.47 20.21 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -79.29 -36.39 39.76 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 29' ' ' TYR . 59.0 t -71.7 -39.01 68.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 123.449 0.7 . . . . 0.0 109.316 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.488 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.46 -23.09 67.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.235 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 t -75.02 -45.62 40.55 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.145 -0.347 . . . . 0.0 111.126 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 pp -82.02 -28.12 32.71 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.56 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.582 HG13 HG23 ' A' ' 46' ' ' VAL . 2.1 p -83.55 -16.92 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 118.219 0.463 . . . . 0.0 111.515 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -67.96 -11.99 59.88 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.103 0.478 . . . . 0.0 109.786 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -86.01 -4.26 59.13 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.341 0.656 . . . . 0.0 111.346 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -122.78 -16.44 7.15 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.938 0.495 . . . . 0.0 112.289 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -142.74 154.48 62.69 Favored Pre-proline 0 N--CA 1.462 0.166 0 C-N-CA 123.587 0.755 . . . . 0.0 109.353 175.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.96 164.21 30.77 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.423 2.748 . . . . 0.0 111.009 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.5 p -66.43 -9.5 34.54 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.05 54.35 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.818 -0.435 . . . . 0.0 112.05 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -116.18 -6.01 11.88 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 117.518 0.659 . . . . 0.0 111.453 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.582 HG23 HG13 ' A' ' 37' ' ' VAL . 8.1 p -66.45 -32.76 5.65 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 117.774 -1.108 . . . . 0.0 113.853 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 78.9 Cg_endo -77.96 -23.07 9.6 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 CA-C-N 121.834 1.691 . . . . 0.0 111.056 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.86 -29.39 32.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.95 -28.91 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.78 -35.8 66.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -71.11 -42.77 68.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -67.98 -29.89 69.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.22 0.464 . . . . 0.0 109.855 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.09 -36.56 77.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 119.55 -0.262 . . . . 0.0 110.297 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -74.69 -33.57 62.47 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.245 0.475 . . . . 0.0 112.024 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.54 -39.17 75.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -75.37 -30.84 60.31 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.812 0.445 . . . . 0.0 110.638 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.53 -44.67 67.06 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.344 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -59.6 -39.23 83.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.61 0.641 . . . . 0.0 111.38 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -72.19 -28.46 63.21 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.512 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 -12.01 40.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.803 0.441 . . . . 0.0 111.351 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.7 tp -75.55 -28.06 58.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.349 0.659 . . . . 0.0 110.721 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -71.38 -6.26 38.79 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.1 m -113.4 4.15 16.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.83 0.852 . . . . 0.0 111.198 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.443 ' CZ ' ' HA2' ' A' ' 66' ' ' GLY . 25.6 t80 -84.68 150.02 25.41 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.973 0.509 . . . . 0.0 110.14 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.01 -2.78 9.15 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -175.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.443 ' HA2' ' CZ ' ' A' ' 64' ' ' PHE . . . 70.49 17.64 74.74 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.314 0.507 . . . . 0.0 112.489 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.57 -10.69 57.43 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 117.842 0.821 . . . . 0.0 111.063 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.0 m -139.95 172.65 12.46 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.972 1.309 . . . . 0.0 108.689 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.79 146.06 53.22 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.781 -0.574 . . . . 0.0 110.35 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -67.85 -32.11 72.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -176.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -70.07 -37.41 75.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.817 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -71.28 -33.79 70.08 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 56.9 t90 -73.75 -28.23 61.57 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.483 0.313 . . . . 0.0 110.846 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -85.63 -36.66 20.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.929 0.331 . . . . 0.0 111.029 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -69.36 -21.03 63.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.989 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -78.27 -21.87 49.13 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.908 0.776 . . . . 0.0 110.61 173.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mm -70.44 -34.33 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.95 -41.24 52.18 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.35 -29.03 13.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 O-C-N 121.997 -0.44 . . . . 0.0 111.356 -178.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -75.69 -24.22 56.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.152 -0.343 . . . . 0.0 110.287 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -81.73 -26.98 34.12 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.201 -0.312 . . . . 0.0 110.363 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.91 -32.64 63.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.423 0.556 . . . . 0.0 110.72 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.33 -25.74 46.57 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.501 ' HA ' HG12 ' A' ' 87' ' ' VAL . 13.4 t30 -83.56 -17.36 42.02 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.447 0.165 . . . . 0.0 110.701 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -79.86 -34.76 39.03 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.855 -0.528 . . . . 0.0 110.274 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.5 mt -81.42 -22.44 38.21 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 84' ' ' ASN . 7.1 p -83.92 -24.48 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 118.44 0.564 . . . . 0.0 110.151 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.31 -20.64 61.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.223 -0.298 . . . . 0.0 110.99 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -108.9 -15.42 14.38 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.992 0.517 . . . . 0.0 111.028 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.73 -16.83 71.99 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.7 mmm-85 -101.89 -10.58 19.71 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 123.795 0.838 . . . . 0.0 110.762 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 46.59 43.29 12.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.632 0.773 . . . . 0.0 112.664 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.54 24.98 12.55 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.893 0.877 . . . . 0.0 112.597 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -65.59 -19.95 66.12 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.722 0.809 . . . . 0.0 110.565 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.0 tp -107.32 12.01 28.56 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.765 0.826 . . . . 0.0 110.922 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.6 136.54 28.85 Favored Pre-proline 0 CA--C 1.53 0.211 0 C-N-CA 123.111 0.564 . . . . 0.0 109.803 -176.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -70.87 160.85 48.06 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.393 2.728 . . . . 0.0 111.301 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 -100.22 -9.0 22.9 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.253 0.621 . . . . 0.0 111.394 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -68.72 165.63 47.63 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.3 t -150.45 156.3 41.19 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 122.961 0.505 . . . . 0.0 110.355 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -89.9 1.2 56.5 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.539 0.736 . . . . 0.0 111.318 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -124.77 19.37 8.59 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.587 0.755 . . . . 0.0 111.094 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -136.47 173.37 11.78 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.112 0.565 . . . . 0.0 110.342 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 58.98 16.73 4.85 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.422 1.089 . . . . 0.0 113.104 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -91.12 -2.16 57.62 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.687 0.395 . . . . 0.0 111.24 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 16.3 p80 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.544 -179.344 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 110.588 -0.153 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.6 m -133.85 7.94 3.79 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.952 0.501 . . . . 0.0 111.347 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -150.47 154.18 37.21 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.117 0.567 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -140.37 157.38 45.63 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.921 0.488 . . . . 0.0 110.391 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.9 mt -77.33 154.73 32.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.482 1.113 . . . . 0.0 111.623 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.49 HG22 ' H ' ' A' ' 7' ' ' ASP . 28.0 m -139.87 173.93 11.03 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.131 0.973 . . . . 0.0 108.894 -176.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' H ' HG22 ' A' ' 6' ' ' THR . 3.4 p30 -55.16 -17.14 3.79 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -66.41 -53.05 40.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.056 -0.402 . . . . 0.0 110.257 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.413 ' H ' HG12 ' A' ' 9' ' ' VAL . 2.8 p -85.34 -25.75 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 122.906 0.482 . . . . 0.0 110.559 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.8 mp -70.85 -28.65 64.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.154 -0.451 . . . . 0.0 110.974 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.8 t -82.54 -28.12 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 118.858 0.754 . . . . 0.0 110.024 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.442 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 44.1 mt-10 -72.11 -36.61 69.49 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.762 -0.586 . . . . 0.0 110.504 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -70.58 -36.67 73.72 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 m -73.13 -23.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 118.298 0.499 . . . . 0.0 110.827 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -78.0 -18.16 56.26 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -80.99 -5.93 58.16 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.297 0.639 . . . . 0.0 111.863 172.494 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.72 2.13 46.36 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 119.559 -0.578 . . . . 0.0 112.876 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -85.86 84.19 7.62 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.19 0.995 . . . . 0.0 109.349 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -64.36 -19.65 65.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.419 0.288 . . . . 0.0 110.624 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -61.48 -25.5 67.29 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.94 0.496 . . . . 0.0 111.121 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.88 -18.8 38.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.74 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -77.91 -36.16 49.78 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -61.84 -41.07 97.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -76.83 -18.41 58.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 tp -82.08 -41.66 20.25 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 122.139 -0.351 . . . . 0.0 110.74 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.6 m -72.16 -24.28 22.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.885 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -67.74 -26.33 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 119.866 1.212 . . . . 0.0 110.887 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -69.74 -32.13 70.49 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.43 ' HB3' HG23 ' A' ' 33' ' ' VAL . 64.6 m-85 -99.34 -9.08 23.97 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.411 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -62.77 -30.4 71.42 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.206 -0.934 . . . . 0.0 110.751 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -86.99 -32.36 20.09 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 176.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -80.24 -36.37 34.74 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' A' ' 29' ' ' TYR . 61.6 t -70.96 -38.44 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.96 -23.27 67.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 t -74.68 -45.19 46.16 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.047 0.385 . . . . 0.0 111.012 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.413 HD21 ' CD1' ' A' ' 75' ' ' TYR . 3.8 pp -82.92 -27.03 30.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.498 -177.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.571 HG13 HG23 ' A' ' 46' ' ' VAL . 1.8 p -84.97 -16.71 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 118.117 0.417 . . . . 0.0 111.478 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -68.35 -11.77 60.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.21 0.529 . . . . 0.0 109.845 172.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -85.83 -5.98 59.16 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.425 0.69 . . . . 0.0 111.312 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -122.6 -16.51 7.22 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.799 0.44 . . . . 0.0 112.164 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 m -141.34 153.76 66.46 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 123.462 0.705 . . . . 0.0 109.443 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.9 164.97 29.61 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.656 2.904 . . . . 0.0 110.984 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -65.87 -10.75 41.1 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -175.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.41 -17.98 56.09 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.082 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -116.49 -5.85 11.71 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 117.726 0.763 . . . . 0.0 111.538 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.571 HG23 HG13 ' A' ' 37' ' ' VAL . 6.8 p -67.35 -32.02 4.21 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 117.785 -1.102 . . . . 0.0 113.722 -176.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 82.4 Cg_endo -78.41 -23.11 8.93 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 121.804 1.68 . . . . 0.0 111.076 -177.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -82.4 -28.21 31.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.343 -0.223 . . . . 0.0 110.62 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.4 t -79.36 -28.61 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -69.15 -35.85 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -70.36 -43.24 70.55 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -68.17 -29.16 67.97 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.736 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.63 -35.47 75.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.987 0.358 . . . . 0.0 110.2 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.46 -33.62 60.86 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.076 0.398 . . . . 0.0 111.72 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.04 -38.46 71.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -75.39 -32.35 60.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.04 0.536 . . . . 0.0 110.579 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.27 77.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.098 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -61.14 -37.8 84.13 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.769 0.713 . . . . 0.0 111.287 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -71.81 -24.72 61.77 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.709 0.404 . . . . 0.0 111.059 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.11 -11.85 25.67 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.167 0.587 . . . . 0.0 111.442 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.2 tp -75.63 -24.06 56.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.26 0.624 . . . . 0.0 110.376 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.56 -11.33 57.83 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.422 0.289 . . . . 0.0 110.604 174.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.2 m -109.46 0.23 19.21 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.754 0.822 . . . . 0.0 111.65 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -79.45 134.32 36.54 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.125 0.57 . . . . 0.0 110.196 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -124.73 6.17 8.14 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -176.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.12 16.99 77.68 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.395 -0.669 . . . . 0.0 113.28 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -68.93 -10.69 58.54 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.267 1.033 . . . . 0.0 111.107 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.4 m -146.04 166.41 26.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.542 1.137 . . . . 0.0 108.676 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.37 144.49 56.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -67.47 -33.22 74.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -69.84 -38.81 76.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.839 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.2 m -70.45 -35.66 73.47 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -69.28 -33.59 73.44 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 122.379 -0.201 . . . . 0.0 110.74 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.2 tp -79.8 -35.91 37.77 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.261 0.225 . . . . 0.0 111.18 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.413 ' CD1' HD21 ' A' ' 36' ' ' LEU . 20.5 m-85 -69.18 -20.25 64.0 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.787 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.5 mtm105 -75.51 -23.76 56.75 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.412 0.551 . . . . 0.0 110.517 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.54 -33.72 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.23 -39.13 55.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -173.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -80.52 -29.65 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 O-C-N 122.126 -0.359 . . . . 0.0 111.409 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -75.88 -23.92 55.65 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 122.208 -0.307 . . . . 0.0 110.309 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.3 m -81.67 -29.59 33.02 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.177 -0.327 . . . . 0.0 110.399 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.84 -35.28 67.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.207 0.458 . . . . 0.0 110.877 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -76.87 -28.27 55.34 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -78.94 -26.52 43.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.261 0.224 . . . . 0.0 110.595 176.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -73.55 -36.49 65.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.834 0.453 . . . . 0.0 111.195 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.6 mt -79.59 -26.25 41.31 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.07 -22.21 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 119.088 0.858 . . . . 0.0 111.005 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.41 -11.81 59.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.279 0.231 . . . . 0.0 111.278 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -118.8 -16.78 9.29 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 122.502 0.321 . . . . 0.0 110.778 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.89 -19.15 61.9 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -106.47 0.01 24.39 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.324 0.65 . . . . 0.0 111.148 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.47 128.03 35.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.919 0.488 . . . . 0.0 110.302 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.1 mp 52.36 17.19 0.71 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.373 1.069 . . . . 0.0 113.278 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -96.06 -16.42 21.61 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.966 -0.459 . . . . 0.0 110.202 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.3 pp -141.86 15.98 2.12 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.415 0.686 . . . . 0.0 111.284 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.2 t 50.06 75.6 0.64 Allowed Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.324 1.049 . . . . 0.0 110.393 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.86 148.43 76.69 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.186 2.591 . . . . 0.0 110.829 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 52.27 20.51 1.38 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.941 0.896 . . . . 0.0 112.801 -177.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.73 169.01 53.83 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.3 p -144.32 4.33 1.21 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.105 0.562 . . . . 0.0 111.93 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -148.59 150.89 34.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.805 0.442 . . . . 0.0 110.535 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -144.9 160.61 41.04 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.709 0.804 . . . . 0.0 109.901 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -138.86 11.05 2.65 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.898 0.479 . . . . 0.0 111.131 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -82.26 -2.18 51.71 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.178 0.591 . . . . 0.0 111.842 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -150.03 165.62 32.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.651 0.78 . . . . 0.0 110.363 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 80.5 t60 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 117.252 -1.356 . . . . 0.0 110.304 -179.998 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 7' ' ' ASP . 27.4 m . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.472 ' N ' HG22 ' A' ' 6' ' ' THR . 3.7 p30 -55.11 -17.55 4.25 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.157 0.583 . . . . 0.0 112.21 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -66.0 -51.98 53.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.99 -0.444 . . . . 0.0 110.251 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.89 -25.58 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 122.396 0.278 . . . . 0.0 110.611 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.84 -28.74 64.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.154 -0.341 . . . . 0.0 110.703 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.1 t -82.17 -28.45 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 118.534 0.606 . . . . 0.0 109.876 176.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.469 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 39.8 mt-10 -70.9 -37.02 72.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.69 -0.631 . . . . 0.0 110.345 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -71.7 -36.42 70.54 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.44 -24.6 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.032 0 CA-C-N 118.338 0.517 . . . . 0.0 110.956 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -78.77 -18.26 54.45 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -83.16 -5.18 59.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.446 0.699 . . . . 0.0 111.898 174.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.52 0.14 34.75 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.614 -0.548 . . . . 0.0 113.351 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -88.77 84.29 6.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.232 1.016 . . . . 0.0 109.547 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -63.7 -20.61 65.86 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.711 0.405 . . . . 0.0 110.831 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -62.85 -23.23 67.19 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.095 0.558 . . . . 0.0 111.294 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.52 -18.7 44.14 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.378 -0.202 . . . . 0.0 110.674 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -77.1 -36.51 55.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -62.52 -41.11 98.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -75.19 -18.95 60.05 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.288 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.5 tp -83.54 -47.34 11.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 122.405 0.282 . . . . 0.0 111.238 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 m -67.61 -24.69 31.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.399 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.68 -26.97 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 119.133 0.878 . . . . 0.0 110.891 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -67.93 -32.17 72.45 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -101.49 -8.63 21.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -62.73 -27.6 69.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.342 0.519 . . . . 0.0 110.503 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -86.59 -30.56 21.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.339 -0.226 . . . . 0.0 110.512 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -76.83 -41.87 42.5 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -82.18 -25.5 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.074 0 CA-C-N 118.0 0.364 . . . . 0.0 110.997 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.18 -23.64 63.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.179 0.445 . . . . 0.0 110.193 176.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 t -76.19 -44.22 38.89 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -80.04 -24.94 40.39 Favored 'General case' 0 C--O 1.227 -0.093 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 46' ' ' VAL . 3.2 p -86.76 -17.64 8.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 CA-C-N 118.104 0.411 . . . . 0.0 111.145 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.9 t -67.75 -9.18 41.68 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 122.046 -0.409 . . . . 0.0 110.197 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -88.42 -5.84 58.03 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.033 0.533 . . . . 0.0 111.713 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -122.18 -12.42 8.29 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.56 154.02 59.28 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.813 0.845 . . . . 0.0 109.1 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.18 163.69 35.13 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.363 2.708 . . . . 0.0 110.611 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.0 p -65.61 -10.63 37.42 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.82 -19.54 53.53 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.05 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -116.31 -3.41 11.95 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 117.718 0.759 . . . . 0.0 111.618 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.525 HG23 HG13 ' A' ' 37' ' ' VAL . 5.9 p -67.02 -32.85 5.19 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 117.615 -1.183 . . . . 0.0 113.381 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 95.6 Cg_endo -77.75 -25.17 8.04 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 122.093 1.783 . . . . 0.0 111.492 -177.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -79.73 -29.67 40.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.586 0.232 . . . . 0.0 110.449 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -80.57 -25.89 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -70.79 -36.23 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -72.02 -40.98 68.06 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.895 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -66.24 -29.73 70.03 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.98 -27.8 63.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 122.243 -0.286 . . . . 0.0 110.728 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -85.32 -31.4 23.04 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.278 0.49 . . . . 0.0 111.597 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.3 mt -71.29 -37.13 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -75.58 -32.61 60.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.948 0.499 . . . . 0.0 110.471 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.59 -45.17 69.23 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 119.456 -0.306 . . . . 0.0 110.336 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -60.51 -37.78 82.24 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.594 0.634 . . . . 0.0 111.609 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -72.31 -25.83 61.72 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.826 0.45 . . . . 0.0 111.148 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.22 -12.91 29.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.06 0.544 . . . . 0.0 111.576 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 tp -76.78 -25.84 53.81 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.143 0.577 . . . . 0.0 110.792 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.32 -14.92 63.34 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.307 0.243 . . . . 0.0 110.408 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.0 p -112.94 8.14 18.46 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.241 0.616 . . . . 0.0 111.789 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 t80 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-N 118.025 0.375 . . . . 0.0 110.639 177.364 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.3 t80 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -69.09 -36.41 77.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.658 0.663 . . . . 0.0 111.786 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -70.76 -33.76 71.12 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.59 0.632 . . . . 0.0 109.756 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 58.6 t90 -75.32 -27.98 59.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 122.752 0.421 . . . . 0.0 110.902 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.5 tp -85.81 -37.0 19.71 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.74 0.416 . . . . 0.0 111.312 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -61.63 -32.31 72.44 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.788 0.267 . . . . 0.0 110.344 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -75.56 -22.42 57.04 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.993 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.08 -36.79 75.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.775 0.716 . . . . 0.0 109.5 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.87 -38.74 57.6 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.0 p -78.24 -29.78 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 118.271 0.487 . . . . 0.0 110.801 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -75.28 -23.83 57.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.994 0.361 . . . . 0.0 110.159 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.8 m -79.17 -31.42 43.91 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.76 -29.83 62.44 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 117.56 0.164 . . . . 0.0 110.647 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -80.4 -28.6 37.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 119.444 -0.313 . . . . 0.0 110.999 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.171 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.58 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 7' ' ' ASP . 29.9 m . . . . . 0 CA--C 1.526 0.055 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.493 ' H ' HG22 ' A' ' 6' ' ' THR . 3.1 p30 -55.29 -17.33 4.48 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.454 0.701 . . . . 0.0 112.046 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -67.04 -51.58 52.97 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 122.016 -0.428 . . . . 0.0 110.3 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.59 -26.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 122.993 0.517 . . . . 0.0 110.73 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -69.05 -29.02 67.06 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.02 -0.425 . . . . 0.0 110.532 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.5 t -82.31 -28.78 9.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 118.565 0.621 . . . . 0.0 110.105 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.32 -35.48 68.62 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.571 -0.706 . . . . 0.0 110.433 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -69.97 -37.29 75.75 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.311 0.244 . . . . 0.0 111.347 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 m -73.44 -23.76 19.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 121.771 -0.581 . . . . 0.0 111.078 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -78.38 -16.25 57.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.273 0.229 . . . . 0.0 110.576 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -91.91 3.91 54.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.67 0.788 . . . . 0.0 111.764 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.15 1.64 51.32 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.977 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.88 83.98 4.09 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.851 0.826 . . . . 0.0 109.442 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -67.11 -18.09 65.16 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.982 0.513 . . . . 0.0 110.675 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -60.75 -25.38 66.45 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.582 0.353 . . . . 0.0 110.69 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.12 -18.81 45.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.54 0.155 . . . . 0.0 111.056 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -76.7 -36.77 57.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.57 -40.59 97.34 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.83 -19.04 59.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.272 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.9 tp -83.51 -47.11 11.69 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.428 0.291 . . . . 0.0 111.242 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.04 -24.9 30.87 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.541 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.8 p -70.71 -26.98 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.32 0.964 . . . . 0.0 110.879 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -67.95 -31.62 71.5 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.84 -8.7 21.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -62.03 -29.2 70.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.334 0.515 . . . . 0.0 110.665 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -86.47 -30.53 21.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.044 -0.071 . . . . 0.0 110.955 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.29 -42.27 55.19 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 m -80.94 -25.32 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-N 118.306 0.503 . . . . 0.0 110.98 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.79 -22.09 62.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.083 0.402 . . . . 0.0 110.195 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -77.2 -41.63 40.68 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.87 -24.9 30.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.554 HG13 HG23 ' A' ' 46' ' ' VAL . 2.3 p -88.71 -19.38 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 118.343 0.519 . . . . 0.0 111.717 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.2 t -68.34 -9.37 47.43 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -90.32 -4.35 57.17 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.7 0.8 . . . . 0.0 111.66 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -122.4 -13.0 8.13 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.686 0.394 . . . . 0.0 111.864 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 m -144.0 154.53 58.4 Favored Pre-proline 0 N--CA 1.462 0.152 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.71 164.46 31.24 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.269 2.646 . . . . 0.0 111.08 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.8 p -66.34 -10.17 40.44 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.29 -17.95 56.36 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.175 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -116.37 -6.4 11.77 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 117.423 0.611 . . . . 0.0 111.691 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.554 HG23 HG13 ' A' ' 37' ' ' VAL . 9.9 p -66.34 -33.52 6.82 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 117.587 -1.197 . . . . 0.0 113.428 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 95.5 Cg_endo -76.13 -25.25 10.34 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 CA-C-N 122.212 1.826 . . . . 0.0 111.4 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -81.96 -29.42 32.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.631 0.253 . . . . 0.0 110.381 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.5 t -78.4 -26.94 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.1 t -71.74 -34.95 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 118.419 0.554 . . . . 0.0 109.531 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -72.96 -43.07 62.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -67.73 -26.49 66.17 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.234 0.47 . . . . 0.0 110.156 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.78 -29.32 63.19 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.58 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -85.14 -28.72 25.35 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.575 0.625 . . . . 0.0 111.113 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.6 mt -73.03 -37.92 54.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -75.41 -32.28 60.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.789 0.436 . . . . 0.0 110.613 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.85 -44.51 76.97 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.104 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -60.87 -37.15 81.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.587 0.63 . . . . 0.0 111.621 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -72.87 -25.26 61.03 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.758 0.423 . . . . 0.0 111.047 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.18 -11.03 28.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.144 0.577 . . . . 0.0 111.278 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.96 -23.64 55.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.228 0.611 . . . . 0.0 110.201 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.25 -11.07 56.51 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.261 0.224 . . . . 0.0 110.552 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -110.91 3.18 18.64 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.639 0.776 . . . . 0.0 111.672 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.1 t80 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.506 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 73.7 t80 . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -69.41 -38.04 77.74 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.544 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.7 m -69.62 -37.96 77.05 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.8 t90 -69.05 -31.2 69.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.741 -0.208 . . . . 0.0 110.993 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.6 tp -83.22 -35.15 25.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.576 0.35 . . . . 0.0 111.313 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -63.01 -26.8 69.02 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.005 0.366 . . . . 0.0 110.209 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.64 -27.03 61.04 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 122.8 0.44 . . . . 0.0 111.318 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.2 mm -72.05 -36.25 56.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.94 -36.34 56.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -78.83 -28.87 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.475 0.579 . . . . 0.0 111.274 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.91 -25.28 52.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.152 0.433 . . . . 0.0 110.407 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.2 m -80.63 -28.14 37.03 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 122.448 -0.158 . . . . 0.0 110.597 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.16 -32.84 56.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.087 0.403 . . . . 0.0 111.205 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.45 -26.19 51.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t30 . . . . . 0 CA--C 1.533 0.291 0 C-N-CA 122.454 0.302 . . . . 0.0 110.327 174.601 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 7' ' ' ASP . 31.1 m . . . . . 0 CA--C 1.528 0.114 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 6' ' ' THR . 3.6 p30 -55.28 -17.34 4.44 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.164 0.585 . . . . 0.0 112.385 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -66.23 -53.18 40.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.111 -0.368 . . . . 0.0 110.418 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -84.48 -26.13 7.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.779 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -69.69 -28.99 66.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.642 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.1 t -82.26 -28.22 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 118.839 0.745 . . . . 0.0 109.894 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.85 -37.63 70.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.641 -0.662 . . . . 0.0 110.368 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -69.57 -36.16 76.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 122.057 -0.402 . . . . 0.0 111.76 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -73.62 -23.78 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.038 0 CA-C-N 118.299 0.5 . . . . 0.0 111.205 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -79.69 -14.64 58.62 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.408 0.283 . . . . 0.0 110.335 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -93.18 3.2 56.08 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.632 0.773 . . . . 0.0 112.028 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.54 1.24 43.5 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 119.75 -0.472 . . . . 0.0 113.345 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -92.69 84.24 4.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.025 0.912 . . . . 0.0 109.558 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -65.09 -20.11 66.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.655 0.382 . . . . 0.0 110.659 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -61.72 -24.54 66.86 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.142 0.577 . . . . 0.0 111.007 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.36 -18.79 40.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 119.62 -0.228 . . . . 0.0 110.873 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -77.38 -36.83 53.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.51 -41.95 98.07 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.9 mt -76.53 -18.41 58.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.628 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 tp -81.97 -42.87 18.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.713 0.233 . . . . 0.0 110.659 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 m -69.83 -27.03 31.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.538 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -66.23 -26.86 39.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 CA-C-N 119.859 1.209 . . . . 0.0 111.129 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -69.44 -33.27 72.7 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.016 0.436 . . . . 0.0 109.919 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -100.27 -8.71 23.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.349 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -61.55 -30.08 70.42 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.234 0.613 . . . . 0.0 110.824 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -86.75 -29.5 22.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 121.994 0.118 . . . . 0.0 111.084 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -76.35 -41.22 49.0 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 m -82.79 -24.86 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 118.062 0.392 . . . . 0.0 111.064 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.15 -25.23 63.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -76.81 -46.27 25.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.834 0.35 . . . . 0.0 110.817 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.06 -24.62 59.53 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.595 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 46' ' ' VAL . 2.4 p -88.8 -19.95 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 118.139 0.427 . . . . 0.0 112.146 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.3 m -66.6 -9.93 40.41 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.36 0.527 . . . . 0.0 112.245 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -95.11 -3.75 47.46 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.229 0.468 . . . . 0.0 111.671 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -111.03 -20.63 12.34 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.854 0.462 . . . . 0.0 110.997 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -141.83 152.63 62.93 Favored Pre-proline 0 C--N 1.34 0.176 0 C-N-CA 124.057 0.943 . . . . 0.0 109.541 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.54 167.43 24.17 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.716 2.944 . . . . 0.0 111.249 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.7 m -65.58 -11.77 47.09 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.054 0.542 . . . . 0.0 112.418 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.81 -18.86 53.6 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.609 -0.55 . . . . 0.0 112.795 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.47 -6.98 11.71 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 117.808 0.804 . . . . 0.0 112.035 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.531 HG23 HG13 ' A' ' 37' ' ' VAL . 7.6 p -66.25 -36.04 11.95 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 46' ' ' VAL . 83.2 Cg_endo -73.68 -24.37 15.88 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 CA-C-N 121.697 1.642 . . . . 0.0 111.246 -172.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.5 -30.49 29.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.07 -30.2 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 122.556 0.342 . . . . 0.0 110.133 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -72.16 -33.53 47.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -72.5 -42.9 64.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -65.59 -30.71 71.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.418 0.554 . . . . 0.0 109.595 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.57 -29.3 66.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 117.746 0.248 . . . . 0.0 110.952 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -85.18 -28.92 25.14 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.299 0.5 . . . . 0.0 111.385 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 99.2 mt -72.93 -36.87 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -77.76 -31.07 51.82 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.445 0.698 . . . . 0.0 111.015 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.67 -42.47 74.13 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.121 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -62.05 -38.33 88.34 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.536 0.607 . . . . 0.0 111.485 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.23 -25.78 62.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.622 0.369 . . . . 0.0 111.166 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.34 -10.53 29.86 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.967 0.507 . . . . 0.0 111.395 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.5 tp -75.24 -24.53 57.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.972 0.509 . . . . 0.0 110.249 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.09 -10.25 52.47 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.454 0.302 . . . . 0.0 110.473 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.0 m -110.83 0.75 17.36 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.647 0.779 . . . . 0.0 111.662 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.5 t80 . . . . . 0 N--CA 1.454 -0.269 0 C-N-CA 123.103 0.561 . . . . 0.0 109.68 176.962 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 N--CA 1.455 -0.222 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -68.88 -37.15 78.86 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.737 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.0 m -69.41 -39.61 77.82 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -67.37 -32.96 74.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.95 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.3 tp -81.12 -34.11 32.77 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.726 0.41 . . . . 0.0 111.515 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.4 m-30 -64.0 -27.37 69.07 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.074 -0.391 . . . . 0.0 110.431 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -75.68 -25.04 56.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.165 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.5 mm -70.29 -39.25 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-N 118.296 0.498 . . . . 0.0 109.726 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.56 -37.06 57.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.06 -30.66 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-N 118.469 0.577 . . . . 0.0 111.43 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -76.07 -24.55 55.1 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.969 -0.457 . . . . 0.0 110.167 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.7 m -77.34 -29.37 53.4 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.08 62.5 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.877 0.308 . . . . 0.0 110.973 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.44 -29.7 57.08 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.6 t30 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-N 116.828 -0.169 . . . . 0.0 110.615 176.524 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 7' ' ' ASP . 24.9 m . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.469 ' H ' HG22 ' A' ' 6' ' ' THR . 3.5 p30 -55.52 -17.67 5.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.154 0.582 . . . . 0.0 112.222 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.69 -52.81 40.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.423 ' H ' HG12 ' A' ' 9' ' ' VAL . 2.8 p -85.94 -25.9 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 122.85 0.46 . . . . 0.0 110.882 -176.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mp -69.44 -28.18 65.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.909 -0.494 . . . . 0.0 110.515 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.3 t -81.14 -28.54 10.9 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 CA-C-N 118.398 0.545 . . . . 0.0 109.839 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 38.8 mt-10 -72.45 -34.7 67.94 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.824 -0.547 . . . . 0.0 110.271 174.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -68.98 -39.79 79.2 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.688 0.395 . . . . 0.0 111.257 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 m -72.94 -24.16 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 117.698 0.226 . . . . 0.0 111.054 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -78.67 -20.5 50.07 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.887 0.312 . . . . 0.0 110.301 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -81.42 -5.22 57.68 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.328 0.651 . . . . 0.0 111.799 174.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.88 0.38 34.05 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.487 -0.618 . . . . 0.0 112.79 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -87.68 83.96 7.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.008 0.904 . . . . 0.0 109.471 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -66.39 -20.6 66.11 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.683 0.393 . . . . 0.0 110.6 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -60.77 -24.92 66.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.998 0.519 . . . . 0.0 110.834 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.26 -18.77 41.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 119.583 -0.246 . . . . 0.0 111.07 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -76.51 -36.85 57.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -62.49 -40.76 97.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.74 -18.76 59.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.521 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.0 tp -83.7 -47.81 10.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.39 0.276 . . . . 0.0 110.885 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.89 -25.08 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.383 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.3 p -70.37 -26.63 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 119.329 0.968 . . . . 0.0 110.681 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -68.65 -33.13 73.47 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -99.66 -8.91 23.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.352 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -62.62 -27.2 69.04 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.4 0.545 . . . . 0.0 110.609 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -86.12 -30.82 22.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -76.9 -42.23 40.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.3 m -81.59 -25.36 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 118.158 0.435 . . . . 0.0 110.911 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.482 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.86 -22.89 62.25 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.177 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.0 t -76.53 -43.38 39.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.3 -25.22 36.66 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 46' ' ' VAL . 2.8 p -87.35 -18.45 8.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.089 0 CA-C-N 118.094 0.406 . . . . 0.0 111.226 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.2 t -68.21 -9.51 47.62 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 174.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -90.86 -3.87 57.03 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.659 0.784 . . . . 0.0 111.484 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.35 -14.45 8.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.75 0.42 . . . . 0.0 111.807 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.41 153.46 59.08 Favored Pre-proline 0 N--CA 1.462 0.148 0 C-N-CA 123.953 0.901 . . . . 0.0 109.466 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.72 164.5 31.07 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.559 2.839 . . . . 0.0 110.756 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.3 p -66.61 -10.11 42.41 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.06 -18.33 56.07 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 118.262 0.483 . . . . 0.0 112.093 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.36 -5.09 11.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.427 0.613 . . . . 0.0 111.451 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.525 HG23 HG13 ' A' ' 37' ' ' VAL . 5.2 p -67.3 -33.08 5.21 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 117.707 -1.139 . . . . 0.0 113.368 -177.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 97.0 Cg_endo -76.84 -25.25 9.28 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 CA-C-N 122.12 1.793 . . . . 0.0 111.687 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.4 -29.79 30.59 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -78.06 -25.84 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.97 -37.07 59.71 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -71.31 -42.85 68.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -67.83 -26.45 66.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.233 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.41 -27.9 61.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.668 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -85.26 -29.67 24.43 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.531 0.605 . . . . 0.0 111.069 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.99 -37.46 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 175.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -75.58 -32.93 60.54 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.197 0.599 . . . . 0.0 110.538 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.72 -42.75 77.21 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 119.141 -0.456 . . . . 0.0 110.733 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -62.49 -37.62 86.68 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.906 0.776 . . . . 0.0 111.255 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -71.53 -25.12 62.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.679 0.392 . . . . 0.0 111.014 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.98 -11.77 27.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.132 0.573 . . . . 0.0 111.508 176.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -74.72 -24.53 58.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 110.264 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.56 -10.79 58.0 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.276 0.23 . . . . 0.0 110.506 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -109.43 1.92 20.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.649 0.78 . . . . 0.0 111.722 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.5 t80 . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 123.092 0.557 . . . . 0.0 109.732 177.534 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.6 t80 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -69.03 -37.64 78.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.67 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -69.65 -37.25 76.67 Favored 'General case' 0 C--O 1.227 -0.095 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -70.22 -32.18 69.93 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 122.246 0.218 . . . . 0.0 110.953 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.9 tp -81.89 -34.78 29.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.644 0.378 . . . . 0.0 111.319 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -63.63 -28.0 69.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -72.82 -26.04 61.35 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 122.817 0.447 . . . . 0.0 111.527 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mm -72.84 -38.38 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.159 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.85 -35.44 59.94 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 p -77.41 -31.87 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 118.344 0.52 . . . . 0.0 111.245 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -77.87 -23.96 48.67 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.038 0.381 . . . . 0.0 110.649 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.6 m -77.3 -30.45 54.17 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.44 -32.41 62.62 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.726 0.239 . . . . 0.0 111.415 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.53 -30.89 61.94 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.9 t30 . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 176.917 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 7' ' ' ASP . 29.9 m . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 6' ' ' THR . 3.7 p30 -54.94 -18.87 5.55 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.103 0.561 . . . . 0.0 112.284 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -65.79 -52.28 52.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 9' ' ' VAL . 2.9 p -85.68 -25.6 6.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 122.795 0.438 . . . . 0.0 110.923 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 mp -71.67 -28.34 63.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.783 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.4 t -81.86 -28.97 9.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 118.442 0.565 . . . . 0.0 110.055 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.92 -37.15 72.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.719 -0.613 . . . . 0.0 110.206 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -69.82 -37.88 76.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.494 0.318 . . . . 0.0 111.532 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.21 -23.98 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 O-C-N 121.901 -0.499 . . . . 0.0 110.907 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -80.44 -14.62 58.14 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.21 -0.306 . . . . 0.0 110.398 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -93.13 3.65 55.34 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.623 0.769 . . . . 0.0 111.709 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.47 2.79 47.34 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.168 172.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -95.92 84.02 3.79 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.04 0.92 . . . . 0.0 110.086 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -65.58 -20.34 66.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.276 0.63 . . . . 0.0 110.966 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -61.02 -23.81 65.7 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 122.883 0.473 . . . . 0.0 110.871 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.87 -19.03 41.78 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.583 -0.246 . . . . 0.0 110.835 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -76.57 -37.23 56.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.5 -41.86 97.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -76.62 -18.49 58.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.451 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.2 tp -81.0 -43.04 20.22 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.253 -0.279 . . . . 0.0 110.805 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.07 -27.1 31.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.459 -175.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -65.72 -27.3 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 119.97 1.259 . . . . 0.0 111.216 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -70.56 -32.29 69.64 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.121 0.419 . . . . 0.0 109.954 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -100.02 -8.65 23.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.381 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -62.69 -27.97 69.61 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.421 0.689 . . . . 0.0 110.446 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -86.31 -29.67 22.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.475 -0.141 . . . . 0.0 110.859 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -76.67 -43.04 39.51 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -80.92 -25.89 10.84 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 O-C-N 121.928 -0.483 . . . . 0.0 111.145 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -71.55 -22.16 61.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.049 0.386 . . . . 0.0 110.104 176.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 t -76.51 -41.62 46.27 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.123 0.169 . . . . 0.0 110.58 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.96 -25.29 30.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.529 HG13 HG23 ' A' ' 46' ' ' VAL . 2.6 p -88.25 -18.95 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.036 0 CA-C-N 118.165 0.439 . . . . 0.0 111.55 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.5 t -68.61 -8.88 45.98 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 173.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -90.91 -3.87 56.99 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.033 0.933 . . . . 0.0 111.289 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -121.37 -17.5 7.59 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.831 0.452 . . . . 0.0 111.458 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.4 m -141.09 153.19 66.69 Favored Pre-proline 0 N--CA 1.463 0.176 0 C-N-CA 123.406 0.682 . . . . 0.0 109.441 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.82 165.62 29.12 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.718 2.946 . . . . 0.0 111.17 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.7 m -64.87 -11.02 32.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.09 -18.09 56.47 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.272 0.487 . . . . 0.0 112.07 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -116.64 -6.11 11.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.223 0.511 . . . . 0.0 111.642 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.529 HG23 HG13 ' A' ' 37' ' ' VAL . 6.0 p -67.66 -33.18 5.03 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.592 -1.195 . . . . 0.0 113.462 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 98.2 Cg_endo -76.51 -25.5 9.53 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 CA-C-N 122.23 1.832 . . . . 0.0 111.511 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.43 -30.39 30.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.415 -0.178 . . . . 0.0 110.593 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -77.15 -27.02 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.3 t -72.27 -35.44 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -72.05 -42.61 66.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.03 -28.04 67.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.24 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.99 -28.4 63.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.458 -0.305 . . . . 0.0 110.793 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -85.08 -29.97 24.44 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.576 0.625 . . . . 0.0 111.216 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 99.0 mt -72.05 -37.23 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -76.64 -32.37 57.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.118 0.567 . . . . 0.0 110.98 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.71 75.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.32 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -61.58 -38.7 88.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.383 0.538 . . . . 0.0 111.419 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -71.53 -26.12 62.52 Favored 'General case' 0 C--O 1.228 -0.05 0 C-N-CA 122.779 0.431 . . . . 0.0 111.175 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.8 -11.29 31.6 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.063 0.545 . . . . 0.0 111.462 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.1 tp -75.74 -25.81 56.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.689 0.396 . . . . 0.0 110.45 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.86 -10.7 59.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.511 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.6 m -113.37 0.08 14.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.796 0.838 . . . . 0.0 111.213 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.4 t80 . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.367 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 59.2 t80 . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -68.59 -35.74 77.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.97 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.8 m -70.86 -37.84 73.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -70.47 -32.21 69.66 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.249 0.22 . . . . 0.0 111.016 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.8 tp -81.33 -34.77 31.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.602 0.361 . . . . 0.0 111.516 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.2 m-30 -63.52 -28.4 69.92 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 122.086 -0.383 . . . . 0.0 110.109 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -74.01 -25.08 59.69 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.552 0.341 . . . . 0.0 111.363 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.67 -38.24 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.02 -36.26 59.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -174.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.2 p -78.21 -31.23 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-N 118.329 0.513 . . . . 0.0 111.471 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.86 -24.02 52.65 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.137 0.426 . . . . 0.0 110.091 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.5 m -78.73 -29.64 45.43 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.77 -32.97 66.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.876 0.307 . . . . 0.0 110.906 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.24 -30.13 57.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.347 -0.22 . . . . 0.0 110.477 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.5 t30 . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.674 0.274 . . . . 0.0 110.513 177.251 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 7' ' ' ASP . 32.4 m . . . . . 0 C--O 1.232 0.165 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.469 ' N ' HG22 ' A' ' 6' ' ' THR . 3.4 p30 -55.6 -17.1 4.87 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 123.384 0.673 . . . . 0.0 112.182 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.0 tp60 -66.36 -52.76 43.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 121.825 -0.547 . . . . 0.0 110.159 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.408 ' H ' HG12 ' A' ' 9' ' ' VAL . 3.0 p -85.02 -25.79 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 C-N-CA 122.626 0.37 . . . . 0.0 110.9 -177.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.96 -28.54 64.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.079 -0.388 . . . . 0.0 110.841 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.2 t -82.44 -29.18 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 CA-C-N 118.683 0.674 . . . . 0.0 109.771 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.6 -40.92 76.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.514 -0.741 . . . . 0.0 109.971 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -68.39 -36.9 79.83 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.051 0.54 . . . . 0.0 112.204 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -70.47 -22.56 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.051 0 O-C-N 121.489 -0.757 . . . . 0.0 110.43 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -81.03 -14.56 57.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 119.592 -0.242 . . . . 0.0 110.67 174.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -80.41 -6.4 58.0 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.156 0.435 . . . . 0.0 110.759 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.61 4.02 52.57 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.6 0.619 . . . . 0.0 112.187 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -89.6 84.06 6.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.802 0.801 . . . . 0.0 109.487 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -65.68 -19.27 65.84 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.73 0.412 . . . . 0.0 110.774 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -60.32 -24.99 65.44 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 122.753 0.421 . . . . 0.0 110.977 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.57 -18.59 40.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.595 -0.24 . . . . 0.0 110.9 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -77.66 -37.38 50.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -61.32 -41.22 96.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.8 mt -76.94 -18.32 58.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.6 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.1 tp -82.13 -41.9 19.83 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.995 -0.441 . . . . 0.0 110.637 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.8 -26.76 28.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.587 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.4 m -66.58 -27.21 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.933 1.242 . . . . 0.0 111.253 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -70.84 -31.85 68.69 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -100.27 -8.73 23.13 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.376 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -62.95 -28.15 69.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.195 0.598 . . . . 0.0 110.514 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -86.61 -29.42 22.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.448 0.165 . . . . 0.0 110.749 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -77.39 -42.39 36.51 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -80.82 -26.69 11.04 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 118.127 0.421 . . . . 0.0 110.988 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.59 -22.53 62.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 t -77.78 -41.99 35.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.413 0.149 . . . . 0.0 110.668 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.6 -24.97 36.11 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.515 HG13 HG23 ' A' ' 46' ' ' VAL . 2.7 p -88.4 -18.8 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.18 0.446 . . . . 0.0 111.407 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -67.28 -11.09 56.62 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.986 -0.446 . . . . 0.0 110.043 173.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -86.7 -6.46 58.84 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.594 0.758 . . . . 0.0 111.535 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -122.66 -13.09 8.01 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -143.32 153.07 58.93 Favored Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 123.642 0.777 . . . . 0.0 109.211 173.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.08 164.0 33.72 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.66 2.907 . . . . 0.0 110.997 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.0 m -64.84 -10.64 29.78 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.06 -19.17 54.24 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 118.147 0.43 . . . . 0.0 112.166 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.18 -4.92 11.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.501 0.651 . . . . 0.0 111.619 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.515 HG23 HG13 ' A' ' 37' ' ' VAL . 5.3 p -67.43 -32.76 4.79 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.4 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 96.7 Cg_endo -76.78 -24.87 9.73 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 CA-C-N 122.095 1.784 . . . . 0.0 111.79 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.76 -30.8 32.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.289 -0.257 . . . . 0.0 110.528 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.1 t -77.98 -25.49 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.8 t -73.25 -35.42 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.38 -42.22 68.69 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -66.03 -30.84 71.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.78 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.1 -28.39 65.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.477 -0.296 . . . . 0.0 110.932 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -85.38 -28.73 24.97 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.519 0.6 . . . . 0.0 111.386 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.3 mt -72.7 -37.69 56.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -76.91 -32.81 57.66 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.105 0.562 . . . . 0.0 110.92 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.49 -42.16 79.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.279 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -61.82 -39.29 91.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.601 0.637 . . . . 0.0 111.542 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -70.82 -25.12 62.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.73 0.412 . . . . 0.0 111.289 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.22 -11.93 27.18 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.23 0.612 . . . . 0.0 111.419 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.0 tp -74.94 -24.82 58.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.005 0.522 . . . . 0.0 110.444 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.85 -10.75 51.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.271 0.228 . . . . 0.0 110.676 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.3 m -110.93 2.27 18.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.535 0.734 . . . . 0.0 111.7 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 t80 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.655 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.6 t80 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -69.56 -36.67 76.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.479 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.2 m -70.4 -34.23 72.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 62.0 t90 -76.21 -26.83 56.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 122.908 0.483 . . . . 0.0 111.325 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.8 tp -86.25 -35.19 20.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.22 -0.3 . . . . 0.0 111.289 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -63.91 -30.63 71.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -74.49 -22.17 59.21 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 117.999 0.363 . . . . 0.0 111.817 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.4 mm -70.26 -37.61 71.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.716 0.689 . . . . 0.0 109.504 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.97 -37.38 55.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 p -78.91 -29.35 14.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 CA-C-N 118.45 0.568 . . . . 0.0 111.336 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -76.13 -24.82 54.92 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.884 -0.51 . . . . 0.0 109.975 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.8 m -80.1 -30.74 39.21 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 122.206 -0.309 . . . . 0.0 110.246 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.56 -34.63 65.24 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.13 0.423 . . . . 0.0 111.016 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.44 -27.77 52.27 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.5 t30 . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 176.648 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 7' ' ' ASP . 32.7 m . . . . . 0 C--O 1.23 0.075 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.469 ' N ' HG22 ' A' ' 6' ' ' THR . 3.7 p30 -55.18 -17.38 4.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.498 0.719 . . . . 0.0 112.11 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.44 -53.25 37.62 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.101 -0.375 . . . . 0.0 110.144 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 p -85.08 -26.14 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.965 0.506 . . . . 0.0 110.781 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.78 -28.66 64.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.758 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.7 t -82.22 -28.78 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 118.791 0.723 . . . . 0.0 110.013 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.93 -37.65 72.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.584 -0.697 . . . . 0.0 110.401 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -71.64 -35.4 70.38 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.133 -0.354 . . . . 0.0 111.952 -175.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -73.24 -23.88 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.174 0.443 . . . . 0.0 111.036 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -80.13 -14.96 58.07 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -92.39 3.32 55.68 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.47 0.708 . . . . 0.0 111.922 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.06 0.11 41.42 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.583 -0.565 . . . . 0.0 113.471 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -93.95 84.15 4.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.164 0.982 . . . . 0.0 109.294 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.2 tm0? -65.66 -19.91 66.09 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.82 0.448 . . . . 0.0 110.438 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -62.57 -22.44 66.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.102 0.561 . . . . 0.0 111.119 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.66 -18.78 43.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.842 0.292 . . . . 0.0 110.494 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -76.88 -36.11 56.97 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -61.98 -40.39 95.43 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.96 -19.07 59.04 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.292 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 tp -83.67 -48.08 10.55 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 119.634 -0.222 . . . . 0.0 111.126 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -66.72 -25.04 33.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.616 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.28 -26.74 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 119.399 1.0 . . . . 0.0 111.083 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -68.72 -31.68 70.93 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -101.52 -9.01 21.4 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -62.08 -28.38 69.57 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.389 0.54 . . . . 0.0 110.332 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -86.69 -31.39 21.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.716 -0.105 . . . . 0.0 110.716 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -75.74 -42.17 51.26 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -80.84 -25.22 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 O-C-N 121.739 -0.601 . . . . 0.0 110.873 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.458 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -69.39 -23.43 63.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.115 0.416 . . . . 0.0 110.149 176.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -76.27 -44.47 37.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 pp -79.05 -25.21 43.2 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.513 HG13 HG23 ' A' ' 46' ' ' VAL . 3.2 p -88.51 -17.95 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 118.108 0.413 . . . . 0.0 111.626 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.7 t -67.17 -9.36 39.17 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.941 -0.474 . . . . 0.0 110.009 173.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -86.71 -7.65 58.11 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.346 0.659 . . . . 0.0 111.501 176.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -120.9 -13.8 8.58 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 m -144.42 154.23 56.54 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 124.152 0.981 . . . . 0.0 109.182 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.62 164.45 33.0 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.368 2.712 . . . . 0.0 110.881 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -66.51 -9.96 39.96 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.11 -19.14 54.21 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.05 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -116.35 -5.2 11.79 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.554 0.677 . . . . 0.0 111.621 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.513 HG23 HG13 ' A' ' 37' ' ' VAL . 5.0 p -66.39 -32.69 5.63 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.67 -1.157 . . . . 0.0 113.703 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 91.4 Cg_endo -76.75 -25.46 9.2 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 CA-C-N 121.989 1.746 . . . . 0.0 111.458 -176.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.06 -30.39 31.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.132 -0.355 . . . . 0.0 110.57 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.2 t -75.53 -27.21 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.92 -35.74 55.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -71.85 -43.17 65.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -67.28 -27.91 67.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.089 0.404 . . . . 0.0 110.18 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.62 -27.17 61.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.7 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -84.58 -31.32 24.39 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.538 0.608 . . . . 0.0 110.918 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.9 mt -70.08 -36.94 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -78.03 -33.75 50.9 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.443 0.297 . . . . 0.0 110.921 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.29 -39.85 89.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.585 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -64.94 -36.77 85.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.521 0.601 . . . . 0.0 111.07 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -71.58 -17.74 62.27 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.943 0.497 . . . . 0.0 110.78 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.28 -10.8 17.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.137 0.575 . . . . 0.0 111.439 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.1 tp -76.06 -23.95 55.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.279 0.631 . . . . 0.0 110.155 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.62 -9.12 47.82 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.663 0.385 . . . . 0.0 110.463 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.1 m -113.17 4.8 16.72 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.114 0.966 . . . . 0.0 111.528 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.3 t80 . . . . . 0 C--O 1.233 0.186 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.232 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.0 t80 . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -69.76 -36.51 75.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.705 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.3 m -70.78 -34.31 71.66 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -74.23 -28.84 61.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.061 0.544 . . . . 0.0 110.947 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.7 tp -86.24 -35.36 20.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.558 0.343 . . . . 0.0 111.387 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -62.74 -33.62 75.51 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -74.86 -21.86 59.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.678 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.8 mm -68.71 -39.91 80.89 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 118.836 0.744 . . . . 0.0 109.231 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.04 -34.47 64.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.65 -30.92 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.082 0 CA-C-N 118.713 0.688 . . . . 0.0 111.05 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -78.51 -19.02 53.89 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.979 -0.451 . . . . 0.0 110.522 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 81.4 m -78.64 -31.45 46.89 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.66 -35.55 62.81 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.743 0.247 . . . . 0.0 111.188 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -77.67 -24.03 49.45 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.9 t30 . . . . . 0 CA--C 1.532 0.272 0 O-C-N 122.361 -0.212 . . . . 0.0 111.111 175.473 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 7' ' ' ASP . 23.4 m . . . . . 0 N--CA 1.461 0.124 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.471 ' N ' HG22 ' A' ' 6' ' ' THR . 3.2 p30 -55.29 -17.13 4.13 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.988 0.515 . . . . 0.0 112.165 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -66.96 -51.2 58.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.111 -0.368 . . . . 0.0 110.226 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.5 p -85.57 -26.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 122.772 0.429 . . . . 0.0 110.818 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.64 -29.16 67.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.252 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.66 -28.66 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 118.611 0.641 . . . . 0.0 110.154 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.94 -35.07 69.5 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.598 -0.689 . . . . 0.0 110.269 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -70.6 -37.37 73.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.451 0.3 . . . . 0.0 111.647 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -73.09 -23.69 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 118.139 0.427 . . . . 0.0 111.291 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -79.64 -16.42 55.81 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.362 0.265 . . . . 0.0 110.608 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -91.72 3.36 55.27 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.939 0.896 . . . . 0.0 111.88 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.25 3.11 48.03 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.782 -0.454 . . . . 0.0 113.28 173.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -97.99 83.64 3.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 117.923 0.862 . . . . 0.0 109.526 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 tm0? -67.01 -17.73 65.05 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.158 0.583 . . . . 0.0 110.62 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -60.67 -24.6 65.72 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.85 0.46 . . . . 0.0 110.927 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.0 -18.92 41.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 119.639 -0.22 . . . . 0.0 110.892 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -76.76 -37.22 56.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.26 -39.85 94.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.823 0.344 . . . . 0.0 110.282 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.4 -18.95 58.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.808 0.443 . . . . 0.0 111.335 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -83.48 -47.09 11.74 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.775 0.43 . . . . 0.0 111.008 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -69.5 -24.44 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.881 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.47 -26.27 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 119.231 0.923 . . . . 0.0 110.62 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -67.78 -33.93 75.8 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.444 ' HB3' HG23 ' A' ' 33' ' ' VAL . 78.1 m-85 -97.7 -8.93 27.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.41 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -63.58 -29.49 70.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.357 -0.839 . . . . 0.0 110.479 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -86.81 -32.04 20.53 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -83.87 -32.16 25.35 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 29' ' ' TYR . 61.3 t -73.32 -38.41 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -63.24 -25.78 68.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.919 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.3 t -72.9 -48.04 40.63 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.007 0.367 . . . . 0.0 110.942 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.417 HD21 ' CD1' ' A' ' 75' ' ' TYR . 3.7 pp -79.34 -27.17 42.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.553 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.584 HG13 HG23 ' A' ' 46' ' ' VAL . 2.1 p -84.93 -15.35 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 117.715 0.234 . . . . 0.0 111.463 -177.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.4 t -68.34 -11.86 60.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.977 -0.452 . . . . 0.0 109.973 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -84.8 -6.76 59.36 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.963 0.505 . . . . 0.0 111.686 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -122.31 -12.52 8.23 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 m -146.31 153.96 48.95 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 123.509 0.723 . . . . 0.0 109.118 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.19 162.76 36.99 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.469 2.779 . . . . 0.0 111.07 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.3 p -65.08 -10.14 27.95 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.18 -19.04 54.46 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.194 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -116.15 -5.03 11.9 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.591 0.696 . . . . 0.0 111.224 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.584 HG23 HG13 ' A' ' 37' ' ' VAL . 6.3 p -66.85 -32.3 4.83 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -176.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 85.0 Cg_endo -78.17 -22.81 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 CA-C-N 121.789 1.674 . . . . 0.0 111.162 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -81.56 -28.82 33.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.526 0.203 . . . . 0.0 110.499 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.97 -27.79 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.58 -37.06 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -70.18 -42.91 71.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.3 -27.25 65.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.23 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -35.45 70.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -74.98 -33.7 61.9 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 118.256 0.48 . . . . 0.0 111.788 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.3 mt -70.23 -38.73 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -74.38 -31.95 62.55 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.144 0.578 . . . . 0.0 110.462 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.32 -44.85 70.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.249 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -61.36 -37.14 82.29 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.913 0.779 . . . . 0.0 111.329 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -71.65 -25.88 62.32 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 122.663 0.385 . . . . 0.0 110.989 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.23 -11.18 28.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.145 0.578 . . . . 0.0 111.393 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.9 tp -75.36 -24.45 57.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.243 0.617 . . . . 0.0 110.277 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.99 -10.77 53.12 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 173.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.7 m -108.22 3.76 24.0 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.668 0.787 . . . . 0.0 111.856 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.2 t80 . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 123.11 0.564 . . . . 0.0 109.994 178.754 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 64.7 t80 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -69.72 -34.89 74.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.037 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 88.5 m -76.03 -32.66 59.45 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 57.3 t90 -72.92 -28.0 62.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.56 0.344 . . . . 0.0 110.66 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.5 tp -85.87 -37.45 19.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.394 0.277 . . . . 0.0 111.167 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.417 ' CD1' HD21 ' A' ' 36' ' ' LEU . 19.4 m-85 -69.33 -20.6 63.87 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.942 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -77.94 -21.89 50.38 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.445 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.9 mm -71.63 -37.42 63.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.82 -39.64 66.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.56 -29.01 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 118.181 0.446 . . . . 0.0 111.07 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -76.46 -23.62 53.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.172 -0.33 . . . . 0.0 110.479 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.5 m -80.16 -29.12 38.73 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.27 -33.14 61.22 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.322 -0.236 . . . . 0.0 111.22 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -75.98 -28.58 57.92 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.3 t30 . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 174.6 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 7' ' ' ASP . 26.3 m . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.458 ' H ' HG22 ' A' ' 6' ' ' THR . 3.3 p30 -55.27 -17.21 4.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.087 0.555 . . . . 0.0 112.261 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -65.21 -53.52 43.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.725 0.298 . . . . 0.0 110.203 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 p -85.5 -26.23 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 123.038 0.535 . . . . 0.0 111.006 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.02 -28.83 64.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 122.065 -0.397 . . . . 0.0 110.957 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.7 t -82.58 -28.19 8.63 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 CA-C-N 118.562 0.619 . . . . 0.0 110.153 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.435 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 42.9 mt-10 -71.37 -35.74 71.2 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.561 -0.712 . . . . 0.0 110.36 175.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -71.22 -38.78 71.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.654 0.382 . . . . 0.0 111.637 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.05 -24.22 22.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 O-C-N 121.92 -0.488 . . . . 0.0 110.81 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -78.39 -18.78 54.56 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -79.12 -5.84 55.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.336 0.654 . . . . 0.0 111.21 172.135 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.95 2.54 48.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 123.235 0.445 . . . . 0.0 112.61 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.88 83.99 7.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 117.915 0.858 . . . . 0.0 109.505 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -64.98 -19.87 66.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.911 0.484 . . . . 0.0 110.714 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -60.27 -25.05 65.41 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.865 0.466 . . . . 0.0 111.096 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.89 -18.93 38.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.285 -0.259 . . . . 0.0 111.078 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -77.17 -36.93 54.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.74 -42.14 96.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.4 mt -76.2 -18.32 59.12 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.9 tp -82.27 -41.6 19.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.906 0.321 . . . . 0.0 111.009 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.2 m -72.26 -24.7 22.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.739 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.26 -26.87 37.23 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-N 119.915 1.234 . . . . 0.0 110.884 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -69.91 -31.7 69.61 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.415 ' HB3' HG23 ' A' ' 33' ' ' VAL . 66.6 m-85 -99.49 -8.76 24.21 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.328 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -62.98 -29.7 71.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.186 -0.946 . . . . 0.0 110.853 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -86.87 -32.09 20.42 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.379 0.14 . . . . 0.0 111.379 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -81.06 -33.69 33.26 Favored 'General case' 0 CA--C 1.527 0.082 0 O-C-N 122.037 -0.414 . . . . 0.0 111.995 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 29' ' ' TYR . 53.8 t -74.88 -37.18 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.513 0.725 . . . . 0.0 109.415 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.47 -27.22 69.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.531 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -73.67 -49.41 26.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.945 0.339 . . . . 0.0 111.191 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.4 HD21 ' CD1' ' A' ' 75' ' ' TYR . 3.3 pp -75.23 -25.02 57.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.151 -0.343 . . . . 0.0 111.211 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.47 ' CG1' HG23 ' A' ' 46' ' ' VAL . 1.4 p -86.76 -16.86 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.2 m -66.41 -12.4 56.82 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.807 -0.558 . . . . 0.0 111.669 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -92.87 -3.68 54.2 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.673 0.67 . . . . 0.0 111.941 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -113.11 -19.52 11.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.714 0.406 . . . . 0.0 111.419 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 m -142.65 152.87 60.8 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 123.472 0.709 . . . . 0.0 109.485 173.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.15 168.82 20.95 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.614 2.876 . . . . 0.0 111.446 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.9 m -65.14 -11.65 42.49 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.106 0.562 . . . . 0.0 112.404 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.8 -19.31 51.99 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.832 -0.427 . . . . 0.0 112.986 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -116.22 -5.64 11.85 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.601 0.701 . . . . 0.0 112.122 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.47 HG23 ' CG1' ' A' ' 37' ' ' VAL . 4.0 p -64.7 -34.73 11.34 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 46' ' ' VAL . 87.5 Cg_endo -73.9 -25.52 14.2 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 CA-C-N 121.738 1.656 . . . . 0.0 111.33 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.03 -27.68 28.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 122.449 -0.157 . . . . 0.0 110.735 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.4 t -80.45 -29.98 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.0 t -69.25 -35.96 70.33 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.84 -44.03 70.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -67.44 -30.3 69.99 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.834 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.34 -34.84 76.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -75.96 -34.41 59.83 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.105 0.412 . . . . 0.0 111.764 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.5 mt -71.01 -36.35 63.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -77.1 -33.29 56.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.248 0.619 . . . . 0.0 110.333 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.54 82.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 119.323 -0.37 . . . . 0.0 110.16 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -63.34 -37.71 88.33 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.66 0.664 . . . . 0.0 111.262 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -70.57 -20.07 62.82 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 122.862 0.465 . . . . 0.0 111.358 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 -10.43 18.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.01 0.524 . . . . 0.0 111.106 177.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.07 -24.06 58.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.282 0.633 . . . . 0.0 110.159 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.06 -9.8 43.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.4 m -111.8 1.43 16.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.76 0.824 . . . . 0.0 111.454 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 86.3 t80 . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.511 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.4 t80 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 119.577 -0.249 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -69.96 -37.61 75.85 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.379 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.1 m -70.39 -37.84 74.58 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -68.77 -33.43 73.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.87 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.8 tp -79.09 -35.91 41.59 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.178 0.191 . . . . 0.0 111.198 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.4 ' CD1' HD21 ' A' ' 36' ' ' LEU . 21.8 m-30 -69.43 -20.28 63.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.215 -0.303 . . . . 0.0 111.593 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -74.0 -26.44 60.44 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.4 mm -73.76 -36.1 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.08 -36.91 64.32 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 p -81.35 -28.74 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 118.119 0.418 . . . . 0.0 110.93 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -76.7 -25.41 53.57 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 117.817 0.28 . . . . 0.0 110.359 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.3 m -79.21 -29.73 42.98 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.92 -33.5 63.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.259 -0.276 . . . . 0.0 111.369 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -76.39 -31.07 57.76 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.1 t30 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 175.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 7' ' ' ASP . 27.3 m . . . . . 0 CA--C 1.524 -0.025 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 6' ' ' THR . 3.1 p30 -55.29 -18.04 5.64 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.257 0.623 . . . . 0.0 112.437 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -65.85 -52.45 50.22 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.82 -0.55 . . . . 0.0 110.041 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.409 ' H ' HG12 ' A' ' 9' ' ' VAL . 2.7 p -85.22 -26.03 6.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 C-N-CA 122.704 0.402 . . . . 0.0 111.022 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.73 -27.99 64.38 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.887 -0.508 . . . . 0.0 110.803 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.0 t -81.84 -28.63 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.04 0 CA-C-N 118.833 0.742 . . . . 0.0 110.077 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.72 -36.66 70.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.707 -0.62 . . . . 0.0 110.461 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -71.15 -35.89 71.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -72.71 -25.05 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 118.098 0.408 . . . . 0.0 110.945 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -79.49 -14.81 58.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.172 0.189 . . . . 0.0 110.521 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -92.74 3.23 56.01 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.908 0.883 . . . . 0.0 112.143 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.81 -0.49 39.07 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.558 172.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -93.47 84.06 4.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.107 0.953 . . . . 0.0 109.633 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -66.33 -19.98 65.96 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.52 0.328 . . . . 0.0 110.467 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -62.26 -23.08 66.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.218 0.607 . . . . 0.0 111.137 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.83 -18.92 42.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 117.786 0.266 . . . . 0.0 110.533 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -77.46 -36.63 52.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -61.45 -41.18 96.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -76.92 -18.54 58.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.593 0.357 . . . . 0.0 111.507 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.8 tp -81.41 -42.71 20.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 122.328 -0.232 . . . . 0.0 110.593 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.4 m -71.77 -24.39 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.863 -176.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.6 -26.45 35.45 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 119.944 1.247 . . . . 0.0 111.012 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -69.9 -31.73 69.68 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.432 ' HB3' HG23 ' A' ' 33' ' ' VAL . 60.8 m-85 -99.03 -8.85 24.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.343 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -63.07 -30.06 71.3 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.254 -0.904 . . . . 0.0 110.786 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -86.92 -31.73 20.54 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -81.27 -35.43 31.14 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.138 -0.351 . . . . 0.0 111.808 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 29' ' ' TYR . 61.1 t -72.39 -38.57 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.493 0.717 . . . . 0.0 109.175 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.482 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.49 -24.48 67.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.195 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.2 t -73.97 -45.7 48.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.297 -0.252 . . . . 0.0 111.088 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 pp -81.61 -28.29 33.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.726 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.568 HG13 HG23 ' A' ' 46' ' ' VAL . 2.3 p -83.78 -15.88 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 117.954 0.343 . . . . 0.0 111.552 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -68.89 -11.61 60.75 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.922 -0.486 . . . . 0.0 109.802 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -86.01 -4.72 59.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.245 0.618 . . . . 0.0 111.409 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.84 -16.12 7.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.008 0.523 . . . . 0.0 112.295 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.76 154.51 62.65 Favored Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 123.671 0.789 . . . . 0.0 109.517 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.72 164.01 32.98 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.671 2.914 . . . . 0.0 111.013 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.0 p -66.05 -10.33 39.04 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.56 -19.13 55.46 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.629 -0.54 . . . . 0.0 111.987 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.45 -5.08 11.74 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.68 0.74 . . . . 0.0 111.53 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.568 HG23 HG13 ' A' ' 37' ' ' VAL . 5.5 p -67.08 -32.8 5.1 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 75.3 Cg_endo -78.18 -22.8 9.52 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.699 1.643 . . . . 0.0 111.384 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.48 -28.65 31.06 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.308 -0.245 . . . . 0.0 110.492 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.9 t -77.94 -28.68 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.02 -36.85 75.87 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -71.27 -43.4 67.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.47 -27.59 66.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.142 0.428 . . . . 0.0 110.266 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.4 69.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -72.22 -35.37 68.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.491 0.587 . . . . 0.0 111.493 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.0 -40.99 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -76.7 -28.85 56.03 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.552 0.341 . . . . 0.0 111.143 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.95 -40.66 75.3 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 119.25 -0.405 . . . . 0.0 110.006 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.58 -38.22 89.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.846 0.748 . . . . 0.0 111.295 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.03 -24.65 62.4 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.977 0.511 . . . . 0.0 111.027 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.82 -11.26 27.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.025 0.53 . . . . 0.0 111.393 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.6 tp -75.29 -24.29 57.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.217 0.607 . . . . 0.0 110.138 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.15 -11.1 56.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.79 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.0 m -110.36 4.56 20.81 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.559 0.744 . . . . 0.0 111.615 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.1 t80 . . . . . 0 C--O 1.235 0.323 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.237 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.2 t80 . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -70.41 -36.86 74.28 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.421 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.0 m -71.84 -33.23 68.28 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -75.46 -27.25 58.82 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.381 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 tp -86.02 -35.94 20.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.377 0.271 . . . . 0.0 111.293 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -70.21 -20.64 63.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.083 -0.386 . . . . 0.0 111.745 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -76.63 -24.19 53.37 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.494 0.588 . . . . 0.0 110.56 172.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.8 mm -70.69 -41.2 77.63 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.7 74.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.67 -29.91 16.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 118.193 0.452 . . . . 0.0 110.791 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.65 -19.14 53.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.844 -0.535 . . . . 0.0 110.409 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -83.1 -26.73 30.75 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.069 0.395 . . . . 0.0 110.034 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.12 -36.13 64.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.94 -0.475 . . . . 0.0 110.333 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -74.03 -28.59 61.5 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 123.961 0.904 . . . . 0.0 111.065 177.236 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 7' ' ' ASP . 25.6 m . . . . . 0 CA--C 1.528 0.123 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.483 ' H ' HG22 ' A' ' 6' ' ' THR . 3.8 p30 -56.08 -17.73 7.82 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.663 0.385 . . . . 0.0 111.942 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -62.82 -53.44 54.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.6 p -86.0 -26.38 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.146 0.578 . . . . 0.0 110.896 -176.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.0 -28.7 64.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 119.086 -0.483 . . . . 0.0 110.964 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.1 t -82.64 -30.74 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 CA-C-N 118.862 0.756 . . . . 0.0 109.97 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.1 -41.62 81.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.812 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -69.66 -35.44 75.17 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.2 m -71.31 -22.19 22.22 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-N 118.554 0.616 . . . . 0.0 110.441 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -80.46 -14.79 57.98 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.858 0.299 . . . . 0.0 110.385 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -80.45 -8.04 59.39 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 122.006 -0.434 . . . . 0.0 110.908 172.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.86 2.47 45.97 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.464 0.554 . . . . 0.0 112.826 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.48 84.17 7.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.042 0.921 . . . . 0.0 109.505 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.97 -21.41 66.48 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.825 0.45 . . . . 0.0 110.417 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -61.72 -24.62 66.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.918 0.487 . . . . 0.0 111.239 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.19 -18.79 41.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.363 -0.211 . . . . 0.0 110.682 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -77.79 -35.57 51.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -62.56 -41.03 98.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.29 -19.0 59.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.201 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -83.68 -46.82 11.88 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.137 -0.352 . . . . 0.0 111.528 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.3 m -67.63 -25.49 33.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 118.654 -0.689 . . . . 0.0 111.34 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.7 -26.41 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 119.337 0.971 . . . . 0.0 110.893 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -68.62 -32.31 72.09 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -100.83 -8.66 22.42 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -63.07 -28.01 69.79 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 118.421 0.555 . . . . 0.0 110.758 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -85.83 -30.14 23.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -76.38 -43.25 41.49 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 m -81.35 -26.01 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.18 0.445 . . . . 0.0 111.24 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.53 -22.5 62.61 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 t -76.8 -43.14 37.88 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.594 0.235 . . . . 0.0 110.754 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.46 -25.1 39.06 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 46' ' ' VAL . 3.8 p -87.58 -18.54 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-N 118.007 0.367 . . . . 0.0 111.169 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -63.23 -13.55 39.1 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 171.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -89.32 -3.94 58.3 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.799 0.84 . . . . 0.0 111.78 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -122.51 -17.73 6.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.779 0.432 . . . . 0.0 111.815 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.27 153.68 66.62 Favored Pre-proline 0 N--CA 1.462 0.146 0 C-N-CA 123.353 0.661 . . . . 0.0 110.055 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.21 164.01 35.62 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.584 2.856 . . . . 0.0 110.755 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -66.29 -10.29 41.04 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.14 -18.61 57.33 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -116.52 -6.69 11.68 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.216 0.607 . . . . 0.0 111.258 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 37' ' ' VAL . 4.5 p -66.78 -33.11 5.72 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 117.811 -1.09 . . . . 0.0 113.772 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 86.8 Cg_endo -77.11 -25.01 9.12 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 122.004 1.752 . . . . 0.0 111.518 -175.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -81.97 -29.55 32.1 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.235 -0.29 . . . . 0.0 110.341 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.4 t -77.85 -27.52 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.3 -33.91 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -72.97 -42.52 63.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -66.13 -29.05 69.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.785 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.67 -29.53 64.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.755 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -85.04 -28.97 25.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.278 0.49 . . . . 0.0 111.362 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.4 mt -72.13 -38.42 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -75.01 -32.51 61.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.215 0.606 . . . . 0.0 110.652 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.94 -46.86 67.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.208 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -59.69 -37.19 78.14 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.613 0.642 . . . . 0.0 111.508 -175.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -72.66 -25.7 61.37 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.907 0.483 . . . . 0.0 111.253 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.18 -13.52 28.3 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.077 0.551 . . . . 0.0 111.548 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.8 tp -76.71 -25.81 53.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.293 0.637 . . . . 0.0 110.819 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.4 -12.74 61.91 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -112.48 -0.4 15.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.664 0.786 . . . . 0.0 111.909 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.9 t80 . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.35 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.0 t80 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -70.52 -43.62 69.27 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 118.505 0.593 . . . . 0.0 111.651 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -68.69 -33.2 73.55 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -72.82 -28.46 62.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.925 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.0 tp -85.89 -37.85 18.68 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.846 0.458 . . . . 0.0 111.034 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -60.09 -32.0 70.55 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.616 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -77.07 -21.3 54.62 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.107 -0.473 . . . . 0.0 111.951 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.72 -38.3 75.85 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.942 0.792 . . . . 0.0 109.492 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.62 -38.96 58.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.5 p -76.4 -31.84 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.064 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -75.88 -20.88 57.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.035 -0.416 . . . . 0.0 110.552 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 m -78.68 -30.46 46.16 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.99 -29.78 63.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 122.263 -0.273 . . . . 0.0 110.319 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -79.51 -28.94 41.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.332 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-N 118.771 0.714 . . . . 0.0 110.644 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 8' ' ' GLN . 5.8 t . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -59.86 -17.01 33.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.058 0.543 . . . . 0.0 110.763 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.485 ' H ' HG23 ' A' ' 6' ' ' THR . 19.2 tp60 -69.94 -52.27 25.84 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.539 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.2 -26.65 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 122.673 0.389 . . . . 0.0 110.934 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 mp -70.04 -30.08 67.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.841 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.9 t -80.59 -28.01 11.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-N 118.623 0.647 . . . . 0.0 110.0 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.32 -36.44 68.88 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.627 -0.671 . . . . 0.0 110.188 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -69.95 -37.13 75.75 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.506 0.322 . . . . 0.0 111.497 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.5 m -73.46 -23.62 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.06 0 CA-C-N 118.117 0.417 . . . . 0.0 111.224 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -79.95 -15.76 56.61 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.534 0.334 . . . . 0.0 110.72 174.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -92.23 4.34 53.47 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.728 0.811 . . . . 0.0 111.99 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.28 2.38 51.03 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 119.8 -0.445 . . . . 0.0 113.128 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -97.26 83.88 3.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.001 0.901 . . . . 0.0 109.771 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -66.95 -18.35 65.34 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -60.79 -23.96 65.43 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.73 0.412 . . . . 0.0 110.824 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.77 -18.61 43.55 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.378 -0.201 . . . . 0.0 110.849 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -77.48 -36.98 52.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -61.85 -40.11 94.21 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.46 -19.07 58.42 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.442 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.6 tp -83.62 -46.46 12.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.691 0.396 . . . . 0.0 111.008 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.87 -24.55 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.546 -175.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.48 -27.13 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.157 0.89 . . . . 0.0 110.674 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -67.39 -32.77 73.91 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.44 ' HB3' HG23 ' A' ' 33' ' ' VAL . 67.0 m-85 -98.67 -9.08 25.17 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -62.86 -28.82 70.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.474 -0.766 . . . . 0.0 110.48 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -86.91 -32.51 20.13 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -82.0 -33.03 30.3 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 122.054 -0.404 . . . . 0.0 111.998 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 29' ' ' TYR . 56.8 t -74.23 -38.33 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.85 -23.95 67.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.934 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.7 t -74.64 -46.07 40.65 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.944 0.338 . . . . 0.0 111.019 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.88 -29.47 39.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.181 -0.325 . . . . 0.0 111.473 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.565 HG13 HG23 ' A' ' 46' ' ' VAL . 2.4 p -83.4 -15.71 11.41 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.056 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.4 t -67.7 -11.72 58.94 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.858 -0.526 . . . . 0.0 109.887 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -84.7 -6.54 59.36 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.042 0.537 . . . . 0.0 111.644 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -122.5 -13.44 8.0 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.27 154.8 57.79 Favored Pre-proline 0 C--O 1.231 0.123 0 C-N-CA 123.923 0.889 . . . . 0.0 109.567 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.27 162.94 38.26 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.455 2.77 . . . . 0.0 110.758 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.4 p -65.88 -10.61 40.0 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.13 -18.89 54.9 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.81 -0.439 . . . . 0.0 112.05 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -116.35 -4.78 11.81 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.384 0.592 . . . . 0.0 111.677 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.565 HG23 HG13 ' A' ' 37' ' ' VAL . 5.7 p -66.51 -32.12 4.95 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 117.79 -1.1 . . . . 0.0 113.719 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 74.5 Cg_endo -78.18 -23.28 9.11 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 CA-C-N 121.904 1.716 . . . . 0.0 111.266 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -81.74 -27.74 33.69 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.96 -27.42 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.5 -34.59 62.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.67 -42.92 66.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -67.5 -28.58 67.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.383 0.538 . . . . 0.0 109.99 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.42 -36.42 74.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.2 -33.18 61.37 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.371 0.532 . . . . 0.0 111.967 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.57 -38.89 75.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -75.22 -31.72 60.94 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.081 0.552 . . . . 0.0 110.555 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.73 -43.93 71.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.236 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -61.28 -37.91 84.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.863 0.756 . . . . 0.0 111.36 -176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -71.68 -25.39 62.09 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.552 0.341 . . . . 0.0 111.062 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.93 -10.76 27.91 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.28 0.632 . . . . 0.0 111.441 176.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.4 tp -74.93 -23.84 58.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.104 0.562 . . . . 0.0 110.119 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.35 -11.48 51.36 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.509 0.324 . . . . 0.0 110.544 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -110.39 2.68 19.16 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.722 0.809 . . . . 0.0 111.851 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 t80 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.553 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.5 t80 . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -70.39 -36.57 74.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.62 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -72.02 -36.28 69.65 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 64.5 t90 -70.28 -32.88 70.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.678 -0.201 . . . . 0.0 110.747 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.0 tp -80.23 -37.15 33.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.597 0.359 . . . . 0.0 111.292 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -68.67 -20.27 64.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.133 -0.354 . . . . 0.0 111.63 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -74.69 -26.75 60.04 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.186 0.448 . . . . 0.0 110.323 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.76 -36.88 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.98 -40.08 63.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.63 -32.04 15.9 Favored 'Isoleucine or valine' 0 C--N 1.337 0.043 0 O-C-N 121.993 -0.442 . . . . 0.0 111.268 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -74.61 -24.33 58.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.014 -0.429 . . . . 0.0 110.3 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.1 m -78.08 -30.45 49.63 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 117.741 0.246 . . . . 0.0 110.44 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.29 -29.46 62.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.316 -0.24 . . . . 0.0 110.496 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.05 -31.05 55.9 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.339 0.137 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.837 176.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 7' ' ' ASP . 26.8 m . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 6' ' ' THR . 3.1 p30 -55.26 -18.19 5.81 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.005 0.522 . . . . 0.0 111.937 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -65.17 -51.37 61.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.238 -0.289 . . . . 0.0 110.453 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 p -84.06 -25.8 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 122.594 0.357 . . . . 0.0 110.631 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.89 -30.14 67.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.095 -0.378 . . . . 0.0 110.634 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.9 t -81.74 -28.48 9.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 CA-C-N 118.634 0.652 . . . . 0.0 110.029 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.05 -40.8 71.45 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.066 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -69.06 -34.35 75.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -70.49 -23.01 24.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 118.702 0.683 . . . . 0.0 110.398 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -81.15 -14.98 57.11 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 119.503 -0.284 . . . . 0.0 110.92 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.62 -7.0 59.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.287 0.494 . . . . 0.0 110.752 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.48 3.12 47.28 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.479 0.562 . . . . 0.0 112.779 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.81 83.98 5.33 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 117.954 0.877 . . . . 0.0 108.991 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -64.48 -17.73 64.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.091 0.557 . . . . 0.0 110.643 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -60.82 -25.62 66.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.991 0.516 . . . . 0.0 110.794 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.34 -18.99 43.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.781 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -76.54 -36.97 57.36 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -61.82 -39.8 93.04 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.8 mt -76.79 -18.98 58.09 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.352 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.6 tp -83.3 -47.36 11.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.554 0.342 . . . . 0.0 111.308 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.8 m -68.13 -25.69 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.222 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.56 -26.92 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.326 0.966 . . . . 0.0 110.915 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -67.82 -33.05 74.03 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -100.85 -8.73 22.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.308 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -62.16 -28.78 69.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.357 0.526 . . . . 0.0 110.42 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -86.1 -28.94 23.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 121.977 0.111 . . . . 0.0 110.763 174.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -78.4 -40.64 35.41 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 m -83.85 -23.53 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 O-C-N 121.966 -0.459 . . . . 0.0 110.835 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.63 -22.09 61.0 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.5 t -79.37 -40.23 30.67 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -81.38 -24.56 36.93 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 119.242 -0.409 . . . . 0.0 112.081 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.16 -21.08 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.674 0.67 . . . . 0.0 112.212 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -69.27 -10.53 58.24 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.845 -0.534 . . . . 0.0 111.611 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -92.28 -4.01 54.61 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 121.805 -0.56 . . . . 0.0 111.642 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -110.16 -23.57 11.19 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.644 0.378 . . . . 0.0 111.304 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.441 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 26.9 m -138.13 155.73 74.21 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 123.433 0.693 . . . . 0.0 109.461 175.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 94.2 Cg_endo -71.42 170.59 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.515 2.81 . . . . 0.0 111.339 -176.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.0 m -63.41 -11.91 26.76 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.118 0.567 . . . . 0.0 112.132 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.68 -16.28 58.61 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.593 -0.559 . . . . 0.0 112.598 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -116.3 -10.86 11.33 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 117.938 0.869 . . . . 0.0 111.801 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.416 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 8.0 p -62.89 -34.34 13.75 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 117.78 -1.105 . . . . 0.0 112.929 -177.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 46' ' ' VAL . 94.7 Cg_endo -77.5 -25.42 8.16 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 CA-C-N 121.927 1.724 . . . . 0.0 112.135 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.38 -33.11 23.87 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.191 0.45 . . . . 0.0 111.098 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.5 t -78.17 -25.39 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.16 -34.68 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -71.44 -42.05 68.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -66.36 -29.64 69.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.29 0.496 . . . . 0.0 110.0 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.01 -28.38 64.38 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 119.478 -0.296 . . . . 0.0 110.837 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -85.2 -29.33 24.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.523 0.601 . . . . 0.0 111.232 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -72.42 -37.86 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -76.54 -32.29 58.13 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.224 0.61 . . . . 0.0 110.804 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.92 77.65 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.463 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -62.06 -38.35 88.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.755 0.707 . . . . 0.0 111.329 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -71.36 -24.94 62.18 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.599 0.36 . . . . 0.0 111.336 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.7 -11.74 28.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.972 0.509 . . . . 0.0 111.454 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.0 tp -75.68 -24.24 56.29 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.951 0.5 . . . . 0.0 110.538 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.95 -10.37 57.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.468 0.307 . . . . 0.0 110.741 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.4 m -109.63 3.03 20.64 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.682 0.793 . . . . 0.0 111.442 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 t80 . . . . . 0 CA--C 1.531 0.224 0 C-N-CA 123.144 0.578 . . . . 0.0 109.817 178.023 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.0 t80 . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -69.72 -37.41 76.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.838 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.6 m -70.58 -33.78 71.47 Favored 'General case' 0 CA--C 1.527 0.068 0 O-C-N 121.895 -0.503 . . . . 0.0 109.757 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -73.96 -28.64 61.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.968 0.507 . . . . 0.0 110.881 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.7 tp -86.01 -36.0 20.03 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.804 0.442 . . . . 0.0 111.297 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -61.87 -32.57 72.94 Favored 'General case' 0 C--O 1.23 0.077 0 O-C-N 122.201 -0.312 . . . . 0.0 110.599 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -76.54 -21.24 55.95 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.075 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.3 mm -68.01 -38.83 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 118.979 0.809 . . . . 0.0 109.216 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.01 -38.38 53.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.26 -28.01 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 CA-C-N 118.919 0.781 . . . . 0.0 111.171 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -75.42 -24.76 57.15 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.105 0.411 . . . . 0.0 110.101 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.2 m -79.05 -29.97 43.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 176.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.83 -33.77 66.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.049 0.386 . . . . 0.0 111.025 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -77.96 -29.0 49.6 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.6 t30 . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.955 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 7' ' ' ASP . 47.0 m . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.499 ' N ' HG22 ' A' ' 6' ' ' THR . 3.1 p30 -55.69 -16.93 4.81 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.18 0.592 . . . . 0.0 112.479 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -67.25 -51.43 53.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 117.917 0.326 . . . . 0.0 110.127 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.5 p -85.66 -25.67 6.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 122.449 0.3 . . . . 0.0 110.981 -176.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -68.56 -30.13 68.84 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.276 -0.265 . . . . 0.0 110.439 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.8 t -81.58 -28.43 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 118.316 0.507 . . . . 0.0 110.215 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.63 -35.11 70.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.574 -0.704 . . . . 0.0 111.357 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -83.6 -25.41 30.88 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.454 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.07 -23.06 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 119.16 0.891 . . . . 0.0 109.358 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -78.86 -25.54 43.96 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.282 0.233 . . . . 0.0 110.68 174.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -89.33 -7.26 55.68 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.84 -3.52 8.0 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 118.835 -0.98 . . . . 0.0 114.889 170.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -86.61 83.72 7.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.331 1.566 . . . . 0.0 109.961 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -66.38 -21.79 66.24 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.39 -24.58 66.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.536 0.734 . . . . 0.0 110.897 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.69 -19.2 35.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 119.579 -0.248 . . . . 0.0 110.742 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -76.97 -35.89 56.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -63.22 -40.81 98.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.41 -18.81 59.83 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.154 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.9 tp -83.41 -47.09 11.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.521 0.328 . . . . 0.0 111.044 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.4 m -69.32 -24.53 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.717 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.5 p -69.24 -27.32 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 119.146 0.884 . . . . 0.0 110.771 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -67.11 -33.1 74.74 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.448 ' HB3' HG23 ' A' ' 33' ' ' VAL . 73.2 m-85 -98.4 -8.92 26.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.102 0.561 . . . . 0.0 112.326 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -63.32 -30.44 71.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.503 -0.748 . . . . 0.0 110.633 -174.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -87.03 -32.05 20.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -81.43 -34.74 31.32 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 29' ' ' TYR . 60.4 t -71.28 -38.86 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -63.56 -24.21 67.71 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.095 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.2 t -73.85 -48.16 33.13 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.851 0.296 . . . . 0.0 110.734 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 pp -79.98 -27.82 39.6 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.479 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.577 HG13 HG23 ' A' ' 46' ' ' VAL . 2.2 p -83.5 -15.74 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.334 -178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 t -68.92 -9.65 53.01 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.825 -0.547 . . . . 0.0 110.28 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -88.8 -3.91 58.64 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.408 0.683 . . . . 0.0 111.427 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.31 -16.2 7.45 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.2 m -143.17 153.78 60.34 Favored Pre-proline 0 C--N 1.338 0.069 0 C-N-CA 124.168 0.987 . . . . 0.0 109.613 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.28 164.25 33.15 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.483 2.788 . . . . 0.0 111.062 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.2 p -65.92 -10.25 37.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.43 -18.03 55.96 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -116.44 -5.64 11.74 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.527 0.664 . . . . 0.0 111.481 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.577 HG23 HG13 ' A' ' 37' ' ' VAL . 5.8 p -67.28 -32.03 4.27 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 117.755 -1.117 . . . . 0.0 114.001 -176.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 81.2 Cg_endo -78.12 -23.53 8.98 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 CA-C-N 121.758 1.664 . . . . 0.0 111.308 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.84 -29.24 32.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.5 t -77.09 -28.54 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.4 t -69.72 -35.71 66.79 Favored 'Isoleucine or valine' 0 C--N 1.337 0.063 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -70.95 -42.83 69.27 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -67.31 -28.77 68.28 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.731 -0.606 . . . . 0.0 109.873 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.23 -36.13 74.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -75.39 -32.65 60.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.353 0.524 . . . . 0.0 112.204 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -71.33 -38.16 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -76.22 -31.37 58.35 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.015 0.526 . . . . 0.0 110.458 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.27 -44.0 72.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.187 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -61.19 -38.1 85.32 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.812 0.733 . . . . 0.0 111.366 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -71.45 -25.32 62.25 Favored 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 122.596 0.358 . . . . 0.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.08 -10.74 27.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.184 0.594 . . . . 0.0 111.266 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.42 -23.97 57.04 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.999 0.52 . . . . 0.0 110.3 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.02 -11.47 48.35 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.335 0.254 . . . . 0.0 110.508 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.4 m -110.8 -2.24 16.25 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.622 0.769 . . . . 0.0 112.034 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.6 t80 . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.404 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.0 t80 . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -69.51 -36.97 76.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.863 -0.523 . . . . 0.0 110.708 -176.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.2 m -72.7 -36.43 67.85 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -69.39 -33.27 72.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -78.94 -36.62 41.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.557 0.343 . . . . 0.0 111.578 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -69.17 -20.09 64.0 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.078 -0.388 . . . . 0.0 111.574 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -74.6 -25.9 59.56 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 117.965 0.348 . . . . 0.0 110.283 173.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.4 mm -73.23 -35.74 47.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.11 -39.52 60.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.3 p -79.05 -30.63 14.39 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 O-C-N 122.26 -0.275 . . . . 0.0 110.979 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -76.3 -23.04 54.32 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.053 0.388 . . . . 0.0 110.623 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.5 m -80.21 -28.49 38.59 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.7 -33.26 66.36 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.209 0.459 . . . . 0.0 110.284 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.39 -25.82 54.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.9 t30 . . . . . 0 CA--C 1.531 0.249 0 C-N-CA 122.464 0.306 . . . . 0.0 110.711 177.132 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 7' ' ' ASP . 28.5 m . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 6' ' ' THR . 3.8 p30 -56.02 -17.31 6.52 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -66.67 -53.5 33.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 122.148 -0.345 . . . . 0.0 110.391 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 p -83.63 -25.41 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 122.676 0.39 . . . . 0.0 110.782 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.88 -27.92 64.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.847 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -82.6 -28.45 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.058 0 CA-C-N 118.899 0.772 . . . . 0.0 109.909 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.442 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 44.3 mt-10 -72.51 -35.95 68.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.498 -0.751 . . . . 0.0 110.322 176.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -71.28 -37.12 71.89 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.53 -23.87 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 118.155 0.434 . . . . 0.0 110.749 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -78.27 -17.39 56.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.759 0.254 . . . . 0.0 110.438 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -82.54 -5.86 59.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.219 0.608 . . . . 0.0 111.695 172.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.36 0.63 37.81 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.322 -0.71 . . . . 0.0 113.098 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -85.52 84.16 7.7 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.304 1.052 . . . . 0.0 109.071 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -64.38 -20.91 66.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.548 0.339 . . . . 0.0 110.87 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -62.48 -23.95 67.19 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.575 0.75 . . . . 0.0 111.168 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.34 -19.2 39.79 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.614 0.188 . . . . 0.0 110.784 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -77.77 -36.64 50.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -60.75 -42.79 98.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.57 -18.47 59.74 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.571 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.0 tp -81.47 -43.1 19.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.214 -0.304 . . . . 0.0 110.931 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.7 m -70.92 -24.58 24.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.874 -175.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.86 -26.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 119.685 1.13 . . . . 0.0 110.706 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -70.15 -31.2 68.59 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.433 ' HB3' HG23 ' A' ' 33' ' ' VAL . 69.7 m-85 -99.76 -9.01 23.51 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.481 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -62.69 -30.27 71.27 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.189 -0.944 . . . . 0.0 110.499 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -86.56 -32.84 20.46 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.475 0.31 . . . . 0.0 111.601 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -80.67 -36.37 32.5 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 29' ' ' TYR . 62.0 t -71.21 -38.86 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.47 -23.38 67.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.934 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 t -74.47 -45.93 42.9 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.019 -0.426 . . . . 0.0 111.112 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.424 HD21 ' CD1' ' A' ' 75' ' ' TYR . 3.8 pp -82.61 -26.43 32.27 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.432 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.566 HG13 HG23 ' A' ' 46' ' ' VAL . 1.9 p -85.45 -16.91 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 118.131 0.423 . . . . 0.0 111.761 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.8 t -69.67 -9.07 52.82 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -89.29 -4.42 58.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.47 0.708 . . . . 0.0 111.221 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -122.76 -15.21 7.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.891 0.476 . . . . 0.0 112.245 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -143.1 153.84 60.65 Favored Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 123.721 0.808 . . . . 0.0 109.541 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -68.59 164.85 31.42 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.551 2.834 . . . . 0.0 111.062 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -65.76 -10.3 35.89 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.49 -18.02 55.87 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 118.094 0.407 . . . . 0.0 112.333 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -116.58 -5.78 11.66 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 117.561 0.681 . . . . 0.0 111.605 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.566 HG23 HG13 ' A' ' 37' ' ' VAL . 6.0 p -67.37 -32.63 4.73 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 77.9 Cg_endo -77.86 -23.85 9.05 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 CA-C-N 121.844 1.694 . . . . 0.0 111.437 -176.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.4 -28.74 34.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -79.03 -27.91 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.64 -36.01 68.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.14 -43.09 68.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -67.84 -28.99 68.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.427 0.558 . . . . 0.0 109.765 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.22 73.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -75.61 -33.73 60.56 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 118.272 0.487 . . . . 0.0 112.203 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -71.41 -37.26 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -77.18 -32.86 56.42 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.909 0.483 . . . . 0.0 110.586 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.47 -44.92 81.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -61.55 -36.71 81.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.508 0.595 . . . . 0.0 111.215 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -72.05 -20.72 61.63 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 122.694 0.397 . . . . 0.0 111.281 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.85 -11.83 18.74 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.94 0.496 . . . . 0.0 111.109 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.2 tp -76.26 -25.71 55.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.583 0.753 . . . . 0.0 110.617 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.94 -13.18 62.28 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.376 0.27 . . . . 0.0 110.651 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.9 m -113.45 0.9 14.87 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.592 0.757 . . . . 0.0 111.785 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.9 t80 . . . . . 0 N--CA 1.453 -0.286 0 O-C-N 121.963 -0.46 . . . . 0.0 110.454 179.95 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.5 t80 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -67.73 -37.83 82.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.303 0.501 . . . . 0.0 111.984 -174.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.7 m -70.72 -37.7 73.53 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -69.27 -34.02 74.12 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.7 -0.191 . . . . 0.0 110.798 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.8 tp -77.09 -36.53 55.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.716 0.406 . . . . 0.0 111.199 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.424 ' CD1' HD21 ' A' ' 36' ' ' LEU . 20.9 m-85 -69.56 -20.03 63.67 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.804 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -76.1 -23.98 54.98 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.087 0.403 . . . . 0.0 110.456 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.2 mm -73.55 -35.94 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.44 -39.69 62.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.71 -29.66 13.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 O-C-N 122.086 -0.384 . . . . 0.0 111.402 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -75.74 -23.21 56.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.821 -0.55 . . . . 0.0 110.618 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.2 m -82.94 -28.93 29.5 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 119.556 -0.259 . . . . 0.0 110.339 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.09 -32.78 61.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.093 0.406 . . . . 0.0 110.932 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.37 -29.68 53.43 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t30 . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 175.889 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 7' ' ' ASP . 25.4 m . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 6' ' ' THR . 3.5 p30 -55.34 -17.29 4.55 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.982 0.513 . . . . 0.0 111.87 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -65.88 -51.51 58.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.3 p -85.81 -26.48 6.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 122.734 0.413 . . . . 0.0 110.952 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.72 -29.92 68.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 122.136 -0.352 . . . . 0.0 110.34 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.8 t -84.23 -27.35 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.186 0.448 . . . . 0.0 110.296 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.37 -35.68 65.98 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.51 -0.744 . . . . 0.0 109.998 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -70.81 -34.9 72.22 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.0 m -74.75 -24.09 18.08 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 CA-C-N 118.108 0.413 . . . . 0.0 111.228 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -77.13 -16.14 59.28 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 174.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.36 2.26 56.75 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.723 0.809 . . . . 0.0 112.161 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.23 44.18 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.55 -0.583 . . . . 0.0 113.554 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -91.81 83.97 5.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.413 1.107 . . . . 0.0 109.31 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.69 -20.2 66.18 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.727 0.411 . . . . 0.0 110.435 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -62.08 -24.52 67.16 Favored 'General case' 0 N--CA 1.458 -0.041 0 C-N-CA 122.863 0.465 . . . . 0.0 111.441 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.44 -18.75 44.25 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.792 0.269 . . . . 0.0 110.574 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -77.8 -37.14 49.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -61.73 -40.22 94.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.43 -19.22 58.3 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.401 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.4 tp -83.47 -46.9 11.96 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.426 0.29 . . . . 0.0 111.245 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.65 -25.09 29.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 CA-C-O 118.578 -0.725 . . . . 0.0 111.479 -175.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.4 p -69.7 -26.64 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 119.32 0.964 . . . . 0.0 110.693 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.9 mtp85 -68.54 -34.54 76.02 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -97.35 -8.73 28.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.282 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -63.33 -28.35 69.94 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 118.453 0.57 . . . . 0.0 110.8 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -85.07 -30.17 24.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -77.05 -43.47 34.38 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 m -79.78 -25.32 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 O-C-N 121.971 -0.456 . . . . 0.0 110.885 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.03 -22.75 63.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.149 0.432 . . . . 0.0 110.436 176.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -76.31 -42.3 45.7 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.43 -24.85 31.7 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.524 HG13 HG23 ' A' ' 46' ' ' VAL . 2.7 p -87.94 -19.44 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 118.326 0.512 . . . . 0.0 111.467 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.4 t -67.26 -9.26 38.88 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.878 -0.514 . . . . 0.0 109.854 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -90.45 -3.92 57.33 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.7 0.8 . . . . 0.0 111.438 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -122.18 -15.38 7.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.985 0.514 . . . . 0.0 111.884 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 m -142.42 153.32 62.32 Favored Pre-proline 0 N--CA 1.463 0.176 0 C-N-CA 123.829 0.852 . . . . 0.0 109.229 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.38 165.33 29.27 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.385 2.723 . . . . 0.0 110.959 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -65.38 -12.54 53.13 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.782 0.433 . . . . 0.0 112.132 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.02 -19.58 59.03 Favored Glycine 0 CA--C 1.527 0.83 0 O-C-N 121.928 -0.483 . . . . 0.0 112.192 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -116.55 -5.67 11.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.633 0.716 . . . . 0.0 111.681 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.524 HG23 HG13 ' A' ' 37' ' ' VAL . 5.9 p -66.58 -33.32 6.25 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.782 -1.104 . . . . 0.0 113.7 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 93.7 Cg_endo -76.68 -25.88 8.88 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 122.084 1.78 . . . . 0.0 111.774 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -82.7 -28.84 30.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.227 -0.296 . . . . 0.0 110.408 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.2 t -77.76 -27.63 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -71.72 -35.59 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -72.27 -43.2 64.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -67.45 -27.35 66.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.784 -0.572 . . . . 0.0 110.208 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.48 -28.51 62.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.683 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.31 -29.81 24.25 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.411 0.551 . . . . 0.0 110.89 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.66 -37.11 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -78.74 -31.64 46.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.865 0.466 . . . . 0.0 111.016 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.94 -42.46 85.25 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.165 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -62.76 -36.5 83.27 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 118.63 0.65 . . . . 0.0 111.211 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -71.64 -17.68 62.25 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 122.501 0.32 . . . . 0.0 111.122 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.49 -11.51 16.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.863 0.465 . . . . 0.0 111.066 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.2 tp -73.77 -23.22 59.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.472 0.709 . . . . 0.0 110.099 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.48 -13.13 37.46 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.445 0.298 . . . . 0.0 110.673 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.2 t -113.48 4.44 16.24 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.6 t80 . . . . . 0 C--N 1.339 0.11 0 O-C-N 121.509 -0.744 . . . . 0.0 109.503 177.286 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.8 t80 . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 119.701 -0.19 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -69.69 -40.4 76.36 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.042 0.383 . . . . 0.0 111.297 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -70.78 -35.11 72.44 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -69.53 -31.02 68.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.5 tp -82.92 -36.15 25.49 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.586 0.354 . . . . 0.0 111.629 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -62.44 -29.13 70.29 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.129 -0.357 . . . . 0.0 110.387 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -73.33 -25.29 60.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.489 0.315 . . . . 0.0 111.48 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mm -71.53 -39.76 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.035 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.56 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.41 -36.11 68.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -174.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -75.64 -29.25 20.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.378 0.536 . . . . 0.0 110.775 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -79.07 -20.54 48.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.266 -0.271 . . . . 0.0 110.609 177.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 79.1 m -79.85 -33.37 40.2 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 122.014 -0.429 . . . . 0.0 109.963 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.96 69.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.281 -0.262 . . . . 0.0 110.928 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -75.17 -28.64 60.14 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 t30 . . . . . 0 N--CA 1.455 -0.195 0 C-N-CA 122.128 0.171 . . . . 0.0 110.99 177.154 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.475 HG22 ' N ' ' A' ' 7' ' ' ASP . 29.5 m . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.475 ' N ' HG22 ' A' ' 6' ' ' THR . 3.3 p30 -55.17 -16.81 3.44 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.319 0.648 . . . . 0.0 111.822 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -65.76 -54.12 31.37 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 122.107 -0.37 . . . . 0.0 110.032 176.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.52 -25.44 6.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.756 0.423 . . . . 0.0 111.031 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 mp -70.1 -31.72 69.42 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 119.299 -0.381 . . . . 0.0 110.338 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.0 t -80.17 -27.91 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 118.62 0.645 . . . . 0.0 110.15 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.02 -39.37 75.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.815 -0.553 . . . . 0.0 111.373 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -82.19 -25.1 34.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.74 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.41 -24.25 23.61 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 CA-C-N 118.755 0.707 . . . . 0.0 109.695 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -78.78 -21.66 47.49 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.674 0.389 . . . . 0.0 110.293 174.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -89.43 -7.3 55.42 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.368 0.667 . . . . 0.0 111.818 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.69 0.58 17.81 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.932 -0.927 . . . . 0.0 114.16 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -87.32 83.71 7.31 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.213 1.507 . . . . 0.0 109.761 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -65.88 -23.77 66.72 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -59.69 -24.35 63.86 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.425 0.69 . . . . 0.0 111.048 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.37 -20.12 32.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 119.777 -0.154 . . . . 0.0 111.26 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -76.45 -35.12 58.66 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.06 -40.63 98.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.0 mt -75.01 -19.02 60.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.672 0.389 . . . . 0.0 111.396 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 tp -83.55 -46.75 12.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.899 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 m -68.77 -24.34 28.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.646 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.9 p -69.88 -26.76 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 119.239 0.927 . . . . 0.0 110.756 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -68.1 -30.67 69.9 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.44 ' HB3' HG23 ' A' ' 33' ' ' VAL . 70.1 m-85 -101.09 -8.89 21.87 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.75 -30.22 71.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.134 -0.979 . . . . 0.0 110.551 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -86.87 -32.47 20.21 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -79.29 -36.39 39.76 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 29' ' ' TYR . 59.0 t -71.7 -39.01 68.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 123.449 0.7 . . . . 0.0 109.316 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.488 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.46 -23.09 67.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.235 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 t -75.02 -45.62 40.55 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.145 -0.347 . . . . 0.0 111.126 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 pp -82.02 -28.12 32.71 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.56 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.582 HG13 HG23 ' A' ' 46' ' ' VAL . 2.1 p -83.55 -16.92 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 118.219 0.463 . . . . 0.0 111.515 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -67.96 -11.99 59.88 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.103 0.478 . . . . 0.0 109.786 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -86.01 -4.26 59.13 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.341 0.656 . . . . 0.0 111.346 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -122.78 -16.44 7.15 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.938 0.495 . . . . 0.0 112.289 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -142.74 154.48 62.69 Favored Pre-proline 0 N--CA 1.462 0.166 0 C-N-CA 123.587 0.755 . . . . 0.0 109.353 175.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.96 164.21 30.77 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.423 2.748 . . . . 0.0 111.009 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.5 p -66.43 -9.5 34.54 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.05 54.35 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.818 -0.435 . . . . 0.0 112.05 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -116.18 -6.01 11.88 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 117.518 0.659 . . . . 0.0 111.453 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.582 HG23 HG13 ' A' ' 37' ' ' VAL . 8.1 p -66.45 -32.76 5.65 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 117.774 -1.108 . . . . 0.0 113.853 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 78.9 Cg_endo -77.96 -23.07 9.6 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 CA-C-N 121.834 1.691 . . . . 0.0 111.056 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.86 -29.39 32.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.95 -28.91 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.78 -35.8 66.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -71.11 -42.77 68.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -67.98 -29.89 69.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.22 0.464 . . . . 0.0 109.855 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.09 -36.56 77.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 119.55 -0.262 . . . . 0.0 110.297 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -74.69 -33.57 62.47 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.245 0.475 . . . . 0.0 112.024 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.54 -39.17 75.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -75.37 -30.84 60.31 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.812 0.445 . . . . 0.0 110.638 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.53 -44.67 67.06 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.344 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -59.6 -39.23 83.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.61 0.641 . . . . 0.0 111.38 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -72.19 -28.46 63.21 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.512 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 -12.01 40.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.803 0.441 . . . . 0.0 111.351 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.7 tp -75.55 -28.06 58.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.349 0.659 . . . . 0.0 110.721 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -71.38 -6.26 38.79 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.1 m -113.4 4.15 16.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.83 0.852 . . . . 0.0 111.198 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.6 t80 . . . . . 0 CA--C 1.531 0.248 0 C-N-CA 122.973 0.509 . . . . 0.0 110.14 179.549 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.3 t80 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -70.07 -37.41 75.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.817 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -71.28 -33.79 70.08 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 56.9 t90 -73.75 -28.23 61.57 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.483 0.313 . . . . 0.0 110.846 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -85.63 -36.66 20.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.929 0.331 . . . . 0.0 111.029 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -69.36 -21.03 63.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.989 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -78.27 -21.87 49.13 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.908 0.776 . . . . 0.0 110.61 173.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mm -70.44 -34.33 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.95 -41.24 52.18 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.35 -29.03 13.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 O-C-N 121.997 -0.44 . . . . 0.0 111.356 -178.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -75.69 -24.22 56.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.152 -0.343 . . . . 0.0 110.287 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -81.73 -26.98 34.12 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.201 -0.312 . . . . 0.0 110.363 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.91 -32.64 63.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.423 0.556 . . . . 0.0 110.72 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.33 -25.74 46.57 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.4 t30 . . . . . 0 CA--C 1.531 0.245 0 CA-C-O 120.447 0.165 . . . . 0.0 110.701 175.154 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.49 HG22 ' H ' ' A' ' 7' ' ' ASP . 28.0 m . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.49 ' H ' HG22 ' A' ' 6' ' ' THR . 3.4 p30 -55.16 -17.14 3.79 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -66.41 -53.05 40.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.056 -0.402 . . . . 0.0 110.257 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.413 ' H ' HG12 ' A' ' 9' ' ' VAL . 2.8 p -85.34 -25.75 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 122.906 0.482 . . . . 0.0 110.559 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.8 mp -70.85 -28.65 64.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.154 -0.451 . . . . 0.0 110.974 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.8 t -82.54 -28.12 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 118.858 0.754 . . . . 0.0 110.024 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.442 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 44.1 mt-10 -72.11 -36.61 69.49 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.762 -0.586 . . . . 0.0 110.504 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -70.58 -36.67 73.72 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 m -73.13 -23.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 118.298 0.499 . . . . 0.0 110.827 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -78.0 -18.16 56.26 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -80.99 -5.93 58.16 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.297 0.639 . . . . 0.0 111.863 172.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.72 2.13 46.36 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 119.559 -0.578 . . . . 0.0 112.876 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -85.86 84.19 7.62 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.19 0.995 . . . . 0.0 109.349 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -64.36 -19.65 65.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.419 0.288 . . . . 0.0 110.624 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -61.48 -25.5 67.29 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.94 0.496 . . . . 0.0 111.121 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.88 -18.8 38.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.74 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -77.91 -36.16 49.78 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -61.84 -41.07 97.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -76.83 -18.41 58.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 tp -82.08 -41.66 20.25 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 122.139 -0.351 . . . . 0.0 110.74 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.6 m -72.16 -24.28 22.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.885 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -67.74 -26.33 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 119.866 1.212 . . . . 0.0 110.887 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -69.74 -32.13 70.49 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.43 ' HB3' HG23 ' A' ' 33' ' ' VAL . 64.6 m-85 -99.34 -9.08 23.97 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.411 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -62.77 -30.4 71.42 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.206 -0.934 . . . . 0.0 110.751 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -86.99 -32.36 20.09 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 176.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -80.24 -36.37 34.74 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' A' ' 29' ' ' TYR . 61.6 t -70.96 -38.44 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.96 -23.27 67.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 t -74.68 -45.19 46.16 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.047 0.385 . . . . 0.0 111.012 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.413 HD21 ' CD1' ' A' ' 75' ' ' TYR . 3.8 pp -82.92 -27.03 30.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.498 -177.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.571 HG13 HG23 ' A' ' 46' ' ' VAL . 1.8 p -84.97 -16.71 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 118.117 0.417 . . . . 0.0 111.478 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -68.35 -11.77 60.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.21 0.529 . . . . 0.0 109.845 172.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -85.83 -5.98 59.16 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.425 0.69 . . . . 0.0 111.312 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -122.6 -16.51 7.22 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.799 0.44 . . . . 0.0 112.164 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 m -141.34 153.76 66.46 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 123.462 0.705 . . . . 0.0 109.443 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.9 164.97 29.61 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.656 2.904 . . . . 0.0 110.984 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -65.87 -10.75 41.1 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -175.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.41 -17.98 56.09 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.082 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -116.49 -5.85 11.71 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 117.726 0.763 . . . . 0.0 111.538 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.571 HG23 HG13 ' A' ' 37' ' ' VAL . 6.8 p -67.35 -32.02 4.21 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 117.785 -1.102 . . . . 0.0 113.722 -176.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 82.4 Cg_endo -78.41 -23.11 8.93 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 121.804 1.68 . . . . 0.0 111.076 -177.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -82.4 -28.21 31.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.343 -0.223 . . . . 0.0 110.62 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.4 t -79.36 -28.61 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -69.15 -35.85 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -70.36 -43.24 70.55 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -68.17 -29.16 67.97 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.736 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.63 -35.47 75.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.987 0.358 . . . . 0.0 110.2 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.46 -33.62 60.86 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.076 0.398 . . . . 0.0 111.72 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.04 -38.46 71.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -75.39 -32.35 60.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.04 0.536 . . . . 0.0 110.579 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.27 77.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.098 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -61.14 -37.8 84.13 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.769 0.713 . . . . 0.0 111.287 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -71.81 -24.72 61.77 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.709 0.404 . . . . 0.0 111.059 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.11 -11.85 25.67 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.167 0.587 . . . . 0.0 111.442 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.2 tp -75.63 -24.06 56.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.26 0.624 . . . . 0.0 110.376 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.56 -11.33 57.83 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.422 0.289 . . . . 0.0 110.604 174.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.2 m -109.46 0.23 19.21 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.754 0.822 . . . . 0.0 111.65 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.6 t80 . . . . . 0 N--CA 1.455 -0.179 0 C-N-CA 123.125 0.57 . . . . 0.0 110.196 178.026 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.3 t80 . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -69.84 -38.81 76.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.839 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.2 m -70.45 -35.66 73.47 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -69.28 -33.59 73.44 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 122.379 -0.201 . . . . 0.0 110.74 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.2 tp -79.8 -35.91 37.77 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.261 0.225 . . . . 0.0 111.18 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.413 ' CD1' HD21 ' A' ' 36' ' ' LEU . 20.5 m-85 -69.18 -20.25 64.0 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.787 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.5 mtm105 -75.51 -23.76 56.75 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.412 0.551 . . . . 0.0 110.517 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.54 -33.72 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.23 -39.13 55.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -173.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -80.52 -29.65 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 O-C-N 122.126 -0.359 . . . . 0.0 111.409 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -75.88 -23.92 55.65 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 122.208 -0.307 . . . . 0.0 110.309 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.3 m -81.67 -29.59 33.02 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.177 -0.327 . . . . 0.0 110.399 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.84 -35.28 67.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.207 0.458 . . . . 0.0 110.877 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -76.87 -28.27 55.34 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 t30 . . . . . 0 N--CA 1.455 -0.198 0 C-N-CA 122.261 0.224 . . . . 0.0 110.595 176.79 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.277 0.084 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -141.04 160.98 38.93 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.051 0.54 . . . . 0.0 110.387 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -84.49 161.13 20.37 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.778 0.431 . . . . 0.0 110.663 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -89.1 -3.75 58.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.641 0.376 . . . . 0.0 111.719 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 5' ' ' LEU . 2.0 mm? -119.93 148.17 43.85 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 7' ' ' ASP . 27.4 m -139.43 172.54 12.67 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.497 0.719 . . . . 0.0 109.352 -175.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.472 ' N ' HG22 ' A' ' 6' ' ' THR . 3.7 p30 -55.11 -17.55 4.25 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.157 0.583 . . . . 0.0 112.21 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -66.0 -51.98 53.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.99 -0.444 . . . . 0.0 110.251 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.89 -25.58 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 122.396 0.278 . . . . 0.0 110.611 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.84 -28.74 64.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.154 -0.341 . . . . 0.0 110.703 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.1 t -82.17 -28.45 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 118.534 0.606 . . . . 0.0 109.876 176.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.469 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 39.8 mt-10 -70.9 -37.02 72.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.69 -0.631 . . . . 0.0 110.345 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -71.7 -36.42 70.54 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.5 m -72.44 -24.6 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.032 0 CA-C-N 118.338 0.517 . . . . 0.0 110.956 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -78.77 -18.26 54.45 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -83.16 -5.18 59.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.446 0.699 . . . . 0.0 111.898 174.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.52 0.14 34.75 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.614 -0.548 . . . . 0.0 113.351 174.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -88.77 84.29 6.69 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.232 1.016 . . . . 0.0 109.547 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -63.7 -20.61 65.86 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.711 0.405 . . . . 0.0 110.831 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -62.85 -23.23 67.19 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.095 0.558 . . . . 0.0 111.294 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.52 -18.7 44.14 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.378 -0.202 . . . . 0.0 110.674 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -77.1 -36.51 55.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -62.52 -41.11 98.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -75.19 -18.95 60.05 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.288 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.5 tp -83.54 -47.34 11.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 122.405 0.282 . . . . 0.0 111.238 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 m -67.61 -24.69 31.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.399 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.68 -26.97 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 119.133 0.878 . . . . 0.0 110.891 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -67.93 -32.17 72.45 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -101.49 -8.63 21.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -62.73 -27.6 69.38 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.342 0.519 . . . . 0.0 110.503 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -86.59 -30.56 21.75 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.339 -0.226 . . . . 0.0 110.512 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -76.83 -41.87 42.5 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -82.18 -25.5 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.074 0 CA-C-N 118.0 0.364 . . . . 0.0 110.997 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.18 -23.64 63.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.179 0.445 . . . . 0.0 110.193 176.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 t -76.19 -44.22 38.89 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -80.04 -24.94 40.39 Favored 'General case' 0 C--O 1.227 -0.093 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 46' ' ' VAL . 3.2 p -86.76 -17.64 8.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 CA-C-N 118.104 0.411 . . . . 0.0 111.145 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.9 t -67.75 -9.18 41.68 Favored 'General case' 0 C--N 1.341 0.224 0 O-C-N 122.046 -0.409 . . . . 0.0 110.197 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.6 mtm105 -88.42 -5.84 58.03 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.033 0.533 . . . . 0.0 111.713 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -122.18 -12.42 8.29 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.56 154.02 59.28 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.813 0.845 . . . . 0.0 109.1 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.18 163.69 35.13 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.363 2.708 . . . . 0.0 110.611 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.0 p -65.61 -10.63 37.42 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.82 -19.54 53.53 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.05 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -116.31 -3.41 11.95 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 117.718 0.759 . . . . 0.0 111.618 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.525 HG23 HG13 ' A' ' 37' ' ' VAL . 5.9 p -67.02 -32.85 5.19 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 117.615 -1.183 . . . . 0.0 113.381 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 95.6 Cg_endo -77.75 -25.17 8.04 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 122.093 1.783 . . . . 0.0 111.492 -177.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -79.73 -29.67 40.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.586 0.232 . . . . 0.0 110.449 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -80.57 -25.89 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -70.79 -36.23 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -72.02 -40.98 68.06 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.895 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -66.24 -29.73 70.03 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.98 -27.8 63.98 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 122.243 -0.286 . . . . 0.0 110.728 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -85.32 -31.4 23.04 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.278 0.49 . . . . 0.0 111.597 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.3 mt -71.29 -37.13 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -75.58 -32.61 60.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.948 0.499 . . . . 0.0 110.471 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.59 -45.17 69.23 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 119.456 -0.306 . . . . 0.0 110.336 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -60.51 -37.78 82.24 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.594 0.634 . . . . 0.0 111.609 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -72.31 -25.83 61.72 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.826 0.45 . . . . 0.0 111.148 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.22 -12.91 29.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.06 0.544 . . . . 0.0 111.576 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 tp -76.78 -25.84 53.81 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.143 0.577 . . . . 0.0 110.792 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.32 -14.92 63.34 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.307 0.243 . . . . 0.0 110.408 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.0 p -112.94 8.14 18.46 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.241 0.616 . . . . 0.0 111.789 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -87.23 113.05 22.62 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.025 0.375 . . . . 0.0 110.639 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -139.21 29.71 2.22 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.388 1.075 . . . . 0.0 109.07 176.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.2 -5.62 42.58 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.135 0.874 . . . . 0.0 113.816 -173.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.9 t70 52.0 31.04 8.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.27 1.035 . . . . 0.0 111.431 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 t -129.1 177.01 7.45 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.965 0.906 . . . . 0.0 109.482 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.46 143.96 55.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.176 0.512 . . . . 0.0 111.652 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -75.81 -29.89 58.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.343 0.657 . . . . 0.0 112.224 -177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -69.09 -36.41 77.55 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.658 0.663 . . . . 0.0 111.786 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -70.76 -33.76 71.12 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.59 0.632 . . . . 0.0 109.756 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 58.6 t90 -75.32 -27.98 59.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 122.752 0.421 . . . . 0.0 110.902 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 64.5 tp -85.81 -37.0 19.71 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.74 0.416 . . . . 0.0 111.312 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -61.63 -32.31 72.44 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 117.788 0.267 . . . . 0.0 110.344 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -75.56 -22.42 57.04 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.993 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.08 -36.79 75.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.775 0.716 . . . . 0.0 109.5 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.87 -38.74 57.6 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.0 p -78.24 -29.78 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 118.271 0.487 . . . . 0.0 110.801 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -75.28 -23.83 57.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.994 0.361 . . . . 0.0 110.159 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.8 m -79.17 -31.42 43.91 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.76 -29.83 62.44 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 117.56 0.164 . . . . 0.0 110.647 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -80.4 -28.6 37.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 119.444 -0.313 . . . . 0.0 110.999 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -17.26 35.23 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.58 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -74.72 -41.09 60.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.285 -0.259 . . . . 0.0 110.949 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.8 mt -79.94 -26.51 40.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.772 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.3 p -81.31 -23.21 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 CA-C-N 118.757 0.708 . . . . 0.0 110.315 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.96 -14.13 59.39 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -114.7 -19.65 10.98 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 122.486 0.315 . . . . 0.0 111.286 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.07 -21.97 47.32 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -109.44 11.18 25.16 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.542 0.671 . . . . 0.0 111.713 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -122.82 4.59 9.43 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.79 0.836 . . . . 0.0 110.935 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 38.2 tp -126.51 -13.56 5.97 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.812 0.445 . . . . 0.0 111.227 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.5 1.06 17.64 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.811 -0.555 . . . . 0.0 111.72 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.42 ' N ' HD22 ' A' ' 95' ' ' LEU . 2.9 mm? -81.75 -7.67 59.62 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.763 0.425 . . . . 0.0 110.528 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.95 142.69 48.65 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -52.25 151.85 16.44 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.518 2.812 . . . . 0.0 111.913 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.6 mmt-85 -70.36 159.81 33.45 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-O 121.1 0.476 . . . . 0.0 111.392 -175.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.58 -8.01 77.15 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.7 t -156.02 138.39 14.84 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 117.695 0.747 . . . . 0.0 109.735 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 49.14 24.3 0.92 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.627 0.771 . . . . 0.0 112.845 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -84.01 2.4 39.21 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -76.34 149.51 37.0 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.382 0.273 . . . . 0.0 110.395 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -153.19 165.05 36.9 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.962 0.505 . . . . 0.0 110.682 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -100.56 151.11 21.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.888 0.475 . . . . 0.0 109.817 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 52.1 t60 . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.656 -1.164 . . . . 0.0 110.413 -178.126 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 120.368 0.128 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.2 m -69.88 169.18 13.67 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.075 0.55 . . . . 0.0 111.329 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -70.33 163.57 26.3 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -78.56 0.19 27.18 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.512 0.325 . . . . 0.0 111.858 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.4 mt -129.73 155.17 46.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.88 0.872 . . . . 0.0 109.124 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 7' ' ' ASP . 29.9 m -139.93 173.5 11.46 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.594 0.758 . . . . 0.0 109.303 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.493 ' H ' HG22 ' A' ' 6' ' ' THR . 3.1 p30 -55.29 -17.33 4.48 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.454 0.701 . . . . 0.0 112.046 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -67.04 -51.58 52.97 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 122.016 -0.428 . . . . 0.0 110.3 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.59 -26.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 122.993 0.517 . . . . 0.0 110.73 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -69.05 -29.02 67.06 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.02 -0.425 . . . . 0.0 110.532 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.5 t -82.31 -28.78 9.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 118.565 0.621 . . . . 0.0 110.105 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.32 -35.48 68.62 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.571 -0.706 . . . . 0.0 110.433 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -69.97 -37.29 75.75 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.311 0.244 . . . . 0.0 111.347 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 m -73.44 -23.76 19.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 O-C-N 121.771 -0.581 . . . . 0.0 111.078 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -78.38 -16.25 57.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.273 0.229 . . . . 0.0 110.576 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -91.91 3.91 54.14 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.67 0.788 . . . . 0.0 111.764 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.15 1.64 51.32 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.977 173.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.88 83.98 4.09 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.851 0.826 . . . . 0.0 109.442 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -67.11 -18.09 65.16 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.982 0.513 . . . . 0.0 110.675 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -60.75 -25.38 66.45 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.582 0.353 . . . . 0.0 110.69 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.12 -18.81 45.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.54 0.155 . . . . 0.0 111.056 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -76.7 -36.77 57.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.57 -40.59 97.34 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.83 -19.04 59.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.272 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.9 tp -83.51 -47.11 11.69 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.428 0.291 . . . . 0.0 111.242 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.04 -24.9 30.87 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.541 -175.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.8 p -70.71 -26.98 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.32 0.964 . . . . 0.0 110.879 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -67.95 -31.62 71.5 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.84 -8.7 21.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -62.03 -29.2 70.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.334 0.515 . . . . 0.0 110.665 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -86.47 -30.53 21.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.044 -0.071 . . . . 0.0 110.955 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -75.29 -42.27 55.19 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 m -80.94 -25.32 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-N 118.306 0.503 . . . . 0.0 110.98 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.79 -22.09 62.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.083 0.402 . . . . 0.0 110.195 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -77.2 -41.63 40.68 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.87 -24.9 30.65 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.554 HG13 HG23 ' A' ' 46' ' ' VAL . 2.3 p -88.71 -19.38 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 118.343 0.519 . . . . 0.0 111.717 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.2 t -68.34 -9.37 47.43 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -90.32 -4.35 57.17 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.7 0.8 . . . . 0.0 111.66 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -122.4 -13.0 8.13 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.686 0.394 . . . . 0.0 111.864 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 m -144.0 154.53 58.4 Favored Pre-proline 0 N--CA 1.462 0.152 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 174.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.71 164.46 31.24 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.269 2.646 . . . . 0.0 111.08 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.8 p -66.34 -10.17 40.44 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.29 -17.95 56.36 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.175 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -116.37 -6.4 11.77 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-N 117.423 0.611 . . . . 0.0 111.691 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.554 HG23 HG13 ' A' ' 37' ' ' VAL . 9.9 p -66.34 -33.52 6.82 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 117.587 -1.197 . . . . 0.0 113.428 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 95.5 Cg_endo -76.13 -25.25 10.34 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 CA-C-N 122.212 1.826 . . . . 0.0 111.4 -175.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -81.96 -29.42 32.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.631 0.253 . . . . 0.0 110.381 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.5 t -78.4 -26.94 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.1 t -71.74 -34.95 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 118.419 0.554 . . . . 0.0 109.531 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -72.96 -43.07 62.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -67.73 -26.49 66.17 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.234 0.47 . . . . 0.0 110.156 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.78 -29.32 63.19 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.58 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -85.14 -28.72 25.35 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.575 0.625 . . . . 0.0 111.113 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.6 mt -73.03 -37.92 54.45 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -75.41 -32.28 60.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.789 0.436 . . . . 0.0 110.613 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.85 -44.51 76.97 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.104 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -60.87 -37.15 81.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.587 0.63 . . . . 0.0 111.621 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -72.87 -25.26 61.03 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.758 0.423 . . . . 0.0 111.047 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.18 -11.03 28.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.144 0.577 . . . . 0.0 111.278 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.96 -23.64 55.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.228 0.611 . . . . 0.0 110.201 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.25 -11.07 56.51 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.261 0.224 . . . . 0.0 110.552 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -110.91 3.18 18.64 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.639 0.776 . . . . 0.0 111.672 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -74.38 141.27 45.13 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -136.07 7.62 3.17 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -175.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.63 14.85 82.07 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.43 -0.65 . . . . 0.0 113.677 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -70.75 -6.87 40.72 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.287 1.043 . . . . 0.0 111.295 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.2 t -150.87 164.4 36.37 Favored 'General case' 0 N--CA 1.458 -0.075 0 C-N-CA 124.321 1.049 . . . . 0.0 108.473 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.55 145.99 55.01 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -66.86 -33.72 76.22 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.304 -0.248 . . . . 0.0 111.605 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -69.41 -38.04 77.74 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.544 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.7 m -69.62 -37.96 77.05 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.8 t90 -69.05 -31.2 69.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.741 -0.208 . . . . 0.0 110.993 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.6 tp -83.22 -35.15 25.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.576 0.35 . . . . 0.0 111.313 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -63.01 -26.8 69.02 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.005 0.366 . . . . 0.0 110.209 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.64 -27.03 61.04 Favored 'General case' 0 C--O 1.227 -0.108 0 C-N-CA 122.8 0.44 . . . . 0.0 111.318 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.2 mm -72.05 -36.25 56.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.94 -36.34 56.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -78.83 -28.87 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.475 0.579 . . . . 0.0 111.274 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.91 -25.28 52.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.152 0.433 . . . . 0.0 110.407 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.2 m -80.63 -28.14 37.03 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 122.448 -0.158 . . . . 0.0 110.597 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.16 -32.84 56.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 118.087 0.403 . . . . 0.0 111.205 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.45 -26.19 51.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -78.42 -23.49 46.63 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.454 0.302 . . . . 0.0 110.327 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -77.79 -35.37 51.6 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.612 0.365 . . . . 0.0 111.057 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.0 mt -75.63 -31.15 59.75 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 119.467 -0.301 . . . . 0.0 111.782 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.7 m -78.34 -22.03 13.35 Favored 'Isoleucine or valine' 0 C--N 1.337 0.052 0 CA-C-N 118.653 0.66 . . . . 0.0 110.402 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.19 -23.91 67.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -95.2 -27.4 15.55 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.82 0.448 . . . . 0.0 110.222 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.32 -4.96 65.55 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.88 -0.4 . . . . 0.0 112.194 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -124.87 10.72 8.3 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.538 0.669 . . . . 0.0 112.229 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -136.99 -22.61 1.18 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 122.826 0.451 . . . . 0.0 111.919 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.7 mt -128.37 10.69 6.27 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.24 0.616 . . . . 0.0 111.052 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -83.35 -19.36 36.26 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.604 0.362 . . . . 0.0 110.653 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 63.4 mt 53.73 19.37 1.82 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.166 1.387 . . . . 0.0 114.652 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.0 m -81.84 150.94 66.76 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 118.576 0.625 . . . . 0.0 110.531 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.74 167.66 26.7 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.922 3.081 . . . . 0.0 110.942 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -133.28 162.41 31.87 Favored 'General case' 0 C--N 1.338 0.076 0 C-N-CA 123.804 0.841 . . . . 0.0 110.06 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.73 0.9 89.92 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.3 m -102.56 2.44 36.19 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.24 0.616 . . . . 0.0 111.066 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -87.12 162.38 17.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.634 0.774 . . . . 0.0 110.836 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -142.41 11.9 1.93 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.915 0.486 . . . . 0.0 111.223 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 54.81 21.2 3.44 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.82 0.848 . . . . 0.0 112.802 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -147.1 154.73 41.5 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.326 0.651 . . . . 0.0 110.27 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -152.21 159.89 43.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.179 0.592 . . . . 0.0 110.07 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 14.3 p80 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.946 -179.065 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 120.579 0.228 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -142.01 25.35 1.94 Allowed 'General case' 0 C--N 1.339 0.132 0 CA-C-O 121.091 0.472 . . . . 0.0 111.012 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -78.24 -9.13 59.08 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.865 -0.522 . . . . 0.0 111.459 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 54.51 -172.65 0.05 OUTLIER 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.885 1.274 . . . . 0.0 112.843 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 43.2 mt -94.57 156.55 16.39 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.194 0.598 . . . . 0.0 110.665 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 7' ' ' ASP . 31.1 m -140.07 172.96 12.01 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.734 0.814 . . . . 0.0 109.363 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 6' ' ' THR . 3.6 p30 -55.28 -17.34 4.44 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.164 0.585 . . . . 0.0 112.385 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -66.23 -53.18 40.12 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.111 -0.368 . . . . 0.0 110.418 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 p -84.48 -26.13 7.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.779 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -69.69 -28.99 66.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.642 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.1 t -82.26 -28.22 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 118.839 0.745 . . . . 0.0 109.894 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.85 -37.63 70.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.641 -0.662 . . . . 0.0 110.368 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -69.57 -36.16 76.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 122.057 -0.402 . . . . 0.0 111.76 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -73.62 -23.78 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.038 0 CA-C-N 118.299 0.5 . . . . 0.0 111.205 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -79.69 -14.64 58.62 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.408 0.283 . . . . 0.0 110.335 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -93.18 3.2 56.08 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.632 0.773 . . . . 0.0 112.028 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.54 1.24 43.5 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 119.75 -0.472 . . . . 0.0 113.345 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -92.69 84.24 4.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.025 0.912 . . . . 0.0 109.558 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -65.09 -20.11 66.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.655 0.382 . . . . 0.0 110.659 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -61.72 -24.54 66.86 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.142 0.577 . . . . 0.0 111.007 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.36 -18.79 40.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 119.62 -0.228 . . . . 0.0 110.873 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -77.38 -36.83 53.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.51 -41.95 98.07 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.9 mt -76.53 -18.41 58.73 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.628 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 tp -81.97 -42.87 18.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.713 0.233 . . . . 0.0 110.659 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 m -69.83 -27.03 31.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.538 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -66.23 -26.86 39.02 Favored 'Isoleucine or valine' 0 C--N 1.339 0.144 0 CA-C-N 119.859 1.209 . . . . 0.0 111.129 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -69.44 -33.27 72.7 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.016 0.436 . . . . 0.0 109.919 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -100.27 -8.71 23.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.349 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -61.55 -30.08 70.42 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.234 0.613 . . . . 0.0 110.824 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -86.75 -29.5 22.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 121.994 0.118 . . . . 0.0 111.084 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -76.35 -41.22 49.0 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 m -82.79 -24.86 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 118.062 0.392 . . . . 0.0 111.064 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.15 -25.23 63.36 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -76.81 -46.27 25.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.834 0.35 . . . . 0.0 110.817 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.06 -24.62 59.53 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.595 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 46' ' ' VAL . 2.4 p -88.8 -19.95 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 118.139 0.427 . . . . 0.0 112.146 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.3 m -66.6 -9.93 40.41 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.36 0.527 . . . . 0.0 112.245 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -95.11 -3.75 47.46 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.229 0.468 . . . . 0.0 111.671 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -111.03 -20.63 12.34 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.854 0.462 . . . . 0.0 110.997 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -141.83 152.63 62.93 Favored Pre-proline 0 C--N 1.34 0.176 0 C-N-CA 124.057 0.943 . . . . 0.0 109.541 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.54 167.43 24.17 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.716 2.944 . . . . 0.0 111.249 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.7 m -65.58 -11.77 47.09 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.054 0.542 . . . . 0.0 112.418 -176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.81 -18.86 53.6 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.609 -0.55 . . . . 0.0 112.795 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.47 -6.98 11.71 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 117.808 0.804 . . . . 0.0 112.035 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.531 HG23 HG13 ' A' ' 37' ' ' VAL . 7.6 p -66.25 -36.04 11.95 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 46' ' ' VAL . 83.2 Cg_endo -73.68 -24.37 15.88 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 CA-C-N 121.697 1.642 . . . . 0.0 111.246 -172.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.5 -30.49 29.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.07 -30.2 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 122.556 0.342 . . . . 0.0 110.133 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -72.16 -33.53 47.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -72.5 -42.9 64.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -65.59 -30.71 71.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.418 0.554 . . . . 0.0 109.595 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.57 -29.3 66.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 117.746 0.248 . . . . 0.0 110.952 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -85.18 -28.92 25.14 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.299 0.5 . . . . 0.0 111.385 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 99.2 mt -72.93 -36.87 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -77.76 -31.07 51.82 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.445 0.698 . . . . 0.0 111.015 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.67 -42.47 74.13 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.121 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -62.05 -38.33 88.34 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.536 0.607 . . . . 0.0 111.485 -177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.23 -25.78 62.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.622 0.369 . . . . 0.0 111.166 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.34 -10.53 29.86 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.967 0.507 . . . . 0.0 111.395 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.5 tp -75.24 -24.53 57.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.972 0.509 . . . . 0.0 110.249 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.09 -10.25 52.47 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.454 0.302 . . . . 0.0 110.473 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.0 m -110.83 0.75 17.36 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.647 0.779 . . . . 0.0 111.662 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -74.06 146.38 43.71 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.103 0.561 . . . . 0.0 109.68 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -134.74 4.81 3.35 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.4 15.67 80.22 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 118.169 0.441 . . . . 0.0 112.5 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -69.0 -11.01 60.39 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.65 0.725 . . . . 0.0 110.961 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 81.3 p -147.95 170.05 18.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.518 1.127 . . . . 0.0 108.928 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.06 145.0 54.85 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -66.21 -35.12 79.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 122.28 -0.262 . . . . 0.0 111.676 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -68.88 -37.15 78.86 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.737 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.0 m -69.41 -39.61 77.82 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -67.37 -32.96 74.24 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.95 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.3 tp -81.12 -34.11 32.77 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.726 0.41 . . . . 0.0 111.515 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.4 m-30 -64.0 -27.37 69.07 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.074 -0.391 . . . . 0.0 110.431 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -75.68 -25.04 56.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 119.566 -0.254 . . . . 0.0 111.165 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.5 mm -70.29 -39.25 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-N 118.296 0.498 . . . . 0.0 109.726 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.56 -37.06 57.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.06 -30.66 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-N 118.469 0.577 . . . . 0.0 111.43 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -76.07 -24.55 55.1 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.969 -0.457 . . . . 0.0 110.167 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.7 m -77.34 -29.37 53.4 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.08 62.5 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.877 0.308 . . . . 0.0 110.973 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -76.44 -29.7 57.08 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.412 ' HA ' HG12 ' A' ' 87' ' ' VAL . 16.6 t30 -83.63 -16.61 44.53 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.828 -0.169 . . . . 0.0 110.615 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -78.27 -36.42 46.81 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.904 -0.497 . . . . 0.0 110.394 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.0 mt -81.35 -17.68 48.29 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 84' ' ' ASN . 3.8 p -85.77 -25.31 6.62 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 CA-C-N 118.675 0.671 . . . . 0.0 110.051 175.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.11 -26.96 60.65 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.456 -0.153 . . . . 0.0 110.921 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -103.04 -11.68 17.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.064 0.545 . . . . 0.0 110.091 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.69 -9.04 69.27 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.097 177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 -126.8 159.22 34.48 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.831 0.853 . . . . 0.0 110.084 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 -137.68 155.05 49.54 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 124.703 1.201 . . . . 0.0 108.314 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.0 mt 51.62 33.16 10.22 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.077 0.551 . . . . 0.0 110.241 -173.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -139.56 172.62 12.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.709 1.204 . . . . 0.0 109.018 -172.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.8 tp 61.67 28.9 17.91 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.926 0.891 . . . . 0.0 110.786 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.4 156.17 73.17 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 124.718 1.207 . . . . 0.0 108.956 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.63 158.71 48.68 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.821 2.348 . . . . 0.0 110.936 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.7 mmt-85 -120.86 162.6 19.55 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.764 0.826 . . . . 0.0 110.138 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.45 9.01 81.46 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 119.83 -0.428 . . . . 0.0 112.417 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.5 p -117.01 14.16 14.97 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.776 0.83 . . . . 0.0 111.393 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -115.98 161.8 18.32 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.245 0.618 . . . . 0.0 110.769 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -131.43 2.75 4.2 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.843 0.457 . . . . 0.0 111.674 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -151.54 167.02 29.37 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.547 0.739 . . . . 0.0 109.406 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.7 m80 55.11 -168.26 0.08 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.72 0.808 . . . . 0.0 111.64 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -138.22 155.19 48.89 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.796 0.438 . . . . 0.0 110.177 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.8 m80 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 117.393 -1.289 . . . . 0.0 110.227 -176.939 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 tpp . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 t -141.84 8.19 1.89 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.043 0.537 . . . . 0.0 111.327 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 55.63 13.79 1.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.327 1.051 . . . . 0.0 113.768 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 60.95 27.09 16.98 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.236 0.614 . . . . 0.0 111.304 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 75.2 mt -110.2 160.31 16.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.085 0.954 . . . . 0.0 109.786 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.469 HG22 ' H ' ' A' ' 7' ' ' ASP . 24.9 m -139.79 173.12 11.85 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.746 0.818 . . . . 0.0 109.476 -175.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.469 ' H ' HG22 ' A' ' 6' ' ' THR . 3.5 p30 -55.52 -17.67 5.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.154 0.582 . . . . 0.0 112.222 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.69 -52.81 40.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.423 ' H ' HG12 ' A' ' 9' ' ' VAL . 2.8 p -85.94 -25.9 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 122.85 0.46 . . . . 0.0 110.882 -176.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mp -69.44 -28.18 65.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.909 -0.494 . . . . 0.0 110.515 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.3 t -81.14 -28.54 10.9 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 CA-C-N 118.398 0.545 . . . . 0.0 109.839 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 38.8 mt-10 -72.45 -34.7 67.94 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.824 -0.547 . . . . 0.0 110.271 174.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -68.98 -39.79 79.2 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.688 0.395 . . . . 0.0 111.257 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 m -72.94 -24.16 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 117.698 0.226 . . . . 0.0 111.054 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -78.67 -20.5 50.07 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.887 0.312 . . . . 0.0 110.301 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -81.42 -5.22 57.68 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.328 0.651 . . . . 0.0 111.799 174.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.88 0.38 34.05 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.487 -0.618 . . . . 0.0 112.79 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -87.68 83.96 7.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.008 0.904 . . . . 0.0 109.471 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -66.39 -20.6 66.11 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.683 0.393 . . . . 0.0 110.6 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -60.77 -24.92 66.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.998 0.519 . . . . 0.0 110.834 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.26 -18.77 41.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 119.583 -0.246 . . . . 0.0 111.07 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -76.51 -36.85 57.52 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -62.49 -40.76 97.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.74 -18.76 59.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.521 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.0 tp -83.7 -47.81 10.81 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.39 0.276 . . . . 0.0 110.885 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.89 -25.08 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 118.513 -0.756 . . . . 0.0 111.383 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.3 p -70.37 -26.63 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 119.329 0.968 . . . . 0.0 110.681 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -68.65 -33.13 73.47 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -99.66 -8.91 23.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.352 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -62.62 -27.2 69.04 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.4 0.545 . . . . 0.0 110.609 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -86.12 -30.82 22.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -76.9 -42.23 40.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.3 m -81.59 -25.36 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 118.158 0.435 . . . . 0.0 110.911 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.482 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.86 -22.89 62.25 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.177 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.0 t -76.53 -43.38 39.42 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.3 -25.22 36.66 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.525 HG13 HG23 ' A' ' 46' ' ' VAL . 2.8 p -87.35 -18.45 8.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.089 0 CA-C-N 118.094 0.406 . . . . 0.0 111.226 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.2 t -68.21 -9.51 47.62 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 174.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -90.86 -3.87 57.03 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.659 0.784 . . . . 0.0 111.484 176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.35 -14.45 8.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.75 0.42 . . . . 0.0 111.807 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.41 153.46 59.08 Favored Pre-proline 0 N--CA 1.462 0.148 0 C-N-CA 123.953 0.901 . . . . 0.0 109.466 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.72 164.5 31.07 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.559 2.839 . . . . 0.0 110.756 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.3 p -66.61 -10.11 42.41 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.06 -18.33 56.07 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 118.262 0.483 . . . . 0.0 112.093 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.36 -5.09 11.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.427 0.613 . . . . 0.0 111.451 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.525 HG23 HG13 ' A' ' 37' ' ' VAL . 5.2 p -67.3 -33.08 5.21 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 117.707 -1.139 . . . . 0.0 113.368 -177.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 97.0 Cg_endo -76.84 -25.25 9.28 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 CA-C-N 122.12 1.793 . . . . 0.0 111.687 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.4 -29.79 30.59 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -78.06 -25.84 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.97 -37.07 59.71 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -71.31 -42.85 68.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -67.83 -26.45 66.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.233 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.41 -27.9 61.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.668 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -85.26 -29.67 24.43 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.531 0.605 . . . . 0.0 111.069 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.99 -37.46 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 175.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -75.58 -32.93 60.54 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.197 0.599 . . . . 0.0 110.538 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.72 -42.75 77.21 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 119.141 -0.456 . . . . 0.0 110.733 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -62.49 -37.62 86.68 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.906 0.776 . . . . 0.0 111.255 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -71.53 -25.12 62.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.679 0.392 . . . . 0.0 111.014 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.98 -11.77 27.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.132 0.573 . . . . 0.0 111.508 176.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -74.72 -24.53 58.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 110.264 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.56 -10.79 58.0 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.276 0.23 . . . . 0.0 110.506 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -109.43 1.92 20.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.649 0.78 . . . . 0.0 111.722 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -74.45 147.66 41.78 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.092 0.557 . . . . 0.0 109.732 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -137.83 2.97 2.44 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.49 18.0 78.37 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.698 -0.501 . . . . 0.0 112.519 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -66.55 -11.74 54.43 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.051 0.926 . . . . 0.0 110.933 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.9 p -151.2 170.23 19.96 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.606 1.162 . . . . 0.0 109.054 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.17 147.76 52.84 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -67.49 -33.55 75.33 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -69.03 -37.64 78.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.67 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -69.65 -37.25 76.67 Favored 'General case' 0 C--O 1.227 -0.095 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -70.22 -32.18 69.93 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 122.246 0.218 . . . . 0.0 110.953 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.9 tp -81.89 -34.78 29.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.644 0.378 . . . . 0.0 111.319 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.1 m-30 -63.63 -28.0 69.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -72.82 -26.04 61.35 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 122.817 0.447 . . . . 0.0 111.527 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.0 mm -72.84 -38.38 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.159 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.85 -35.44 59.94 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 p -77.41 -31.87 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 118.344 0.52 . . . . 0.0 111.245 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -77.87 -23.96 48.67 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.038 0.381 . . . . 0.0 110.649 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.6 m -77.3 -30.45 54.17 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.44 -32.41 62.62 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.726 0.239 . . . . 0.0 111.415 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.53 -30.89 61.94 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -78.23 -26.33 47.3 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -72.4 -39.5 67.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 122.261 -0.274 . . . . 0.0 111.29 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -78.05 -29.16 49.13 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.16 -20.97 17.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 CA-C-N 118.95 0.796 . . . . 0.0 110.133 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.16 -14.78 61.43 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 119.486 -0.293 . . . . 0.0 111.045 175.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -101.08 -32.43 10.59 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.088 0.404 . . . . 0.0 111.39 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.68 -10.75 69.52 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 119.287 -0.73 . . . . 0.0 113.638 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -105.41 11.38 32.73 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 118.271 1.035 . . . . 0.0 112.701 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -74.95 131.53 40.75 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 93' ' ' LEU . 7.6 mp 52.05 30.4 7.43 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.112 0.965 . . . . 0.0 111.686 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -66.77 -3.18 6.13 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.419 ' N ' HD22 ' A' ' 95' ' ' LEU . 3.0 mm? -78.48 -10.61 59.78 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.114 0.415 . . . . 0.0 110.99 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.4 m -141.36 153.92 66.58 Favored Pre-proline 0 CA--C 1.529 0.163 0 C-N-CA 123.42 0.688 . . . . 0.0 110.378 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.09 -18.7 16.25 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.309 2.673 . . . . 0.0 110.97 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -157.05 150.08 23.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.123 0.969 . . . . 0.0 108.409 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.87 146.2 50.22 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.5 p -155.12 168.45 26.98 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 122.992 0.517 . . . . 0.0 110.615 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -135.5 14.29 3.45 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.278 0.631 . . . . 0.0 111.276 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.445 ' CG ' ' H ' ' A' ' 103' ' ' HIS . 11.9 t60 58.98 176.57 0.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.5 1.12 . . . . 0.0 112.392 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.445 ' H ' ' CG ' ' A' ' 102' ' ' HIS . 32.0 t-80 -146.29 160.42 42.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.898 0.479 . . . . 0.0 110.537 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -144.75 164.48 30.88 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.138 0.575 . . . . 0.0 110.726 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -127.9 4.54 5.97 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.883 0.473 . . . . 0.0 111.953 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.045 -1.455 . . . . 0.0 110.097 179.521 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.461 0.172 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -105.09 161.16 14.48 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.86 0.464 . . . . 0.0 110.792 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -147.78 151.54 36.19 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 122.944 0.498 . . . . 0.0 110.197 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -148.11 163.92 35.46 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.055 0.542 . . . . 0.0 109.919 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.7 mt -107.02 154.37 21.21 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.621 0.768 . . . . 0.0 110.901 -173.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 7' ' ' ASP . 29.9 m -138.41 174.14 10.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.963 0.905 . . . . 0.0 109.299 -174.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 6' ' ' THR . 3.7 p30 -54.94 -18.87 5.55 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.103 0.561 . . . . 0.0 112.284 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -65.79 -52.28 52.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 9' ' ' VAL . 2.9 p -85.68 -25.6 6.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 122.795 0.438 . . . . 0.0 110.923 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 mp -71.67 -28.34 63.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.783 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.4 t -81.86 -28.97 9.84 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 118.442 0.565 . . . . 0.0 110.055 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.92 -37.15 72.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.719 -0.613 . . . . 0.0 110.206 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -69.82 -37.88 76.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.494 0.318 . . . . 0.0 111.532 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -73.21 -23.98 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 O-C-N 121.901 -0.499 . . . . 0.0 110.907 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -80.44 -14.62 58.14 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 122.21 -0.306 . . . . 0.0 110.398 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -93.13 3.65 55.34 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.623 0.769 . . . . 0.0 111.709 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.47 2.79 47.34 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.168 172.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -95.92 84.02 3.79 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.04 0.92 . . . . 0.0 110.086 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -65.58 -20.34 66.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.276 0.63 . . . . 0.0 110.966 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -61.02 -23.81 65.7 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 122.883 0.473 . . . . 0.0 110.871 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.87 -19.03 41.78 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 119.583 -0.246 . . . . 0.0 110.835 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -76.57 -37.23 56.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -61.5 -41.86 97.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -76.62 -18.49 58.59 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.451 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.2 tp -81.0 -43.04 20.22 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.253 -0.279 . . . . 0.0 110.805 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.3 m -70.07 -27.1 31.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.459 -175.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -65.72 -27.3 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 119.97 1.259 . . . . 0.0 111.216 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -70.56 -32.29 69.64 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.121 0.419 . . . . 0.0 109.954 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -100.02 -8.65 23.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.381 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -62.69 -27.97 69.61 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.421 0.689 . . . . 0.0 110.446 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -86.31 -29.67 22.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.475 -0.141 . . . . 0.0 110.859 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -76.67 -43.04 39.51 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -80.92 -25.89 10.84 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 O-C-N 121.928 -0.483 . . . . 0.0 111.145 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -71.55 -22.16 61.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.049 0.386 . . . . 0.0 110.104 176.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 t -76.51 -41.62 46.27 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.123 0.169 . . . . 0.0 110.58 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.96 -25.29 30.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.529 HG13 HG23 ' A' ' 46' ' ' VAL . 2.6 p -88.25 -18.95 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.036 0 CA-C-N 118.165 0.439 . . . . 0.0 111.55 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.5 t -68.61 -8.88 45.98 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 173.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -90.91 -3.87 56.99 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.033 0.933 . . . . 0.0 111.289 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -121.37 -17.5 7.59 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.831 0.452 . . . . 0.0 111.458 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.4 m -141.09 153.19 66.69 Favored Pre-proline 0 N--CA 1.463 0.176 0 C-N-CA 123.406 0.682 . . . . 0.0 109.441 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.82 165.62 29.12 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.718 2.946 . . . . 0.0 111.17 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.7 m -64.87 -11.02 32.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.09 -18.09 56.47 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.272 0.487 . . . . 0.0 112.07 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -116.64 -6.11 11.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.223 0.511 . . . . 0.0 111.642 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.529 HG23 HG13 ' A' ' 37' ' ' VAL . 6.0 p -67.66 -33.18 5.03 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.592 -1.195 . . . . 0.0 113.462 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 98.2 Cg_endo -76.51 -25.5 9.53 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 CA-C-N 122.23 1.832 . . . . 0.0 111.511 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -82.43 -30.39 30.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.415 -0.178 . . . . 0.0 110.593 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -77.15 -27.02 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.3 t -72.27 -35.44 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -72.05 -42.61 66.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.03 -28.04 67.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.24 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.99 -28.4 63.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.458 -0.305 . . . . 0.0 110.793 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -85.08 -29.97 24.44 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.576 0.625 . . . . 0.0 111.216 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 99.0 mt -72.05 -37.23 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -76.64 -32.37 57.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.118 0.567 . . . . 0.0 110.98 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.71 75.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.32 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -61.58 -38.7 88.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.383 0.538 . . . . 0.0 111.419 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -71.53 -26.12 62.52 Favored 'General case' 0 C--O 1.228 -0.05 0 C-N-CA 122.779 0.431 . . . . 0.0 111.175 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.8 -11.29 31.6 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.063 0.545 . . . . 0.0 111.462 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.1 tp -75.74 -25.81 56.88 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.689 0.396 . . . . 0.0 110.45 -177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.86 -10.7 59.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.511 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 54.6 m -113.37 0.08 14.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.796 0.838 . . . . 0.0 111.213 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.407 ' CZ ' ' HA2' ' A' ' 66' ' ' GLY . 25.4 t80 -72.91 147.35 45.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -121.23 -4.36 9.46 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.407 ' HA2' ' CZ ' ' A' ' 64' ' ' PHE . . . 69.27 17.33 72.12 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 118.092 0.405 . . . . 0.0 112.489 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.34 -8.31 45.14 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.712 0.756 . . . . 0.0 111.189 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.1 t -145.7 170.23 16.91 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.521 1.128 . . . . 0.0 108.027 176.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.24 146.76 54.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.873 -0.517 . . . . 0.0 110.28 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -65.28 -34.09 77.52 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.507 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -68.59 -35.74 77.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.97 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.8 m -70.86 -37.84 73.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -70.47 -32.21 69.66 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.249 0.22 . . . . 0.0 111.016 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.8 tp -81.33 -34.77 31.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.602 0.361 . . . . 0.0 111.516 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.2 m-30 -63.52 -28.4 69.92 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 122.086 -0.383 . . . . 0.0 110.109 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -74.01 -25.08 59.69 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.552 0.341 . . . . 0.0 111.363 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.67 -38.24 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.02 -36.26 59.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -174.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.2 p -78.21 -31.23 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-N 118.329 0.513 . . . . 0.0 111.471 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.86 -24.02 52.65 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.137 0.426 . . . . 0.0 110.091 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.5 m -78.73 -29.64 45.43 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.77 -32.97 66.01 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.876 0.307 . . . . 0.0 110.906 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.24 -30.13 57.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 122.347 -0.22 . . . . 0.0 110.477 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -79.23 -24.68 42.91 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.674 0.274 . . . . 0.0 110.513 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -74.46 -35.39 63.3 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.431 0.292 . . . . 0.0 110.906 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.3 mt -77.43 -25.23 50.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.84 -19.0 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 118.922 0.783 . . . . 0.0 111.113 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.27 -12.57 60.31 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.09 -0.381 . . . . 0.0 111.073 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -118.05 -17.69 9.6 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.753 0.421 . . . . 0.0 111.284 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.38 -21.3 62.61 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -88.69 8.18 29.97 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.471 0.709 . . . . 0.0 111.054 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -92.98 -13.9 28.16 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.265 0.626 . . . . 0.0 110.579 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 93.7 mt -125.46 4.39 7.64 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.626 0.77 . . . . 0.0 111.286 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -137.15 147.54 46.03 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.0 tp 56.36 9.48 0.53 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.436 1.094 . . . . 0.0 112.371 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.44 135.32 14.81 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.13 163.76 37.38 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.441 2.761 . . . . 0.0 111.507 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -145.96 166.37 26.23 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.307 0.643 . . . . 0.0 110.68 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -174.66 -174.84 41.69 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.9 t -146.39 158.27 43.87 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 122.788 0.435 . . . . 0.0 110.39 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -149.94 163.12 38.92 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.418 0.687 . . . . 0.0 109.678 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -81.96 1.12 36.89 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -143.95 155.89 44.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.694 0.798 . . . . 0.0 109.92 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -152.35 163.93 38.48 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.784 0.433 . . . . 0.0 110.764 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -76.11 166.98 22.68 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.075 0.55 . . . . 0.0 111.103 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 . . . . . 0 C--O 1.252 1.222 0 CA-C-O 117.993 -1.003 . . . . 0.0 111.345 179.733 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.7 mtp . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.3 p -146.71 166.78 25.57 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.109 0.564 . . . . 0.0 110.472 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -134.27 19.63 3.69 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.132 0.573 . . . . 0.0 111.322 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -130.75 176.39 8.24 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.263 0.554 . . . . 0.0 110.499 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.3 mt -91.18 153.73 19.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.198 0.599 . . . . 0.0 111.107 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 7' ' ' ASP . 32.4 m -138.26 173.79 11.24 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.926 0.891 . . . . 0.0 108.92 -175.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.469 ' N ' HG22 ' A' ' 6' ' ' THR . 3.4 p30 -55.6 -17.1 4.87 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 123.384 0.673 . . . . 0.0 112.182 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.0 tp60 -66.36 -52.76 43.6 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 121.825 -0.547 . . . . 0.0 110.159 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' H ' HG12 ' A' ' 9' ' ' VAL . 3.0 p -85.02 -25.79 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 C-N-CA 122.626 0.37 . . . . 0.0 110.9 -177.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.96 -28.54 64.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.079 -0.388 . . . . 0.0 110.841 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.2 t -82.44 -29.18 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 CA-C-N 118.683 0.674 . . . . 0.0 109.771 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.6 -40.92 76.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.514 -0.741 . . . . 0.0 109.971 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -68.39 -36.9 79.83 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.051 0.54 . . . . 0.0 112.204 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -70.47 -22.56 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.051 0 O-C-N 121.489 -0.757 . . . . 0.0 110.43 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -81.03 -14.56 57.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 119.592 -0.242 . . . . 0.0 110.67 174.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -80.41 -6.4 58.0 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.156 0.435 . . . . 0.0 110.759 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.61 4.02 52.57 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 123.6 0.619 . . . . 0.0 112.187 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -89.6 84.06 6.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.802 0.801 . . . . 0.0 109.487 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -65.68 -19.27 65.84 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.73 0.412 . . . . 0.0 110.774 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -60.32 -24.99 65.44 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 122.753 0.421 . . . . 0.0 110.977 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.57 -18.59 40.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.595 -0.24 . . . . 0.0 110.9 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -77.66 -37.38 50.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -61.32 -41.22 96.64 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.8 mt -76.94 -18.32 58.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.6 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.1 tp -82.13 -41.9 19.83 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.995 -0.441 . . . . 0.0 110.637 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -70.8 -26.76 28.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.587 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.4 m -66.58 -27.21 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.933 1.242 . . . . 0.0 111.253 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -70.84 -31.85 68.69 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -100.27 -8.73 23.13 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.376 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -62.95 -28.15 69.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.195 0.598 . . . . 0.0 110.514 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -86.61 -29.42 22.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.448 0.165 . . . . 0.0 110.749 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -77.39 -42.39 36.51 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.0 m -80.82 -26.69 11.04 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 118.127 0.421 . . . . 0.0 110.988 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.59 -22.53 62.55 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.3 t -77.78 -41.99 35.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.413 0.149 . . . . 0.0 110.668 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.6 -24.97 36.11 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.515 HG13 HG23 ' A' ' 46' ' ' VAL . 2.7 p -88.4 -18.8 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.18 0.446 . . . . 0.0 111.407 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -67.28 -11.09 56.62 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.986 -0.446 . . . . 0.0 110.043 173.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -86.7 -6.46 58.84 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.594 0.758 . . . . 0.0 111.535 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -122.66 -13.09 8.01 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.1 m -143.32 153.07 58.93 Favored Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 123.642 0.777 . . . . 0.0 109.211 173.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.08 164.0 33.72 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.66 2.907 . . . . 0.0 110.997 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.0 m -64.84 -10.64 29.78 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.06 -19.17 54.24 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 118.147 0.43 . . . . 0.0 112.166 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.18 -4.92 11.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.501 0.651 . . . . 0.0 111.619 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.515 HG23 HG13 ' A' ' 37' ' ' VAL . 5.3 p -67.43 -32.76 4.79 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.4 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 96.7 Cg_endo -76.78 -24.87 9.73 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 CA-C-N 122.095 1.784 . . . . 0.0 111.79 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.76 -30.8 32.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.289 -0.257 . . . . 0.0 110.528 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.1 t -77.98 -25.49 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.8 t -73.25 -35.42 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.38 -42.22 68.69 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -66.03 -30.84 71.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.78 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.1 -28.39 65.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 119.477 -0.296 . . . . 0.0 110.932 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -85.38 -28.73 24.97 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.519 0.6 . . . . 0.0 111.386 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.3 mt -72.7 -37.69 56.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -76.91 -32.81 57.66 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.105 0.562 . . . . 0.0 110.92 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.49 -42.16 79.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.279 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -61.82 -39.29 91.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.601 0.637 . . . . 0.0 111.542 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -70.82 -25.12 62.71 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.73 0.412 . . . . 0.0 111.289 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.22 -11.93 27.18 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.23 0.612 . . . . 0.0 111.419 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.0 tp -74.94 -24.82 58.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.005 0.522 . . . . 0.0 110.444 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.85 -10.75 51.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.271 0.228 . . . . 0.0 110.676 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.3 m -110.93 2.27 18.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.535 0.734 . . . . 0.0 111.7 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -72.65 143.82 48.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -136.43 7.9 3.1 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -175.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.55 14.61 79.51 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.611 -0.549 . . . . 0.0 112.868 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.5 -14.63 63.14 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.15 0.975 . . . . 0.0 110.842 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.6 m -142.77 164.93 28.76 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.914 1.286 . . . . 0.0 108.937 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.13 147.08 53.88 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -66.59 -34.73 78.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -175.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -69.56 -36.67 76.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.479 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.2 m -70.4 -34.23 72.3 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 62.0 t90 -76.21 -26.83 56.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 122.908 0.483 . . . . 0.0 111.325 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.8 tp -86.25 -35.19 20.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.22 -0.3 . . . . 0.0 111.289 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -63.91 -30.63 71.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -74.49 -22.17 59.21 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 117.999 0.363 . . . . 0.0 111.817 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.4 mm -70.26 -37.61 71.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.716 0.689 . . . . 0.0 109.504 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.97 -37.38 55.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.1 p -78.91 -29.35 14.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 CA-C-N 118.45 0.568 . . . . 0.0 111.336 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -76.13 -24.82 54.92 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.884 -0.51 . . . . 0.0 109.975 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.8 m -80.1 -30.74 39.21 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 122.206 -0.309 . . . . 0.0 110.246 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.56 -34.63 65.24 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.13 0.423 . . . . 0.0 111.016 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.44 -27.77 52.27 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -80.33 -25.91 39.04 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -72.64 -38.68 67.64 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.742 0.417 . . . . 0.0 111.135 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.3 mt -79.01 -26.42 43.26 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.1 m -84.64 -20.88 8.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 CA-C-N 119.038 0.835 . . . . 0.0 111.163 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.61 -10.3 59.77 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 122.25 -0.281 . . . . 0.0 111.287 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -118.63 -23.11 7.2 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.422 0.289 . . . . 0.0 111.337 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -98.82 -12.19 44.35 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.672 -0.515 . . . . 0.0 113.069 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -131.84 18.42 4.65 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 118.037 0.918 . . . . 0.0 111.896 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -61.91 -16.56 51.7 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.011 0.524 . . . . 0.0 111.919 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.0 mt -109.55 9.33 25.28 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.219 0.608 . . . . 0.0 112.212 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -142.19 -20.27 0.71 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 44.8 tp -100.96 -19.34 15.91 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.213 0.46 . . . . 0.0 111.11 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.439 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 59.8 t -86.88 -46.84 0.52 Allowed Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 118.824 -0.608 . . . . 0.0 111.21 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 96' ' ' VAL . 78.0 Cg_endo -77.42 -3.56 13.77 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.345 2.03 . . . . 0.0 111.344 174.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 52.37 29.96 7.53 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.542 1.137 . . . . 0.0 112.412 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.92 179.65 43.46 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.2 t -81.08 -12.34 59.31 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.678 0.391 . . . . 0.0 111.512 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.7 t60 52.72 28.53 6.38 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.829 0.852 . . . . 0.0 112.24 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -144.34 160.14 41.52 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.506 0.722 . . . . 0.0 110.098 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -140.44 164.14 30.94 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 122.978 0.511 . . . . 0.0 110.808 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -145.43 171.08 15.15 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.41 0.684 . . . . 0.0 110.512 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -135.69 160.91 37.07 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 123.02 0.528 . . . . 0.0 110.644 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.71 -179.123 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttp . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.644 -0.132 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.2 p -154.94 163.39 40.37 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.87 0.468 . . . . 0.0 110.736 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -149.9 149.92 31.14 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -150.38 171.05 17.62 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.173 0.511 . . . . 0.0 111.272 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 69.7 mt -109.82 155.61 21.41 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.369 1.067 . . . . 0.0 109.917 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 7' ' ' ASP . 32.7 m -138.26 173.17 11.9 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.381 0.672 . . . . 0.0 109.692 -175.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.469 ' N ' HG22 ' A' ' 6' ' ' THR . 3.7 p30 -55.18 -17.38 4.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.498 0.719 . . . . 0.0 112.11 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.44 -53.25 37.62 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.101 -0.375 . . . . 0.0 110.144 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 p -85.08 -26.14 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.965 0.506 . . . . 0.0 110.781 -176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.78 -28.66 64.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.758 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.7 t -82.22 -28.78 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 118.791 0.723 . . . . 0.0 110.013 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.93 -37.65 72.89 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.584 -0.697 . . . . 0.0 110.401 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -71.64 -35.4 70.38 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.133 -0.354 . . . . 0.0 111.952 -175.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -73.24 -23.88 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 118.174 0.443 . . . . 0.0 111.036 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -80.13 -14.96 58.07 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -92.39 3.32 55.68 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.47 0.708 . . . . 0.0 111.922 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.06 0.11 41.42 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.583 -0.565 . . . . 0.0 113.471 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -93.95 84.15 4.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.164 0.982 . . . . 0.0 109.294 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.2 tm0? -65.66 -19.91 66.09 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.82 0.448 . . . . 0.0 110.438 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -62.57 -22.44 66.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.102 0.561 . . . . 0.0 111.119 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.66 -18.78 43.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.842 0.292 . . . . 0.0 110.494 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -76.88 -36.11 56.97 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -61.98 -40.39 95.43 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.96 -19.07 59.04 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.292 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 tp -83.67 -48.08 10.55 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 119.634 -0.222 . . . . 0.0 111.126 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -66.72 -25.04 33.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.616 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.28 -26.74 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 119.399 1.0 . . . . 0.0 111.083 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -68.72 -31.68 70.93 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -101.52 -9.01 21.4 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -62.08 -28.38 69.57 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.389 0.54 . . . . 0.0 110.332 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -86.69 -31.39 21.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.716 -0.105 . . . . 0.0 110.716 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -75.74 -42.17 51.26 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 m -80.84 -25.22 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 O-C-N 121.739 -0.601 . . . . 0.0 110.873 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.458 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -69.39 -23.43 63.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.115 0.416 . . . . 0.0 110.149 176.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -76.27 -44.47 37.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 pp -79.05 -25.21 43.2 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.513 HG13 HG23 ' A' ' 46' ' ' VAL . 3.2 p -88.51 -17.95 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 118.108 0.413 . . . . 0.0 111.626 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.7 t -67.17 -9.36 39.17 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.941 -0.474 . . . . 0.0 110.009 173.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -86.71 -7.65 58.11 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.346 0.659 . . . . 0.0 111.501 176.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -120.9 -13.8 8.58 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 m -144.42 154.23 56.54 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 124.152 0.981 . . . . 0.0 109.182 174.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.62 164.45 33.0 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.368 2.712 . . . . 0.0 110.881 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -66.51 -9.96 39.96 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.11 -19.14 54.21 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.05 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -116.35 -5.2 11.79 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.554 0.677 . . . . 0.0 111.621 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.513 HG23 HG13 ' A' ' 37' ' ' VAL . 5.0 p -66.39 -32.69 5.63 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 117.67 -1.157 . . . . 0.0 113.703 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 91.4 Cg_endo -76.75 -25.46 9.2 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 CA-C-N 121.989 1.746 . . . . 0.0 111.458 -176.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.06 -30.39 31.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.132 -0.355 . . . . 0.0 110.57 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.2 t -75.53 -27.21 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.92 -35.74 55.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -71.85 -43.17 65.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -67.28 -27.91 67.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.089 0.404 . . . . 0.0 110.18 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.62 -27.17 61.14 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.7 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -84.58 -31.32 24.39 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.538 0.608 . . . . 0.0 110.918 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.9 mt -70.08 -36.94 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -78.03 -33.75 50.9 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.443 0.297 . . . . 0.0 110.921 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.29 -39.85 89.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.585 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -64.94 -36.77 85.46 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.521 0.601 . . . . 0.0 111.07 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -71.58 -17.74 62.27 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.943 0.497 . . . . 0.0 110.78 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.28 -10.8 17.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.137 0.575 . . . . 0.0 111.439 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.1 tp -76.06 -23.95 55.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.279 0.631 . . . . 0.0 110.155 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.62 -9.12 47.82 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.663 0.385 . . . . 0.0 110.463 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.1 m -113.17 4.8 16.72 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.114 0.966 . . . . 0.0 111.528 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -71.53 145.36 49.17 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -132.58 -0.45 3.55 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.34 15.25 80.3 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 119.666 -0.519 . . . . 0.0 113.378 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -69.39 -8.18 44.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.297 1.049 . . . . 0.0 111.12 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.3 p -148.26 166.72 27.12 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.663 1.185 . . . . 0.0 108.661 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.46 147.89 51.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 122.124 -0.36 . . . . 0.0 110.266 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -66.2 -33.83 76.64 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -175.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -69.76 -36.51 75.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.705 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.3 m -70.78 -34.31 71.66 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -74.23 -28.84 61.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.061 0.544 . . . . 0.0 110.947 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.7 tp -86.24 -35.36 20.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.558 0.343 . . . . 0.0 111.387 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -62.74 -33.62 75.51 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -74.86 -21.86 59.01 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.678 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.8 mm -68.71 -39.91 80.89 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 118.836 0.744 . . . . 0.0 109.231 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.04 -34.47 64.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -173.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.65 -30.92 22.25 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.082 0 CA-C-N 118.713 0.688 . . . . 0.0 111.05 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -78.51 -19.02 53.89 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.979 -0.451 . . . . 0.0 110.522 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 81.4 m -78.64 -31.45 46.89 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.66 -35.55 62.81 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.743 0.247 . . . . 0.0 111.188 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -77.67 -24.03 49.45 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.482 ' HA ' HG12 ' A' ' 87' ' ' VAL . 17.9 t30 -86.8 -18.76 30.24 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.361 -0.212 . . . . 0.0 111.111 175.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -78.23 -36.55 46.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.002 -0.436 . . . . 0.0 110.818 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.7 mt -82.4 -25.86 33.35 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.482 HG12 ' HA ' ' A' ' 84' ' ' ASN . 7.0 p -79.95 -28.25 12.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 CA-C-N 118.447 0.567 . . . . 0.0 110.125 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.51 -17.12 60.2 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 122.5 -0.125 . . . . 0.0 111.029 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -111.11 -8.32 14.43 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.751 0.42 . . . . 0.0 110.586 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -93.78 -14.59 52.21 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.45 -0.639 . . . . 0.0 112.045 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -112.53 -15.69 13.01 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 117.987 0.894 . . . . 0.0 112.502 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 mtp85 -96.11 131.31 42.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.159 0.436 . . . . 0.0 110.323 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.3 mp 52.43 33.33 12.89 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.921 0.888 . . . . 0.0 111.795 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -126.0 144.85 50.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.174 0.59 . . . . 0.0 110.062 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.3 mp -97.44 48.79 1.03 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.085 0.954 . . . . 0.0 110.66 -175.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 98' ' ' ARG . 21.4 t -59.98 133.66 89.92 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.4 5.95 3.87 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.13 3.22 . . . . 0.0 112.804 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.417 ' H ' HG12 ' A' ' 96' ' ' VAL . 73.3 ttp85 -139.83 148.48 42.19 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 123.072 0.549 . . . . 0.0 110.212 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.52 154.27 6.42 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 123.76 0.695 . . . . 0.0 111.542 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.3 p -154.82 172.69 17.58 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.818 0.447 . . . . 0.0 110.595 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -112.69 157.25 21.51 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.214 0.606 . . . . 0.0 110.279 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -150.32 167.63 26.45 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.63 0.372 . . . . 0.0 110.504 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -93.37 5.66 50.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.048 0.539 . . . . 0.0 112.417 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -139.18 163.27 32.89 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.021 0.528 . . . . 0.0 110.465 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -82.42 167.53 18.38 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.581 0.352 . . . . 0.0 111.411 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 117.727 -1.13 . . . . 0.0 110.3 -179.944 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -140.24 156.31 46.54 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.236 0.614 . . . . 0.0 110.262 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -152.82 169.49 22.66 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.981 0.42 . . . . 0.0 110.693 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -131.19 8.43 4.71 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.23 0.612 . . . . 0.0 111.627 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.8 mt -127.28 156.15 42.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.953 0.501 . . . . 0.0 109.817 -177.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 7' ' ' ASP . 23.4 m -139.89 172.76 12.3 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.929 0.892 . . . . 0.0 109.788 -175.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.471 ' N ' HG22 ' A' ' 6' ' ' THR . 3.2 p30 -55.29 -17.13 4.13 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.988 0.515 . . . . 0.0 112.165 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -66.96 -51.2 58.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.111 -0.368 . . . . 0.0 110.226 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.5 p -85.57 -26.2 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 122.772 0.429 . . . . 0.0 110.818 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.64 -29.16 67.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.252 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.66 -28.66 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 118.611 0.641 . . . . 0.0 110.154 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.94 -35.07 69.5 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.598 -0.689 . . . . 0.0 110.269 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -70.6 -37.37 73.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.451 0.3 . . . . 0.0 111.647 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -73.09 -23.69 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 118.139 0.427 . . . . 0.0 111.291 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -79.64 -16.42 55.81 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.362 0.265 . . . . 0.0 110.608 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -91.72 3.36 55.27 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.939 0.896 . . . . 0.0 111.88 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.25 3.11 48.03 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.782 -0.454 . . . . 0.0 113.28 173.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -97.99 83.64 3.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 117.923 0.862 . . . . 0.0 109.526 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 tm0? -67.01 -17.73 65.05 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.158 0.583 . . . . 0.0 110.62 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -60.67 -24.6 65.72 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.85 0.46 . . . . 0.0 110.927 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.0 -18.92 41.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 119.639 -0.22 . . . . 0.0 110.892 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -76.76 -37.22 56.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.26 -39.85 94.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.823 0.344 . . . . 0.0 110.282 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.4 -18.95 58.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.808 0.443 . . . . 0.0 111.335 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -83.48 -47.09 11.74 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.775 0.43 . . . . 0.0 111.008 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -69.5 -24.44 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.881 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.47 -26.27 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 119.231 0.923 . . . . 0.0 110.62 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -67.78 -33.93 75.8 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.444 ' HB3' HG23 ' A' ' 33' ' ' VAL . 78.1 m-85 -97.7 -8.93 27.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.41 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -63.58 -29.49 70.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.357 -0.839 . . . . 0.0 110.479 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -86.81 -32.04 20.53 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -83.87 -32.16 25.35 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 29' ' ' TYR . 61.3 t -73.32 -38.41 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -63.24 -25.78 68.48 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.919 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.3 t -72.9 -48.04 40.63 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.007 0.367 . . . . 0.0 110.942 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.417 HD21 ' CD1' ' A' ' 75' ' ' TYR . 3.7 pp -79.34 -27.17 42.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.553 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.584 HG13 HG23 ' A' ' 46' ' ' VAL . 2.1 p -84.93 -15.35 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 117.715 0.234 . . . . 0.0 111.463 -177.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.4 t -68.34 -11.86 60.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.977 -0.452 . . . . 0.0 109.973 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -84.8 -6.76 59.36 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.963 0.505 . . . . 0.0 111.686 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -122.31 -12.52 8.23 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 m -146.31 153.96 48.95 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 123.509 0.723 . . . . 0.0 109.118 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.19 162.76 36.99 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.469 2.779 . . . . 0.0 111.07 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 96.3 p -65.08 -10.14 27.95 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.18 -19.04 54.46 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.194 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -116.15 -5.03 11.9 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 117.591 0.696 . . . . 0.0 111.224 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.584 HG23 HG13 ' A' ' 37' ' ' VAL . 6.3 p -66.85 -32.3 4.83 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -176.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 85.0 Cg_endo -78.17 -22.81 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 CA-C-N 121.789 1.674 . . . . 0.0 111.162 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -81.56 -28.82 33.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.526 0.203 . . . . 0.0 110.499 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.97 -27.79 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.58 -37.06 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -70.18 -42.91 71.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.3 -27.25 65.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.23 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.79 -35.45 70.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.127 -0.324 . . . . 0.0 110.127 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -74.98 -33.7 61.9 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 118.256 0.48 . . . . 0.0 111.788 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.3 mt -70.23 -38.73 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -74.38 -31.95 62.55 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.144 0.578 . . . . 0.0 110.462 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.32 -44.85 70.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.249 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -61.36 -37.14 82.29 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.913 0.779 . . . . 0.0 111.329 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -71.65 -25.88 62.32 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 122.663 0.385 . . . . 0.0 110.989 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.23 -11.18 28.46 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.145 0.578 . . . . 0.0 111.393 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.9 tp -75.36 -24.45 57.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.243 0.617 . . . . 0.0 110.277 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.99 -10.77 53.12 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 173.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.7 m -108.22 3.76 24.0 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.668 0.787 . . . . 0.0 111.856 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -78.03 147.43 34.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.11 0.564 . . . . 0.0 109.994 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -135.07 3.97 3.2 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.34 15.37 78.94 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.678 -0.512 . . . . 0.0 112.556 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.17 -9.53 58.23 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.956 0.878 . . . . 0.0 110.75 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.1 p -147.04 169.37 19.38 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.571 1.149 . . . . 0.0 109.1 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.68 144.69 52.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.16 -0.337 . . . . 0.0 110.276 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -67.21 -33.59 75.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -69.72 -34.89 74.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.037 -176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 88.5 m -76.03 -32.66 59.45 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 57.3 t90 -72.92 -28.0 62.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.56 0.344 . . . . 0.0 110.66 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.5 tp -85.87 -37.45 19.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.394 0.277 . . . . 0.0 111.167 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.417 ' CD1' HD21 ' A' ' 36' ' ' LEU . 19.4 m-85 -69.33 -20.6 63.87 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.942 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -77.94 -21.89 50.38 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.445 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.9 mm -71.63 -37.42 63.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.82 -39.64 66.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.5 p -79.56 -29.01 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 118.181 0.446 . . . . 0.0 111.07 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -76.46 -23.62 53.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.172 -0.33 . . . . 0.0 110.479 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.5 m -80.16 -29.12 38.73 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.27 -33.14 61.22 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.322 -0.236 . . . . 0.0 111.22 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -75.98 -28.58 57.92 Favored 'General case' 0 CA--C 1.522 -0.1 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -76.41 -22.26 54.93 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 174.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -78.33 -36.23 46.61 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.073 -0.392 . . . . 0.0 110.783 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.5 mt -72.57 -24.68 61.14 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.398 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.7 -18.9 8.06 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 CA-C-N 118.906 0.775 . . . . 0.0 111.052 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.42 -27.19 62.18 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.124 0.42 . . . . 0.0 110.267 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -100.93 -24.67 14.3 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.962 0.505 . . . . 0.0 110.62 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.14 -24.01 74.6 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -90.27 4.21 51.33 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 122.94 0.496 . . . . 0.0 111.379 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.9 ttp-105 -120.6 12.01 11.4 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.904 0.882 . . . . 0.0 109.92 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 27.4 tp -144.9 13.28 1.47 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.383 1.073 . . . . 0.0 110.037 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -68.18 -21.93 64.86 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.746 -0.596 . . . . 0.0 112.051 -174.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.9 tp -150.17 -30.68 0.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.225 -0.297 . . . . 0.0 111.28 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.3 p -152.4 137.43 10.93 Favored Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.56 129.19 18.43 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.763 2.309 . . . . 0.0 110.882 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 51.63 17.88 0.64 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.607 1.163 . . . . 0.0 113.958 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -119.62 -1.04 13.69 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 118.052 0.387 . . . . 0.0 112.329 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.5 t -84.79 158.19 20.77 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.599 0.699 . . . . 0.0 111.045 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -148.57 160.57 42.98 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.502 0.721 . . . . 0.0 110.267 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -137.38 15.06 2.98 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.116 0.566 . . . . 0.0 111.146 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -78.82 158.95 28.06 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.957 0.503 . . . . 0.0 110.805 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -134.52 12.95 3.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.459 0.704 . . . . 0.0 111.423 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -72.55 155.97 39.5 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.782 0.433 . . . . 0.0 110.733 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 79.0 t60 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 117.107 -1.425 . . . . 0.0 110.293 -179.256 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 ttp . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.8 p -135.83 -1.35 2.48 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.904 0.481 . . . . 0.0 111.903 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 47.58 25.77 0.71 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.486 1.514 . . . . 0.0 114.261 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -144.84 170.64 15.73 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-O 121.229 0.538 . . . . 0.0 111.499 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.2 mt -96.27 154.12 17.43 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.828 0.851 . . . . 0.0 109.665 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 7' ' ' ASP . 26.3 m -138.84 172.81 12.31 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.588 0.755 . . . . 0.0 109.39 -174.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.458 ' H ' HG22 ' A' ' 6' ' ' THR . 3.3 p30 -55.27 -17.21 4.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.087 0.555 . . . . 0.0 112.261 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -65.21 -53.52 43.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.725 0.298 . . . . 0.0 110.203 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 p -85.5 -26.23 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 123.038 0.535 . . . . 0.0 111.006 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.02 -28.83 64.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 122.065 -0.397 . . . . 0.0 110.957 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.7 t -82.58 -28.19 8.63 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 CA-C-N 118.562 0.619 . . . . 0.0 110.153 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.435 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 42.9 mt-10 -71.37 -35.74 71.2 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.561 -0.712 . . . . 0.0 110.36 175.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -71.22 -38.78 71.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.654 0.382 . . . . 0.0 111.637 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.05 -24.22 22.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 O-C-N 121.92 -0.488 . . . . 0.0 110.81 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -78.39 -18.78 54.56 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -79.12 -5.84 55.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.336 0.654 . . . . 0.0 111.21 172.135 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.95 2.54 48.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 123.235 0.445 . . . . 0.0 112.61 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.88 83.99 7.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 117.915 0.858 . . . . 0.0 109.505 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -64.98 -19.87 66.2 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.911 0.484 . . . . 0.0 110.714 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -60.27 -25.05 65.41 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.865 0.466 . . . . 0.0 111.096 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.89 -18.93 38.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.285 -0.259 . . . . 0.0 111.078 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -77.17 -36.93 54.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.74 -42.14 96.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.4 mt -76.2 -18.32 59.12 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.9 tp -82.27 -41.6 19.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.906 0.321 . . . . 0.0 111.009 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.2 m -72.26 -24.7 22.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.739 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.26 -26.87 37.23 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 CA-C-N 119.915 1.234 . . . . 0.0 110.884 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -69.91 -31.7 69.61 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.415 ' HB3' HG23 ' A' ' 33' ' ' VAL . 66.6 m-85 -99.49 -8.76 24.21 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.328 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -62.98 -29.7 71.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.186 -0.946 . . . . 0.0 110.853 -176.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -86.87 -32.09 20.42 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.379 0.14 . . . . 0.0 111.379 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -81.06 -33.69 33.26 Favored 'General case' 0 CA--C 1.527 0.082 0 O-C-N 122.037 -0.414 . . . . 0.0 111.995 -175.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 29' ' ' TYR . 53.8 t -74.88 -37.18 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.513 0.725 . . . . 0.0 109.415 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.47 -27.22 69.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.531 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -73.67 -49.41 26.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.945 0.339 . . . . 0.0 111.191 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.4 HD21 ' CD1' ' A' ' 75' ' ' TYR . 3.3 pp -75.23 -25.02 57.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.151 -0.343 . . . . 0.0 111.211 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.47 ' CG1' HG23 ' A' ' 46' ' ' VAL . 1.4 p -86.76 -16.86 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.2 m -66.41 -12.4 56.82 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.807 -0.558 . . . . 0.0 111.669 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -92.87 -3.68 54.2 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.673 0.67 . . . . 0.0 111.941 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -113.11 -19.52 11.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.714 0.406 . . . . 0.0 111.419 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 m -142.65 152.87 60.8 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 123.472 0.709 . . . . 0.0 109.485 173.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.15 168.82 20.95 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.614 2.876 . . . . 0.0 111.446 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.9 m -65.14 -11.65 42.49 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.106 0.562 . . . . 0.0 112.404 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.8 -19.31 51.99 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.832 -0.427 . . . . 0.0 112.986 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -116.22 -5.64 11.85 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.601 0.701 . . . . 0.0 112.122 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.47 HG23 ' CG1' ' A' ' 37' ' ' VAL . 4.0 p -64.7 -34.73 11.34 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 46' ' ' VAL . 87.5 Cg_endo -73.9 -25.52 14.2 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 CA-C-N 121.738 1.656 . . . . 0.0 111.33 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.03 -27.68 28.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 122.449 -0.157 . . . . 0.0 110.735 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.4 t -80.45 -29.98 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.0 t -69.25 -35.96 70.33 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.84 -44.03 70.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -67.44 -30.3 69.99 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 120.539 -0.464 . . . . 0.0 109.834 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.34 -34.84 76.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -75.96 -34.41 59.83 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.105 0.412 . . . . 0.0 111.764 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.5 mt -71.01 -36.35 63.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -77.1 -33.29 56.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.248 0.619 . . . . 0.0 110.333 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.54 82.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 119.323 -0.37 . . . . 0.0 110.16 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -63.34 -37.71 88.33 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.66 0.664 . . . . 0.0 111.262 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -70.57 -20.07 62.82 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 122.862 0.465 . . . . 0.0 111.358 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 -10.43 18.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.01 0.524 . . . . 0.0 111.106 177.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.07 -24.06 58.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.282 0.633 . . . . 0.0 110.159 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.06 -9.8 43.16 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.4 m -111.8 1.43 16.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.76 0.824 . . . . 0.0 111.454 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -74.26 147.54 42.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -146.45 13.67 1.23 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.07 16.4 80.6 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-O 119.654 -0.526 . . . . 0.0 113.119 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -67.17 -13.71 62.22 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.235 1.018 . . . . 0.0 110.555 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.3 p -151.92 169.49 22.17 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.615 1.166 . . . . 0.0 108.907 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.21 144.22 56.1 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -65.09 -33.53 76.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 119.577 -0.249 . . . . 0.0 111.664 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -69.96 -37.61 75.85 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.379 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.1 m -70.39 -37.84 74.58 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -68.77 -33.43 73.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.87 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.8 tp -79.09 -35.91 41.59 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.178 0.191 . . . . 0.0 111.198 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.4 ' CD1' HD21 ' A' ' 36' ' ' LEU . 21.8 m-30 -69.43 -20.28 63.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.215 -0.303 . . . . 0.0 111.593 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -74.0 -26.44 60.44 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.4 mm -73.76 -36.1 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.08 -36.91 64.32 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 p -81.35 -28.74 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 118.119 0.418 . . . . 0.0 110.93 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -76.7 -25.41 53.57 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 117.817 0.28 . . . . 0.0 110.359 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.3 m -79.21 -29.73 42.98 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.92 -33.5 63.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.259 -0.276 . . . . 0.0 111.369 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -76.39 -31.07 57.76 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -74.91 -24.42 58.52 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -76.66 -37.12 56.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.484 0.314 . . . . 0.0 111.046 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.5 mt -72.31 -23.74 61.22 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.884 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.3 m -89.43 -21.89 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.105 0 CA-C-N 118.783 0.72 . . . . 0.0 111.336 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.14 -22.06 60.59 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.064 0.393 . . . . 0.0 111.331 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -111.23 -12.8 14.06 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.112 0.565 . . . . 0.0 110.277 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.18 -2.29 64.24 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-O 119.561 -0.577 . . . . 0.0 112.665 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -116.39 1.21 12.98 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 118.128 0.964 . . . . 0.0 112.458 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -70.14 129.44 39.41 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 52.6 23.02 2.42 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.733 0.813 . . . . 0.0 111.888 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -134.39 2.13 3.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.931 0.492 . . . . 0.0 111.086 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 45.7 tp -128.59 -16.09 4.36 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.07 0.548 . . . . 0.0 110.894 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 98' ' ' ARG . 12.2 p -153.0 136.11 9.72 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.21 1.44 7.27 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.935 3.09 . . . . 0.0 112.899 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.406 ' H ' HG22 ' A' ' 96' ' ' VAL . 75.4 mtp85 -122.52 21.0 10.29 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.901 0.88 . . . . 0.0 110.966 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.9 173.51 30.99 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 112.136 -0.385 . . . . 0.0 112.136 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 63.4 p -151.88 173.77 14.4 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.696 0.798 . . . . 0.0 109.979 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -95.6 -3.86 45.61 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.779 0.432 . . . . 0.0 111.664 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -150.57 152.09 33.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.317 0.647 . . . . 0.0 109.965 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 49.3 t60 53.39 26.6 5.52 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.43 0.692 . . . . 0.0 111.52 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -84.95 6.78 23.64 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.996 0.919 . . . . 0.0 112.038 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -138.33 153.66 48.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.434 0.694 . . . . 0.0 110.002 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 48.4 m80 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.53 -176.494 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 110.689 -0.115 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -148.26 162.16 40.05 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.369 0.668 . . . . 0.0 110.351 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -108.7 0.43 20.56 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.252 0.621 . . . . 0.0 111.42 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -95.83 176.87 5.97 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.509 0.724 . . . . 0.0 110.135 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.0 mt -116.57 151.61 35.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.002 0.43 . . . . 0.0 110.89 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 7' ' ' ASP . 27.3 m -139.85 173.78 11.18 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 124.286 1.034 . . . . 0.0 109.278 -174.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 6' ' ' THR . 3.1 p30 -55.29 -18.04 5.64 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.257 0.623 . . . . 0.0 112.437 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -65.85 -52.45 50.22 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.82 -0.55 . . . . 0.0 110.041 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.409 ' H ' HG12 ' A' ' 9' ' ' VAL . 2.7 p -85.22 -26.03 6.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 C-N-CA 122.704 0.402 . . . . 0.0 111.022 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.73 -27.99 64.38 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.887 -0.508 . . . . 0.0 110.803 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.0 t -81.84 -28.63 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.04 0 CA-C-N 118.833 0.742 . . . . 0.0 110.077 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.72 -36.66 70.57 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.707 -0.62 . . . . 0.0 110.461 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -71.15 -35.89 71.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -175.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -72.71 -25.05 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 118.098 0.408 . . . . 0.0 110.945 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -79.49 -14.81 58.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.172 0.189 . . . . 0.0 110.521 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -92.74 3.23 56.01 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.908 0.883 . . . . 0.0 112.143 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.81 -0.49 39.07 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.558 172.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -93.47 84.06 4.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.107 0.953 . . . . 0.0 109.633 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -66.33 -19.98 65.96 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.52 0.328 . . . . 0.0 110.467 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -62.26 -23.08 66.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.218 0.607 . . . . 0.0 111.137 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.83 -18.92 42.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 117.786 0.266 . . . . 0.0 110.533 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -77.46 -36.63 52.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -61.45 -41.18 96.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -76.92 -18.54 58.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.593 0.357 . . . . 0.0 111.507 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.8 tp -81.41 -42.71 20.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 122.328 -0.232 . . . . 0.0 110.593 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.4 m -71.77 -24.39 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.863 -176.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.6 -26.45 35.45 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 CA-C-N 119.944 1.247 . . . . 0.0 111.012 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -69.9 -31.73 69.68 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.432 ' HB3' HG23 ' A' ' 33' ' ' VAL . 60.8 m-85 -99.03 -8.85 24.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.343 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -63.07 -30.06 71.3 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.254 -0.904 . . . . 0.0 110.786 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -86.92 -31.73 20.54 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -81.27 -35.43 31.14 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 122.138 -0.351 . . . . 0.0 111.808 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 29' ' ' TYR . 61.1 t -72.39 -38.57 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 123.493 0.717 . . . . 0.0 109.175 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.482 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.49 -24.48 67.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.195 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.2 t -73.97 -45.7 48.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 122.297 -0.252 . . . . 0.0 111.088 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 pp -81.61 -28.29 33.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.726 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.568 HG13 HG23 ' A' ' 46' ' ' VAL . 2.3 p -83.78 -15.88 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 117.954 0.343 . . . . 0.0 111.552 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -68.89 -11.61 60.75 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.922 -0.486 . . . . 0.0 109.802 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -86.01 -4.72 59.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.245 0.618 . . . . 0.0 111.409 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.84 -16.12 7.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.008 0.523 . . . . 0.0 112.295 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.76 154.51 62.65 Favored Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 123.671 0.789 . . . . 0.0 109.517 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.72 164.01 32.98 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.671 2.914 . . . . 0.0 111.013 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.0 p -66.05 -10.33 39.04 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.56 -19.13 55.46 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 119.629 -0.54 . . . . 0.0 111.987 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -116.45 -5.08 11.74 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.68 0.74 . . . . 0.0 111.53 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.568 HG23 HG13 ' A' ' 37' ' ' VAL . 5.5 p -67.08 -32.8 5.1 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 75.3 Cg_endo -78.18 -22.8 9.52 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.699 1.643 . . . . 0.0 111.384 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -82.48 -28.65 31.06 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.308 -0.245 . . . . 0.0 110.492 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.9 t -77.94 -28.68 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.02 -36.85 75.87 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -71.27 -43.4 67.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -68.47 -27.59 66.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.142 0.428 . . . . 0.0 110.266 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.01 -37.4 69.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -72.22 -35.37 68.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.491 0.587 . . . . 0.0 111.493 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.0 -40.99 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -76.7 -28.85 56.03 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.552 0.341 . . . . 0.0 111.143 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.95 -40.66 75.3 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 119.25 -0.405 . . . . 0.0 110.006 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.58 -38.22 89.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.846 0.748 . . . . 0.0 111.295 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.03 -24.65 62.4 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.977 0.511 . . . . 0.0 111.027 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.82 -11.26 27.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.025 0.53 . . . . 0.0 111.393 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.6 tp -75.29 -24.29 57.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.217 0.607 . . . . 0.0 110.138 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.15 -11.1 56.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.79 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.0 m -110.36 4.56 20.81 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.559 0.744 . . . . 0.0 111.615 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -73.99 145.07 44.89 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.85 3.25 3.2 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.84 13.99 81.92 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.457 -0.635 . . . . 0.0 113.46 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -72.28 -5.55 36.87 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.32 1.06 . . . . 0.0 111.13 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.4 p -149.82 168.68 23.04 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.322 1.049 . . . . 0.0 109.022 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.83 146.5 51.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.125 -0.359 . . . . 0.0 110.154 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -66.37 -33.37 75.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -70.41 -36.86 74.28 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.421 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.0 m -71.84 -33.23 68.28 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -75.46 -27.25 58.82 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.381 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 tp -86.02 -35.94 20.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.377 0.271 . . . . 0.0 111.293 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -70.21 -20.64 63.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.083 -0.386 . . . . 0.0 111.745 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -76.63 -24.19 53.37 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.494 0.588 . . . . 0.0 110.56 172.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.8 mm -70.69 -41.2 77.63 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.7 74.32 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.67 -29.91 16.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 118.193 0.452 . . . . 0.0 110.791 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.65 -19.14 53.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.844 -0.535 . . . . 0.0 110.409 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -83.1 -26.73 30.75 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.069 0.395 . . . . 0.0 110.034 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.12 -36.13 64.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.94 -0.475 . . . . 0.0 110.333 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -74.03 -28.59 61.5 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -74.89 -29.85 61.12 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.961 0.904 . . . . 0.0 111.065 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -77.47 -35.07 54.11 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.424 0.29 . . . . 0.0 111.102 -175.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -79.42 -24.26 42.63 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.3 m -88.8 -22.09 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 118.952 0.796 . . . . 0.0 111.014 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.93 -13.38 60.88 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.17 -0.331 . . . . 0.0 110.625 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -117.55 -19.49 9.41 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.123 0.569 . . . . 0.0 110.773 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.24 -22.83 56.28 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -81.27 1.89 30.42 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 117.686 0.743 . . . . 0.0 111.264 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -99.08 -2.21 37.64 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.371 0.668 . . . . 0.0 111.621 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.73 13.17 2.3 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.867 0.467 . . . . 0.0 111.864 -177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -123.03 14.14 9.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.577 0.751 . . . . 0.0 110.312 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.2 tp 57.23 21.38 6.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.46 1.104 . . . . 0.0 112.833 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.14 135.79 57.89 Favored Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.73 161.43 45.44 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.145 2.563 . . . . 0.0 111.612 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 53.68 22.54 3.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.486 1.114 . . . . 0.0 112.831 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.6 -13.17 83.21 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.6 p -153.87 171.56 18.77 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.862 0.865 . . . . 0.0 109.877 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -142.3 157.45 44.8 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.569 0.347 . . . . 0.0 110.101 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -136.85 20.27 3.05 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.112 0.565 . . . . 0.0 111.33 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 54.8 t60 56.33 23.1 6.91 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.675 0.79 . . . . 0.0 111.984 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -77.32 166.64 22.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.197 0.599 . . . . 0.0 111.114 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -147.76 166.88 26.16 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.309 0.644 . . . . 0.0 110.506 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.1 m80 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.592 -1.194 . . . . 0.0 110.371 -179.348 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.1 p -84.5 4.81 30.11 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.235 0.614 . . . . 0.0 112.432 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -146.52 161.02 41.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.16 0.584 . . . . 0.0 109.623 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 58.65 178.36 0.07 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.997 1.319 . . . . 0.0 112.366 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.0 mt -127.72 154.51 45.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.026 0.531 . . . . 0.0 110.648 -175.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 7' ' ' ASP . 25.6 m -139.37 173.92 11.05 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.937 0.895 . . . . 0.0 108.896 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.483 ' H ' HG22 ' A' ' 6' ' ' THR . 3.8 p30 -56.08 -17.73 7.82 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.663 0.385 . . . . 0.0 111.942 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -62.82 -53.44 54.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.6 p -86.0 -26.38 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.146 0.578 . . . . 0.0 110.896 -176.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -71.0 -28.7 64.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 119.086 -0.483 . . . . 0.0 110.964 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 65.1 t -82.64 -30.74 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 CA-C-N 118.862 0.756 . . . . 0.0 109.97 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.1 -41.62 81.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.812 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -69.66 -35.44 75.17 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.2 m -71.31 -22.19 22.22 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-N 118.554 0.616 . . . . 0.0 110.441 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -80.46 -14.79 57.98 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.858 0.299 . . . . 0.0 110.385 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -80.45 -8.04 59.39 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 122.006 -0.434 . . . . 0.0 110.908 172.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.86 2.47 45.97 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.464 0.554 . . . . 0.0 112.826 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -85.48 84.17 7.71 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.042 0.921 . . . . 0.0 109.505 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.97 -21.41 66.48 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.825 0.45 . . . . 0.0 110.417 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -61.72 -24.62 66.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.918 0.487 . . . . 0.0 111.239 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.19 -18.79 41.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.363 -0.211 . . . . 0.0 110.682 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -77.79 -35.57 51.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -62.56 -41.03 98.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.29 -19.0 59.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.201 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -83.68 -46.82 11.88 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.137 -0.352 . . . . 0.0 111.528 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.3 m -67.63 -25.49 33.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 118.654 -0.689 . . . . 0.0 111.34 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.7 -26.41 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 119.337 0.971 . . . . 0.0 110.893 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -68.62 -32.31 72.09 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -100.83 -8.66 22.42 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -63.07 -28.01 69.79 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 118.421 0.555 . . . . 0.0 110.758 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -85.83 -30.14 23.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -76.38 -43.25 41.49 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 m -81.35 -26.01 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.18 0.445 . . . . 0.0 111.24 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.48 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.53 -22.5 62.61 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 t -76.8 -43.14 37.88 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.594 0.235 . . . . 0.0 110.754 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.46 -25.1 39.06 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 46' ' ' VAL . 3.8 p -87.58 -18.54 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.068 0 CA-C-N 118.007 0.367 . . . . 0.0 111.169 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -63.23 -13.55 39.1 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 171.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -89.32 -3.94 58.3 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.799 0.84 . . . . 0.0 111.78 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -122.51 -17.73 6.9 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.779 0.432 . . . . 0.0 111.815 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.27 153.68 66.62 Favored Pre-proline 0 N--CA 1.462 0.146 0 C-N-CA 123.353 0.661 . . . . 0.0 110.055 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.21 164.01 35.62 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.584 2.856 . . . . 0.0 110.755 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -66.29 -10.29 41.04 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.14 -18.61 57.33 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -116.52 -6.69 11.68 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.216 0.607 . . . . 0.0 111.258 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 37' ' ' VAL . 4.5 p -66.78 -33.11 5.72 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 117.811 -1.09 . . . . 0.0 113.772 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 86.8 Cg_endo -77.11 -25.01 9.12 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 CA-C-N 122.004 1.752 . . . . 0.0 111.518 -175.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -81.97 -29.55 32.1 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.235 -0.29 . . . . 0.0 110.341 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.4 t -77.85 -27.52 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.3 -33.91 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -72.97 -42.52 63.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -66.13 -29.05 69.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.785 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.67 -29.53 64.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.755 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -85.04 -28.97 25.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.278 0.49 . . . . 0.0 111.362 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.4 mt -72.13 -38.42 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -75.01 -32.51 61.65 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.215 0.606 . . . . 0.0 110.652 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.94 -46.86 67.14 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.208 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -59.69 -37.19 78.14 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.613 0.642 . . . . 0.0 111.508 -175.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -72.66 -25.7 61.37 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 122.907 0.483 . . . . 0.0 111.253 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.18 -13.52 28.3 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.077 0.551 . . . . 0.0 111.548 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.8 tp -76.71 -25.81 53.99 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.293 0.637 . . . . 0.0 110.819 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.4 -12.74 61.91 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -112.48 -0.4 15.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.664 0.786 . . . . 0.0 111.909 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -72.55 130.87 41.62 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' HA ' ' HE ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -126.37 -0.21 6.97 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -173.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.92 -40.25 36.34 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 49.23 17.72 0.21 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.649 1.58 . . . . 0.0 114.51 177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.1 m -141.81 0.59 1.43 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.344 0.52 . . . . 0.0 111.977 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.25 54.69 1.45 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.935 0.398 . . . . 0.0 110.552 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -67.51 -32.78 73.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -70.52 -43.62 69.27 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 118.505 0.593 . . . . 0.0 111.651 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -68.69 -33.2 73.55 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -72.82 -28.46 62.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.925 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.0 tp -85.89 -37.85 18.68 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.846 0.458 . . . . 0.0 111.034 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -60.09 -32.0 70.55 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.616 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -77.07 -21.3 54.62 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.107 -0.473 . . . . 0.0 111.951 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.72 -38.3 75.85 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.942 0.792 . . . . 0.0 109.492 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.62 -38.96 58.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.5 p -76.4 -31.84 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.064 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -75.88 -20.88 57.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.035 -0.416 . . . . 0.0 110.552 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 m -78.68 -30.46 46.16 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.99 -29.78 63.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 122.263 -0.273 . . . . 0.0 110.319 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -79.51 -28.94 41.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.332 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.435 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -85.37 -16.6 39.33 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.771 0.714 . . . . 0.0 110.644 175.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -77.62 -37.7 49.6 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 122.428 -0.17 . . . . 0.0 110.973 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.13 -25.96 33.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 84' ' ' ASN . 6.6 p -81.12 -26.16 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.073 0 CA-C-N 118.899 0.772 . . . . 0.0 110.266 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.61 -16.98 61.22 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 121.372 -0.131 . . . . 0.0 110.879 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -111.05 -17.55 13.24 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.759 0.424 . . . . 0.0 110.947 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.68 -14.93 76.94 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -109.03 3.24 21.89 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.259 0.623 . . . . 0.0 111.265 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -79.67 -21.79 44.28 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.026 0.53 . . . . 0.0 111.187 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.1 tp -89.23 -15.16 34.26 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.913 0.485 . . . . 0.0 110.558 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -82.69 2.15 35.03 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.121 0.568 . . . . 0.0 111.24 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.37 -7.06 59.42 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.933 0.493 . . . . 0.0 111.466 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.9 m -139.23 152.26 69.19 Favored Pre-proline 0 N--CA 1.454 -0.243 0 C-N-CA 123.594 0.758 . . . . 0.0 110.391 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.27 -7.14 16.0 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.792 2.995 . . . . 0.0 111.526 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -85.04 165.84 17.19 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.278 0.631 . . . . 0.0 111.161 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.32 1.03 87.95 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.414 -0.659 . . . . 0.0 112.893 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 63.0 m -142.87 149.16 38.15 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.969 0.885 . . . . 0.0 110.679 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -156.93 160.03 38.69 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.556 0.742 . . . . 0.0 109.622 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -150.47 167.4 27.27 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.962 0.411 . . . . 0.0 110.896 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -142.44 28.8 1.63 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.282 0.633 . . . . 0.0 110.07 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.6 m80 58.31 178.15 0.06 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.53 1.132 . . . . 0.0 112.809 -175.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -134.71 17.07 3.58 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.334 0.654 . . . . 0.0 111.4 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 117.778 -1.106 . . . . 0.0 111.051 -178.851 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -142.1 163.16 33.63 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.326 0.65 . . . . 0.0 110.556 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.95 7.03 4.32 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.107 0.563 . . . . 0.0 111.774 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -144.59 158.89 43.57 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.452 0.701 . . . . 0.0 110.314 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.7 mt -70.02 157.79 36.85 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.962 0.905 . . . . 0.0 111.506 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 8' ' ' GLN . 5.8 t -140.55 178.42 7.33 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.372 1.069 . . . . 0.0 109.966 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -59.86 -17.01 33.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.058 0.543 . . . . 0.0 110.763 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.485 ' H ' HG23 ' A' ' 6' ' ' THR . 19.2 tp60 -69.94 -52.27 25.84 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.539 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 p -82.2 -26.65 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 122.673 0.389 . . . . 0.0 110.934 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 mp -70.04 -30.08 67.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.841 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.9 t -80.59 -28.01 11.57 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-N 118.623 0.647 . . . . 0.0 110.0 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.32 -36.44 68.88 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.627 -0.671 . . . . 0.0 110.188 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -69.95 -37.13 75.75 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.506 0.322 . . . . 0.0 111.497 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.5 m -73.46 -23.62 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.06 0 CA-C-N 118.117 0.417 . . . . 0.0 111.224 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -79.95 -15.76 56.61 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.534 0.334 . . . . 0.0 110.72 174.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -92.23 4.34 53.47 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.728 0.811 . . . . 0.0 111.99 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.28 2.38 51.03 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 119.8 -0.445 . . . . 0.0 113.128 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -97.26 83.88 3.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.001 0.901 . . . . 0.0 109.771 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.7 tm0? -66.95 -18.35 65.34 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -60.79 -23.96 65.43 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.73 0.412 . . . . 0.0 110.824 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.77 -18.61 43.55 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.378 -0.201 . . . . 0.0 110.849 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -77.48 -36.98 52.22 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -61.85 -40.11 94.21 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.46 -19.07 58.42 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.442 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.6 tp -83.62 -46.46 12.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.691 0.396 . . . . 0.0 111.008 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.87 -24.55 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.546 -175.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.2 p -69.48 -27.13 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.157 0.89 . . . . 0.0 110.674 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -67.39 -32.77 73.91 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.44 ' HB3' HG23 ' A' ' 33' ' ' VAL . 67.0 m-85 -98.67 -9.08 25.17 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -62.86 -28.82 70.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.474 -0.766 . . . . 0.0 110.48 -176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -86.91 -32.51 20.13 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -82.0 -33.03 30.3 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 122.054 -0.404 . . . . 0.0 111.998 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 29' ' ' TYR . 56.8 t -74.23 -38.33 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.85 -23.95 67.39 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.934 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.7 t -74.64 -46.07 40.65 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.944 0.338 . . . . 0.0 111.019 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.88 -29.47 39.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.181 -0.325 . . . . 0.0 111.473 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.565 HG13 HG23 ' A' ' 46' ' ' VAL . 2.4 p -83.4 -15.71 11.41 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.056 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.4 t -67.7 -11.72 58.94 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.858 -0.526 . . . . 0.0 109.887 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -84.7 -6.54 59.36 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.042 0.537 . . . . 0.0 111.644 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -122.5 -13.44 8.0 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.27 154.8 57.79 Favored Pre-proline 0 C--O 1.231 0.123 0 C-N-CA 123.923 0.889 . . . . 0.0 109.567 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.27 162.94 38.26 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.455 2.77 . . . . 0.0 110.758 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.4 p -65.88 -10.61 40.0 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.13 -18.89 54.9 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.81 -0.439 . . . . 0.0 112.05 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -116.35 -4.78 11.81 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.384 0.592 . . . . 0.0 111.677 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.565 HG23 HG13 ' A' ' 37' ' ' VAL . 5.7 p -66.51 -32.12 4.95 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 117.79 -1.1 . . . . 0.0 113.719 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 74.5 Cg_endo -78.18 -23.28 9.11 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 CA-C-N 121.904 1.716 . . . . 0.0 111.266 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -81.74 -27.74 33.69 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.96 -27.42 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.5 -34.59 62.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.67 -42.92 66.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -67.5 -28.58 67.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.383 0.538 . . . . 0.0 109.99 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.42 -36.42 74.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.2 -33.18 61.37 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.371 0.532 . . . . 0.0 111.967 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.57 -38.89 75.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -75.22 -31.72 60.94 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.081 0.552 . . . . 0.0 110.555 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.73 -43.93 71.3 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.236 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -61.28 -37.91 84.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.863 0.756 . . . . 0.0 111.36 -176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -71.68 -25.39 62.09 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.552 0.341 . . . . 0.0 111.062 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.93 -10.76 27.91 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.28 0.632 . . . . 0.0 111.441 176.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.4 tp -74.93 -23.84 58.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.104 0.562 . . . . 0.0 110.119 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.35 -11.48 51.36 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.509 0.324 . . . . 0.0 110.544 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -110.39 2.68 19.16 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.722 0.809 . . . . 0.0 111.851 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.22 144.81 46.62 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -135.65 6.16 3.2 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.27 15.04 76.84 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.759 -0.467 . . . . 0.0 112.82 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.84 -10.46 59.63 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.764 0.782 . . . . 0.0 110.921 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.7 t -149.36 165.73 31.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.252 1.021 . . . . 0.0 108.854 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.32 145.38 56.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -67.5 -32.57 73.47 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -175.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -70.39 -36.57 74.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.62 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -72.02 -36.28 69.65 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 64.5 t90 -70.28 -32.88 70.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.678 -0.201 . . . . 0.0 110.747 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.0 tp -80.23 -37.15 33.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.597 0.359 . . . . 0.0 111.292 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -68.67 -20.27 64.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 122.133 -0.354 . . . . 0.0 111.63 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -74.69 -26.75 60.04 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 118.186 0.448 . . . . 0.0 110.323 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.76 -36.88 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.98 -40.08 63.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.63 -32.04 15.9 Favored 'Isoleucine or valine' 0 C--N 1.337 0.043 0 O-C-N 121.993 -0.442 . . . . 0.0 111.268 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -74.61 -24.33 58.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.014 -0.429 . . . . 0.0 110.3 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.1 m -78.08 -30.45 49.63 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 117.741 0.246 . . . . 0.0 110.44 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.29 -29.46 62.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.316 -0.24 . . . . 0.0 110.496 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.05 -31.05 55.9 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.125 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.75 -15.92 43.39 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.837 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -76.77 -39.59 51.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.632 0.196 . . . . 0.0 111.253 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -81.93 -25.21 35.09 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-O 119.122 -0.466 . . . . 0.0 112.19 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.9 p -80.98 -25.62 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.048 0 CA-C-N 119.067 0.849 . . . . 0.0 110.44 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.56 -12.32 59.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.463 -0.148 . . . . 0.0 111.072 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -118.29 -4.16 10.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.128 0.571 . . . . 0.0 110.581 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -108.2 -7.05 31.21 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.565 -0.575 . . . . 0.0 112.409 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -129.44 3.99 5.12 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 117.768 0.784 . . . . 0.0 111.925 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -140.09 6.45 2.17 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.893 0.477 . . . . 0.0 112.065 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.8 tp -146.66 0.89 0.78 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.195 0.452 . . . . 0.0 111.875 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 2.9 pm0 -70.3 156.47 39.24 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.562 -0.711 . . . . 0.0 110.904 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.87 -17.06 28.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.807 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.1 t -144.58 132.91 10.83 Favored Pre-proline 0 CA--C 1.528 0.116 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.08 158.96 51.22 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.399 2.733 . . . . 0.0 110.66 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.3 ptt-85 -149.88 152.13 34.58 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 122.489 0.316 . . . . 0.0 111.397 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.67 166.51 19.59 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 91.0 p -152.63 166.64 31.46 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 122.648 0.379 . . . . 0.0 110.896 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -130.79 11.36 5.18 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.44 0.696 . . . . 0.0 111.633 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -120.16 8.97 11.0 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.304 0.641 . . . . 0.0 111.191 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -134.61 4.29 3.35 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.32 0.648 . . . . 0.0 110.958 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -139.53 163.24 33.08 Favored 'General case' 0 CA--C 1.526 0.052 0 C-N-CA 123.596 0.758 . . . . 0.0 110.101 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 46.3 m80 54.61 21.45 3.42 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.794 0.838 . . . . 0.0 112.912 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.197 -1.382 . . . . 0.0 110.328 -179.36 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttp . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 119.918 -0.086 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -142.62 156.71 45.11 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.899 0.48 . . . . 0.0 110.148 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -134.69 -1.46 2.77 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.203 0.601 . . . . 0.0 111.612 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 55.64 4.53 0.11 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.639 1.575 . . . . 0.0 115.069 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.2 mt -141.42 155.33 45.89 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.838 0.855 . . . . 0.0 109.154 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 7' ' ' ASP . 26.8 m -140.35 173.12 11.82 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.788 0.835 . . . . 0.0 109.456 -177.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 6' ' ' THR . 3.1 p30 -55.26 -18.19 5.81 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.005 0.522 . . . . 0.0 111.937 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -65.17 -51.37 61.53 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.238 -0.289 . . . . 0.0 110.453 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 p -84.06 -25.8 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 122.594 0.357 . . . . 0.0 110.631 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.89 -30.14 67.52 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.095 -0.378 . . . . 0.0 110.634 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.9 t -81.74 -28.48 9.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 CA-C-N 118.634 0.652 . . . . 0.0 110.029 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.05 -40.8 71.45 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.066 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -69.06 -34.35 75.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -70.49 -23.01 24.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 118.702 0.683 . . . . 0.0 110.398 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -81.15 -14.98 57.11 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 119.503 -0.284 . . . . 0.0 110.92 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.62 -7.0 59.13 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.287 0.494 . . . . 0.0 110.752 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.48 3.12 47.28 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.479 0.562 . . . . 0.0 112.779 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.81 83.98 5.33 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 117.954 0.877 . . . . 0.0 108.991 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -64.48 -17.73 64.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.091 0.557 . . . . 0.0 110.643 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -60.82 -25.62 66.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.991 0.516 . . . . 0.0 110.794 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.34 -18.99 43.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.781 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -76.54 -36.97 57.36 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -61.82 -39.8 93.04 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.8 mt -76.79 -18.98 58.09 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.352 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.6 tp -83.3 -47.36 11.58 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.554 0.342 . . . . 0.0 111.308 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.8 m -68.13 -25.69 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.222 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 p -69.56 -26.92 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 119.326 0.966 . . . . 0.0 110.915 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -67.82 -33.05 74.03 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -100.85 -8.73 22.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.308 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -62.16 -28.78 69.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.357 0.526 . . . . 0.0 110.42 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -86.1 -28.94 23.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 121.977 0.111 . . . . 0.0 110.763 174.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -78.4 -40.64 35.41 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 m -83.85 -23.53 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 O-C-N 121.966 -0.459 . . . . 0.0 110.835 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.63 -22.09 61.0 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.5 t -79.37 -40.23 30.67 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -81.38 -24.56 36.93 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 119.242 -0.409 . . . . 0.0 112.081 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.16 -21.08 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 118.674 0.67 . . . . 0.0 112.212 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -69.27 -10.53 58.24 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.845 -0.534 . . . . 0.0 111.611 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -92.28 -4.01 54.61 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 121.805 -0.56 . . . . 0.0 111.642 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -110.16 -23.57 11.19 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.644 0.378 . . . . 0.0 111.304 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.441 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 26.9 m -138.13 155.73 74.21 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 123.433 0.693 . . . . 0.0 109.461 175.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 94.2 Cg_endo -71.42 170.59 18.06 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.515 2.81 . . . . 0.0 111.339 -176.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.0 m -63.41 -11.91 26.76 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.118 0.567 . . . . 0.0 112.132 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.68 -16.28 58.61 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.593 -0.559 . . . . 0.0 112.598 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -116.3 -10.86 11.33 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 117.938 0.869 . . . . 0.0 111.801 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.416 ' N ' ' HD2' ' A' ' 47' ' ' PRO . 8.0 p -62.89 -34.34 13.75 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 117.78 -1.105 . . . . 0.0 112.929 -177.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 46' ' ' VAL . 94.7 Cg_endo -77.5 -25.42 8.16 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 CA-C-N 121.927 1.724 . . . . 0.0 112.135 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -84.38 -33.11 23.87 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.191 0.45 . . . . 0.0 111.098 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.5 t -78.17 -25.39 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.16 -34.68 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.083 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 174.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -71.44 -42.05 68.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -66.36 -29.64 69.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.29 0.496 . . . . 0.0 110.0 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.01 -28.38 64.38 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 119.478 -0.296 . . . . 0.0 110.837 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -85.2 -29.33 24.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.523 0.601 . . . . 0.0 111.232 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -72.42 -37.86 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -76.54 -32.29 58.13 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.224 0.61 . . . . 0.0 110.804 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.56 -42.92 77.65 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.463 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -62.06 -38.35 88.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.755 0.707 . . . . 0.0 111.329 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -71.36 -24.94 62.18 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 122.599 0.36 . . . . 0.0 111.336 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.7 -11.74 28.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.972 0.509 . . . . 0.0 111.454 176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.0 tp -75.68 -24.24 56.29 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.951 0.5 . . . . 0.0 110.538 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -68.95 -10.37 57.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.468 0.307 . . . . 0.0 110.741 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.4 m -109.63 3.03 20.64 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.682 0.793 . . . . 0.0 111.442 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -71.61 151.85 43.4 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.144 0.578 . . . . 0.0 109.817 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -133.3 -6.71 2.97 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.3 13.63 81.32 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.584 -0.565 . . . . 0.0 111.978 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -71.74 -5.89 37.29 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.117 0.958 . . . . 0.0 111.215 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.9 t -149.88 165.83 31.39 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.514 1.126 . . . . 0.0 108.466 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.29 146.53 54.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.128 -0.357 . . . . 0.0 110.457 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -68.35 -33.26 73.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.275 -0.266 . . . . 0.0 111.691 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -69.72 -37.41 76.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.838 -177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 49.6 m -70.58 -33.78 71.47 Favored 'General case' 0 CA--C 1.527 0.068 0 O-C-N 121.895 -0.503 . . . . 0.0 109.757 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -73.96 -28.64 61.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.968 0.507 . . . . 0.0 110.881 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.7 tp -86.01 -36.0 20.03 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.804 0.442 . . . . 0.0 111.297 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -61.87 -32.57 72.94 Favored 'General case' 0 C--O 1.23 0.077 0 O-C-N 122.201 -0.312 . . . . 0.0 110.599 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -76.54 -21.24 55.95 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.075 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.3 mm -68.01 -38.83 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 118.979 0.809 . . . . 0.0 109.216 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.01 -38.38 53.13 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.26 -28.01 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 CA-C-N 118.919 0.781 . . . . 0.0 111.171 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -75.42 -24.76 57.15 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.105 0.411 . . . . 0.0 110.101 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.2 m -79.05 -29.97 43.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 176.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.83 -33.77 66.38 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.049 0.386 . . . . 0.0 111.025 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -77.96 -29.0 49.6 Favored 'General case' 0 N--CA 1.458 -0.062 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -76.12 -28.3 57.41 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -74.02 -35.9 64.42 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 122.588 0.355 . . . . 0.0 110.984 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.1 mt -78.13 -18.9 55.04 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.8 m -91.75 -18.79 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.037 0 CA-C-N 119.053 0.842 . . . . 0.0 110.988 175.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.39 -23.02 46.97 Favored 'General case' 0 CA--C 1.527 0.065 0 O-C-N 122.043 -0.411 . . . . 0.0 111.252 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -109.79 -17.88 13.56 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.98 0.512 . . . . 0.0 110.394 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -80.7 -22.21 62.35 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -93.76 14.11 20.28 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.483 0.713 . . . . 0.0 110.767 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -117.8 8.17 12.63 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.811 0.844 . . . . 0.0 111.261 -176.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 pp -144.96 15.01 1.53 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.665 0.786 . . . . 0.0 111.824 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -65.87 -28.07 68.69 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.714 0.406 . . . . 0.0 111.836 -174.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.9 mt -139.73 -35.88 0.52 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 122.803 0.441 . . . . 0.0 110.315 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.3 m -143.96 151.52 52.81 Favored Pre-proline 0 N--CA 1.456 -0.14 0 C-N-CA 124.099 0.96 . . . . 0.0 108.501 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.89 13.59 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.318 3.345 . . . . 0.0 113.283 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -130.1 -2.69 4.54 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.478 0.711 . . . . 0.0 112.207 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.86 -158.46 29.14 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 m 52.19 35.09 15.83 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.679 0.792 . . . . 0.0 113.01 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -143.65 165.34 27.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.735 0.414 . . . . 0.0 110.24 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -136.42 157.36 46.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.055 0.542 . . . . 0.0 110.589 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -73.07 -5.78 41.27 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.062 0.545 . . . . 0.0 111.844 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -133.26 16.73 4.09 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.647 0.779 . . . . 0.0 110.388 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 58.3 177.7 0.06 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.675 1.19 . . . . 0.0 112.576 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.568 -1.206 . . . . 0.0 110.364 -179.839 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.3 mtp . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 110.61 -0.144 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.1 m 52.91 27.92 6.01 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.703 0.801 . . . . 0.0 112.746 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -147.11 156.45 43.01 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.132 0.573 . . . . 0.0 109.821 -177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -123.59 -179.42 4.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.507 0.723 . . . . 0.0 110.299 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.72 149.44 43.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.203 0.525 . . . . 0.0 110.94 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 7' ' ' ASP . 47.0 m -140.0 174.48 10.48 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.125 0.97 . . . . 0.0 109.08 -176.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.499 ' N ' HG22 ' A' ' 6' ' ' THR . 3.1 p30 -55.69 -16.93 4.81 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.18 0.592 . . . . 0.0 112.479 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -67.25 -51.43 53.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 117.917 0.326 . . . . 0.0 110.127 177.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.5 p -85.66 -25.67 6.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 122.449 0.3 . . . . 0.0 110.981 -176.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.5 mp -68.56 -30.13 68.84 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.276 -0.265 . . . . 0.0 110.439 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.8 t -81.58 -28.43 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 118.316 0.507 . . . . 0.0 110.215 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.63 -35.11 70.31 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.574 -0.704 . . . . 0.0 111.357 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -83.6 -25.41 30.88 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.454 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.07 -23.06 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 119.16 0.891 . . . . 0.0 109.358 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -78.86 -25.54 43.96 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.282 0.233 . . . . 0.0 110.68 174.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -89.33 -7.26 55.68 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.84 -3.52 8.0 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 118.835 -0.98 . . . . 0.0 114.889 170.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -86.61 83.72 7.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.331 1.566 . . . . 0.0 109.961 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -66.38 -21.79 66.24 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.39 -24.58 66.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.536 0.734 . . . . 0.0 110.897 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.69 -19.2 35.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 119.579 -0.248 . . . . 0.0 110.742 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -76.97 -35.89 56.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -63.22 -40.81 98.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.9 mt -75.41 -18.81 59.83 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.154 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.9 tp -83.41 -47.09 11.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.521 0.328 . . . . 0.0 111.044 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.4 m -69.32 -24.53 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.717 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.5 p -69.24 -27.32 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 119.146 0.884 . . . . 0.0 110.771 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -67.11 -33.1 74.74 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.448 ' HB3' HG23 ' A' ' 33' ' ' VAL . 73.2 m-85 -98.4 -8.92 26.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.102 0.561 . . . . 0.0 112.326 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -63.32 -30.44 71.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.503 -0.748 . . . . 0.0 110.633 -174.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -87.03 -32.05 20.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -81.43 -34.74 31.32 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 29' ' ' TYR . 60.4 t -71.28 -38.86 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -63.56 -24.21 67.71 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.095 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.2 t -73.85 -48.16 33.13 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.851 0.296 . . . . 0.0 110.734 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 pp -79.98 -27.82 39.6 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.479 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.577 HG13 HG23 ' A' ' 46' ' ' VAL . 2.2 p -83.5 -15.74 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.334 -178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 t -68.92 -9.65 53.01 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.825 -0.547 . . . . 0.0 110.28 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -88.8 -3.91 58.64 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.408 0.683 . . . . 0.0 111.427 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -122.31 -16.2 7.45 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.2 m -143.17 153.78 60.34 Favored Pre-proline 0 C--N 1.338 0.069 0 C-N-CA 124.168 0.987 . . . . 0.0 109.613 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.28 164.25 33.15 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.483 2.788 . . . . 0.0 111.062 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.2 p -65.92 -10.25 37.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.43 -18.03 55.96 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.944 -0.462 . . . . 0.0 111.944 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -116.44 -5.64 11.74 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.527 0.664 . . . . 0.0 111.481 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.577 HG23 HG13 ' A' ' 37' ' ' VAL . 5.8 p -67.28 -32.03 4.27 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 117.755 -1.117 . . . . 0.0 114.001 -176.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 81.2 Cg_endo -78.12 -23.53 8.98 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 CA-C-N 121.758 1.664 . . . . 0.0 111.308 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.84 -29.24 32.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.5 t -77.09 -28.54 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.4 t -69.72 -35.71 66.79 Favored 'Isoleucine or valine' 0 C--N 1.337 0.063 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -70.95 -42.83 69.27 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -67.31 -28.77 68.28 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.731 -0.606 . . . . 0.0 109.873 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.23 -36.13 74.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -75.39 -32.65 60.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.353 0.524 . . . . 0.0 112.204 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -71.33 -38.16 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -76.22 -31.37 58.35 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.015 0.526 . . . . 0.0 110.458 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.27 -44.0 72.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.187 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -61.19 -38.1 85.32 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.812 0.733 . . . . 0.0 111.366 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -71.45 -25.32 62.25 Favored 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 122.596 0.358 . . . . 0.0 111.092 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.08 -10.74 27.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.184 0.594 . . . . 0.0 111.266 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -75.42 -23.97 57.04 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.999 0.52 . . . . 0.0 110.3 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -66.02 -11.47 48.35 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.335 0.254 . . . . 0.0 110.508 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.4 m -110.8 -2.24 16.25 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.622 0.769 . . . . 0.0 112.034 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -72.24 134.79 45.8 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.407 ' HA ' ' HE ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -124.78 4.25 8.14 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -173.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.31 17.62 77.64 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.662 -0.521 . . . . 0.0 113.322 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -70.93 -8.16 51.09 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.066 0.933 . . . . 0.0 111.196 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.5 t -151.81 168.6 24.58 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.953 0.901 . . . . 0.0 108.751 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.24 146.84 53.76 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.051 -0.406 . . . . 0.0 110.072 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -67.78 -33.14 74.25 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -175.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -69.51 -36.97 76.96 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.863 -0.523 . . . . 0.0 110.708 -176.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.2 m -72.7 -36.43 67.85 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -69.39 -33.27 72.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -78.94 -36.62 41.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.557 0.343 . . . . 0.0 111.578 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -69.17 -20.09 64.0 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.078 -0.388 . . . . 0.0 111.574 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -74.6 -25.9 59.56 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 117.965 0.348 . . . . 0.0 110.283 173.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.4 mm -73.23 -35.74 47.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.11 -39.52 60.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.3 p -79.05 -30.63 14.39 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 O-C-N 122.26 -0.275 . . . . 0.0 110.979 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -76.3 -23.04 54.32 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.053 0.388 . . . . 0.0 110.623 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.5 m -80.21 -28.49 38.59 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.7 -33.26 66.36 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.209 0.459 . . . . 0.0 110.284 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -76.39 -25.82 54.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.487 ' HA ' HG12 ' A' ' 87' ' ' VAL . 14.9 t30 -86.09 -19.21 30.57 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.464 0.306 . . . . 0.0 110.711 177.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -77.04 -36.98 55.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 121.977 -0.452 . . . . 0.0 110.334 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.6 mt -82.52 -22.78 34.9 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 84' ' ' ASN . 3.3 p -82.94 -25.92 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-N 118.716 0.689 . . . . 0.0 109.892 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.59 -18.95 61.0 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -108.21 -15.66 14.44 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.307 0.643 . . . . 0.0 111.1 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.03 -26.62 36.56 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -90.49 14.38 13.24 Favored 'General case' 0 N--CA 1.458 -0.064 0 C-N-CA 123.225 0.61 . . . . 0.0 111.146 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -94.4 -14.99 24.71 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.674 0.79 . . . . 0.0 110.291 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.4 mt -126.96 -2.81 6.49 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.951 0.9 . . . . 0.0 111.077 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -135.0 160.38 38.49 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.432 1.093 . . . . 0.0 108.419 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.2 tp 57.19 27.48 13.61 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.42 0.688 . . . . 0.0 111.408 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.81 152.76 70.18 Favored Pre-proline 0 N--CA 1.456 -0.14 0 C-N-CA 124.109 0.963 . . . . 0.0 109.507 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.8 -11.56 32.21 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.576 2.851 . . . . 0.0 112.54 -176.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -93.38 -2.05 55.15 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.004 0.366 . . . . 0.0 111.796 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.17 -12.36 81.66 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.961 -0.455 . . . . 0.0 111.961 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.1 t -82.91 -9.05 59.5 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.455 0.627 . . . . 0.0 110.93 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -98.96 5.16 47.36 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.305 0.642 . . . . 0.0 111.299 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 55.69 18.31 2.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.411 1.084 . . . . 0.0 113.226 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 55.9 -176.22 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.61 1.164 . . . . 0.0 112.979 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.551 ' CG ' ' H ' ' A' ' 105' ' ' HIS . 19.2 t-80 57.07 -175.74 0.06 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.37 1.068 . . . . 0.0 112.045 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.551 ' H ' ' CG ' ' A' ' 104' ' ' HIS . 88.0 m-70 57.29 -179.03 0.05 Allowed 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.558 1.143 . . . . 0.0 112.602 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.1 t60 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 116.692 -1.623 . . . . 0.0 111.79 -179.286 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptm . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.523 0.201 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m 56.09 5.68 0.19 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -159.65 -26.25 0.07 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.449 0.568 . . . . 0.0 110.578 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -146.38 159.96 42.69 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.556 0.742 . . . . 0.0 109.507 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 26.9 mt -61.54 151.87 31.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.276 1.03 . . . . 0.0 111.795 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 7' ' ' ASP . 28.5 m -139.26 174.13 10.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.481 1.113 . . . . 0.0 108.918 -175.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 6' ' ' THR . 3.8 p30 -56.02 -17.31 6.52 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -66.67 -53.5 33.14 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 122.148 -0.345 . . . . 0.0 110.391 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 p -83.63 -25.41 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 122.676 0.39 . . . . 0.0 110.782 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.88 -27.92 64.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.229 -0.415 . . . . 0.0 110.847 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -82.6 -28.45 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.058 0 CA-C-N 118.899 0.772 . . . . 0.0 109.909 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.442 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 44.3 mt-10 -72.51 -35.95 68.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.498 -0.751 . . . . 0.0 110.322 176.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -71.28 -37.12 71.89 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.7 m -72.53 -23.87 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-N 118.155 0.434 . . . . 0.0 110.749 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -78.27 -17.39 56.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.759 0.254 . . . . 0.0 110.438 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -82.54 -5.86 59.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.219 0.608 . . . . 0.0 111.695 172.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.36 0.63 37.81 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.322 -0.71 . . . . 0.0 113.098 175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -85.52 84.16 7.7 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.304 1.052 . . . . 0.0 109.071 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -64.38 -20.91 66.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.548 0.339 . . . . 0.0 110.87 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -62.48 -23.95 67.19 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.575 0.75 . . . . 0.0 111.168 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.34 -19.2 39.79 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.614 0.188 . . . . 0.0 110.784 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -77.77 -36.64 50.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -60.75 -42.79 98.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.57 -18.47 59.74 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.571 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 66.0 tp -81.47 -43.1 19.33 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.214 -0.304 . . . . 0.0 110.931 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.7 m -70.92 -24.58 24.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.874 -175.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.86 -26.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 119.685 1.13 . . . . 0.0 110.706 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -70.15 -31.2 68.59 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.433 ' HB3' HG23 ' A' ' 33' ' ' VAL . 69.7 m-85 -99.76 -9.01 23.51 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.481 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -62.69 -30.27 71.27 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.189 -0.944 . . . . 0.0 110.499 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -86.56 -32.84 20.46 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.475 0.31 . . . . 0.0 111.601 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -80.67 -36.37 32.5 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 29' ' ' TYR . 62.0 t -71.21 -38.86 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.47 -23.38 67.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.934 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 t -74.47 -45.93 42.9 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.019 -0.426 . . . . 0.0 111.112 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.424 HD21 ' CD1' ' A' ' 75' ' ' TYR . 3.8 pp -82.61 -26.43 32.27 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.432 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.566 HG13 HG23 ' A' ' 46' ' ' VAL . 1.9 p -85.45 -16.91 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 118.131 0.423 . . . . 0.0 111.761 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.8 t -69.67 -9.07 52.82 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -89.29 -4.42 58.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.47 0.708 . . . . 0.0 111.221 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -122.76 -15.21 7.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.891 0.476 . . . . 0.0 112.245 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 m -143.1 153.84 60.65 Favored Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 123.721 0.808 . . . . 0.0 109.541 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -68.59 164.85 31.42 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.551 2.834 . . . . 0.0 111.062 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -65.76 -10.3 35.89 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -175.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.49 -18.02 55.87 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 118.094 0.407 . . . . 0.0 112.333 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -116.58 -5.78 11.66 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 117.561 0.681 . . . . 0.0 111.605 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.566 HG23 HG13 ' A' ' 37' ' ' VAL . 6.0 p -67.37 -32.63 4.73 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -176.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 77.9 Cg_endo -77.86 -23.85 9.05 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 CA-C-N 121.844 1.694 . . . . 0.0 111.437 -176.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.4 -28.74 34.19 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.6 t -79.03 -27.91 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.64 -36.01 68.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 172.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -71.14 -43.09 68.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -67.84 -28.99 68.04 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.427 0.558 . . . . 0.0 109.765 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.22 73.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -75.61 -33.73 60.56 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 118.272 0.487 . . . . 0.0 112.203 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.7 mt -71.41 -37.26 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -77.18 -32.86 56.42 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.909 0.483 . . . . 0.0 110.586 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.47 -44.92 81.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -61.55 -36.71 81.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.508 0.595 . . . . 0.0 111.215 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -72.05 -20.72 61.63 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 122.694 0.397 . . . . 0.0 111.281 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.85 -11.83 18.74 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.94 0.496 . . . . 0.0 111.109 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.2 tp -76.26 -25.71 55.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.583 0.753 . . . . 0.0 110.617 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.94 -13.18 62.28 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.376 0.27 . . . . 0.0 110.651 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.9 m -113.45 0.9 14.87 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.592 0.757 . . . . 0.0 111.785 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -72.61 119.11 16.37 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.963 -0.46 . . . . 0.0 110.454 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.73 25.31 1.47 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.015 1.326 . . . . 0.0 109.749 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.77 -6.13 49.38 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.157 -0.802 . . . . 0.0 113.58 -173.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t70 51.67 28.87 5.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.299 1.049 . . . . 0.0 111.532 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.3 m -128.84 176.2 8.03 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.153 0.981 . . . . 0.0 109.96 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.44 148.11 52.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.175 0.512 . . . . 0.0 111.249 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -75.54 -30.5 59.76 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.393 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -67.73 -37.83 82.73 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.303 0.501 . . . . 0.0 111.984 -174.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.7 m -70.72 -37.7 73.53 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 66.2 t90 -69.27 -34.02 74.12 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 119.7 -0.191 . . . . 0.0 110.798 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.8 tp -77.09 -36.53 55.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.716 0.406 . . . . 0.0 111.199 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.424 ' CD1' HD21 ' A' ' 36' ' ' LEU . 20.9 m-85 -69.56 -20.03 63.67 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.804 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -76.1 -23.98 54.98 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.087 0.403 . . . . 0.0 110.456 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.2 mm -73.55 -35.94 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.44 -39.69 62.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.71 -29.66 13.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 O-C-N 122.086 -0.384 . . . . 0.0 111.402 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -75.74 -23.21 56.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.821 -0.55 . . . . 0.0 110.618 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.2 m -82.94 -28.93 29.5 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 119.556 -0.259 . . . . 0.0 110.339 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.09 -32.78 61.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.093 0.406 . . . . 0.0 110.932 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.37 -29.68 53.43 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -76.27 -24.67 54.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -75.87 -36.86 59.39 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.499 0.32 . . . . 0.0 110.808 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.7 mt -76.84 -21.22 55.35 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.51 -20.61 6.87 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 CA-C-N 119.076 0.853 . . . . 0.0 111.286 176.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.21 -28.55 53.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.971 0.35 . . . . 0.0 111.014 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -101.97 -16.33 16.53 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.843 0.457 . . . . 0.0 110.498 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.48 -14.92 67.29 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 119.741 -0.477 . . . . 0.0 112.023 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -119.78 11.71 11.97 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-N 117.604 0.702 . . . . 0.0 111.572 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -68.11 -9.71 48.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.675 0.79 . . . . 0.0 111.304 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.0 tp -118.03 -1.21 11.48 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.641 0.777 . . . . 0.0 110.746 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -99.61 -35.63 9.78 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.688 -0.632 . . . . 0.0 110.65 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.49 -23.67 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.451 2.3 . . . . 0.0 116.341 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 m -145.97 157.62 50.14 Favored Pre-proline 0 CA--C 1.526 0.052 0 CA-C-N 119.786 1.175 . . . . 0.0 110.598 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -67.7 149.93 79.12 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.99 2.46 . . . . 0.0 109.658 173.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -141.57 162.24 35.96 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 122.894 0.477 . . . . 0.0 110.702 -176.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.78 177.58 46.69 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 t -149.58 160.17 43.71 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.7 0.4 . . . . 0.0 110.477 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -139.12 15.96 2.62 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.615 0.766 . . . . 0.0 110.864 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -139.99 167.62 21.71 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.272 0.629 . . . . 0.0 110.755 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -74.33 0.65 13.69 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.386 0.674 . . . . 0.0 111.538 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.4 p80 49.91 22.41 0.86 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.675 1.59 . . . . 0.0 113.621 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -147.17 158.51 43.97 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.432 0.693 . . . . 0.0 109.816 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 52.9 t60 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 116.68 -1.629 . . . . 0.0 111.776 -178.225 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.421 0.153 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 m -71.78 161.6 30.72 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.069 0.461 . . . . 0.0 111.162 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.78 -5.2 58.82 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.032 0.533 . . . . 0.0 111.581 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 56.88 7.25 0.38 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.281 1.432 . . . . 0.0 114.376 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 98.0 mt -140.32 155.09 46.94 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.408 0.683 . . . . 0.0 109.369 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 7' ' ' ASP . 25.4 m -140.28 173.33 11.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.559 0.744 . . . . 0.0 109.805 -176.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 6' ' ' THR . 3.5 p30 -55.34 -17.29 4.55 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.982 0.513 . . . . 0.0 111.87 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -65.88 -51.51 58.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 9' ' ' VAL . 2.3 p -85.81 -26.48 6.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 122.734 0.413 . . . . 0.0 110.952 -176.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.72 -29.92 68.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 122.136 -0.352 . . . . 0.0 110.34 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.8 t -84.23 -27.35 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.186 0.448 . . . . 0.0 110.296 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.37 -35.68 65.98 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.51 -0.744 . . . . 0.0 109.998 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -70.81 -34.9 72.22 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.0 m -74.75 -24.09 18.08 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 CA-C-N 118.108 0.413 . . . . 0.0 111.228 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -77.13 -16.14 59.28 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 174.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.36 2.26 56.75 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.723 0.809 . . . . 0.0 112.161 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.23 44.18 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.55 -0.583 . . . . 0.0 113.554 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -91.81 83.97 5.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.413 1.107 . . . . 0.0 109.31 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.69 -20.2 66.18 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.727 0.411 . . . . 0.0 110.435 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -62.08 -24.52 67.16 Favored 'General case' 0 N--CA 1.458 -0.041 0 C-N-CA 122.863 0.465 . . . . 0.0 111.441 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.44 -18.75 44.25 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.792 0.269 . . . . 0.0 110.574 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -77.8 -37.14 49.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -61.73 -40.22 94.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.43 -19.22 58.3 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.401 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.4 tp -83.47 -46.9 11.96 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.426 0.29 . . . . 0.0 111.245 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.65 -25.09 29.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 CA-C-O 118.578 -0.725 . . . . 0.0 111.479 -175.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.4 p -69.7 -26.64 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 119.32 0.964 . . . . 0.0 110.693 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.9 mtp85 -68.54 -34.54 76.02 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -97.35 -8.73 28.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.282 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -63.33 -28.35 69.94 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 118.453 0.57 . . . . 0.0 110.8 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -85.07 -30.17 24.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -77.05 -43.47 34.38 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 m -79.78 -25.32 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 O-C-N 121.971 -0.456 . . . . 0.0 110.885 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -70.03 -22.75 63.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.149 0.432 . . . . 0.0 110.436 176.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 t -76.31 -42.3 45.7 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.43 -24.85 31.7 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.524 HG13 HG23 ' A' ' 46' ' ' VAL . 2.7 p -87.94 -19.44 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 CA-C-N 118.326 0.512 . . . . 0.0 111.467 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.4 t -67.26 -9.26 38.88 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.878 -0.514 . . . . 0.0 109.854 173.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -90.45 -3.92 57.33 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.7 0.8 . . . . 0.0 111.438 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -122.18 -15.38 7.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.985 0.514 . . . . 0.0 111.884 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 m -142.42 153.32 62.32 Favored Pre-proline 0 N--CA 1.463 0.176 0 C-N-CA 123.829 0.852 . . . . 0.0 109.229 174.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.38 165.33 29.27 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.385 2.723 . . . . 0.0 110.959 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -65.38 -12.54 53.13 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.782 0.433 . . . . 0.0 112.132 -176.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.02 -19.58 59.03 Favored Glycine 0 CA--C 1.527 0.83 0 O-C-N 121.928 -0.483 . . . . 0.0 112.192 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -116.55 -5.67 11.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.633 0.716 . . . . 0.0 111.681 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.524 HG23 HG13 ' A' ' 37' ' ' VAL . 5.9 p -66.58 -33.32 6.25 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.782 -1.104 . . . . 0.0 113.7 -177.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 93.7 Cg_endo -76.68 -25.88 8.88 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 122.084 1.78 . . . . 0.0 111.774 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -82.7 -28.84 30.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.227 -0.296 . . . . 0.0 110.408 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 72.2 t -77.76 -27.63 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.7 t -71.72 -35.59 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -72.27 -43.2 64.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -67.45 -27.35 66.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.784 -0.572 . . . . 0.0 110.208 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.48 -28.51 62.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.683 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.31 -29.81 24.25 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.411 0.551 . . . . 0.0 110.89 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.7 mt -71.66 -37.11 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -78.74 -31.64 46.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.865 0.466 . . . . 0.0 111.016 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.94 -42.46 85.25 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.165 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -62.76 -36.5 83.27 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 118.63 0.65 . . . . 0.0 111.211 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -71.64 -17.68 62.25 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 122.501 0.32 . . . . 0.0 111.122 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.49 -11.51 16.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.863 0.465 . . . . 0.0 111.066 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 26.2 tp -73.77 -23.22 59.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.472 0.709 . . . . 0.0 110.099 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.48 -13.13 37.46 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.445 0.298 . . . . 0.0 110.673 174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.2 t -113.48 4.44 16.24 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -71.14 126.47 29.69 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.509 -0.744 . . . . 0.0 109.503 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -140.17 13.71 2.42 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.995 0.918 . . . . 0.0 110.513 -175.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.93 -35.31 54.37 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 47.97 22.01 0.35 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.857 1.263 . . . . 0.0 113.813 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 77.9 p -157.77 -8.78 0.08 Allowed 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.24 54.82 1.45 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.338 0.517 . . . . 0.0 111.611 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -68.91 -34.86 76.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.187 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -69.69 -40.4 76.36 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.042 0.383 . . . . 0.0 111.297 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.5 m -70.78 -35.11 72.44 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.1 t90 -69.53 -31.02 68.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.5 tp -82.92 -36.15 25.49 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.586 0.354 . . . . 0.0 111.629 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -62.44 -29.13 70.29 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.129 -0.357 . . . . 0.0 110.387 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -73.33 -25.29 60.56 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.489 0.315 . . . . 0.0 111.48 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.4 mm -71.53 -39.76 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.035 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.56 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.41 -36.11 68.56 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -174.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -75.64 -29.25 20.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 118.378 0.536 . . . . 0.0 110.775 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -79.07 -20.54 48.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.266 -0.271 . . . . 0.0 110.609 177.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 79.1 m -79.85 -33.37 40.2 Favored 'General case' 0 C--N 1.341 0.22 0 O-C-N 122.014 -0.429 . . . . 0.0 109.963 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.19 -37.96 69.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 122.281 -0.262 . . . . 0.0 110.928 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -75.17 -28.64 60.14 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -78.81 -30.03 45.18 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.128 0.171 . . . . 0.0 110.99 177.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -69.88 -37.09 75.93 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.138 0.575 . . . . 0.0 111.091 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 94.6 mt -76.56 -29.22 56.56 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.33 -19.79 7.57 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 CA-C-N 118.558 0.617 . . . . 0.0 111.415 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.04 -10.24 59.24 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.151 -0.343 . . . . 0.0 111.311 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -117.1 -19.19 9.82 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.364 0.266 . . . . 0.0 111.18 177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.75 -16.88 64.76 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.834 -0.426 . . . . 0.0 112.073 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -100.4 8.89 43.33 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 117.675 0.738 . . . . 0.0 112.436 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -92.64 -0.94 57.23 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.3 tp -141.16 -7.78 1.03 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.52 0.328 . . . . 0.0 111.238 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -93.28 126.99 38.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.94 -0.475 . . . . 0.0 109.776 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.7 mt -135.65 10.89 3.43 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.244 1.018 . . . . 0.0 110.717 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.4 m -133.15 154.85 81.38 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 123.714 0.806 . . . . 0.0 110.181 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.97 167.2 25.41 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.589 2.859 . . . . 0.0 111.412 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -121.37 7.31 10.14 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.608 0.763 . . . . 0.0 111.05 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.73 -162.74 41.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.0 t -140.89 163.06 33.96 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.867 0.467 . . . . 0.0 110.52 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -84.29 0.24 49.82 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.654 0.781 . . . . 0.0 111.62 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -141.94 154.03 44.77 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.165 0.586 . . . . 0.0 110.295 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -153.22 161.8 42.0 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.148 0.579 . . . . 0.0 110.109 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -145.84 158.38 43.86 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.958 0.503 . . . . 0.0 110.506 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 55.9 -176.14 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.362 1.065 . . . . 0.0 112.234 -175.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.101 -1.428 . . . . 0.0 110.731 -179.479 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.911 0 CA-C-O 120.481 0.182 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 m -142.38 162.78 34.58 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.293 0.637 . . . . 0.0 110.468 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -75.31 136.85 40.85 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.554 0.216 . . . . 0.0 110.45 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -158.57 -176.48 5.91 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.157 0.583 . . . . 0.0 111.07 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.545 HD22 ' N ' ' A' ' 5' ' ' LEU . 1.2 mm? -74.01 151.05 40.35 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.277 1.031 . . . . 0.0 109.804 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.475 HG22 ' N ' ' A' ' 7' ' ' ASP . 29.5 m -139.73 172.33 12.94 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.229 0.612 . . . . 0.0 109.526 -175.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.475 ' N ' HG22 ' A' ' 6' ' ' THR . 3.3 p30 -55.17 -16.81 3.44 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.319 0.648 . . . . 0.0 111.822 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -65.76 -54.12 31.37 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 122.107 -0.37 . . . . 0.0 110.032 176.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.52 -25.44 6.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 122.756 0.423 . . . . 0.0 111.031 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.0 mp -70.1 -31.72 69.42 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 119.299 -0.381 . . . . 0.0 110.338 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.0 t -80.17 -27.91 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 118.62 0.645 . . . . 0.0 110.15 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -70.02 -39.37 75.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.815 -0.553 . . . . 0.0 111.373 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -82.19 -25.1 34.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.74 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.41 -24.25 23.61 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 CA-C-N 118.755 0.707 . . . . 0.0 109.695 173.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -78.78 -21.66 47.49 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.674 0.389 . . . . 0.0 110.293 174.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -89.43 -7.3 55.42 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.368 0.667 . . . . 0.0 111.818 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.69 0.58 17.81 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.932 -0.927 . . . . 0.0 114.16 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -87.32 83.71 7.31 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.213 1.507 . . . . 0.0 109.761 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -65.88 -23.77 66.72 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -59.69 -24.35 63.86 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.425 0.69 . . . . 0.0 111.048 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.37 -20.12 32.47 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 119.777 -0.154 . . . . 0.0 111.26 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -76.45 -35.12 58.66 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.06 -40.63 98.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.0 mt -75.01 -19.02 60.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.672 0.389 . . . . 0.0 111.396 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 tp -83.55 -46.75 12.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.899 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 m -68.77 -24.34 28.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.646 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.9 p -69.88 -26.76 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 119.239 0.927 . . . . 0.0 110.756 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -68.1 -30.67 69.9 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.44 ' HB3' HG23 ' A' ' 33' ' ' VAL . 70.1 m-85 -101.09 -8.89 21.87 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.75 -30.22 71.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.134 -0.979 . . . . 0.0 110.551 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -86.87 -32.47 20.21 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -79.29 -36.39 39.76 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -176.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 29' ' ' TYR . 59.0 t -71.7 -39.01 68.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 123.449 0.7 . . . . 0.0 109.316 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.488 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.46 -23.09 67.16 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.235 178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 t -75.02 -45.62 40.55 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.145 -0.347 . . . . 0.0 111.126 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 pp -82.02 -28.12 32.71 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.56 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.582 HG13 HG23 ' A' ' 46' ' ' VAL . 2.1 p -83.55 -16.92 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 118.219 0.463 . . . . 0.0 111.515 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -67.96 -11.99 59.88 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.103 0.478 . . . . 0.0 109.786 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -86.01 -4.26 59.13 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.341 0.656 . . . . 0.0 111.346 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -122.78 -16.44 7.15 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.938 0.495 . . . . 0.0 112.289 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -142.74 154.48 62.69 Favored Pre-proline 0 N--CA 1.462 0.166 0 C-N-CA 123.587 0.755 . . . . 0.0 109.353 175.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.96 164.21 30.77 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.423 2.748 . . . . 0.0 111.009 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.5 p -66.43 -9.5 34.54 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.05 54.35 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.818 -0.435 . . . . 0.0 112.05 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -116.18 -6.01 11.88 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 117.518 0.659 . . . . 0.0 111.453 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.582 HG23 HG13 ' A' ' 37' ' ' VAL . 8.1 p -66.45 -32.76 5.65 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 117.774 -1.108 . . . . 0.0 113.853 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 78.9 Cg_endo -77.96 -23.07 9.6 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 CA-C-N 121.834 1.691 . . . . 0.0 111.056 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -81.86 -29.39 32.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.95 -28.91 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.78 -35.8 66.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -71.11 -42.77 68.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -67.98 -29.89 69.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.22 0.464 . . . . 0.0 109.855 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.09 -36.56 77.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 119.55 -0.262 . . . . 0.0 110.297 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -74.69 -33.57 62.47 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.245 0.475 . . . . 0.0 112.024 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.54 -39.17 75.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -75.37 -30.84 60.31 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.812 0.445 . . . . 0.0 110.638 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.53 -44.67 67.06 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.344 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -59.6 -39.23 83.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 118.61 0.641 . . . . 0.0 111.38 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -72.19 -28.46 63.21 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.512 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 -12.01 40.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.803 0.441 . . . . 0.0 111.351 176.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 20.7 tp -75.55 -28.06 58.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.349 0.659 . . . . 0.0 110.721 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -71.38 -6.26 38.79 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.1 m -113.4 4.15 16.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.83 0.852 . . . . 0.0 111.198 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.443 ' CZ ' ' HA2' ' A' ' 66' ' ' GLY . 25.6 t80 -84.68 150.02 25.41 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.973 0.509 . . . . 0.0 110.14 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.01 -2.78 9.15 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -175.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.443 ' HA2' ' CZ ' ' A' ' 64' ' ' PHE . . . 70.49 17.64 74.74 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.314 0.507 . . . . 0.0 112.489 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.57 -10.69 57.43 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 117.842 0.821 . . . . 0.0 111.063 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.0 m -139.95 172.65 12.46 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.972 1.309 . . . . 0.0 108.689 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.79 146.06 53.22 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.781 -0.574 . . . . 0.0 110.35 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -67.85 -32.11 72.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -176.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -70.07 -37.41 75.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.817 -177.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -71.28 -33.79 70.08 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 56.9 t90 -73.75 -28.23 61.57 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.483 0.313 . . . . 0.0 110.846 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 61.3 tp -85.63 -36.66 20.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.929 0.331 . . . . 0.0 111.029 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -69.36 -21.03 63.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.989 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -78.27 -21.87 49.13 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.908 0.776 . . . . 0.0 110.61 173.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mm -70.44 -34.33 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.95 -41.24 52.18 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -173.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.35 -29.03 13.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 O-C-N 121.997 -0.44 . . . . 0.0 111.356 -178.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -75.69 -24.22 56.24 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.152 -0.343 . . . . 0.0 110.287 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.4 m -81.73 -26.98 34.12 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.201 -0.312 . . . . 0.0 110.363 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.91 -32.64 63.65 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.423 0.556 . . . . 0.0 110.72 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.33 -25.74 46.57 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.501 ' HA ' HG12 ' A' ' 87' ' ' VAL . 13.4 t30 -83.56 -17.36 42.02 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.447 0.165 . . . . 0.0 110.701 175.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -79.86 -34.76 39.03 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.855 -0.528 . . . . 0.0 110.274 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.5 mt -81.42 -22.44 38.21 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 84' ' ' ASN . 7.1 p -83.92 -24.48 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 118.44 0.564 . . . . 0.0 110.151 176.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.31 -20.64 61.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.223 -0.298 . . . . 0.0 110.99 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -108.9 -15.42 14.38 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 122.992 0.517 . . . . 0.0 111.028 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.73 -16.83 71.99 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.7 mmm-85 -101.89 -10.58 19.71 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 123.795 0.838 . . . . 0.0 110.762 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 46.59 43.29 12.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.632 0.773 . . . . 0.0 112.664 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.8 mp 58.54 24.98 12.55 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.893 0.877 . . . . 0.0 112.597 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -65.59 -19.95 66.12 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.722 0.809 . . . . 0.0 110.565 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.0 tp -107.32 12.01 28.56 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.765 0.826 . . . . 0.0 110.922 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.6 136.54 28.85 Favored Pre-proline 0 CA--C 1.53 0.211 0 C-N-CA 123.111 0.564 . . . . 0.0 109.803 -176.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -70.87 160.85 48.06 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.393 2.728 . . . . 0.0 111.301 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 -100.22 -9.0 22.9 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.253 0.621 . . . . 0.0 111.394 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -68.72 165.63 47.63 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.3 t -150.45 156.3 41.19 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 122.961 0.505 . . . . 0.0 110.355 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -89.9 1.2 56.5 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.539 0.736 . . . . 0.0 111.318 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -124.77 19.37 8.59 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.587 0.755 . . . . 0.0 111.094 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -136.47 173.37 11.78 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.112 0.565 . . . . 0.0 110.342 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 58.98 16.73 4.85 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.422 1.089 . . . . 0.0 113.104 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -91.12 -2.16 57.62 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.687 0.395 . . . . 0.0 111.24 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 16.3 p80 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.544 -179.344 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 110.588 -0.153 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.6 m -133.85 7.94 3.79 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.952 0.501 . . . . 0.0 111.347 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -150.47 154.18 37.21 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.117 0.567 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -140.37 157.38 45.63 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.921 0.488 . . . . 0.0 110.391 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.9 mt -77.33 154.73 32.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.482 1.113 . . . . 0.0 111.623 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.49 HG22 ' H ' ' A' ' 7' ' ' ASP . 28.0 m -139.87 173.93 11.03 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.131 0.973 . . . . 0.0 108.894 -176.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' H ' HG22 ' A' ' 6' ' ' THR . 3.4 p30 -55.16 -17.14 3.79 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -66.41 -53.05 40.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.056 -0.402 . . . . 0.0 110.257 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.413 ' H ' HG12 ' A' ' 9' ' ' VAL . 2.8 p -85.34 -25.75 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 122.906 0.482 . . . . 0.0 110.559 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.8 mp -70.85 -28.65 64.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 119.154 -0.451 . . . . 0.0 110.974 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 71.8 t -82.54 -28.12 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 118.858 0.754 . . . . 0.0 110.024 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.442 ' O ' ' HE3' ' A' ' 16' ' ' LYS . 44.1 mt-10 -72.11 -36.61 69.49 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.762 -0.586 . . . . 0.0 110.504 176.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -70.58 -36.67 73.72 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.4 m -73.13 -23.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 118.298 0.499 . . . . 0.0 110.827 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -78.0 -18.16 56.26 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -80.99 -5.93 58.16 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.297 0.639 . . . . 0.0 111.863 172.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.72 2.13 46.36 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 119.559 -0.578 . . . . 0.0 112.876 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -85.86 84.19 7.62 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 118.19 0.995 . . . . 0.0 109.349 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -64.36 -19.65 65.6 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.419 0.288 . . . . 0.0 110.624 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -61.48 -25.5 67.29 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.94 0.496 . . . . 0.0 111.121 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.88 -18.8 38.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.74 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -77.91 -36.16 49.78 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -61.84 -41.07 97.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -76.83 -18.41 58.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 tp -82.08 -41.66 20.25 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 122.139 -0.351 . . . . 0.0 110.74 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.6 m -72.16 -24.28 22.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.885 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.0 m -67.74 -26.33 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 119.866 1.212 . . . . 0.0 110.887 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -69.74 -32.13 70.49 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.43 ' HB3' HG23 ' A' ' 33' ' ' VAL . 64.6 m-85 -99.34 -9.08 23.97 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.411 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -62.77 -30.4 71.42 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.206 -0.934 . . . . 0.0 110.751 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -86.99 -32.36 20.09 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 176.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -80.24 -36.37 34.74 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' A' ' 29' ' ' TYR . 61.6 t -70.96 -38.44 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -64.96 -23.27 67.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 t -74.68 -45.19 46.16 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.047 0.385 . . . . 0.0 111.012 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.413 HD21 ' CD1' ' A' ' 75' ' ' TYR . 3.8 pp -82.92 -27.03 30.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.498 -177.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.571 HG13 HG23 ' A' ' 46' ' ' VAL . 1.8 p -84.97 -16.71 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 118.117 0.417 . . . . 0.0 111.478 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -68.35 -11.77 60.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.21 0.529 . . . . 0.0 109.845 172.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -85.83 -5.98 59.16 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.425 0.69 . . . . 0.0 111.312 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -122.6 -16.51 7.22 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.799 0.44 . . . . 0.0 112.164 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 m -141.34 153.76 66.46 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 123.462 0.705 . . . . 0.0 109.443 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.9 164.97 29.61 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.656 2.904 . . . . 0.0 110.984 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.7 p -65.87 -10.75 41.1 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -175.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.41 -17.98 56.09 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.782 -0.455 . . . . 0.0 112.082 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -116.49 -5.85 11.71 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 117.726 0.763 . . . . 0.0 111.538 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.571 HG23 HG13 ' A' ' 37' ' ' VAL . 6.8 p -67.35 -32.02 4.21 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 117.785 -1.102 . . . . 0.0 113.722 -176.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 46' ' ' VAL . 82.4 Cg_endo -78.41 -23.11 8.93 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 121.804 1.68 . . . . 0.0 111.076 -177.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -82.4 -28.21 31.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.343 -0.223 . . . . 0.0 110.62 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.4 t -79.36 -28.61 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -69.15 -35.85 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -70.36 -43.24 70.55 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -68.17 -29.16 67.97 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.736 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.63 -35.47 75.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.987 0.358 . . . . 0.0 110.2 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.46 -33.62 60.86 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.076 0.398 . . . . 0.0 111.72 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.04 -38.46 71.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -75.39 -32.35 60.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.04 0.536 . . . . 0.0 110.579 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.94 -44.27 77.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.098 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -61.14 -37.8 84.13 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 118.769 0.713 . . . . 0.0 111.287 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -71.81 -24.72 61.77 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.709 0.404 . . . . 0.0 111.059 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.11 -11.85 25.67 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.167 0.587 . . . . 0.0 111.442 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.2 tp -75.63 -24.06 56.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.26 0.624 . . . . 0.0 110.376 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.56 -11.33 57.83 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.422 0.289 . . . . 0.0 110.604 174.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.2 m -109.46 0.23 19.21 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.754 0.822 . . . . 0.0 111.65 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -79.45 134.32 36.54 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.125 0.57 . . . . 0.0 110.196 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -124.73 6.17 8.14 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -176.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.12 16.99 77.68 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.395 -0.669 . . . . 0.0 113.28 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -68.93 -10.69 58.54 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.267 1.033 . . . . 0.0 111.107 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.4 m -146.04 166.41 26.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.542 1.137 . . . . 0.0 108.676 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.37 144.49 56.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -67.47 -33.22 74.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -175.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -69.84 -38.81 76.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.839 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 76.2 m -70.45 -35.66 73.47 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -69.28 -33.59 73.44 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 122.379 -0.201 . . . . 0.0 110.74 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.2 tp -79.8 -35.91 37.77 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.261 0.225 . . . . 0.0 111.18 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.413 ' CD1' HD21 ' A' ' 36' ' ' LEU . 20.5 m-85 -69.18 -20.25 64.0 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.787 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.5 mtm105 -75.51 -23.76 56.75 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.412 0.551 . . . . 0.0 110.517 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.54 -33.72 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.23 -39.13 55.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -173.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.3 p -80.52 -29.65 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 O-C-N 122.126 -0.359 . . . . 0.0 111.409 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -75.88 -23.92 55.65 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 122.208 -0.307 . . . . 0.0 110.309 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.3 m -81.67 -29.59 33.02 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.177 -0.327 . . . . 0.0 110.399 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.84 -35.28 67.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.207 0.458 . . . . 0.0 110.877 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -76.87 -28.27 55.34 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -78.94 -26.52 43.62 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.261 0.224 . . . . 0.0 110.595 176.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -73.55 -36.49 65.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.834 0.453 . . . . 0.0 111.195 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.6 mt -79.59 -26.25 41.31 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.07 -22.21 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 119.088 0.858 . . . . 0.0 111.005 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.41 -11.81 59.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.279 0.231 . . . . 0.0 111.278 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -118.8 -16.78 9.29 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 122.502 0.321 . . . . 0.0 110.778 177.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.89 -19.15 61.9 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -106.47 0.01 24.39 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.324 0.65 . . . . 0.0 111.148 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.47 128.03 35.14 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.919 0.488 . . . . 0.0 110.302 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.1 mp 52.36 17.19 0.71 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.373 1.069 . . . . 0.0 113.278 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -96.06 -16.42 21.61 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.966 -0.459 . . . . 0.0 110.202 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.3 pp -141.86 15.98 2.12 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.415 0.686 . . . . 0.0 111.284 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.2 t 50.06 75.6 0.64 Allowed Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.324 1.049 . . . . 0.0 110.393 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.86 148.43 76.69 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.186 2.591 . . . . 0.0 110.829 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 52.27 20.51 1.38 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.941 0.896 . . . . 0.0 112.801 -177.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.73 169.01 53.83 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.3 p -144.32 4.33 1.21 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.105 0.562 . . . . 0.0 111.93 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -148.59 150.89 34.1 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.805 0.442 . . . . 0.0 110.535 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -144.9 160.61 41.04 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.709 0.804 . . . . 0.0 109.901 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -138.86 11.05 2.65 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.898 0.479 . . . . 0.0 111.131 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -82.26 -2.18 51.71 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.178 0.591 . . . . 0.0 111.842 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -150.03 165.62 32.17 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.651 0.78 . . . . 0.0 110.363 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 80.5 t60 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 117.252 -1.356 . . . . 0.0 110.304 -179.998 . . . . . . . . 0 0 . 1 stop_ save_